Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPCAM,Epithelial cell adhesion molecule,35951,0.24780093551124,0.0570121224990318,0.136057175413137,0.359544695609342,1.40215093905153e-05
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICAM3,Intercellular adhesion molecule 3,36072,-0.0656488616437242,0.0167533774390556,-0.0984854814242731,-0.0328122418631753,8.9879969752942e-05
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MZB1,Marginal zone B- and B1-cell-specific protein,35979,-0.125673174674133,0.0320720948236974,-0.18853448052858,-0.0628118688196863,8.992214643029e-05
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPA33,Cell surface A33 antigen,35937,0.317214101820535,0.0822329112189298,0.156037595831433,0.478390607809637,0.000115529793426261
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGS8,Regulator of G-protein signaling 8,35842,0.135907259144468,0.0394183617419206,0.0586472701303041,0.213167248158633,0.000568353848428951
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRE1,Adhesion G protein-coupled receptor E1,34964,-0.118049245564487,0.0344301645872768,-0.185532368155549,-0.0505661229734243,0.000610421208005459
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC6A,C-type lectin domain family 6 member A,35800,-0.100795704813985,0.0296092166074755,-0.158829769364636,-0.0427616402633326,0.00066720180473752
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBP7,Retinoid-binding protein 7,34964,-0.133301941559747,0.0399238467401265,-0.211552681170395,-0.0550512019490992,0.000845925330077679
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFA,Protransforming growth factor alpha,35971,-0.0919026982654231,0.0278723387097266,-0.146532482136487,-0.0372729143943589,0.000980908909832295
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCAN,Brevican core protein,35902,0.0688953876892101,0.0215919126257375,0.0265752389427647,0.111215536435655,0.00142481974187905
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFI30,Gamma-interferon-inducible lysosomal thiol reductase,34794,-0.0811149395587997,0.0255727317210296,-0.131237493732018,-0.0309923853855817,0.00152168415009602
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LSP1,Lymphocyte-specific protein 1,35971,-0.0792528127207363,0.0252677352575845,-0.128777573825602,-0.0297280516158706,0.00171637433167133
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,36010,-0.112904803132062,0.0361716649879556,-0.183801266508455,-0.0420083397556693,0.00180709961200827
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WFDC2,WAP four-disulfide core domain protein 2,35571,-0.0775097630623152,0.0252448361806711,-0.126989641976431,-0.0280298841481999,0.00214651392931062
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G2A,"Phospholipase A2, membrane associated",35971,-0.0996972706122256,0.032567657993221,-0.163529880278939,-0.0358646609455124,0.00221219217410956
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MARCO,Macrophage receptor MARCO,35972,-0.0485133700070689,0.0159458437469176,-0.0797672237510273,-0.0172595162631104,0.00235538723905153
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HEG1,Protein HEG homolog 1,34822,-0.0529255659341546,0.0175484779532248,-0.0873205827224753,-0.0185305491458339,0.00257198947978057
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC4D,C-type lectin domain family 4 member D,35971,-0.115358723251812,0.0384170968333066,-0.190656233045092,-0.0400612134585307,0.00268408741269621
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NTproBNP,N-terminal prohormone of brain natriuretic peptide,35972,-0.199248748843672,0.067160733083955,-0.330883785688224,-0.0676137119991206,0.00301936804032749
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRE5,Adhesion G protein-coupled receptor E5,36043,-0.056778107778387,0.0191546647686188,-0.0943212507248798,-0.0192349648318943,0.00304440452822513
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),POMC,Pro-opiomelanocortin,34815,-0.140375012048961,0.0473692625302776,-0.233218766608305,-0.0475312574896166,0.00305395090350763
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,35962,-0.0598950867347558,0.0202234869982249,-0.0995331212512767,-0.020257052218235,0.00306963094729033
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLI2,Zinc finger protein GLI2,34778,0.0598832137035958,0.0203283846504741,0.0200395797886665,0.0997268476185251,0.00323330379230897
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCF2,Neutrophil cytosol factor 2,35958,-0.155936783245065,0.0532192816493613,-0.260246575277813,-0.0516269912123172,0.00339915629997094
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLAMF7,SLAM family member 7,35971,-0.10868284295063,0.0370965336130155,-0.18139204883214,-0.0359736370691195,0.00340296571588889
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPE,Carboxypeptidase E,35959,0.0700527532546565,0.0239301688007168,0.0231496224052516,0.116955884104061,0.00342875311749983
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMNDC1,Survival of motor neuron-related-splicing factor 30,34964,-0.118734498765461,0.0410257580610161,-0.199144984565053,-0.0383240129658697,0.00381484243272751
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WDR46,WD repeat-containing protein 46,34949,-0.0683210798411342,0.0236500760795215,-0.114675228956996,-0.021966930725272,0.00387984725943338
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LCN15,Lipocalin-15,34952,-0.110400158351643,0.0382776869430094,-0.185424424759941,-0.0353758919433441,0.00393740062152426
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAG3,Lymphocyte activation gene 3 protein,35937,-0.0717484466329018,0.0249331037055114,-0.120617329895704,-0.0228795633700993,0.00401821118565588
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF12,Tumor necrosis factor ligand superfamily member 12,36067,0.0494484302075351,0.0172789108400158,0.0155817649611041,0.0833150954539661,0.00422441156391448
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DLK1,Protein delta homolog 1,36072,0.102591315264168,0.0358908345995547,0.0322452794490411,0.172937351079296,0.00426925350370179
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLAUR,Urokinase plasminogen activator surface receptor,35904,-0.0503198219834505,0.0177294546204064,-0.085069553039447,-0.0155700909274541,0.00454932007336383
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EBI3_IL27,Interleukin-27,36023,-0.0523308677301026,0.0184602081919529,-0.0885128757863303,-0.0161488596738748,0.00459792992749116
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDC,Aromatic-L-amino-acid decarboxylase,35962,0.0835414605590998,0.0295259740811401,0.0256705513600651,0.141412369758134,0.00467582443842592
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD74,HLA class II histocompatibility antigen gamma chain,36043,-0.0588877337471304,0.0208874514342019,-0.0998271385581661,-0.0179483289360946,0.0048257518214559
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PROC,Vitamin K-dependent protein C,36014,0.0443868304866362,0.0157489221913043,0.0135189429916797,0.0752547179815928,0.00483908481972616
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMP3,Lysosome-associated membrane glycoprotein 3,36056,-0.0889761432827687,0.0317430418617674,-0.151192505331833,-0.0267597812337046,0.0050758458467937
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL22,Interleukin-22,34949,-0.123396068648272,0.0441314648909088,-0.209893739834453,-0.0368983974620907,0.00518786012658065
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,35842,-0.0740241957028909,0.0264819460550002,-0.125928809970691,-0.0221195814350906,0.00519928625245597
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICAM1,Intercellular adhesion molecule 1,35966,-0.0495391506834249,0.0179906897674526,-0.084800902627632,-0.0142773987392179,0.00590884049778197
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",36072,-0.0504237584056006,0.0183392981663657,-0.0863687828116775,-0.0144787339995237,0.00598311637918808
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL17,C-X-C motif chemokine 17,36067,-0.0730790545815534,0.0266261155917082,-0.125266241141301,-0.0208918680218052,0.00607224429006142
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RELT,Tumor necrosis factor receptor superfamily member 19L,35979,-0.0494319158584493,0.0180250737419185,-0.0847610603926095,-0.014102771324289,0.00611395993909858
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGLYRP1,Peptidoglycan recognition protein 1,36043,-0.0721413240157868,0.0264190883321569,-0.123922737146814,-0.0203599108847592,0.00633580907368993
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRTAM,Cytotoxic and regulatory T-cell molecule,35902,-0.0852561436931215,0.0312522493022852,-0.146510552325601,-0.0240017350606425,0.00638719515772094
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB2,Integrin beta-2,35946,-0.0473858659097461,0.0174150287947346,-0.0815193223474259,-0.0132524094720664,0.00652429013699942
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HDAC8,Histone deacetylase 8,34778,0.102876842117996,0.0381817310991313,0.0280406491636984,0.177713035072293,0.00707062311536675
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD300E,CMRF35-like molecule 2,36013,-0.0684045324185837,0.0254054987996801,-0.118199310065957,-0.0186097547712106,0.00710760266442761
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HJV,Hemojuvelin,34952,-0.0683384789495922,0.0254523133106923,-0.118225013038549,-0.0184519448606353,0.00727265599116314
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CST3,Cystatin-C,36009,-0.0464912821897507,0.0173336871760868,-0.0804653090548807,-0.0125172553246206,0.00733162663624545
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRE2,Adhesion G protein-coupled receptor E2,35992,-0.0467138545550551,0.0174375625250975,-0.0808914771042462,-0.012536232005864,0.00740232769303355
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOS3,"Nitric oxide synthase, endothelial",35782,-0.0845657186403902,0.0318235900287431,-0.146939955096727,-0.0221914821840538,0.00789370729329369
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD5L,CD5 antigen-like,34950,-0.0811253996752647,0.0305548926171236,-0.141012989204827,-0.0212378101457024,0.0079489681368653
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HLA_E,,35971,-0.0467788110711864,0.0177589403335989,-0.0815863341250402,-0.0119712880173326,0.00845371263973193
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A16,Protein S100-A16,35772,0.0970210230335012,0.0369612119243377,0.0245770476617994,0.169464998405203,0.00868476666253864
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL21,C-C motif chemokine 21,35992,-0.0625603137140706,0.0238591514118272,-0.109324250481252,-0.0157963769468892,0.00875772048024673
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAP18,Chromatin complexes subunit BAP18,34958,-0.117001544510338,0.0449931034699526,-0.205188027311446,-0.0288150617092313,0.00933217130014786
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,35902,0.0480201943656681,0.0184923628817286,0.0117751631174801,0.084265225613856,0.00942968284840559
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCAR,Immunoglobulin alpha Fc receptor,35971,-0.0770230382583539,0.0298631661411583,-0.135554843895024,-0.0184912326216837,0.00992218062698884
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MNDA,Myeloid cell nuclear differentiation antigen,35962,-0.163757460847984,0.0635032614533107,-0.288223853296473,-0.039291068399495,0.00993580006681955
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NADK,NAD kinase,35972,-0.0905862468459481,0.0353122763863663,-0.159798308563226,-0.0213741851286701,0.0103285488040773
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL19,Interleukin-19,35785,-0.115940079760444,0.0453316269337155,-0.204790068550527,-0.027090090970362,0.0105601303736025
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,34869,-0.113591625349859,0.0444279268571357,-0.200670361989845,-0.0265128887098729,0.0105885031627948
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF17,Tumor necrosis factor receptor superfamily member 17,34822,-0.0668668033573492,0.0262682683205056,-0.11835260926554,-0.0153809974491582,0.0109349533773338
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AZU1,Azurocidin,35769,-0.122428452950716,0.0484008688430445,-0.217294155883083,-0.0275627500183486,0.0114448074659616
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLAMF8,SLAM family member 8,35800,-0.0852588227926466,0.0337170497753255,-0.151344240352285,-0.0191734052330086,0.0114712010083555
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFB4A_DEFB4B,Beta-defensin 4A,35860,-0.227756419176914,0.0904488622262377,-0.40503618914034,-0.0504766492134881,0.0118213737068924
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PON2,Serum paraoxonase/arylesterase 2,35874,-0.0548333386573717,0.0218099360505446,-0.097580813316439,-0.0120858639983043,0.0119535523319559
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP4,Insulin-like growth factor-binding protein 4,35896,-0.0674962239601533,0.026849441703066,-0.120121129698163,-0.014871318222144,0.0119625242622367
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMPRSS11D,Transmembrane protease serine 11D,34942,-0.0596513586930294,0.0238679440575327,-0.106432529045794,-0.0128701883402653,0.0124716157916456
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP12,Macrophage metalloelastase,35976,-0.0837533236125554,0.0336806013670486,-0.149767302291971,-0.0177393449331402,0.0129156010161042
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,34949,-0.0578609841710721,0.0232864367109683,-0.10350240012457,-0.0122195682175743,0.0129897968923854
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VCAM1,Vascular cell adhesion protein 1,36014,-0.0416606319889817,0.0168152665825001,-0.0746185544906819,-0.00870270948728148,0.013250971490265
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADA2,Adenosine deaminase 2,35952,-0.0666946672769428,0.027024810079959,-0.119663295033662,-0.0137260395202232,0.013613231547372
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL14,C-C motif chemokine 14,35978,-0.0623478980305602,0.0253232210584494,-0.111981411305121,-0.0127143847559993,0.0138359276925499
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,35711,-0.0938302712585943,0.0381155010941492,-0.168536653403127,-0.0191238891140619,0.0138502313894228
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",34949,-0.136938883810472,0.0556339088334205,-0.245981345123976,-0.0278964224969674,0.0138649021653181
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAB2,Stabilin-2,34965,-0.0421546778516148,0.0172288271258225,-0.0759231790182268,-0.00838617668500272,0.0144418344016688
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NELL1,Protein kinase C-binding protein NELL1,35991,0.0628943507614604,0.0257515537295359,0.01242130545157,0.113367396071351,0.0146151905319415
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,35979,-0.0546997961337664,0.0224779209388564,-0.098756521173925,-0.0106430710936079,0.0149776276839514
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK2,Serine protease inhibitor Kazal-type 2,34822,-0.054652386859343,0.022460665738164,-0.0986752917061445,-0.0106294820125416,0.0149919914784367
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,36034,-0.0440033763218779,0.0180877954800505,-0.079455455462777,-0.0085512971809789,0.0150074029394698
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,34958,-0.068257932345828,0.02807176185458,-0.123278585580805,-0.0132372791108513,0.015061751764771
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FBN2,Fibrillin-2,34805,-0.0922538191217913,0.0380985335749078,-0.166926944928611,-0.017580693314972,0.015487076354316
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAMBI,BMP and activin membrane-bound inhibitor homolog,35800,-0.0432941217013173,0.0178824306465932,-0.0783436857686401,-0.00824455763399459,0.0155006381879764
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HGF,Hepatocyte growth factor,36067,-0.0533970202373288,0.0220877414911335,-0.0966889935599506,-0.0101050469147071,0.0156515126423097
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,34736,-0.104267811432372,0.0432366315360294,-0.189011609242989,-0.0195240136217541,0.01591353745374
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",34815,-0.0873647233732292,0.0362325025521164,-0.158380428375377,-0.016349018371081,0.0159278495887808
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GDF15,Growth/differentiation factor 15,36072,-0.067262612394578,0.0279473518668822,-0.122039422053667,-0.012485802735489,0.0161187836324047
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SELE,E-selectin,36072,-0.0752832970196577,0.0313156022556967,-0.136661877440823,-0.0139047165984923,0.0162401332284705
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGR,Progesterone receptor,34778,0.153048433609668,0.0637466779488238,0.0281049448299736,0.277991922389363,0.0163848631147331
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD101,Immunoglobulin superfamily member 2,34964,-0.0649162754913965,0.027153013235961,-0.11813618143388,-0.0116963695489128,0.0168425352390174
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNC,Tenascin,36026,-0.0714448166804315,0.0298887865701642,-0.130026838357953,-0.0128627950029096,0.0168568547592555
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPR15L,Protein GPR15L,34964,-0.0951700655408198,0.0398128805819427,-0.173203311481428,-0.017136819600212,0.0168573730729581
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLITRK1,SLIT and NTRK-like protein 1,34778,0.0504379285913699,0.0211483829181011,0.00898709807189178,0.0918887591108481,0.0171112171382989
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EGFR,Epidermal growth factor receptor,36072,0.0235171084318626,0.00988854014955878,0.00413556973872734,0.0428986471249978,0.0174215115995457
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JAM3,Junctional adhesion molecule C,34822,-0.0740751179453272,0.0311866391445135,-0.135200930668574,-0.0129493052220807,0.0175686390493639
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTBP3,Latent-transforming growth factor beta-binding protein 3,35800,-0.0794088626851898,0.0335375635941334,-0.145142487329691,-0.0136752380406882,0.0179224727859157
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPTL4,Angiopoietin-related protein 4,35979,-0.0646849965204543,0.0273560275510855,-0.118302810520582,-0.0110671825203268,0.018077192278066
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STEAP4,Metalloreductase STEAP4,34750,-0.111550674575489,0.0471743688718585,-0.204012437564331,-0.0190889115866462,0.0180782016559041
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH3BP1,SH3 domain-binding protein 1,34964,-0.0757687368175917,0.0320705859899762,-0.138627085357945,-0.0129103882772384,0.0181790405046204
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,35998,-0.0717503825364854,0.0304591751956269,-0.131450365919914,-0.0120503991530568,0.0185175479291398
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,35966,-0.0505690048378176,0.0215002775612108,-0.0927095488577909,-0.00842846081784437,0.0186981335626585
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNLR1,Interferon lambda receptor 1,35971,-0.0537646740365979,0.0229838465810039,-0.0988130133353656,-0.0087163347378303,0.0193497153895869
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DUSP29,Dual specificity phosphatase 29,34805,-0.097593062376625,0.0417748071946644,-0.179471684478167,-0.0157144402750828,0.0195140439008706
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LBP,Lipopolysaccharide-binding protein,36026,-0.0835163086886239,0.0358050006211829,-0.153694109906142,-0.0133385074711055,0.0196993023960657
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UMOD,Uromodulin,36049,0.0769975412349549,0.033015438950275,0.0122872808924159,0.141707801577494,0.0197183778884563
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QL2,Complement C1q-like protein 2,34778,-0.0645453297795575,0.0276941286826247,-0.118825821997502,-0.010264837561613,0.019803826845804
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD79B,B-cell antigen receptor complex-associated protein beta chain,36067,-0.0648657932947544,0.0278402114029449,-0.119432607644526,-0.0102989789449824,0.0198362715021514
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TUBB3,Tubulin beta-3 chain,34750,0.0401163987632607,0.0172590745909834,0.00628861256493331,0.0739441849615881,0.0201383136379711
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL12,Stromal cell-derived factor 1,35842,-0.0556828901547692,0.0239884704431915,-0.102700292223424,-0.00866548808611387,0.0203017527819069
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GUCY2C,Heat-stable enterotoxin receptor,34869,-0.118908375626215,0.0513277303681123,-0.219510727147715,-0.0183060241047146,0.0205548923975975
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STC1,Stanniocalcin-1,36043,-0.064886653971864,0.0281495235169291,-0.120059720065045,-0.00971358787868307,0.021189966860113
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LY9,T-lymphocyte surface antigen Ly-9,35880,-0.0426654013167996,0.0185100895310346,-0.0789451767976274,-0.00638562583597185,0.0211956404637196
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECI2,Enoyl-CoA delta isomerase 2,34736,-0.0873680794505486,0.0379025504717149,-0.16165707837511,-0.0130790805259874,0.021195792824214
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MPO,Myeloperoxidase,35979,-0.0667792868732077,0.0290487933140074,-0.123714921768662,-0.00984365197775327,0.0215403522237647
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD300C,CMRF35-like molecule 6,36043,-0.0493053364680057,0.0214489937776586,-0.0913453642722165,-0.00726530866379492,0.0215481394876451
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL20,C-C motif chemokine 20,36067,-0.12122596180135,0.0529563869468821,-0.225020480217239,-0.0174314433854611,0.0220974911436357
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMP1,Metalloproteinase inhibitor 1,35906,-0.0407366028263207,0.0178458839172727,-0.0757145353041752,-0.00575867034846621,0.0224772957344847
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGAM,Integrin alpha-M,35979,-0.0442561469232535,0.0194055862137015,-0.0822910959021085,-0.00622119794439852,0.0226012226587828
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ESM1,Endothelial cell-specific molecule 1,35949,-0.048612416839293,0.0213541873495763,-0.0904666240444624,-0.0067582096341235,0.022845823832838
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QA,Complement C1q subcomponent subunit A,36032,-0.0309910739685642,0.01362015095929,-0.0576865698487726,-0.00429557808835589,0.0229112464778187
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRSK2,Serine/threonine-protein kinase BRSK2,34952,-0.0531902928966739,0.0233978822324721,-0.0990501420723192,-0.00733044372102863,0.0230416379960194
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GOLM2,Protein GOLM2,36043,-0.0316267292931019,0.0140044666716644,-0.0590754839695641,-0.00417797461663966,0.0239538263904202
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRL5,Fc receptor-like protein 5,35979,-0.0804939844975062,0.0357596940214815,-0.15058298477961,-0.0104049842154024,0.0244167735175235
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OSM,Oncostatin-M,35938,-0.0970420716606025,0.0431392488963744,-0.181594999497496,-0.0124891438237086,0.0245097357223301
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RLN2,Prorelaxin H2,34816,-0.0711096744885124,0.0316726702292729,-0.133188108137887,-0.00903124083913746,0.024793964625127
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSF,Cathepsin F,35991,0.054666528497747,0.0244133862985041,0.00681629135267906,0.102516765642815,0.0251723384672045
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFRC,Transferrin receptor protein 1,36020,-0.0513639620914403,0.0229837561094941,-0.0964121240660487,-0.0063158001168318,0.0254605205441232
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",34739,-0.0795106199372611,0.0356098663479488,-0.149305957979241,-0.00971528189528155,0.0255963611194019
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA6C,Semaphorin-6C,34778,0.0374047076923151,0.0167650705064696,0.00454516949963459,0.0702642458849955,0.0257096263547656
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APRT,Adenine phosphoribosyltransferase,35886,-0.06370678264709,0.0286463454582991,-0.119853619745356,-0.00755994554882378,0.0261852989375832
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIL1,Nucleotide exchange factor SIL1,34815,-0.0431650309774715,0.0194124409109667,-0.0812134151629662,-0.00511664679197676,0.0262128204492007
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WFDC12,WAP four-disulfide core domain protein 12,36015,-0.0874932063035894,0.0393973538178493,-0.164712019786574,-0.0102743928206049,0.0263953637776461
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",34778,0.0881246753547587,0.0397430284999371,0.0102283394948819,0.166021011214635,0.0266346302700619
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBM17,Splicing factor 45,34952,-0.106514113736337,0.048224255158634,-0.20103365384726,-0.0119945736254145,0.02722935226197
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL18,Interleukin-18,35921,-0.0608928126557616,0.0275982827033529,-0.114985446754333,-0.00680017855718987,0.0273870369367099
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SYTL4,Synaptotagmin-like protein 4,34949,-0.100211470625133,0.0454203741757033,-0.189235404009512,-0.0111875372407549,0.0273979072651085
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LUZP2,Leucine zipper protein 2,34949,-0.0620969373642298,0.028253689930687,-0.117474169628376,-0.0067197051000832,0.0279968713490637
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BST2,Bone marrow stromal antigen 2,36043,-0.0686283863139003,0.0312433200981569,-0.129865293706288,-0.00739147892151277,0.0280813323889605
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF8,Tumor necrosis factor ligand superfamily member 8,34965,-0.0497020481212017,0.0226476539922834,-0.0940914499460772,-0.00531264629632629,0.028229869169942
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTLA4,Cytotoxic T-lymphocyte protein 4,34965,-0.0408460108754496,0.0187518286535113,-0.0775995950363319,-0.00409242671456741,0.0294246417892633
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BGLAP,Osteocalcin,34965,-0.116626191871577,0.0535747581807149,-0.221632717905779,-0.0116196658373762,0.0295256288953955
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTAG1A_CTAG1B,Cancer/testis antigen 1,34853,-0.0684496219708629,0.0314997122846399,-0.130189058048757,-0.00671018589296864,0.0298159515220403
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AREG,Amphiregulin,35937,-0.0524053376941,0.0242200184777578,-0.0998765739105053,-0.00493410147769482,0.0305180194634714
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD300A,CMRF35-like molecule 8,34822,-0.0416735003128271,0.0193065781451852,-0.07951439347739,-0.00383260714826412,0.03092609083685
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP1B4,Protein ATP1B4,34739,-0.0561730554781114,0.0260274680988344,-0.107186892951827,-0.005159218004396,0.0309492217247956
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRISP2,Cysteine-rich secretory protein 2,36032,0.0711121032759991,0.033013695877763,0.00640525935558359,0.135818947196415,0.0312707905968955
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APLP1,Amyloid-like protein 1,35972,0.0668852546737891,0.0310600349864082,0.00600758610042912,0.127762923247149,0.0313181294365259
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMOC1,SPARC-related modular calcium-binding protein 1,36032,-0.0424965546609076,0.0197972798292107,-0.0812992231261606,-0.00369388619565469,0.0318585613604414
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",34853,-0.08398261079776,0.0392946512570672,-0.161000127261612,-0.00696509433390831,0.0326161014205263
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ESR1,Estrogen receptor,34778,0.0764985925133846,0.0358455932444745,0.00624122975421462,0.146755955272555,0.0328726883194527
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRN,Progranulin,35944,-0.0319608218191848,0.0150241545477742,-0.0614081647328221,-0.00251347890554741,0.033428736793633
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC8,Sialic acid-binding Ig-like lectin 8,34815,-0.0619494261942732,0.0291395701782707,-0.119062983743684,-0.00483586864486266,0.0335462865940555
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VAMP5,Vesicle-associated membrane protein 5,35874,-0.0671818114263419,0.0316304286356655,-0.129177451552246,-0.00518617130043764,0.0337070137050669
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MELTF,Melanotransferrin,34949,0.0414393456280555,0.01953423825398,0.00315223865025464,0.0797264526058564,0.0339293219670541
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PIGR,Polymeric immunoglobulin receptor,35885,-0.048300025010344,0.0227975295381742,-0.0929831829051654,-0.00361686711552262,0.0341536655502386
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AP1G2,AP-1 complex subunit gamma-like 2,34949,-0.107224049013638,0.0506751255238803,-0.206547295040443,-0.0079008029868325,0.0343912116828731
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NACC1,Nucleus accumbens-associated protein 1,34949,-0.0743069175943931,0.0352063405569115,-0.14331134508594,-0.00530249010284663,0.0348446948068584
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD27,CD27 antigen,35991,-0.0549400500835413,0.0260485436984918,-0.105995195732585,-0.00388490443449738,0.0349659625344702
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPXM2,Inactive carboxypeptidase-like protein X2,34949,-0.0338789049370799,0.0160688833950694,-0.0653739163914158,-0.00238389348274395,0.0350394020749864
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EGLN1,Egl nine homolog 1,35971,-0.0746177455441175,0.0354015172629995,-0.144004719379597,-0.00523077170863843,0.0350858131050137
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX39A,ATP-dependent RNA helicase DDX39A,34778,0.0315109873269013,0.0149687185019255,0.00217229906312736,0.0608496755906753,0.0353209097589547
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDT16,U8 snoRNA-decapping enzyme,34950,-0.116230369243001,0.0553483059002086,-0.22471304880741,-0.00774768967859241,0.0357698982559016
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IMMT,MICOS complex subunit MIC60,34949,-0.0615120719044967,0.0293368378456697,-0.119012274082009,-0.00401186972698409,0.036055004460418
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL24A1,Collagen alpha-1(XXIV) chain,34964,-0.0765612219617906,0.0365255574809118,-0.148151314624378,-0.00497112929920346,0.0361127125312504
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCN2,Ficolin-2,35970,0.0523206616817621,0.0249799831073764,0.00335989479130427,0.10128142857222,0.0362492145829073
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSAPL1,Proactivator polypeptide-like 1,34964,-0.067531453665132,0.0322544177782875,-0.130750112510576,-0.00431279481968851,0.0363251379426358
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PZP,Pregnancy zone protein,34975,-0.0437625405511477,0.0209869324278017,-0.084896928109639,-0.00262815299265647,0.037088286995298
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK13,Kallikrein-13,35802,-0.0566323911783979,0.0271977288106174,-0.109939939647208,-0.00332484270958774,0.0373551204109871
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RETN,Resistin,35974,-0.0556520532704263,0.0267488211593409,-0.108079742742734,-0.00322436379811802,0.0375102615499968
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LY96,Lymphocyte antigen 96,35902,-0.0476995241935604,0.0229455365889084,-0.0926727759078207,-0.0027262724793,0.0376691916326238
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PFDN4,Prefoldin subunit 4,34739,-0.07219969846797,0.0347679639927794,-0.140344907893818,-0.00405448904212243,0.0378785476123167
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WNT9A,Protein Wnt-9a,35842,-0.0369967094954971,0.0178276265900392,-0.0719388576119739,-0.00205456137902026,0.0379989668089209
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A12,Protein S100-A12,35859,-0.0953281759394798,0.0460874608569665,-0.185659599219134,-0.00499675265982542,0.0386359779534704
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BMPER,BMP-binding endothelial regulator protein,34822,-0.031299492283935,0.0151333887391481,-0.0609609342126652,-0.00163805035520469,0.0386586089434418
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",34964,-0.132631687300248,0.0641310571691762,-0.258328559351833,-0.00693481524866296,0.0386676338981211
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCAN,Neurocan core protein,36043,0.0474281842980822,0.0229360646430615,0.00247349759768169,0.0923828709984827,0.0386892466884487
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F11,Coagulation factor XI,34879,0.0387377077926588,0.0187473356186398,0.00199292998012484,0.0754824856051928,0.0388406314887742
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LSM8,U6 snRNA-associated Sm-like protein LSm8,34869,-0.106367534004276,0.0515083273064201,-0.207323855524859,-0.00541121248369265,0.0389588072286845
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD2,T-cell surface antigen CD2,34736,-0.0490900258324955,0.0238315724224442,-0.0957999077804862,-0.00238014388450478,0.0394527120131327
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEL1L,Protein sel-1 homolog 1,34815,-0.0376520762602665,0.0182996096174612,-0.0735193111104904,-0.00178484141004254,0.0396764728684901
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PBLD,Phenazine biosynthesis-like domain-containing protein,35782,0.065258250852793,0.0317330855000315,0.0030614032727312,0.127455098432855,0.0397729421266571
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PVALB,Parvalbumin alpha,35997,-0.143211708105266,0.0697891111367226,-0.279998365933243,-0.00642505027729021,0.0401985843444061
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBM19,Probable RNA-binding protein 19,34736,-0.0597844637525754,0.0291889974670481,-0.11699489878799,-0.0025740287171612,0.04058435271552
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF23,Fibroblast growth factor 23,36016,-0.0659939912117622,0.0322835141199665,-0.129269678886897,-0.00271830353662786,0.0409689406279907
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPARCL1,SPARC-like protein 1,35993,0.0349340963981553,0.01709334625137,0.00143113774547009,0.0684370550508404,0.041016104228553
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,35963,-0.0771009372790981,0.0377863441985753,-0.151162171908306,-0.00303970264989049,0.0413416756989248
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OSBPL2,Oxysterol-binding protein-related protein 2,34958,-0.0486025281933992,0.0238258579207041,-0.0953012097179792,-0.00190384666881917,0.0414008594953161
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHA10,Ephrin type-A receptor 10,35782,-0.0827833346605612,0.0406384154467673,-0.162434628936225,-0.0031320403848973,0.041679525119406
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL18BP,Interleukin-18-binding protein,36026,-0.0385963123230722,0.0189911270176748,-0.0758189212777148,-0.0013737033684296,0.0421553731573276
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPP1,Tripeptidyl-peptidase 1,35903,-0.058481883298438,0.0288424684644245,-0.11501312148871,-0.00195064510816609,0.0426341611617181
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HHEX,Hematopoietically-expressed homeobox protein HHEX,34958,-0.0976947888765598,0.0481812728068992,-0.192130083578082,-0.00325949417503743,0.0426375412703744
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOD3,Extracellular superoxide dismutase,34966,0.0741090009656115,0.0365504564816147,0.00247010626164672,0.145747895669576,0.0426446330134256
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD4,T-cell surface glycoprotein CD4,35957,-0.0358105003791107,0.0176656112975002,-0.0704350985222111,-0.00118590223601026,0.0426850493886683
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTSS2,Protein MTSS 2,34949,-0.128223505298746,0.0633459229708009,-0.252381514321516,-0.00406549627597615,0.0429934988020051
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSO,Cathepsin O,36067,-0.0388554983293827,0.0192003032104585,-0.0764880926218814,-0.00122290403688398,0.0430374073342879
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PEPD,Xaa-Pro dipeptidase,34966,0.0341031236378866,0.0169104366421716,0.00095866781923034,0.0672475794565428,0.0437696883617897
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAGA,Alpha-N-acetylgalactosaminidase,34768,0.0730874097446108,0.0362484249283896,0.00204049688496731,0.144134322604254,0.0438127151438886
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LPL,Lipoprotein lipase,35972,0.0592266409353473,0.0293889608202891,0.00162427772758062,0.116829004143114,0.0439127710271575
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRH,Receptor-type tyrosine-protein phosphatase H,34964,-0.0634176845767111,0.0314789280587622,-0.125116383571885,-0.00171898558153719,0.0439877751726846
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP6AP2,Renin receptor,35800,-0.0478259694428741,0.0237859948692854,-0.0944465193866734,-0.00120541949907472,0.0443967249885345
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",34964,-0.130781011724439,0.0650624277382895,-0.258303370091486,-0.00325865335739109,0.0444643114118222
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTIF3,"Translation initiation factor IF-3, mitochondrial",34964,-0.110246206818629,0.0550123857741406,-0.218070482935945,-0.00242193070131377,0.0451096645939278
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KDM3A,Lysine-specific demethylase 3A,34778,0.111245580860492,0.0555239132240424,0.0024187109413691,0.220072450779615,0.0451606322467695
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC1,Sialoadhesin,35992,-0.050130714803316,0.0250724549078028,-0.0992727264226096,-0.000988703184022444,0.0455979702026506
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GOT1,"Aspartate aminotransferase, cytoplasmic",34965,0.0548339032978749,0.0274614559489017,0.00100944963802766,0.108658356957722,0.045893904769552
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCGN,Secretagogin,35842,0.0550015891061897,0.0276007978134953,0.00090402539173888,0.10909915282064,0.0463259020511781
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ESYT2,Extended synaptotagmin-2,34958,-0.103462493198373,0.0520187544001424,-0.205419251822652,-0.00150573457409379,0.0467499522874166
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNX15,Sorting nexin-15,34822,-0.0686034291698663,0.0345381953871826,-0.136298292128744,-0.00090856621098831,0.0470431445879192
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BHLHE40,Class E basic helix-loop-helix protein 40,34750,0.0867155565440622,0.0436629915234274,0.00113609315814457,0.17229501992998,0.0470754721794607
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYOM1,Myomesin-1,34750,-0.059813914905115,0.0301180445168629,-0.118845282158166,-0.000782547652063668,0.0470795712053688
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL13RA2,Interleukin-13 receptor subunit alpha-2,34750,0.0370527374361886,0.0186680401578019,0.000463378726896897,0.0736420961454803,0.0472086346260481
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRP1,Prolow-density lipoprotein receptor-related protein 1,35937,0.0325159531076449,0.016390422046911,0.000390725895699294,0.0646411803195906,0.0473110346843811
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSNA1,Sjoegren syndrome nuclear autoantigen 1,34964,-0.0639313253911755,0.0322254198960063,-0.127093148387348,-0.000769502395003258,0.0473122546789834
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX53,Probable ATP-dependent RNA helicase DDX53,34805,-0.0453961039934291,0.0230071225598174,-0.0904900642106712,-0.000302143776186981,0.0485247658452505
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA14,Carbonic anhydrase 14,36032,0.0447537094735813,0.022700410830095,0.00026090424659516,0.0892465147005674,0.0487045054603308
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC5A,C-type lectin domain family 5 member A,35949,-0.0375108928440114,0.019068442952142,-0.0748850410302096,-0.000136744657813166,0.0492010300492958
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGA5,Integrin alpha-5,35979,-0.0300970403931125,0.0153048927851959,-0.0600946302520965,-9.9450534128586e-05,0.0492785410303365
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IMPG1,Interphotoreceptor matrix proteoglycan 1,34750,-0.0371397897860565,0.0189032986766791,-0.0741902551923475,-8.93243797655055e-05,0.0494909897957708
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",34815,-0.0596461553876016,0.0303676422606931,-0.11916673421856,-0.000125576556643213,0.0495589143480053
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RRM2,Ribonucleoside-diphosphate reductase subunit M2,35800,-0.0577063695305611,0.0294506824062048,-0.115429707046723,1.69679856004343e-05,0.0501016982946115
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC44A4,Choline transporter-like protein 4,34805,-0.082704975409142,0.0422335467785111,-0.165482727095024,7.27762767396695e-05,0.0502422799019236
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH2D1A,SH2 domain-containing protein 1A,35971,-0.0720200038236906,0.0367784958446921,-0.144105855679287,6.58480319058741e-05,0.0502430863890202
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",34965,-0.0782832952137551,0.0399949391729737,-0.156673375992784,0.000106785565273423,0.0503523213426413
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL15,C-C motif chemokine 15,36072,-0.0519527198880942,0.0265454122029181,-0.103981727805814,7.62880296252821e-05,0.0503698212040495
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RARRES2,Retinoic acid receptor responder protein 2,36035,-0.0585083825807865,0.0299569686695754,-0.117224041173154,0.000207276011581346,0.0508474738933425
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL13,C-X-C motif chemokine 13,36043,-0.0721941299182816,0.0369725113270093,-0.14466025211922,0.000271992282656661,0.0508992968775371
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WFDC1,WAP four-disulfide core domain protein 1,34808,-0.0663029453134238,0.0340091941684511,-0.132960965883588,0.00035507525674032,0.0512736172859976
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,34964,-0.0371548340844982,0.0190797695707069,-0.0745511824430837,0.0002415142740873,0.0515376856943215
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTN3,Contactin-3,35979,0.0339348311998501,0.0174328484676709,-0.000233551796784803,0.0681032141964851,0.0516202741500071
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLRD1,Natural killer cells antigen CD94,36067,-0.0560465456459342,0.0288230562895987,-0.112539735973548,0.000446644681679334,0.0518722148205233
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LETM1,Mitochondrial proton/calcium exchanger protein,34952,-0.064932195266314,0.0335350410155056,-0.130660875656705,0.000796485124076957,0.0528814972535658
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL5RA,Interleukin-5 receptor subunit alpha,35971,-0.0680415881113243,0.0351453381458488,-0.136926450877188,0.00084327465453933,0.0529051434112714
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DSG2,Desmoglein-2,35979,0.0319696358814649,0.0165165290787876,-0.000402761112958713,0.0643420328758886,0.0529530669657527
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MORF4L1,Mortality factor 4-like protein 1,34869,-0.0481637134331458,0.0249034746022973,-0.0969745236536486,0.000647096787356964,0.0531561379911281
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECHS1,"Enoyl-CoA hydratase, mitochondrial",34815,-0.115972620041633,0.0600317877488488,-0.233634924029377,0.00168968394611059,0.0534229914446476
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,34778,0.0568389895041528,0.0294822707689476,-0.000946261202984418,0.11462424021129,0.0539128424732049
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LEFTY2,Left-right determination factor 2,36023,0.0619672991752762,0.0321832868043213,-0.00111194296119353,0.125046541311746,0.0542112839015866
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CINP,Cyclin-dependent kinase 2-interacting protein,34869,-0.0531149122853874,0.0276040227757554,-0.107218796925868,0.000988972355093203,0.054378132391733
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP15,Matrix metalloproteinase-15,34949,-0.0606447084110076,0.0315192700677451,-0.122422477743788,0.00113306092177279,0.0543927402389544
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RSPO1,R-spondin-1,35902,-0.0403918432542388,0.0210164474031284,-0.0815840801643704,0.00080039365589276,0.0546552184595539
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMD1,26S proteasome non-ATPase regulatory subunit 1,34952,-0.061159941772761,0.0318277294637381,-0.123542291521688,0.00122240797616575,0.0547016843350629
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ELOA,Elongin-A,35937,-0.0670142552692546,0.0349533885918977,-0.135522896909374,0.00149438637086485,0.0552454372938913
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THSD1,Thrombospondin type-1 domain-containing protein 1,34730,0.0417901996020683,0.0219078657251753,-0.00114921721927526,0.0847296164234118,0.0564969710821978
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BLNK,B-cell linker protein,34778,-0.0503846216120129,0.0264294597462673,-0.102186362714697,0.00141711949067106,0.0566471355871915
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CKAP4,Cytoskeleton-associated protein 4,36034,-0.0331613092091584,0.0174136243916311,-0.0672920130167554,0.000969394598438582,0.0569056203970124
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENTR1,Endosome-associated-trafficking regulator 1,34815,-0.0749950789658113,0.0394172824626261,-0.152252952592558,0.00226279466093578,0.0571397361639747
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFNA4,Ephrin-A4,35890,-0.0363481250036583,0.0191255122385977,-0.0738341289913098,0.00113787898399326,0.0574063343901974
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DUOX2,Dual oxidase 2,35874,0.0821927343071834,0.0434820708857223,-0.00303212462883239,0.167417593243199,0.0587619432404804
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLAMF1,Signaling lymphocytic activation molecule,35842,-0.070468087651681,0.0373228307911,-0.143620836002237,0.00268466069887489,0.0590565978929212
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLURP1,Secreted Ly-6/uPAR-related protein 1,34917,-0.0425452915766114,0.0225484668281844,-0.0867402865598527,0.00164970340663001,0.0592280092264685
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRC25,Leucine-rich repeat-containing protein 25,35937,-0.0462151292020288,0.0245084588387524,-0.0942517085259835,0.00182145012192597,0.0593774585069574
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CWC15,Spliceosome-associated protein CWC15 homolog,34928,-0.0762621599677473,0.0405279953834551,-0.155697030919319,0.00317271098382477,0.0599205044538928
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA6,Carbonic anhydrase 6,35954,0.07248914975167,0.0386213020608488,-0.00320860228759361,0.148186901790934,0.0605684219759269
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VASN,Vasorin,35871,0.0319621082928652,0.0170391134083262,-0.00143455398745415,0.0653587705731845,0.060721658601795
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFBR1,TGF-beta receptor type-1,34778,-0.0276623555168818,0.0147572820508341,-0.0565866283365167,0.00126191730275316,0.0609102743386105
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CILP,Cartilage intermediate layer protein 1,34965,-0.0640403069300134,0.0341691012802566,-0.131011745439316,0.00293113157928952,0.0609463062908566
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PFDN2,Prefoldin subunit 2,35782,-0.0614454059175232,0.0328129742752977,-0.125758835497107,0.00286802366206033,0.0611649527480492
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRK5,G protein-coupled receptor kinase 5,35874,-0.0591768805140436,0.0316051788077655,-0.121123030977264,0.0027692699491768,0.0611942433345195
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCARB1,Scavenger receptor class B member 1,35782,-0.0630545399659076,0.0337736230095029,-0.129250841064533,0.00314176113271818,0.0619456660115848
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERC2,ERC protein 2,34805,-0.0873662029161772,0.0468374959674176,-0.179167695012316,0.00443528917996119,0.0621858632270496
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD302,CD302 antigen,35937,-0.0353263223544487,0.0189432713146589,-0.0724551341311802,0.00180248942228279,0.0622426012117527
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRTAC1,Cartilage acidic protein 1,36072,-0.0351178161952874,0.0188355311462241,-0.0720354572418867,0.00179982485131195,0.0622983868994333
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,35884,-0.0590728693565309,0.0317128649693627,-0.121230084696482,0.00308434598341997,0.0625388712031769
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COX6B1,Cytochrome c oxidase subunit 6B1,34949,-0.0380229820804894,0.0204239643256998,-0.078053952158861,0.00200798799788212,0.0626937190209533
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSC1,Hamartin,34778,0.0888202103909864,0.0477535998707316,-0.00477684535564758,0.18241726613762,0.0629374185837875
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CX3CL1,Fractalkine,35902,0.0379899736665536,0.0204445751240026,-0.00208139357649151,0.0780613409095987,0.0631817770168883
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB44,Ras-related protein Rab-44,34949,-0.0548905788897562,0.0296142854984051,-0.11293457846663,0.00315342068711778,0.0638546618040406
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCGB3A2,Secretoglobin family 3A member 2,35979,-0.0880390962738223,0.047574753306051,-0.181285612753682,0.00520742020603766,0.06427536096166
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP3,Stromelysin-1,35979,-0.0564145153243813,0.0305888722576723,-0.116368704949419,0.00353967430065642,0.0651820711129285
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TOMM20,Mitochondrial import receptor subunit TOM20 homolog,34949,-0.0879735933665772,0.0477460374626061,-0.181555826793285,0.0056086400601307,0.0654439928463891
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP4,"Fatty acid-binding protein, adipocyte",36072,0.056377297744423,0.030599689895636,-0.00359809445102362,0.11635268993987,0.0654542075692245
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAPG,Macrophage-capping protein,35904,-0.0677084654017752,0.0367563479001378,-0.139750907286045,0.00433397648249495,0.0655026397169731
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK4,Serine protease inhibitor Kazal-type 4,35971,-0.0739757292181826,0.0401731260739624,-0.152715056323149,0.00476359788678365,0.0655997113959257
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OMG,Oligodendrocyte-myelin glycoprotein,35937,0.0798097758040083,0.0433441015692371,-0.00514466327169645,0.164764214879713,0.0656170007092573
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),XCL1,Lymphotactin,36032,-0.0613372575296019,0.0333144382520455,-0.126633556503611,0.00395904144440729,0.065637742528569
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC51B,Organic solute transporter subunit beta,34736,0.0832258874331877,0.0452312989388775,-0.00542745848701214,0.171879233353388,0.0658155420771859
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NIT1,Deaminated glutathione amidase,34815,-0.0514671896766051,0.0279988160287241,-0.106344869092904,0.00341048973969406,0.0660818664733454
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RANGAP1,Ran GTPase-activating protein 1,35800,0.0521249236907042,0.0283835748593008,-0.00350688303352536,0.107756730414934,0.0663328145927109
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRNN,Cornulin,35736,0.07659868670856,0.0417224638912211,-0.00517734251823337,0.158374715935353,0.06641255832756
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GBP4,Guanylate-binding protein 4,35782,0.0537876015261389,0.0292983640494952,-0.00363719201087177,0.11121239506315,0.0664201524655477
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL11,C-X-C motif chemokine 11,36043,-0.0894183046404445,0.0487541059628965,-0.184976352327722,0.00613974304683274,0.0666839262375006
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSP90B1,Endoplasmin,35747,-0.0711588550624899,0.0389221295458005,-0.147446228972259,0.00512851884727915,0.0675557370321054
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPON1,Spondin-1,35966,-0.0369060835496427,0.0202135736300849,-0.076524687864609,0.00271252076532374,0.0679198087487248
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FEN1,Flap endonuclease 1,35800,-0.0757760634309544,0.0415043759651267,-0.157124640322603,0.0055725134606939,0.0679313279031925
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSN,Gelsolin,34935,0.0217173260258115,0.0119052258691412,-0.00161691667770518,0.0450515687293282,0.0681712994860277
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA3G,Semaphorin-3G,34822,-0.0506338023341533,0.0277726534927109,-0.105068203179867,0.00380059851155998,0.0683281501053444
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NT5E,5'-nucleotidase,35991,-0.0597451102213197,0.0327773630475732,-0.123988741794563,0.00449852135192363,0.068380851400573
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INSL4,Early placenta insulin-like peptide,34949,-0.0535593593917813,0.0294722521654441,-0.111324973636052,0.00420625485248912,0.0692212400383582
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP9,Matrix metalloproteinase-9,35971,-0.0676769943587288,0.0372442103720599,-0.140675646687966,0.00532165797050858,0.0692401730153191
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IDI2,Isopentenyl-diphosphate delta-isomerase 2,35782,-0.0555537583858496,0.0306150753918937,-0.115559306153961,0.00445178938226198,0.0696288988981721
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLRK1,NKG2-D type II integral membrane protein,34958,-0.0535345183870816,0.0295279769152327,-0.111409353140938,0.00434031636677457,0.0698774104572204
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPC2,NPC intracellular cholesterol transporter 2,34852,-0.0370134882873552,0.0204157220433196,-0.0770283034922617,0.00300132691755127,0.0698813875686434
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAST,Gastrin,34958,-0.149200633604652,0.082310446445205,-0.310529108637254,0.0121278414279498,0.0699318338457811
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LIF,Leukemia inhibitory factor,35782,-0.0580255175744126,0.0320134126665329,-0.120771806400817,0.00472077125199178,0.0699448897337514
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CARHSP1,Calcium-regulated heat-stable protein 1,35782,-0.057720451102423,0.0319136173335973,-0.120271141076274,0.00483023887142765,0.0705477487574829
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJC6,Putative tyrosine-protein phosphatase auxilin,34815,-0.0953575592121057,0.0527516373112861,-0.198750768342226,0.00803564991801504,0.0707061828268129
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL22,C-C motif chemokine 22,35870,-0.0576971848508104,0.0319217083164288,-0.120263733151011,0.00486936344938999,0.0707320307046688
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSR1,Macrophage scavenger receptor types I and II,36043,-0.0522794154585607,0.0289280192917267,-0.108978333270345,0.00441950235322368,0.0707676958073613
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPC1,Glypican-1,36032,0.0325604077954568,0.0180426948667626,-0.00280327414339779,0.0679240897343114,0.0711728953930229
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD72,B-cell differentiation antigen CD72,34822,-0.0476905473253929,0.0264433799163976,-0.0995195719615322,0.00413847731074641,0.0713586038402407
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NGRN,Neugrin,34958,-0.0255072738397671,0.0141567584927855,-0.0532545204856268,0.00223997280609259,0.0716283838914136
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBPMS2,RNA-binding protein with multiple splicing 2,34815,-0.11659895944189,0.0648535009529599,-0.243711821309692,0.010513902425911,0.0722441829242368
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GZMA,Granzyme A,36067,-0.0367988702206102,0.0205327217278018,-0.0770430048071018,0.00344526436588134,0.0731404198050196
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LONP1,"Lon protease homolog, mitochondrial",34815,-0.0979149201957064,0.0547415745928508,-0.205208406397694,0.00937856600628115,0.073715759098178
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDCP1,CUB domain-containing protein 1,35902,-0.0601195124970518,0.0336337423274112,-0.126041647458778,0.00580262246467408,0.0739020215475052
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRC,Receptor-type tyrosine-protein phosphatase C,34965,-0.0259806778043169,0.0145361501826948,-0.0544715321623987,0.00251017655376485,0.0739341726703376
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TOP2B,DNA topoisomerase 2-beta,34778,-0.0904862123237592,0.0506569496666202,-0.189773833670335,0.00880140902281634,0.074107059407536
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ART3,Ecto-ADP-ribosyltransferase 3,36026,0.0398376471788069,0.0223300228196108,-0.00392919754763037,0.0836044919052441,0.0744580338789754
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL6,Interleukin-6,35937,-0.0801809906528265,0.044971653695404,-0.168325431895818,0.00796345059016533,0.0746401882739104
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,35971,-0.0691464615161302,0.0387961872806355,-0.145186988586176,0.0068940655539154,0.074741401813508
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD244,Natural killer cell receptor 2B4,36067,-0.0295694392118164,0.0165941038571383,-0.0620938827718075,0.00295500434817461,0.0748021812781494
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGT5,Glutathione hydrolase 5 proenzyme,35902,-0.0261487466661191,0.0146859642358193,-0.0549332365683248,0.0026357432360867,0.0750314228822832
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDHR5,Cadherin-related family member 5,35972,0.042513504670843,0.0238779284151511,-0.00428723502285309,0.0893142443645391,0.0750431956295234
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HRAS,GTPase Hras,34861,-0.112983980045971,0.0634684065008418,-0.237382056787621,0.0114140966956789,0.0750981045816041
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDCD1,Programmed cell death protein 1,36017,-0.0441159004648119,0.0247851914183131,-0.0926948756447056,0.00446307471508186,0.0751283827373887
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD99L2,CD99 antigen-like protein 2,35979,-0.0265458189196392,0.014921506883285,-0.0557919724108777,0.0027003345715994,0.0752758826822284
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUCB2,Nucleobindin-2,36020,-0.0405763797854625,0.0228260668282159,-0.0853154707687657,0.00416271119784074,0.0755050252221018
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFBI,Transforming growth factor-beta-induced protein ig-h3,35957,-0.0295392684696369,0.0166328319427284,-0.0621396190773846,0.00306108213811074,0.0757805933640981
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP6V1F,V-type proton ATPase subunit F,35776,-0.0737695364057007,0.0415790290600263,-0.155264433363352,0.00772536055195078,0.0760723748489452
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD8A,T-cell surface glycoprotein CD8 alpha chain,36043,-0.0551879770437534,0.0311082645730163,-0.116160175606865,0.00578422151935852,0.0760938382596527
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASAH2,Neutral ceramidase,35902,0.0584388772564112,0.0329421797138091,-0.00612779498265467,0.123005549495477,0.0761075737741384
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFAP2A,Transcription factor AP-2-alpha,34750,0.0682850049873279,0.0385483771495522,-0.00726981422579444,0.14383982420045,0.0765419557792043
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PILRA,Paired immunoglobulin-like type 2 receptor alpha,35979,-0.0459845349552801,0.0259862011628576,-0.0969174892344809,0.00494841932392074,0.0768392401884732
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOP56,Nucleolar protein 56,34736,-0.125206212580917,0.0708351160853037,-0.264043040108112,0.0136306149462787,0.0771820691661215
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PITHD1,PITH domain-containing protein 1,34724,-0.083990758273497,0.0475949769470517,-0.177276913089718,0.00929539654272436,0.0776643821056331
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS7_LGALS7B,Galectin-7,35929,-0.0474200420202099,0.0268925870080394,-0.100129512555967,0.00528942851554726,0.0778894172520977
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNCA,Alpha-synuclein,34822,-0.128834941676057,0.0730762578798711,-0.272064407120605,0.0143945237684901,0.0779461117339967
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LCN2,Neutrophil gelatinase-associated lipocalin,35770,-0.0432746821802318,0.0245508683377896,-0.0913943841222994,0.00484501976183583,0.0780014891998758
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL19,C-C motif chemokine 19,36043,-0.121835437195715,0.0691256474551607,-0.25732170620783,0.0136508318163996,0.0780222704557925
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGBP1,Immunoglobulin-binding protein 1,34952,-0.0676116252314484,0.038369469526381,-0.142815785503155,0.00759253504025835,0.0780970480124455
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPM1B,Protein phosphatase 1B,34778,0.0678582874957667,0.0385464780099709,-0.00769280940377617,0.14340938439531,0.0783847910506609
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",34952,-0.0440398003445381,0.0250178179167088,-0.0930747234612873,0.0049951227722111,0.0783987383339545
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTNAP4,Contactin-associated protein-like 4,34805,-0.11879749161103,0.0674893648402502,-0.25107664669792,0.0134816634758603,0.0784163543773613
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLT3LG,Fms-related tyrosine kinase 3 ligand,36067,0.0376413805629491,0.0213879611867125,-0.00427902336300742,0.0795617844889056,0.0784600929168776
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFA1_DEFA1B,Neutrophil defensin 1,35832,-0.0594055820851474,0.0337597468421861,-0.125574685895832,0.00676352172553733,0.0785082190187582
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL10,C-X-C motif chemokine 10,35992,-0.0695265509972655,0.0395185886814504,-0.146982984812908,0.00792988281837735,0.0785614961139068
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TLR3,Toll-like receptor 3,36067,-0.0661777136882163,0.0376378298556423,-0.139947860205275,0.00759243282884262,0.0787414283465077
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCARF1,Scavenger receptor class F member 1,36072,-0.0457735127905373,0.0260617608924892,-0.0968545641398162,0.0053075385587416,0.0790700252402318
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINT1,Kunitz-type protease inhibitor 1,35952,-0.0288860531908839,0.0164592686747941,-0.0611462197934804,0.0033741134117126,0.0793005749811794
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASC3,Protein CASC3,34805,-0.0478717501196892,0.0273057871613602,-0.101391092955955,0.00564759271657678,0.0796218096677576
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A14,Protein S100-A14,34952,0.0556968059314873,0.031821497257087,-0.00667332869240317,0.118066940555378,0.0801167939472122
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF9,Tumor necrosis factor receptor superfamily member 9,35902,-0.044135736374777,0.0252360482416065,-0.0935983909283258,0.00532691817877174,0.080347502005323
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,34739,-0.0630663506326403,0.0361058890182425,-0.133833893108396,0.00770119184311506,0.0807384659136614
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNR,Tenascin-R,35902,0.0440613901734893,0.0252370640903289,-0.00540325544355527,0.0935260357905339,0.0808703848869182
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TOR1AIP1,Torsin-1A-interacting protein 1,34815,-0.0584431056164369,0.0334799766010308,-0.124063859754457,0.00717764852158347,0.0809275157728355
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TDO2,"Tryptophan 2,3-dioxygenase",34805,-0.0432946044080541,0.024819030374872,-0.0919399039428032,0.00535069512669502,0.0811368569152933
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFF2,Trefoil factor 2,35979,-0.0622489689802174,0.035864336985583,-0.13254306947196,0.00804513151152539,0.0826623908332548
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,34949,-0.0679242709228719,0.0391490527492839,-0.144656414311468,0.00880787246572456,0.0827863257619708
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",34750,0.0601919920789881,0.0347062590235756,-0.00783227560722013,0.128216259765196,0.0829102374387857
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCDC50,Coiled-coil domain-containing protein 50,34952,-0.0807402268347476,0.0466557295871948,-0.172185456825649,0.0107050031561542,0.0835800332529483
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PI3,Elafin,35878,-0.0584998399308224,0.033824328796155,-0.124795524371286,0.00779584450964145,0.0837585395975609
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAMDC2,MAM domain-containing protein 2,34949,-0.0390190840452488,0.0225673866645873,-0.0832511619078399,0.00521299381734234,0.0838571308327953
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G15,Phospholipase A2 group XV,35991,-0.02933611810619,0.0169891705557592,-0.0626348923954781,0.00396265618309815,0.0842536381361297
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SORCS2,VPS10 domain-containing receptor SorCS2,35800,-0.0375889668551244,0.0217906719587505,-0.0802986838942754,0.00512075018402663,0.0845699084606935
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL15,Interleukin-15,35971,-0.0358191282570021,0.0207647705936278,-0.0765180786205125,0.00487982210650829,0.0845702671323072
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEPTIN8,Septin-8,34942,-0.0365288319831796,0.0212024749380928,-0.0780856828618414,0.00502801889548227,0.0849631391076373
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,34949,-0.0954507285214917,0.0555731823190437,-0.204374165866817,0.0134727088238339,0.0859241756558468
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRSF1,G-rich sequence factor 1,34700,-0.0901977301205387,0.0525449463594563,-0.193185824985073,0.0127903647439958,0.0861062679179296
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,34949,-0.0309604996085591,0.0180445894744803,-0.0663278949785405,0.00440689576142216,0.0862515707146696
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP170,Centrosomal protein of 170 kDa,34815,-0.0827695536842312,0.0482915222089319,-0.177420937213738,0.0118818298452755,0.0865866334012672
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,34952,-0.115016798407531,0.0671067950263488,-0.246546116659175,0.0165125198441123,0.0865891401525324
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17C,Interleukin-17C,35842,-0.0740497496986646,0.0432465289870041,-0.158812946513193,0.0107134471158635,0.0868896664209803
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CENPF,Centromere protein F,34869,-0.0608534055226042,0.0355799276681846,-0.130590063752246,0.00888325270703761,0.0872544092785267
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIMAP8,GTPase IMAP family member 8,34739,-0.0537739534849532,0.0314780183094533,-0.115470869371482,0.00792296240157523,0.0876309208956534
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IDUA,Alpha-L-iduronidase,36032,-0.0492098970800155,0.0288416482368206,-0.105739527624184,0.00731973346415295,0.0880108414272462
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEBPB,CCAAT/enhancer-binding protein beta,35874,-0.0402804133788554,0.0236283479887534,-0.0865919754368121,0.00603114867910137,0.0882838639551716
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NTRK2,BDNF/NT-3 growth factors receptor,35972,0.0263771484167925,0.0154782036868896,-0.00396013080951103,0.056714427643096,0.0883955991402765
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA7A,Semaphorin-7A,36049,-0.030482378383349,0.0178884182393457,-0.0655436781324665,0.00457892136576848,0.0884174286815931
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSS,Cathepsin S,34404,-0.0254973521451648,0.0149872635071928,-0.0548723886192628,0.00387768432893318,0.0889462324117754
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRAP1,Proline-rich acidic protein 1,34965,-0.042022348111063,0.0247420786752172,-0.0905168223144887,0.00647212609236263,0.0894781048109362
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PQBP1,Polyglutamine-binding protein 1,35800,-0.0601561602113493,0.0354276448642343,-0.129594344145248,0.0092820237225499,0.0895508702682479
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMG3,Proteasome assembly chaperone 3,35971,-0.0538031475339975,0.0316987178071803,-0.115932634436071,0.00832633936807581,0.0896767251046264
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARFIP1,Arfaptin-1,34952,-0.0733991066020304,0.0432553557757859,-0.158179603922571,0.0113813907185099,0.0897685237708718
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPTL3,Angiopoietin-related protein 3,36000,-0.0357692735620787,0.0211400433553355,-0.0772037585385362,0.00566521141437892,0.090685186503512
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK1,Serine protease inhibitor Kazal-type 1,35979,-0.0429141487235812,0.0255983596043917,-0.093086933548189,0.00725863610102661,0.0936941342936601
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MICALL2,MICAL-like protein 2,34805,-0.0722695991358896,0.0431125612833829,-0.15677021925132,0.012231020979541,0.0937297640368755
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFNB2,Ephrin-B2,34805,-0.0615778136782294,0.0367457937931301,-0.133599569512764,0.0104439421563055,0.0938319555689454
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB6A,Ras-related protein Rab-6A,35971,0.0468828497659387,0.0280021567810772,-0.00800137752497264,0.10176707705685,0.0941222263335052
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPTLC1,Serine palmitoyltransferase 1,34958,-0.0405762635456652,0.0242360563108864,-0.0880789339150026,0.00692640682367214,0.0941383921810802
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,34869,-0.0514607139171066,0.0307402618972452,-0.111711627235707,0.00879019940149408,0.0941707951830478
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LCP1,Plastin-2,34965,-0.0499072677967376,0.0298608422623772,-0.108434518630997,0.00861998303752168,0.0947060270236612
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIMAP7,GTPase IMAP family member 7,34822,-0.0339828838134652,0.0203697840779658,-0.0739076606062783,0.00594189297934777,0.0953067672541989
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJB14,DnaJ homolog subfamily B member 14,34964,-0.0687845182154903,0.0412587018532328,-0.149651573847827,0.012082537416846,0.0955334327326384
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TP53BP1,TP53-binding protein 1,34778,0.090961905875016,0.054570768137704,-0.0159967996748839,0.197920611424916,0.0955926603653806
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CGA,Glycoprotein hormones alpha chain,35979,-0.0629639159086263,0.0378153903417224,-0.137082080978402,0.0111542491611497,0.0959483977762161
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OLFM4,Olfactomedin-4,34588,-0.13119488761269,0.0788114569775386,-0.285665343288666,0.0232755680632852,0.0960313863185655
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDON,Cell adhesion molecule-related/down-regulated by oncogenes,35966,0.0261415237958913,0.015707336204344,-0.00464485516462287,0.0569279027564055,0.0960975163967908
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDN1,Endothelin-1,34815,-0.0314607746422817,0.0189032014245296,-0.0685110494343597,0.00558950014979632,0.096101037579113
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOLH1,Glutamate carboxypeptidase 2,34778,0.110041518832254,0.0661490281273805,-0.0196105762974114,0.23969361396192,0.096255217126672
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCSK9,Proprotein convertase subtilisin/kexin type 9,36072,0.0408144096680845,0.0245627928476897,-0.0073286643133872,0.0889574836495562,0.0966278218661665
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCIN,Adseverin,34750,-0.0783882505464851,0.0471974269368687,-0.170895207342748,0.0141187062497776,0.0967928309324818
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CR1,Complement receptor type 1,34942,-0.0371822331026561,0.0223882369299565,-0.0810631774853709,0.00669871128005862,0.096804405963474
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSV,Cathepsin L2,35996,0.041876482973226,0.0252699835971718,-0.0076526848772307,0.0914056508236826,0.0975289293378833
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASPSCR1,Tether containing UBX domain for GLUT4,34952,-0.0691189814566963,0.0417083725911369,-0.150867391735325,0.0126294288219321,0.0975290782744529
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH3GLB2,Endophilin-B2,34958,-0.070653159069196,0.0426360525503916,-0.154219822067964,0.0129135039295716,0.0975440632135093
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD274,Programmed cell death 1 ligand 1,35902,-0.0340871789415354,0.020590458999891,-0.0744444785813219,0.00627012069825102,0.0978692964819702
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,36013,-0.0365880500149333,0.0221459692800815,-0.079994149803893,0.00681804977402635,0.0985501298335023
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATXN2,Ataxin-2,34750,-0.111416151545617,0.0674480509332393,-0.243614331374766,0.0207820282835321,0.0986098699320005
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL17,C-C motif chemokine 17,35945,-0.0943797863186086,0.0571653329544772,-0.206423838909384,0.0176642662721666,0.0987819634481596
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,34952,-0.0531300967918898,0.0321801954699387,-0.11620327991297,0.00994308632918995,0.0987842397544559
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RSPO3,R-spondin-3,36032,-0.028033880747861,0.0169996123206074,-0.0613531208962516,0.0052853594005295,0.0991715812928012
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSPN,Persephin,35971,0.0885089821120769,0.0537024107753281,-0.0167477430075662,0.19376570723172,0.0993669824695912
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMC3,Structural maintenance of chromosomes protein 3,34739,-0.0567619337771215,0.0344429853424646,-0.124270185048352,0.0107463174941091,0.099404476818008
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTSL4,ADAMTS-like protein 4,34815,-0.0251966540068995,0.0152965549959976,-0.0551779017990547,0.00478459378525578,0.0995652328708333
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,34739,-0.0588847196648483,0.0357530047488296,-0.128960608972554,0.0111911696428576,0.0996119821573205
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIRT1,NAD-dependent protein deacetylase sirtuin-1,34778,0.0894460402280451,0.0544209697037524,-0.0172190603913095,0.1961111408474,0.100310747012339
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDH9,Protocadherin-9,34964,-0.036050663076738,0.0219425038594455,-0.0790579706412513,0.00695664448777526,0.100440545939665
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MET,Hepatocyte growth factor receptor,35989,0.0195433917820376,0.0119009998671298,-0.00378256795753689,0.0428693515216121,0.100598605646255
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDCL2,Phosducin-like protein 2,34739,-0.0553384267196813,0.0337063600376463,-0.121402892393468,0.0107260389541055,0.100686832990186
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD300LF,CMRF35-like molecule 1,36032,-0.0614675789533805,0.0374990613882753,-0.1349657392744,0.012030581367639,0.101218839012563
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PECAM1,Platelet endothelial cell adhesion molecule,35979,-0.0301109147350248,0.0183759056238662,-0.0661276897578025,0.00590586028775293,0.101337458613227
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL23,C-C motif chemokine 23,35992,-0.0418712958860843,0.0256625811688441,-0.0921699549770187,0.0084273632048502,0.102804499365699
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLMAP,Sarcolemmal membrane-associated protein,34964,-0.0863593273842359,0.0529481431784452,-0.190137688013988,0.0174190332455166,0.102936191811968
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GATA3,Trans-acting T-cell-specific transcription factor GATA-3,34739,-0.0277489208731792,0.0170707580518697,-0.0612076066548438,0.00570976490848544,0.104102359734012
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENG,Endoglin,36072,-0.0173981942559781,0.0107301132940622,-0.0384292163123401,0.00363282780038387,0.104966312565023
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PYY,Peptide YY,34736,-0.100877546277731,0.0622451886272536,-0.222878115987148,0.0211230234316856,0.105144515356388
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EEF1D,Elongation factor 1-delta,34949,-0.0931132468051694,0.0575152212834894,-0.205843080520809,0.0196165869104699,0.105511509409595
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF4,Tumor necrosis factor receptor superfamily member 4,36056,-0.0373368383777172,0.0230723924916751,-0.0825587276614004,0.00788505090596606,0.10565159667922
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMARCA2,Probable global transcription activator SNF2L2,35782,0.0713891629798121,0.0441768595221028,-0.0151974816835094,0.157975807643134,0.10614137721523
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGER,Advanced glycosylation end product-specific receptor,35940,0.0401730132879648,0.0248733009180247,-0.00857865651136355,0.0889246830872932,0.106330759280169
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK6,Kallikrein-6,35978,0.0303561499275964,0.0188057749110839,-0.00650316889812794,0.0672154687533208,0.106528336100806
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRC37A2,Leucine-rich repeat-containing protein 37A2,34964,-0.0441112268558911,0.0273578583938048,-0.0977326293077485,0.00951017559596619,0.106929152373739
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASGR1,Asialoglycoprotein receptor 1,35902,-0.0302048117347096,0.0187490220041307,-0.0669528948628057,0.00654327139338661,0.107221347715757
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PECR,Peroxisomal trans-2-enoyl-CoA reductase,34815,0.029259240957001,0.0181787430156822,-0.00637109535373606,0.0648895772677381,0.107551183304611
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSTM2B,V-set and transmembrane domain-containing protein 2B,34869,0.0425860755825272,0.0264761673627564,-0.00930721244847522,0.0944793636135297,0.107783010989236
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PALM,Paralemmin-1,34921,0.0323275718602631,0.0201081245458338,-0.00708435224957113,0.0717394959700973,0.107953675558078
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMD5,26S proteasome non-ATPase regulatory subunit 5,34805,-0.0523059889440999,0.0326059932609417,-0.116213735735546,0.0116017578473459,0.108724553918518
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLAMF6,SLAM family member 6,35800,-0.0378605010571488,0.0236213392624236,-0.084158326011499,0.00843732389720148,0.109020638995521
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX8,Syntaxin-8,35971,-0.0473265452326911,0.0295327530189999,-0.105210741149931,0.0105576506845487,0.109085627614084
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFB104A_DEFB104B,Beta-defensin 104,34750,0.0561891932943963,0.0352055130865399,-0.0128136123552219,0.125191998944015,0.110532598896606
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LELP1,Late cornified envelope-like proline-rich protein 1,34750,-0.07130971226053,0.0446813499564334,-0.15888515817514,0.0162657336540795,0.110548779697907
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHISA5,Protein shisa-5,34965,-0.0258289711554309,0.0161912108477849,-0.0575637444170892,0.0059058021062275,0.110706788957507
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,34966,0.0374777996523725,0.0235258279405466,-0.00863282311109881,0.0835884224158438,0.111198817297967
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,34815,-0.0525525646784945,0.032989619951971,-0.117212219784358,0.0121070904273688,0.11121036334383
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNF,Tumor necrosis factor,35862,-0.0353692819690169,0.0222061167917833,-0.0788932708809123,0.00815470694287845,0.111254861433504
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STK11,Serine/threonine-protein kinase STK11,35874,-0.0705679221837817,0.0443083602967067,-0.157412308365327,0.0162764639977634,0.11128110589176
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GZMH,Granzyme H,35874,-0.0763699347658212,0.047966277595799,-0.170383838853587,0.0176439693219448,0.111392462093105
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCN2A,Sodium channel protein type 2 subunit alpha,34750,0.0504875491567515,0.0317248307882535,-0.0116931191882254,0.112668217501728,0.111566347532065
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPP10,Inactive dipeptidyl peptidase 10,35971,-0.0357907080710695,0.0225145214268179,-0.0799191700676327,0.00833775392549365,0.111951607188582
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DTYMK,Thymidylate kinase,34949,-0.0674525416265497,0.0424459361759249,-0.150646576531362,0.015741493278263,0.112078545183915
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB10,Ras-related protein Rab-10,34949,-0.0530054568547137,0.0333682746104051,-0.118407275091108,0.0123963613816803,0.112223435107209
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCNE1,G1/S-specific cyclin-E1,34778,0.0923699393391947,0.0581812369051414,-0.0216652849948825,0.206405163673272,0.112422518041808
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PKN3,Serine/threonine-protein kinase N3,34869,-0.0716178275509753,0.0451708294661796,-0.160152653304687,0.0169169982027368,0.11290584037362
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",34952,-0.0416471256602214,0.0262702440274913,-0.0931368039541043,0.00984255263366142,0.112940120058399
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HCLS1,Hematopoietic lineage cell-specific protein,36067,-0.0534763488108544,0.0337487067291629,-0.119623814000014,0.0126711163783048,0.113112067857619
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYH9,Myosin-9,34965,-0.113771663322474,0.0718047148982705,-0.254508904523085,0.0269655778781357,0.113138867922039
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,35800,-0.0574782889379542,0.0362788526236013,-0.128584840080213,0.0136282622043043,0.113158708619361
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPAG1,Sperm-associated antigen 1,34952,-0.0595137398088185,0.0375766473251794,-0.13316396856617,0.014136488948533,0.113289955893119
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARF6,ADP-ribosylation factor 6,34964,-0.106827174660229,0.0674874986085601,-0.239102671933007,0.0254483226125485,0.113489851673972
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASE1,Ribonuclease pancreatic,34966,-0.0245874966785937,0.0155399902345806,-0.0550458775383718,0.00587088418118432,0.113651774096243
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TARS1,"Threonine--tRNA ligase 1, cytoplasmic",34949,-0.0359139877635039,0.0227017201582784,-0.0804093592737294,0.00858138374672172,0.113700723352002
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTA4H,Leukotriene A-4 hydrolase,36032,-0.0579728492170218,0.0366577609020324,-0.129822060585005,0.0138763621509617,0.113815035357073
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBPL,FK506-binding protein-like,34964,-0.0585010351779149,0.0370288212176145,-0.131077524764439,0.0140754544086095,0.114184411923945
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VWA5A,von Willebrand factor A domain-containing protein 5A,34739,-0.0792316970960862,0.0501881483445959,-0.177600467851494,0.0191370736593219,0.114457927459114
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK1,Kallikrein-1,35893,-0.124224506406929,0.0787632815855221,-0.278600538314552,0.0301515255006943,0.114795633810706
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF168,E3 ubiquitin-protein ligase RNF168,34778,0.0395977939346167,0.0251185024189193,-0.0096344708064651,0.0888300586756984,0.114975802001691
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRC38,Leucine-rich repeat-containing protein 38,34805,-0.0455294546605231,0.0289144392124526,-0.10220175551693,0.0111428461958841,0.115393564141862
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPRR1B,Cornifin-B,34869,-0.0854786600267243,0.0543277625188774,-0.191961074563724,0.0210037545102755,0.115679422395452
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UPK3BL1,Uroplakin-3b-like protein 1,34855,-0.0516023403412986,0.0328035720509826,-0.115897341561224,0.0126926608786272,0.115753008601898
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGD,"6-phosphogluconate dehydrogenase, decarboxylating",34949,-0.0525169257639476,0.0334185865564474,-0.118017355414585,0.0129835038866894,0.116119044416174
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPY,Pancreatic prohormone,35956,-0.0994291249743411,0.0632770937745832,-0.223452228772524,0.0245939788238419,0.116149284769282
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGLYRP4,Peptidoglycan recognition protein 4,34736,-0.0602193735457164,0.0383440258760331,-0.135373664262741,0.0149349171713086,0.116349904964653
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JCHAIN,Immunoglobulin J chain,35842,-0.060807590125778,0.0387876098203583,-0.13683130537368,0.0152161251221241,0.116993321355319
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL18A1,Collagen alpha-1(XVIII) chain,36027,-0.0224897360021453,0.0143873130165964,-0.0506888695146743,0.00570939751038367,0.118056528710554
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD5,T-cell surface glycoprotein CD5,36022,-0.0334953586414512,0.0214300705291179,-0.0754982968785223,0.00850757959561998,0.118093490400356
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PMCH,Pro-MCH,34736,0.076069154643983,0.0487313744477981,-0.0194443392737013,0.171582648561667,0.118577843545186
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CST7,Cystatin-F,35971,-0.0922024365018947,0.0591292059739931,-0.208095680210921,0.0236908072071317,0.118959258426056
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BECN1,Beclin-1,34815,-0.0580817972097263,0.0373027470025864,-0.131195181334796,0.015031586915343,0.119512363894211
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCPEP1,Retinoid-inducible serine carboxypeptidase,34789,-0.0499116689371377,0.0320614185228704,-0.112752049241964,0.0129287113676882,0.119580571122133
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,35874,-0.0266147021325317,0.017096825444273,-0.0601244800033068,0.00689507573824342,0.119584205406296
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRG2,Bone marrow proteoglycan,34965,-0.0518795500556964,0.0333265308663554,-0.117199550553753,0.0134404504423602,0.119590451836014
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL12RB1,Interleukin-12 receptor subunit beta-1,35842,-0.035868334840591,0.0230588230109184,-0.0810636279419912,0.00932695826080912,0.119867267353629
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),POF1B,Protein POF1B,34778,-0.0455782740424507,0.0293096147381167,-0.103025118929159,0.011868570844258,0.119982478067626
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD48,CD48 antigen,35979,-0.0292269887759569,0.0188023719747106,-0.0660796378463896,0.00762566029447584,0.120124542976183
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VNN2,Vascular non-inflammatory molecule 2,35937,-0.045508980227204,0.0292897636200007,-0.102916916922405,0.0118989564679975,0.120287110953785
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,35902,0.0344871674572907,0.0222240675672092,-0.00907200497443927,0.0780463398890206,0.120754937800764
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASET2,Ribonuclease T2,36031,-0.0258897886100261,0.0166953371639577,-0.0586126494513831,0.00683307223133098,0.121011451200492
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL18R1,Interleukin-18 receptor 1,36067,-0.0312112706063635,0.0201922566918893,-0.0707880937224665,0.00836555250973958,0.122218225272825
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACVRL1,Serine/threonine-protein kinase receptor R3,35890,-0.0239402627823624,0.0154999696483804,-0.054320203293188,0.00643967772846306,0.122501917108484
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF5,Eukaryotic translation initiation factor 5,34736,0.0412002406317772,0.0266906291815758,-0.0111133925641114,0.0935138738276658,0.122731516689111
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RANBP2,E3 SUMO-protein ligase RanBP2,34750,0.0317213838301686,0.0205807748576034,-0.0086169348907341,0.0720597025510714,0.123292453605184
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PARP1,Poly [ADP-ribose] polymerase 1,35971,-0.0575547550769797,0.037352658602949,-0.13076596593876,0.0156564557848003,0.123396802914228
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDA1,DET1- and DDB1-associated protein 1,34736,-0.0363821795040873,0.0236417849734841,-0.0827200780521162,0.00995571904394149,0.123881962030105
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,35902,-0.0720624313632326,0.0468558595082937,-0.163899915999488,0.019775053273023,0.124101757124207
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC25A,M-phase inducer phosphatase 1,34739,-0.0382396006658542,0.0248921299844798,-0.0870281754354346,0.0105489741037263,0.124537811271814
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGF,Placenta growth factor,36067,-0.0242385988670618,0.0157926659618297,-0.0551922241522479,0.00671502641812443,0.124875094583986
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEBPA,CCAAT/enhancer-binding protein alpha,34778,0.034836068513493,0.0226996515374824,-0.00965524849997256,0.0793273855269586,0.124920507718918
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,34949,-0.0447507795949058,0.0291623031215365,-0.101908893713117,0.0124073345233057,0.124946190935743
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPN1,Epsin-1,34869,-0.0397319798212239,0.0258961768392367,-0.0904884864261278,0.0110245267836801,0.125011307183634
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL12RB2,Interleukin-12 receptor subunit beta-2,34778,0.0412944653257655,0.0269850412666601,-0.0115962155568883,0.0941851462084193,0.126000502304474
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAPPA,Pappalysin-1,35842,-0.0446995084512635,0.0292115593476947,-0.101954164772745,0.0125551478702181,0.126011074563442
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFC1,Cryptic protein,35800,0.0447362163745542,0.0292371228446708,-0.0125685444010005,0.102040977150109,0.126031721922965
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,36072,-0.0663322081970065,0.0433600110440824,-0.151317829843408,0.0186534134493951,0.126108211689787
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),USP28,Ubiquitin carboxyl-terminal hydrolase 28,34958,-0.0341875630726193,0.0223823823358709,-0.0780570324509263,0.00968190630568763,0.126703411473894
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCS,Copper chaperone for superoxide dismutase,35902,-0.0447012037132195,0.0293670423769182,-0.102260606771979,0.0128581993455402,0.128013435624777
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCER2,Coiled-coil domain-containing glutamate-rich protein 2,34815,0.0597199160922746,0.0394299223031547,-0.0175627316219086,0.137002563806458,0.129928724605075
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPT2,Angiopoietin-2,36032,-0.0348965173287493,0.0230455784616453,-0.0800658511135742,0.0102728164560755,0.130007717772612
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AIDA,"Axin interactor, dorsalization-associated protein",34805,-0.0822277222306664,0.0543024689865054,-0.188660561444217,0.0242051169828841,0.130012403939389
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNGB3,Cyclic nucleotide-gated cation channel beta-3,34750,-0.0512227454774757,0.0338285874815486,-0.117526776941311,0.0150812859863595,0.130030270276411
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHGB,Secretogranin-1,36028,-0.0387306598628528,0.0256045626618137,-0.0889156026800075,0.011454282954302,0.130411941499751
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJB1,DnaJ homolog subfamily B member 1,35937,-0.0798619873762389,0.0528492057759304,-0.183446430697062,0.0237224559445846,0.130798557188261
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK4,Kallikrein-4,36032,-0.0573908960350025,0.0379800110433888,-0.131831717680045,0.0170499256100396,0.130810175973145
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL10RB,Interleukin-10 receptor subunit beta,35992,-0.027249279869426,0.0180456260161227,-0.0626187068610265,0.00812014712217453,0.131080728136259
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNNI3,"Troponin I, cardiac muscle",35874,0.0785832154355283,0.0520707089142464,-0.0234753740363946,0.180641804907451,0.131300427394295
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOLR2,Folate receptor beta,36043,-0.026787488588391,0.0177598570243685,-0.0615968083561532,0.00802183117937123,0.131515939801773
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPC5,Glypican-5,35902,0.0520840300745261,0.034536650532074,-0.015607804968339,0.119775865117391,0.13157732950918
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGEF1,Rho guanine nucleotide exchange factor 1,34958,-0.0839775221042247,0.0556931341211786,-0.193136064981735,0.0251810207732854,0.131639711759524
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CETN3,Centrin-3,34964,-0.0743816459301448,0.0493338979617309,-0.171076085935137,0.0223127940748477,0.131676146632953
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB6B,Ras-related protein Rab-6B,35782,0.0429459481089634,0.028508375702245,-0.0129304682674368,0.0988223644853636,0.132000122668328
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCHE,Cholinesterase,34832,0.0256536625604747,0.0170614574691419,-0.00778679407904342,0.0590941191999929,0.132734230945706
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACE,Angiotensin-converting enzyme,34966,0.0257478658946598,0.0171267789464196,-0.00782062084032253,0.0593163526296422,0.132793560188647
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AZI2,5-azacytidine-induced protein 2,34952,-0.0529470465473013,0.0352359502299679,-0.122009508998038,0.0161154159034358,0.132980893624026
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPEP2,Dipeptidase 2,35937,-0.027924961970702,0.0185877414771028,-0.0643569352658235,0.00850701132441956,0.133054380691882
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF43,E3 ubiquitin-protein ligase RNF43,34869,-0.0551758544074971,0.0367324547129306,-0.127171465644841,0.0168197568298469,0.133121411086806
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WARS,"Tryptophan--tRNA ligase, cytoplasmic",35979,-0.0347545925417658,0.0231552024401572,-0.0801387893244739,0.0106296042409424,0.13341361012646
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FRMD7,FERM domain-containing protein 7,34805,-0.0314018238035215,0.0209478259163981,-0.0724595625996619,0.00965591499261883,0.133911714769387
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MATN3,Matrilin-3,35890,-0.0306737904205371,0.0205184867577698,-0.0708900244657659,0.00954244362469173,0.134974863517347
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PER3,Period circadian protein homolog 3,34778,-0.114899461637449,0.076928126389076,-0.265678589360038,0.0358796660851402,0.135332586046067
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",34948,-0.10322988547703,0.0691426613693604,-0.238749501760976,0.0322897308069166,0.135487292762186
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F10,Coagulation factor X,34966,0.0257285772008378,0.0172355877392882,-0.00805317476816693,0.0595103291698426,0.135549861645563
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA6,Corticosteroid-binding globulin,34975,0.014866512206152,0.00999384324566896,-0.00472142055535913,0.0344544449676632,0.136914558942267
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AP3B1,AP-3 complex subunit beta-1,34964,-0.0713706831389152,0.048071083544759,-0.165590006886643,0.0228486406088123,0.137675345516669
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSH,Pro-cathepsin H,35843,-0.0694262314107418,0.0467920876052113,-0.161138723116956,0.0222862602954724,0.137927438257798
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAP3,Cytosol aminopeptidase,35842,-0.0442318881549286,0.0298613050639265,-0.102760046080224,0.0142962697703673,0.138584988458044
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F2R,Proteinase-activated receptor 1,35979,-0.0525920873858362,0.0355089323312452,-0.122189594755077,0.0170054199834043,0.138624067583166
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTN1,Contactin-1,36072,0.0244214887586437,0.0164985659372378,-0.00791570047834234,0.0567586779956297,0.138857004990475
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPGN,Epigen,34949,-0.0432333150879635,0.0292568149744545,-0.100576672437894,0.0141100422619673,0.139532941205767
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOLR3,Folate receptor gamma,35963,-0.17110086906941,0.115873899153492,-0.398213711410254,0.0560119732714338,0.139822255698915
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC15,Sialic acid-binding Ig-like lectin 15,35782,-0.0693762337596154,0.047011422036384,-0.161518620950928,0.0227661534316972,0.14005983931715
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIT1,Signaling threshold-regulating transmembrane adapter 1,35842,-0.0498170026879112,0.0337834322315524,-0.116032529861754,0.0163985244859315,0.140363953670908
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GBA,Lysosomal acid glucosylceramidase,34805,-0.0515709137855145,0.0349877040552403,-0.120146813733785,0.0170049861627564,0.140539723061742
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPRR3,Small proline-rich protein 3,34958,0.0585720299090118,0.0397949026068982,-0.0194259792005088,0.136570039018532,0.141111543660949
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZNRD2,Protein ZNRD2,34964,-0.0644549232671727,0.0438197989002182,-0.1503417291116,0.0214318825772549,0.141365251317152
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DKK3,Dickkopf-related protein 3,36072,0.0268715684273193,0.0183061862521125,-0.00900855662682114,0.0627516934814597,0.142174702246035
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,35902,-0.0519019435846822,0.0353951417923693,-0.121276421497726,0.0174725343283616,0.14259388817396
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INSL5,Insulin-like peptide INSL5,34964,-0.0937150652086445,0.0639171947008237,-0.218992766822259,0.03156263640497,0.142644603720875
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSTP1,Glutathione S-transferase P,35737,-0.0607954779845474,0.0414718994569444,-0.142080400920158,0.0204894449510636,0.142707625902397
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRDT,Bromodomain testis-specific protein,34736,-0.034285323905552,0.0233948077761393,-0.080139147146785,0.011568499335681,0.142833073929807
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB27B,Ras-related protein Rab-27B,34949,-0.0755364086598186,0.0515675120765888,-0.176608732329933,0.0255359150102955,0.143023328390277
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBP5,Retinol-binding protein 5,35937,-0.0513134378322398,0.0350360376089375,-0.119984071545757,0.0173571958812776,0.143075598672719
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SYAP1,Synapse-associated protein 1,34822,-0.0530835203050355,0.0362537170998332,-0.124140805820709,0.0179737652106376,0.143183594098417
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASAH1,Acid ceramidase,34906,-0.0434345709280838,0.0296642949125639,-0.101576588956709,0.0147074471005414,0.143188141550988
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",34958,-0.0389071165033012,0.026586143347111,-0.0910159574636387,0.0132017244570362,0.143397576234445
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPIB,Peptidyl-prolyl cis-trans isomerase B,35990,-0.0869546844221881,0.0595033135523428,-0.20358117898478,0.0296718101404038,0.143964157472089
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD80,T-lymphocyte activation antigen CD80,34949,-0.0307986085273207,0.0210821839026747,-0.0721196889765631,0.0105224719219218,0.144096978998508
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VCPKMT,Protein-lysine methyltransferase METTL21D,34739,-0.0794845029560237,0.0544134772309838,-0.186134918328752,0.0271659124167046,0.144135156750679
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSMB,Beta-microseminoprotein,35967,-0.0619226262246986,0.0424440904030406,-0.145113043414658,0.021267790965261,0.144629152507931
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VMO1,Vitelline membrane outer layer protein 1 homolog,35937,-0.0622996303419971,0.0427160302810952,-0.146023049692944,0.0214237890089494,0.144756540619682
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",35842,0.0564516213907916,0.0387304794289625,-0.0194601182899749,0.132363361071558,0.145007900721907
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",34778,0.0409990832204286,0.0282175754724214,-0.0143073647055174,0.0963055311463745,0.146284913144608
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRK,Receptor-type tyrosine-protein phosphatase kappa,34964,-0.0212730238668617,0.0146525000205902,-0.0499919239072185,0.00744587617349514,0.146596565922407
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",34958,-0.0235584040467136,0.0162280087945568,-0.055365301284045,0.00824849319061774,0.146630888139181
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMPRSS5,Transmembrane protease serine 5,35866,0.0341539414716341,0.0235276608656252,-0.0119602738249913,0.0802681567682594,0.146641973921694
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT19,"Keratin, type I cytoskeletal 19",35953,-0.0608533014985445,0.0419267152875187,-0.143029663462081,0.0213230604649922,0.146705417033157
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTN3A2,Butyrophilin subfamily 3 member A2,35971,-0.0338978875173667,0.0233555395736445,-0.0796747450817099,0.0118789700469764,0.146715149466331
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD200,OX-2 membrane glycoprotein,35971,0.0236979857498675,0.016347811574535,-0.00834372493622105,0.0557396964359561,0.147209259096722
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CIT,Citron Rho-interacting kinase,34805,-0.0439262833622287,0.0303070470306603,-0.103328095542323,0.0154755288178654,0.14728335752475
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPDC1,Neural proliferation differentiation and control protein 1,35972,-0.0294091400246633,0.0202944062907594,-0.0691861763545517,0.0103678963052252,0.14734509511635
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDCD5,Programmed cell death protein 5,36043,-0.051552829871011,0.0355797560284868,-0.121289151686845,0.0181834919448232,0.147397266085763
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PILRB,Paired immunoglobulin-like type 2 receptor beta,35972,-0.0513606228449131,0.0354644532592839,-0.120870951233109,0.0181497055432833,0.147595756123785
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NXPH3,Neurexophilin-3,34778,0.0277851503025814,0.0191879383369386,-0.00982320883781823,0.065393509442981,0.147652993834923
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",34778,0.0431049549671631,0.0298171885070894,-0.0153367345067322,0.101546644441058,0.14832859909611
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP5PO,"ATP synthase subunit O, mitochondrial",35782,0.0378183037653475,0.026172481653682,-0.0134797602758691,0.0891163678065642,0.148511517925077
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SRP14,Signal recognition particle 14 kDa protein,35937,-0.0552572479072477,0.038254752840651,-0.130236563474924,0.0197220676604283,0.148653885926566
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATF2,Cyclic AMP-dependent transcription factor ATF-2,35782,-0.0591319579839173,0.0409728175112012,-0.139438680305872,0.0211747643380371,0.149007836793805
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL18,C-C motif chemokine 18,35899,-0.0629660754850997,0.043662283610694,-0.14854415136206,0.0226120003918606,0.149312572276159
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CIRBP,Cold-inducible RNA-binding protein,34964,-0.0870744436198443,0.0604140355607314,-0.205485953318878,0.0313370660791893,0.149550577957831
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AIF1,Allograft inflammatory factor 1,35800,-0.0470580129947546,0.0326670360604061,-0.111085403673151,0.0169693776836414,0.149759541037243
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPP4,Dipeptidyl peptidase 4,35842,0.0248600720838337,0.0172599889646352,-0.0089695062868513,0.0586896504545187,0.149817414169887
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,34949,-0.0757783041693619,0.0526713154416907,-0.179014082435076,0.0274574740963518,0.150284387453596
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HTR1A,5-hydroxytryptamine receptor 1A,34750,-0.0619547972715204,0.0430851056660795,-0.146401604377036,0.0224920098339954,0.150495370739733
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC39A5,Zinc transporter ZIP5,35971,-0.0461568122333106,0.0321156026974664,-0.109103393520345,0.0167897690537234,0.1507012484209
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP152,Centrosomal protein of 152 kDa,34739,-0.0372682900253255,0.025939983386584,-0.0881106574630303,0.0135740774123792,0.15085075240759
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEB,Nebulin,34736,-0.03661386258078,0.0255157738034153,-0.0866247792354739,0.013397054073914,0.15135227929729
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,34815,0.0322516163525361,0.0224883845484566,-0.0118256173624387,0.076328850067511,0.15158104536948
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH3,Cadherin-3,36043,-0.0316257895476687,0.0220696962869959,-0.0748823942701807,0.0116308151748433,0.151900941189461
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GBP1,Guanylate-binding protein 1,34943,-0.0570090292632709,0.0398201640642915,-0.135056550829282,0.0210384923027404,0.152289749358368
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFAT5,Nuclear factor of activated T-cells 5,34778,-0.0781548191199251,0.054595094358462,-0.185161204062511,0.0288515658226603,0.152327366985555
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFE2,Transcription factor NF-E2 45 kDa subunit,34815,-0.0668166358863832,0.0466759493244944,-0.158301496562392,0.0246682247896258,0.152337161615425
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFF3,Trefoil factor 3,35975,-0.0324878093127919,0.022695579469715,-0.0769711450734333,0.0119955264478496,0.152340858692157
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,34949,-0.0973949316290354,0.0681068164012333,-0.230884291775453,0.0360944285173819,0.152757021909009
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK8,Kallikrein-8,35710,-0.0319998108316574,0.022387382450489,-0.0758790804346159,0.011879458771301,0.152942389772154
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),QPCT,Glutaminyl-peptide cyclotransferase,35985,-0.0238484365099256,0.0166874222935671,-0.0565557842053171,0.00885891118546591,0.153010189935202
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA12,Carbonic anhydrase 12,35937,0.0283919688750904,0.0199064320481878,-0.0106246379393577,0.0674085756895386,0.153832648323141
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH2,Cadherin-2,35972,-0.0315283848327137,0.0221104970465326,-0.0748649590439175,0.0118081893784901,0.153926141328036
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL2RA,Interleukin-2 receptor subunit alpha,35927,-0.0362360981105321,0.0254249419586138,-0.0860689843494152,0.013596788128351,0.154136640349381
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJC9,DnaJ homolog subfamily C member 9,34964,-0.0689687078327962,0.0484165608860058,-0.163865167169367,0.0259277515037751,0.154354899618405
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLRF1,Killer cell lectin-like receptor subfamily F member 1,34778,-0.0405340163332595,0.0284555631564806,-0.0963069201199615,0.0152388874534424,0.154361782701397
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFAIP2,Tumor necrosis factor alpha-induced protein 2,34964,-0.0449292742475704,0.0315479313316334,-0.106763219657572,0.016904671162431,0.15444944399858
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSB,Lupus La protein,35782,-0.0508831291827233,0.0357303423498372,-0.120914600188404,0.0191483418229576,0.154464627397741
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REN,Renin,35972,-0.0712152085010486,0.0500216304733202,-0.169257604228756,0.026827187226659,0.154579052374318
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF1,Macrophage colony-stimulating factor 1,35992,-0.0234434792675283,0.0164727972497282,-0.0557301618769955,0.008843203341939,0.154731045331344
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,34736,-0.0592620025142224,0.0417072238676887,-0.141008161294892,0.0224841562664476,0.155395196691103
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARG2,"Arginase-2, mitochondrial",34949,-0.0373347155931363,0.026281200152963,-0.0888458678929438,0.0141764367066712,0.15548613997481
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",34952,-0.0638882809378923,0.0450676857556713,-0.152220945019008,0.0244443831432233,0.156354493614577
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTDH,Protein LYRIC,34778,-0.0845024490870197,0.0596513655046287,-0.201419125476092,0.0324142273020525,0.15664873580365
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK3,Prostate-specific antigen,34965,-0.103002671141606,0.0727179470946522,-0.245529847447124,0.0395245051639126,0.156687358878388
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB11FIP3,Rab11 family-interacting protein 3,34949,-0.0965547808147597,0.0682585210069454,-0.230341481988373,0.0372319203588532,0.157250848509853
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NSFL1C,NSFL1 cofactor p47,36043,-0.0558581207381955,0.0394950090872943,-0.133268338549292,0.0215520970729014,0.157313217552918
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PARK7,Parkinson disease protein 7,35979,-0.0440769309140111,0.031191511272989,-0.105212293009069,0.0170584311810473,0.15766655754133
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IST1,IST1 homolog,34915,-0.0862165953564548,0.0610182378158667,-0.205812341475554,0.033379150762644,0.157715487259608
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF11,Tumor necrosis factor ligand superfamily member 11,35971,-0.0533956203196828,0.0378329882152685,-0.127548277221609,0.0207570365822433,0.158183392892479
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RRP15,RRP15-like protein,34750,-0.0811119587544398,0.0574884151400187,-0.193789252428877,0.0315653349199969,0.158316712768259
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXADR,Coxsackievirus and adenovirus receptor,35971,0.0428243720672349,0.0303532639681407,-0.0166680253103209,0.102316769444791,0.158326487237653
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",35896,-0.0840373679754097,0.0596003922406703,-0.200854136767124,0.0327794008163041,0.158578272779661
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRN1,Neuritin,34952,-0.0303455074910799,0.0215483812841674,-0.0725803348080481,0.0118893198258883,0.159106002493962
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSIG2,V-set and immunoglobulin domain-containing protein 2,34949,-0.0559931313092503,0.0397681439955459,-0.13393869354052,0.0219524309220196,0.159183124132477
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYCBP2,E3 ubiquitin-protein ligase MYCBP2,34952,-0.0571103939078639,0.0405832508330494,-0.136653565540641,0.0224327777249129,0.159405016734817
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIE1,Tyrosine-protein kinase receptor Tie-1,36072,0.0350582717733766,0.0249329596416888,-0.0138103291243335,0.0839268726710867,0.159735572182849
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX5,Syntaxin-5,34778,0.0350448770594409,0.0249391625544277,-0.0138358815472374,0.0839256356661191,0.160007734557991
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,35800,0.109088066731657,0.0776529227632424,-0.0431116618842983,0.261287795347612,0.160119146169225
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBC1D17,TBC1 domain family member 17,35782,-0.0388379789551821,0.0276507843307891,-0.0930335162435286,0.0153575583331645,0.160186867179593
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GH1,Somatotropin,35962,-0.155407418189856,0.110644741666338,-0.372271111855879,0.0614562754761668,0.160193701202575
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF8,Tumor necrosis factor receptor superfamily member 8,36043,-0.0383497341322414,0.0273068152060531,-0.0918710919361056,0.0151716236716227,0.160241031021595
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",34952,-0.0810521439991915,0.0577148178813006,-0.194173187046541,0.0320688990481576,0.160261794566648
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL36A,Interleukin-36 alpha,34778,0.049850458771895,0.0355014665355225,-0.0197324156377292,0.119433333181519,0.16031544437841
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SELP,P-selectin,36026,-0.0480004917243413,0.0342352549658577,-0.115101591457422,0.0191006080087397,0.160933806928814
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TARBP2,RISC-loading complex subunit TARBP2,35782,-0.0677864050035061,0.0483815636050365,-0.162614269669378,0.0270414596623654,0.161233581752469
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL16,Pro-interleukin-16,36067,-0.0373298040161195,0.0266560419281856,-0.0895756461953633,0.0149160381631243,0.161427453515611
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,35991,0.0390858925698155,0.0279434971779235,-0.0156833618989145,0.0938551470385455,0.161930719952081
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDGFRA,Platelet-derived growth factor receptor alpha,35972,0.0240139670256353,0.0171802149762959,-0.00965925432790468,0.0576871883791752,0.162224588586353
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA3F,Semaphorin-3F,35972,-0.0228432660531658,0.016350688683259,-0.0548906158723535,0.00920408376602184,0.162430720435806
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTSS1,Protein MTSS 1,34964,-0.0986994332566318,0.0706594430330392,-0.237191941601389,0.039793075088125,0.162512538573673
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF6,Fibroblast growth factor 6,34778,-0.032910234937344,0.0235702877830225,-0.0791079989920681,0.01328752911738,0.162686571807283
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,34822,-0.0498934460759276,0.0357384427771893,-0.119940793919219,0.0201539017673635,0.162742564848433
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPR37,Prosaposin receptor GPR37,35874,-0.0559438715940841,0.040086815888918,-0.134514030736363,0.0226262875481951,0.162887267144813
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGEF5,Rho guanine nucleotide exchange factor 5,34750,0.0655898479179088,0.0470167915529274,-0.026563063525829,0.157742759361647,0.163057084974564
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL9,C-X-C motif chemokine 9,35992,-0.0547275871578012,0.0392738876727134,-0.131704406996319,0.022249232680717,0.16351496678183
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPPC,C-type natriuretic peptide,35971,-0.0453037217379315,0.0325282656826972,-0.109059122476018,0.018451679000155,0.163737597699769
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPL46,"39S ribosomal protein L46, mitochondrial",35782,-0.022581226727645,0.0162162559938454,-0.0543650884755819,0.00920263502029197,0.16381246591539
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INHBC,Inhibin beta C chain,35979,-0.0343168094323389,0.0246529177328637,-0.0826365281887517,0.0140029093240739,0.163964989156379
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRRT3,Proline-rich transmembrane protein 3,34815,0.03406389497019,0.0244784138032081,-0.0139137960840979,0.0820415860244779,0.164096650437771
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOD1,Superoxide dismutase [Cu-Zn],35839,-0.0415484097746789,0.0298858278899541,-0.100124632438989,0.0170278128896311,0.164499399044422
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MCAM,Cell surface glycoprotein MUC18,36026,0.0272285796230341,0.0195887999448905,-0.0111654682689513,0.0656226275150196,0.164568251201956
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRP2,Neuropilin-2,35979,-0.0247033316071345,0.0177807807146293,-0.0595536618078079,0.010146998593539,0.164775037937179
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL4,Interleukin-4,35842,-0.0806528692377612,0.0580716773112638,-0.194473356767838,0.0331676182923158,0.164920969753615
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,34964,0.0738358493618845,0.0531973682617279,-0.0304309924311022,0.178102691154871,0.165197641369356
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH3GL3,Endophilin-A3,34828,-0.0739081772779298,0.0532623417975918,-0.17830236720121,0.0304860126453501,0.165300793240289
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL18RAP,Interleukin-18 receptor accessory protein,35850,-0.144760532996164,0.104355425183736,-0.349297166356287,0.0597761003639598,0.165427261661168
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REG1B,Lithostathine-1-beta,36072,-0.0485880571839248,0.0350299635324515,-0.11724678570753,0.02007067133968,0.165470098048852
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSIP1,PC4 and SFRS1-interacting protein,35971,-0.0567612627313495,0.0410148096290951,-0.137150289604376,0.0236277641416769,0.166424500317117
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAAM1,Disheveled-associated activator of morphogenesis 1,34822,-0.0710555235266827,0.0513456633836681,-0.171693023758672,0.0295819767053068,0.166449094076862
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDA2R,Tumor necrosis factor receptor superfamily member 27,36032,-0.0344930385470783,0.024926341005884,-0.083348666918611,0.0143625898244543,0.166461654678129
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHBG,Sex hormone-binding globulin,34966,0.0411031096576728,0.0297255616301751,-0.0171589911374703,0.0993652104528159,0.166789113887956
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BACH1,Transcription regulator protein BACH1,35971,-0.0628150645929862,0.0454392089039647,-0.151875914044757,0.0262457848587847,0.166891460230075
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNM3,Dynamin-3,34952,-0.047388608645421,0.03428798937614,-0.114593067822655,0.0198158505318135,0.166996951718617
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DLL1,Delta-like protein 1,35991,-0.0256089340397898,0.0185387153902417,-0.0619448162046636,0.010726948125084,0.167205180090646
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,34949,-0.0419445894596692,0.0304131423744375,-0.101554348513567,0.0176651695942283,0.167894006849359
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,34965,-0.0344746787663137,0.0249977897075373,-0.0834703465930868,0.0145209890604593,0.167909581050085
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK15,Kallikrein-15,34940,-0.0454094063984715,0.0329489366052242,-0.109989322144711,0.0191705093477679,0.168197844528617
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP2,"Fatty acid-binding protein, intestinal",35972,0.0681337006231263,0.0494741997074001,-0.0288357308033778,0.16510313204963,0.168505774988934
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,35776,-0.0399502335488095,0.0290187267606054,-0.0968269379995961,0.0169264709019771,0.16864634357334
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPN9,Tyrosine-protein phosphatase non-receptor type 9,34764,0.0316115596090718,0.022970073031656,-0.013409783532974,0.0766329027511176,0.168807759883631
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AP3S2,AP-3 complex subunit sigma-2,34958,-0.0412488455399248,0.029994668776412,-0.100038396341692,0.0175407052618427,0.169116071910736
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL25,Interleukin-25,34711,-0.0291336461831554,0.0211879817452765,-0.0706620904038973,0.0123947980375864,0.169179346738926
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GZMB,Granzyme B,35971,-0.0580508493009079,0.0422381065351896,-0.140837538109879,0.0247358395080636,0.169368166914375
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRTN,Neurturin,35842,-0.044049519362022,0.0320535780343305,-0.10687453230931,0.0187754935852657,0.169407676772666
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RASSF2,Ras association domain-containing protein 2,35800,-0.0496788931761946,0.036179931475135,-0.120591558867459,0.0212337725150701,0.169762050792325
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACOT13,Acyl-coenzyme A thioesterase 13,34964,-0.0983376638391079,0.0716425129433235,-0.238756989208022,0.0420816615298062,0.169920105526706
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A11,Protein S100-A11,35922,-0.0410305172507443,0.0299250044202175,-0.0996835259143706,0.0176224914128819,0.170382226362746
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RILP,Rab-interacting lysosomal protein,36013,-0.0503281557582045,0.0367096599002049,-0.122279089162606,0.021622777646197,0.170423150970004
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGCC,Regulator of cell cycle RGCC,34952,-0.0657890243282129,0.0479984819612813,-0.159866048972324,0.0282880003158984,0.170533136310567
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC34A3,Sodium-dependent phosphate transport protein 2C,34739,-0.0406744122320878,0.0297456477445477,-0.0989758818114014,0.0176270573472257,0.171547773928406
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC3B,Tetranectin,34827,0.0175101727174539,0.0128075862286965,-0.00759269629079121,0.0426130417256991,0.171620762350575
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCDC28A,Coiled-coil domain-containing protein 28A,34805,0.0259016902612043,0.0190041682909097,-0.0113464795889786,0.0631498601113872,0.172948404538766
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CGREF1,Cell growth regulator with EF hand domain protein 1,35972,0.0365289122040019,0.0268200775482291,-0.0160384397905271,0.089096264198531,0.173239893528906
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,34964,-0.0552046181132596,0.0405337324891664,-0.134650733792026,0.0242414975655065,0.173264197624274
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMTN,Smoothelin,34945,-0.0792295515312536,0.0581832088476557,-0.193268640872659,0.0348095378101516,0.173332918430437
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP7,Insulin-like growth factor-binding protein 7,36072,-0.025733087009078,0.0189015937763783,-0.0627802108107794,0.0113140367926234,0.173420726255517
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATG16L1,Autophagy-related protein 16-1,34964,-0.0732889723829931,0.0539069333076762,-0.178946561666038,0.0323686169000522,0.174021705080799
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRND,Prion-like protein doppel,34958,0.0415799117940839,0.0306130228489353,-0.0184216129898292,0.101581436577997,0.174434908940668
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDIA4,Protein disulfide-isomerase A4,34965,-0.0521439895387864,0.038451885351548,-0.12750968482782,0.0232217057502477,0.175120522259156
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AK2,"Adenylate kinase 2, mitochondrial",34958,-0.0909386036726439,0.067062003431972,-0.222380130399309,0.0405029230540211,0.175135335634732
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",34736,-0.0361350821880285,0.0266482502776609,-0.0883656527322438,0.0160954883561869,0.175148411874745
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL25,C-C motif chemokine 25,36067,-0.0409563531640327,0.0302240767574621,-0.100195543608658,0.018282837280593,0.175429781107489
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PMS1,PMS1 protein homolog 1,34805,-0.0441980953728602,0.032642889325691,-0.108178158451215,0.0197819677054942,0.175789369938883
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TANK,TRAF family member-associated NF-kappa-B activator,35842,-0.0584525537751314,0.0432275060560599,-0.143178465645009,0.026273358094746,0.176351199106653
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OSTN,Osteocrin,34805,-0.0358872945535715,0.0265656818816019,-0.0879560310415113,0.0161814419343683,0.176780163884394
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIF20B,Kinesin-like protein KIF20B,34750,-0.0633177014760205,0.0469281382708947,-0.155296852486974,0.028661449534933,0.177306958772019
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSIG4,V-set and immunoglobulin domain-containing protein 4,35970,-0.0345410515501565,0.0256057045620466,-0.0847282324917678,0.0156461293914548,0.17739150482041
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LACRT,Extracellular glycoprotein lacritin,34935,-0.038905990637592,0.0288523718120435,-0.0954566393891972,0.0176446581140133,0.177561787283016
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENSA,Alpha-endosulfine,34949,-0.0445483201015344,0.0330414763464018,-0.109309613740482,0.020212973537413,0.177624628013462
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FXN,"Frataxin, mitochondrial",36032,-0.059566254803639,0.0442641144222664,-0.146323919071281,0.0271914094640031,0.178440074524756
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STIP1,Stress-induced-phosphoprotein 1,35964,-0.0527356173346701,0.0391889058149486,-0.129545872731969,0.0240746380626291,0.178448069557383
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,36072,-0.0229176950418651,0.0170344636888305,-0.0563052438719729,0.0104698537882428,0.178545872559269
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT18,"Keratin, type I cytoskeletal 18",35937,-0.0707613738180538,0.052626707387612,-0.173909720297773,0.0323869726616656,0.178799060189642
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHSG,Alpha-2-HS-glycoprotein,34966,0.0234618749728762,0.0174519901170817,-0.010744025656604,0.0576677756023563,0.178877726891851
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP3,Caspase-3,36072,-0.0722828262319379,0.0537743785291828,-0.177680608149136,0.0331149556852603,0.178928699197189
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUSD2,Sushi domain-containing protein 2,35979,-0.0235976517866492,0.0175641564133404,-0.0580233983567964,0.010828094783498,0.17914761385809
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRD2,Bromodomain-containing protein 2,34750,0.0295223107261711,0.0219785563566541,-0.013555659732871,0.0726002811852132,0.179246271988098
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC10A,C-type lectin domain family 10 member A,35902,-0.0300953579053403,0.0224125532517228,-0.0740239622787171,0.0138332464680365,0.179381640593257
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEXN,Nexilin,34966,-0.0593984569027819,0.044261413895805,-0.14615082813856,0.0273539143329958,0.179646497715338
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGL2,Ral guanine nucleotide dissociation stimulator-like 2,34869,0.0508927856839885,0.0379236099281108,-0.0234374897751086,0.125223061143086,0.179650571857956
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GMPR,GMP reductase 1,36067,-0.0400739548806918,0.0299178827949017,-0.098713005158699,0.0185650953973155,0.180460129496883
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCN2,Transcobalamin-2,36066,-0.02477226218114,0.0185163498184496,-0.0610643078253012,0.0115197834630212,0.180983206647159
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAPK2,Death-associated protein kinase 2,34778,-0.0485043996168368,0.0362637923479297,-0.119581432618779,0.0225726333851054,0.181094531231338
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL2,C-C motif chemokine 2,35890,0.0425578836498575,0.0318499068510546,-0.0198679337782095,0.104983701077925,0.181525226168729
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,35902,-0.0350556775075164,0.0262887833708594,-0.0865816929144008,0.016470337899368,0.182414549367078
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRYM,Ketimine reductase mu-crystallin,34750,0.0631360095334186,0.0474231292121513,-0.029813323722398,0.156085342789235,0.183128584327815
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD86,T-lymphocyte activation antigen CD86,34964,-0.0250766245093219,0.0188390923075334,-0.0620012454320873,0.0118479964134436,0.183205385449665
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RANBP1,Ran-specific GTPase-activating protein,34815,-0.0438169947884333,0.0329495694921444,-0.108398150993036,0.0207641614161697,0.183626403894934
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,34815,-0.0319750719429673,0.0240635830849913,-0.0791396947895503,0.0151895509036157,0.18397120986513
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CORO6,Coronin-6,34750,0.0324413230563344,0.0244461310229364,-0.015473093748621,0.0803557398612898,0.184540260223839
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OSMR,Oncostatin-M-specific receptor subunit beta,36035,-0.015734420073212,0.0118579158162144,-0.0389759350729923,0.0075070949265682,0.184578284162541
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,35937,-0.0263463693594001,0.0198559438857884,-0.0652640193755453,0.0125712806567452,0.184591097729664
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1RL2,Interleukin-1 receptor-like 2,35842,0.0308347589248171,0.0232403340603739,-0.0147162958335158,0.07638581368315,0.184624033983098
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB6,Integrin beta-6,35842,0.0253665837521044,0.0191222153500744,-0.0121129583340415,0.0628461258382503,0.184699258334234
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPY30,Protein dpy-30 homolog,36010,-0.0488964030064642,0.0369014404355123,-0.121223226260068,0.02343042024714,0.185194082485125
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMPD1,Sphingomyelin phosphodiesterase,36004,-0.041550341250689,0.0313998386471259,-0.103094024999056,0.0199933424976776,0.18578777030202
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGDCC4,Immunoglobulin superfamily DCC subclass member 4,34965,0.0220677674370229,0.0166798372770212,-0.0106247136259386,0.0547602484999845,0.185876071154888
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UNG,Uracil-DNA glycosylase,34949,-0.0281325884041351,0.0213224769644484,-0.0699246432544539,0.0136594664461837,0.187087507379895
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17F,Interleukin-17F,35842,-0.0612870478046377,0.0464752630169024,-0.152378563317766,0.029804467708491,0.187310273440175
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLTA,Clathrin light chain A,35874,-0.0376416620688125,0.0285544101711393,-0.0936083060042454,0.0183249818666204,0.187463697368306
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HIP1R,Huntingtin-interacting protein 1-related protein,34941,-0.0382741806232509,0.0290357019864773,-0.0951841565167464,0.0186357952702446,0.187492177278755
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,35770,-0.0468295754253001,0.0355559839461665,-0.116519303959786,0.0228601531091863,0.187858612576417
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OCLN,Occludin,34952,-0.0367271443073093,0.0279025306422684,-0.0914161043661554,0.0179618157515368,0.188132370287251
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA11,Serpin A11,36072,-0.0336007285513197,0.0255450661671846,-0.0836690582390016,0.0164676011363621,0.188432323155702
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM40,E3 ubiquitin ligase TRIM40,34805,-0.0613658785876528,0.0466671553788055,-0.152833503130112,0.030101745954806,0.188568800414695
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TLR1,Toll-like receptor 1,34778,-0.022376206779837,0.0170303049253306,-0.055755604433485,0.011003190873811,0.188926882235787
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRCP,Lysosomal Pro-X carboxypeptidase,36021,-0.025815028188468,0.0196827029222458,-0.0643931259160699,0.0127630695391338,0.18970951431031
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,35842,-0.0353102766113984,0.0269420274962945,-0.0881166505041355,0.0174960972813388,0.190033805453561
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGFBP2,Fibroblast growth factor-binding protein 2,34965,-0.0418855975950824,0.0319959473524286,-0.104597654405843,0.0208264592156777,0.190550881389867
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FSTL3,Follistatin-related protein 3,35943,-0.0258186244309426,0.0197512035753457,-0.0645309834386202,0.012893734576735,0.191188285628534
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERMAP,Erythroid membrane-associated protein,34778,-0.0372865412003347,0.0285391244668537,-0.0932232251553679,0.0186501427546984,0.191429128733383
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SART1,U4/U6.U5 tri-snRNP-associated protein 1,34736,-0.0314992302619007,0.0241136918169919,-0.0787620662232049,0.0157636056994035,0.191506362194264
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,34681,-0.0417226287784169,0.0319614671244681,-0.104367104342374,0.0209218467855405,0.191804685661127
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VEGFA,Vascular endothelial growth factor A,36045,-0.0460800396046353,0.0353155085473248,-0.115298436357392,0.0231383571481213,0.191997777140699
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CES1,Liver carboxylesterase 1,36008,0.0679206861293835,0.0520559932755922,-0.0341090606907772,0.169950432949544,0.192014404293553
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDT5,ADP-sugar pyrophosphatase,35979,-0.0399766883366797,0.0306638630413629,-0.100077859897751,0.0201244832243915,0.192374223067773
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTBR,Tumor necrosis factor receptor superfamily member 3,35913,-0.0236737592446573,0.0181589707055871,-0.059265341827608,0.0119178233382934,0.192378633585288
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",35971,-0.079619701361812,0.0610878701685026,-0.199351926892077,0.0401125241684531,0.192491394078137
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFI,Complement factor I,34975,-0.0161756452951187,0.012420473508378,-0.0405197733715395,0.00816848278130215,0.192848171416037
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIT,Mast/stem cell growth factor receptor Kit,36014,0.0233255732917995,0.01791121804512,-0.0117804140766358,0.0584315606602347,0.192858235057801
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLSCR3,Phospholipid scramblase 3,34949,-0.0472234309746253,0.0362689556139135,-0.118310583977896,0.0238637220286451,0.192951831253659
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,36019,0.0242337104974091,0.0186194256590627,-0.0122603637943537,0.060727784789172,0.193118077750969
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WIF1,Wnt inhibitory factor 1,36032,-0.0272774601013548,0.0209595864466653,-0.0683582495368187,0.0138033293341092,0.193151234967349
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTHRC1,Collagen triple helix repeat-containing protein 1,34965,0.0234126025550921,0.0179912387552342,-0.011850225405167,0.0586754305153511,0.193191410135398
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX3,Syntaxin-3,34958,-0.0305031081545972,0.0234734648039288,-0.0765110991702976,0.0155048828611032,0.193829142123733
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLO1,Lactoylglutathione lyase,35874,-0.0456890143859204,0.0351723948360519,-0.114626908264582,0.0232488794927412,0.193984385662757
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",34952,-0.0388680098841528,0.0299768944338317,-0.0976227229744628,0.0198867032061573,0.194816313439492
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERBB4,Receptor tyrosine-protein kinase erbB-4,35991,0.0186201161617054,0.0143689755213484,-0.00954307586013759,0.0467833081835483,0.195065733723774
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DGCR6,Protein DGCR6,34750,-0.0341905531905572,0.0264125350133752,-0.0859591218167726,0.0175780154356582,0.195547557333174
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD163,Scavenger receptor cysteine-rich type 1 protein M130,36026,-0.0341469022719458,0.0263895823006273,-0.0858704835811752,0.0175766790372837,0.1957215945508
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BMP6,Bone morphogenetic protein 6,35863,-0.0321638677089788,0.0248903204426159,-0.0809488957765061,0.0166211603585484,0.196320718819932
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BOC,Brother of CDO,35874,0.0185332686578491,0.0143905473147412,-0.0096722040790437,0.0467387413947419,0.197829419340753
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTSL2,ADAMTS-like protein 2,34965,-0.0285697272056204,0.0221865175421105,-0.072055301588157,0.0149158471769161,0.197894897825816
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA7,Thyroxine-binding globulin,34975,0.0151173471402307,0.0117438700157698,-0.00790063809067821,0.0381353323711395,0.198052400639312
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OTUD6B,Deubiquitinase OTUD6B,34964,-0.0468182914781996,0.0363733871946698,-0.118110130379752,0.0244735474233532,0.198086080988655
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGF2R,Cation-independent mannose-6-phosphate receptor,35979,-0.0189750259447722,0.0147537105893103,-0.0478922986998204,0.00994224681027604,0.198441924689524
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD1C,T-cell surface glycoprotein CD1c,35991,-0.0194546546773127,0.0151349952945106,-0.0491192454545536,0.0102099360999282,0.198689776294175
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMS,Spermine synthase,34750,0.0524079640552738,0.0408062897453922,-0.0275723638456949,0.132388291956242,0.19908155986924
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RPE,Ribulose-phosphate 3-epimerase,34869,-0.0576123451516106,0.0449106882097828,-0.145637294042785,0.0304126037395637,0.199602445663588
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F7,Coagulation factor VII,36014,0.0242836323454546,0.0189480236874208,-0.0128544940818901,0.0614217587727993,0.200025946495863
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",34815,-0.0251590472792367,0.0196398497814069,-0.0636531528507943,0.0133350582923208,0.200234315210438
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HNRNPK,Heterogeneous nuclear ribonucleoprotein K,35847,-0.061400875203196,0.0479457997044636,-0.155374642623945,0.0325728922175526,0.200364306055975
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MORN4,MORN repeat-containing protein 4,34739,-0.0636036545545271,0.0497077042968059,-0.161030754976267,0.0338234458672124,0.200750656528412
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPTXR,Neuronal pentraxin receptor,35972,0.0269984279220945,0.0211041075612921,-0.014365622898038,0.0683624787422271,0.20083264488248
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD83,CD83 antigen,35971,-0.0264863155548689,0.0207207055100809,-0.0670988983546275,0.0141262672448897,0.201200286157431
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STXBP1,Syntaxin-binding protein 1,34952,-0.0621515856870476,0.0486561575763406,-0.157517654536675,0.0332144831625799,0.20152073244976
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFCAB14,EF-hand calcium-binding domain-containing protein 14,34964,-0.0227781912479838,0.0178331890152068,-0.057731241717789,0.0121748592218215,0.20154574183343
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MIF,Macrophage migration inhibitory factor,35964,-0.0521311150018916,0.040842469196675,-0.132182354627375,0.0279201246235914,0.201856247759369
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YJU2,Splicing factor YJU2,34949,-0.0264846192855262,0.0207963093440928,-0.0672453855999481,0.0142761470288956,0.202878438803162
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",35937,-0.0272072361492339,0.0213857848209891,-0.0691233743983725,0.0147089020999048,0.203338388135088
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNIP1,TNFAIP3-interacting protein 1,34958,-0.0701733090173128,0.0551932897725627,-0.178352156971536,0.03800553893691,0.2036292806247
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL11,Interleukin-11,35842,-0.0508790438797856,0.0400555315549639,-0.129387885727515,0.0276297979679436,0.204049691507405
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,34975,-0.0152883443125988,0.0120576363604778,-0.0389213115791353,0.00834462295393773,0.20486613181801
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPSG1,Tryptase gamma,34778,0.0214410269689403,0.0169128198523121,-0.0117080999415915,0.054590153879472,0.20493925287444
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRPV3,Transient receptor potential cation channel subfamily V member 3,34736,-0.0396015664281281,0.0312661049533196,-0.100883132136634,0.0216799992803783,0.205347368954527
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDIA3,Protein disulfide-isomerase A3,34822,-0.0197528260367883,0.0155958053237681,-0.0503206044713737,0.010814952397797,0.205364596796274
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FDX1,"Adrenodoxin, mitochondrial",34736,-0.05263967513889,0.0415674517283813,-0.134111880526517,0.0288325302487373,0.205429567584091
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRB,Receptor-type tyrosine-protein phosphatase beta,34949,-0.0236047633747291,0.0186434373153571,-0.0601459005128291,0.0129363737633709,0.20551783358591
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GHRL,Appetite-regulating hormone,35972,0.0648719507832858,0.0512563008284938,-0.035590398840562,0.165334300407134,0.205682511769569
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,34964,-0.0575060549749752,0.0454900801667911,-0.146666612101886,0.0316545021519353,0.206224304653232
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCTPP1,dCTP pyrophosphatase 1,35972,0.0248827404796348,0.0197155125745398,-0.0137596641664632,0.0635251451257329,0.206956526637702
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL5,C-C motif chemokine 5,36026,-0.0793283233592295,0.0628976048226045,-0.202607628811534,0.0439509820930754,0.207265742455181
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SFTPD,Pulmonary surfactant-associated protein D,35972,-0.053133006501007,0.0421342086198413,-0.135716055395896,0.0294500423938821,0.207333622735639
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",34815,-0.0561474591397662,0.0445283594633837,-0.143423043687998,0.0311281254084658,0.207378852357742
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,35972,-0.0514815692874976,0.0408870867670152,-0.131620259350847,0.0286571207758521,0.20802844265543
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COMT,Catechol O-methyltransferase,35790,-0.064053732147835,0.0509840505233721,-0.163982471173644,0.0358750068779744,0.209030485742845
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNLY,Granulysin,35979,-0.0415885572269467,0.0331046452926228,-0.106473662000487,0.0232965475465939,0.209055845990571
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,34964,-0.110646937879226,0.088108650330784,-0.283339892527563,0.0620460167691105,0.209234203901137
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOLR1,Folate receptor alpha,35955,0.0224180611477385,0.0178850431568071,-0.0126366234396035,0.0574727457350804,0.210080733024688
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL13RA1,Interleukin-13 receptor subunit alpha-1,35878,0.0186669117795605,0.0148994461100226,-0.0105360025960838,0.0478698261552047,0.210297114963947
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC7,Sialic acid-binding Ig-like lectin 7,35972,-0.0216215433889941,0.0172757610371059,-0.0554820350217217,0.0122389482437335,0.21077223019641
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM58,E3 ubiquitin-protein ligase TRIM58,34949,-0.0682165419821286,0.0545126209470567,-0.17506127903836,0.0386281950741026,0.210838374687279
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD70,CD70 antigen,35971,-0.0340476360646117,0.0272201284572984,-0.0873990878409165,0.0193038157116932,0.211037780059916
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1RL1,Interleukin-1 receptor-like 1,36049,-0.0367725660722656,0.0294167247961995,-0.0944293466728165,0.0208842145282853,0.211318203133569
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,34762,-0.0216574259863578,0.0173577642316026,-0.0556786438802989,0.0123637919075833,0.212185324298116
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TALDO1,Transaldolase,34951,-0.0349553167696135,0.028047743422679,-0.0899288938780643,0.0200182603388373,0.212707910602507
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,35800,-0.0596986282701588,0.0480059840886572,-0.153790357083927,0.0343931005436092,0.213699681095795
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRTN3,Myeloblastin,35800,-0.0385507545801586,0.0310251099475292,-0.0993599700773158,0.0222584609169986,0.21406817890568
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX16,Syntaxin-16,35800,-0.042776442650789,0.0344867329464459,-0.110370439225823,0.0248175539242451,0.214877556979926
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CREG1,Protein CREG1,35883,-0.0308946609170166,0.0249115212194896,-0.0797212425072162,0.017931920673183,0.214950402611072
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RUVBL1,RuvB-like 1,35800,-0.0763971622279742,0.0616427167046674,-0.197216886969122,0.044422562513174,0.215254736459955
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSPYL1,Testis-specific Y-encoded-like protein 1,34778,-0.031719305685011,0.0255934778257793,-0.0818825222235384,0.0184439108535163,0.215262569039783
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEPTIN3,Neuronal-specific septin-3,34952,-0.0637399866424649,0.0514310307434415,-0.16454480689961,0.0370648336146804,0.215269336369581
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFF1,Trefoil factor 1,35953,-0.0606183429868877,0.0489425663995655,-0.156545773130036,0.0353090871562607,0.215547740170975
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SWAP70,Switch-associated protein 70,34964,-0.0275152704421102,0.0222259872120934,-0.0710782053778133,0.0160476644935928,0.215770099117067
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,34952,-0.0774883196851285,0.0626191217776669,-0.200221798369356,0.0452451589990987,0.215964103916078
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD28,T-cell-specific surface glycoprotein CD28,35800,-0.0284076299715455,0.0229773051010753,-0.0734431479696532,0.0166278880265621,0.21637466286935
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP8,Neutrophil collagenase,36034,-0.0559786116666704,0.0453098077872366,-0.144785834929654,0.0328286115963134,0.216697110459956
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SDK2,Protein sidekick-2,34822,-0.0296378947394318,0.0240026457069416,-0.0766830803250374,0.0174072908461739,0.216960449506122
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA5A,"Carbonic anhydrase 5A, mitochondrial",35874,0.0698001913344542,0.0565932926196199,-0.0411226622000008,0.180723044868909,0.217479437601622
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RPA2,Replication protein A 32 kDa subunit,34778,-0.0245872564791242,0.0199370322611764,-0.0636638397110299,0.0144893267527815,0.217531082926194
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRL2,Fc receptor-like protein 2,36033,-0.0371856633295378,0.0301610643621351,-0.0963013494793227,0.021930022820247,0.217650989124302
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRF,Receptor-type tyrosine-protein phosphatase F,36072,0.0213235848973035,0.0173078698279355,-0.0125998399654501,0.0552470097600572,0.217981609252688
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HLA_DRA,,35952,-0.0275165581152852,0.0223484544134103,-0.0713195287655694,0.0162864125349989,0.218268365106388
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATRAID,All-trans retinoic acid-induced differentiation factor,34964,-0.0230591916775713,0.0187286973918188,-0.0597674385655362,0.0136490552103936,0.218285194752631
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,35842,-0.0326492604348466,0.0265670757994428,-0.0847207290017546,0.0194222081320613,0.219135386216733
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC6,Sialic acid-binding Ig-like lectin 6,36032,-0.0255581762445506,0.0208019080839737,-0.066329916089139,0.0152135636000378,0.219243552517491
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCN2B,Sodium channel subunit beta-2,34805,0.0220478362668234,0.017947968031664,-0.013130181075238,0.0572258536088849,0.219331891444199
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),XPNPEP2,Xaa-Pro aminopeptidase 2,35991,0.0824199667229183,0.0671905635194521,-0.0492735377752078,0.214113471221044,0.21998953836699
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAPK13,Mitogen-activated protein kinase 13,34739,-0.0338228395212352,0.0275915323823192,-0.0879022429905808,0.0202565639481105,0.220305429363449
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SDHB,Succinate dehydrogenase,34964,-0.0494942382548715,0.0403839909768285,-0.128646860569455,0.0296583840597124,0.220398143724317
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFB1,Transforming growth factor beta-1 proprotein,36056,-0.0299333687774062,0.0244257559676238,-0.0778078504739489,0.0179411129191364,0.220431690429368
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAXX,Protein PAXX,34822,-0.0359403395871344,0.0293450537256392,-0.0934566448893873,0.0215759657151184,0.2207159869086
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYPD8,Ly6/PLAUR domain-containing protein 8,35800,0.0390969116546083,0.0319491269905614,-0.023523377246892,0.101717200556109,0.22109642874635
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDKL5,Cyclin-dependent kinase-like 5,34750,0.0412125297992277,0.0337394426045081,-0.0249167777056082,0.107341837304064,0.221945822160709
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPME1,Protein phosphatase methylesterase 1,35937,-0.0449621479826551,0.0368855010694074,-0.117257730078694,0.0273334341133835,0.222896530293537
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RP2,Protein XRP2,35937,-0.0322995020746908,0.0265160406055422,-0.0842709416615535,0.019671937512172,0.223220657921381
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLIT2,Slit homolog 2 protein,35782,-0.0383287141858502,0.0314691641505695,-0.100008275920966,0.023350847549266,0.223272772461651
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ULBP2,UL16-binding protein 2,35902,-0.0290664952826119,0.0238677606851723,-0.0758473062255496,0.0177143156603259,0.223333978596477
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TDP1,Tyrosyl-DNA phosphodiesterase 1,34949,-0.0556927233570882,0.0457499385812453,-0.145362602976329,0.0339771562621526,0.22352433865797
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL12B,Interleukin-12 subunit beta,36067,-0.0409544366092029,0.0336532928234834,-0.10691489054323,0.0250060173248247,0.223661001568342
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUS,RNA-binding protein FUS,35784,-0.0299914907155599,0.0246613906497758,-0.0783278163891205,0.0183448349580008,0.223974840649438
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDNF,Cerebral dopamine neurotrophic factor,35937,0.0246050350072981,0.0202368401294677,-0.0150591716464586,0.0642692416610547,0.224079812275106
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNL2,Interferon lambda-2,34750,0.0459118212541209,0.037870073791836,-0.0283135233778778,0.120137165886119,0.22542462579091
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,35979,-0.0224192447211701,0.0185195090058119,-0.0587174823725614,0.0138789929302211,0.226097308750051
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GP1BB,Platelet glycoprotein Ib beta chain,34736,-0.0524798526031521,0.0433756724720285,-0.137496170648328,0.0325364654420237,0.226367180565641
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL5A1,Collagen alpha-1(V) chain,34822,-0.0304908030604401,0.0252224678186743,-0.0799268399850416,0.0189452338641615,0.226756926131509
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA3,Annexin A3,36034,-0.0518097364449557,0.0428917489599316,-0.135877564406422,0.0322580915165102,0.227117043688458
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GCC1,GRIP and coiled-coil domain-containing protein 1,34958,-0.081782844989253,0.0677712481155459,-0.214614491295723,0.0510488013172169,0.227573950992596
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDI2,Protein DDI1 homolog 2,34822,-0.0588396595626524,0.0487771771764696,-0.154442926828533,0.036763607703228,0.227749672355259
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",35971,-0.0712217477636608,0.0591260017670337,-0.187108711227047,0.0446652156997253,0.228405799352133
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MZT1,Mitotic-spindle organizing protein 1,35800,-0.0393018600712393,0.0326372443166533,-0.10327085893188,0.0246671387894012,0.228550799796597
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAP1L4,Nucleosome assembly protein 1-like 4,34950,-0.0309234954452626,0.0256858372512341,-0.0812677364576815,0.0194207455671562,0.228668352037401
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YTHDF3,YTH domain-containing family protein 3,35842,-0.0636340890058104,0.0529291075674816,-0.167375139838074,0.0401069618264535,0.229305482881118
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBR1,T-box brain protein 1,34805,-0.0363414451883697,0.0302292101419888,-0.0955906970666678,0.0229078066899283,0.229333350727947
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGM2,Phosphoglucomutase-2,34805,-0.0434950851908654,0.0361896695720599,-0.114426837552103,0.0274366671703719,0.229461832203081
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VPS4B,Vacuolar protein sorting-associated protein 4B,34949,-0.0716282049232096,0.0596811163200821,-0.18860319291057,0.0453467830641514,0.230113422479937
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXNDC5,Thioredoxin domain-containing protein 5,36043,-0.0501436668663787,0.0417832785324659,-0.132038892790012,0.0317515590572545,0.230142843967506
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRL3,Fc receptor-like protein 3,35842,-0.0394353445668147,0.032877388639726,-0.103875026300678,0.0250043371670484,0.230385628280356
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VASP,Vasodilator-stimulated phosphoprotein,34966,-0.055099039347374,0.0459882897902254,-0.145236087336216,0.0350380086414678,0.230918719411515
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNMA1,Paraneoplastic antigen Ma1,34815,-0.0436008093457581,0.0364490581755022,-0.115040963369742,0.0278393446782261,0.231659380424069
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS9,Galectin-9,35958,-0.022767885985998,0.0190347198884639,-0.0600759369673872,0.0145401649953913,0.231686701377135
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SYT1,Synaptotagmin-1,34958,-0.0297466936610355,0.0248984865078875,-0.078547727216495,0.0190543398944241,0.232241421004243
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKD2,Serine/threonine-protein kinase D2,34736,-0.0331913878439793,0.0278569253473322,-0.0877909615247503,0.0214081858367918,0.233505393877308
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLXDC2,Plexin domain-containing protein 2,34958,-0.0209665313484748,0.0176012276974421,-0.0554649376354614,0.0135318749385118,0.233620684929367
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA2,Annexin A2,34712,-0.0536606839188161,0.0450635333826586,-0.141985209348827,0.0346638415111947,0.233786819084697
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CMC1,COX assembly mitochondrial protein homolog,34949,-0.0679750961051492,0.0571557196824152,-0.180000306682683,0.0440501144723846,0.234367496450002
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",34815,-0.0683113222114709,0.0574790393964137,-0.180970239428442,0.0443475950055,0.234699126264446
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HIP1,Huntingtin-interacting protein 1,34736,0.0249611915680146,0.0210112418537985,-0.0162208424654305,0.0661432256014596,0.234882461362181
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AK1,Adenylate kinase isoenzyme 1,35972,-0.0465790169396604,0.0392379136233978,-0.12348532764152,0.0303272937621992,0.235229547681845
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LEO1,RNA polymerase-associated protein LEO1,34952,-0.0214358317897428,0.0180846816641846,-0.0568818078515446,0.014010144272059,0.235941913559955
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGR2,Anterior gradient protein 2 homolog,35727,0.0721389077463299,0.0608802162618646,-0.0471863161269246,0.191464131619584,0.236083900310098
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TLR4,Toll-like receptor 4,34778,0.0211426988408455,0.0178603716752661,-0.0138636296426761,0.056149027324367,0.236546857653243
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BLVRB,Flavin reductase,35979,-0.0488187310387034,0.0412907658172776,-0.129748632040567,0.0321111699631607,0.237118455134862
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNL1,Interferon lambda-1,35782,-0.0326928531235596,0.0276568178917923,-0.0869002161914726,0.0215145099443534,0.237209051802945
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPP7,Dipeptidyl peptidase 2,35916,-0.0454517773383988,0.0384531444549348,-0.120819940470071,0.0299163857932733,0.237242460262042
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HPSE,Heparanase,34877,-0.0707108735651159,0.0598484135807105,-0.188013764183309,0.0465920170530768,0.237449093525122
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRSS2,Trypsin-2,36026,-0.0406851151939423,0.0344389116030815,-0.108185381935982,0.0268151515480975,0.237493392428655
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINB8,Serpin B8,36067,-0.0442608561526485,0.0374900470174963,-0.117741348306941,0.0292196360016443,0.237798138396401
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD84,SLAM family member 5,35971,-0.0232551137084291,0.0196980372012111,-0.0618632666228028,0.0153530392059447,0.237807607275101
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",34869,-0.036531441329633,0.0309468100185817,-0.0971871889660532,0.0241243063067872,0.237862483311251
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTNNA1,Catenin alpha-1,34750,0.024953747519343,0.0211485384474546,-0.016497387837668,0.0664048828763539,0.238074587227087
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC10,Sialic acid-binding Ig-like lectin 10,35971,-0.0252535074615216,0.0214042133700096,-0.0672057656667404,0.0166987507436972,0.23810266989598
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HYAL1,Hyaluronidase-1,35961,0.016854940140529,0.0142872880958476,-0.0111481445273323,0.0448580248083904,0.238151374705044
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NLGN2,Neuroligin-2,34750,-0.0338705403469187,0.0287290836448091,-0.0901795442907446,0.0224384635969072,0.238458328481908
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSB,Cathepsin B,35991,-0.0371225406138707,0.0314979811122556,-0.0988585835938917,0.0246135023661503,0.2386078273112
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZNF75D,Zinc finger protein 75D,34869,0.0459589084974951,0.0390246173845881,-0.0305293415762975,0.122447158571288,0.23896485092179
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD3G,T-cell surface glycoprotein CD3 gamma chain,34778,-0.063176027060989,0.0536479523891605,-0.168326013743744,0.0419739596217656,0.238999997198811
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ST13,Hsc70-interacting protein,34822,-0.0405416781063535,0.0344540630350604,-0.108071641655072,0.0269882854423648,0.239365124265661
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PALLD,Palladin,34778,0.0304795449745493,0.0259063763843952,-0.0202969527388653,0.081256042687964,0.2394297765546
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,35902,-0.0687436122139453,0.0584403965614929,-0.183286789474471,0.0457995650465809,0.239512174803223
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNW1,Interferon omega-1,34736,-0.0258631550759996,0.0219979397159673,-0.0689791169192955,0.0172528067672963,0.239757170991347
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RABEP1,Rab GTPase-binding effector protein 1,34822,-0.0563544259940122,0.0480136709388515,-0.150461221034161,0.0377523690461368,0.240553622870755
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADA,Adenosine deaminase,36067,-0.0263110598687648,0.022444494331739,-0.0703022687589731,0.0176801490214436,0.241125132338414
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAGK,N-acetyl-D-glucosamine kinase,34799,-0.0422739306946538,0.0360751941194834,-0.112981311168841,0.0284334497795338,0.241311063452019
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPING1,Plasma protease C1 inhibitor,34969,0.0138902917027892,0.0118581464024659,-0.00935167524604411,0.0371322586516224,0.241493405478319
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPT1,Palmitoyl-protein thioesterase 1,34805,-0.0560340058925877,0.0478612927369891,-0.149842139657086,0.0377741278719109,0.241740901693159
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MINK1,Misshapen-like kinase 1,34958,-0.067883487884714,0.0579932957721732,-0.181550347598173,0.0457833718287454,0.241827490815309
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD3D,T-cell surface glycoprotein CD3 delta chain,34750,0.0248656317868846,0.0212457789008039,-0.0167760948586909,0.0665073584324602,0.2418934858136
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DFFA,DNA fragmentation factor subunit alpha,36067,-0.0481496346325886,0.0411869162768876,-0.128875990535288,0.0325767212701112,0.24242011899418
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NHLRC3,NHL repeat-containing protein 3,34666,-0.0237605873802966,0.0203260465391311,-0.0635996385969935,0.0160784638364004,0.242460686387918
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK7,Kallikrein-7,34659,-0.0288669628082387,0.0247226978480578,-0.0773234505904321,0.0195895249739547,0.243002003785992
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIP,Gastric inhibitory polypeptide,34815,-0.0376363891744996,0.0322394286103367,-0.100825669250759,0.0255528909017603,0.243092652428083
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GUCA2A,Guanylin,35940,0.0249046195027352,0.0213507488122743,-0.0169428481693224,0.0667520871747928,0.243469720482466
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BID,BH3-interacting domain death agonist,35971,-0.0479882016113442,0.0411847237901253,-0.12871026023999,0.0327338570173014,0.243978095173423
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL24,C-C motif chemokine 24,35979,-0.0588871160354391,0.0505863166653703,-0.158036296699565,0.0402620646286866,0.24442445076124
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EREG,Proepiregulin,35896,-0.0571457060397783,0.0491327302491351,-0.153445857328083,0.0391544452485265,0.24483169758061
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICAM5,Intercellular adhesion molecule 5,35972,-0.033359097828036,0.0286848282682855,-0.0895813612338755,0.0228631655778035,0.244886345750207
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,34964,0.124581306105242,0.10732360480722,-0.0857729593169098,0.334935571527394,0.245766534385986
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFKB1,Nuclear factor NF-kappa-B p105 subunit,34736,-0.0540184881514894,0.0465385126279063,-0.145233972902186,0.0371969965992068,0.245798268551195
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCN,Decorin,35874,-0.0162463139017415,0.0140029029534222,-0.043692003690449,0.0111993758869659,0.246001223872046
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCNA,Proliferating cell nuclear antigen,34739,-0.050663367697372,0.0436692735874642,-0.136255143928802,0.0349284085340578,0.246028568522468
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FARSA,Phenylalanine--tRNA ligase alpha subunit,34805,-0.051335086096667,0.0442535819008344,-0.138072106622302,0.0354019344289685,0.246084871761616
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WASL,Neural Wiskott-Aldrich syndrome protein,34778,0.0414311244854865,0.0357333959295557,-0.0286063315364427,0.111468580507416,0.246317175452502
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DARS1,"Aspartate--tRNA ligase, cytoplasmic",35896,-0.0509813104192193,0.0439850512294735,-0.137192010828987,0.0352293899905487,0.246469690173122
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGRP,Agouti-related protein,36067,-0.0366320336597101,0.0316483330871444,-0.0986627665105132,0.0253986991910929,0.247116927916914
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOTCH1,Neurogenic locus notch homolog protein 1,36072,-0.0115370362356477,0.00996986719658602,-0.0310779759409563,0.00800390346966089,0.247231503717534
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAIP2B,Polyadenylate-binding protein-interacting protein 2B,34724,-0.0400321910621975,0.0346222253732622,-0.107891752793791,0.0278273706693964,0.247621147828162
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMP2,Lysosome-associated membrane glycoprotein 2,35732,0.0146164889768448,0.0126427955462121,-0.0101633902937309,0.0393963682474205,0.247674030729208
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAGR1,PAXIP1-associated glutamate-rich protein 1,34815,-0.0307577769528672,0.0266463800175333,-0.0829846817872325,0.0214691278814981,0.248423724775147
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIRPB1,Signal-regulatory protein beta-1,35934,-0.033628785435083,0.0291454743347706,-0.0907539151312333,0.0234963442610674,0.248609401468651
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM24,Transcription intermediary factor 1-alpha,34853,-0.0479409155732669,0.0415517863746187,-0.12938241686752,0.0335005857209857,0.248641425238608
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNRPB2,U2 small nuclear ribonucleoprotein B'',34958,-0.0348616896783494,0.0302367938498053,-0.0941258056239677,0.0244024262672689,0.248971832088001
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLTP,Phospholipid transfer protein,36060,0.0263930958162941,0.0228927902214705,-0.018476773017788,0.0712629646503762,0.248988408122292
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP85,Centrosomal protein of 85 kDa,35800,-0.0465268840881187,0.0403974846658719,-0.125705954033228,0.0326521858569901,0.249471411031677
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALCB,Calcitonin gene-related peptide 2,34958,-0.0288722309055055,0.0250752466273933,-0.0780197142951964,0.0202752524841854,0.24960130354292
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RPGR,X-linked retinitis pigmentosa GTPase regulator,34805,0.0283721283787136,0.0246547020195483,-0.019951087579601,0.0766953443370282,0.24986725930444
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMED4,Transmembrane emp24 domain-containing protein 4,34736,0.0401956404400981,0.0349430949248255,-0.0282928256125599,0.108684106492756,0.250058108679413
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFRA2,GDNF family receptor alpha-2,35937,0.0149857354650912,0.0130371665953707,-0.0105671110618353,0.0405385819920178,0.250402745908424
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRP2,Low-density lipoprotein receptor-related protein 2,34805,-0.0274315937207814,0.0238930637186941,-0.0742619986094217,0.019398811167859,0.250972109387326
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPPP3,Tubulin polymerization-promoting protein family member 3,35782,-0.0268676308704721,0.0234255401337031,-0.0727816895325303,0.019046427791586,0.251445652427391
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FNDC1,Fibronectin type III domain-containing protein 1,34958,-0.0343274731019752,0.0299625770291142,-0.0930541240790391,0.0243991778750886,0.251971422465953
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHC1,SHC-transforming protein 1,34739,-0.0831925155250509,0.0726628765559077,-0.22561175357463,0.0592267225245282,0.25229072375867
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP43,Centrosomal protein 43,35812,-0.049248415587995,0.0430653771227756,-0.133656554748635,0.0351597235726451,0.252838594880779
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHGA,Chromogranin-A,34965,-0.0626837474715358,0.0548681513512664,-0.170225324120018,0.0448578291769463,0.253312807217336
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,34812,0.0354606556486579,0.0310736005150243,-0.0254436013607898,0.0963649126581056,0.253837888039003
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRAF3,"TNF receptor-associated factor 3, Isoform 2",34778,0.0270571373939891,0.023749823519039,-0.0194925167033274,0.0736067914913056,0.254640416512083
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAPRE3,Microtubule-associated protein RP/EB family member 3,34739,-0.106687736683111,0.0936718297056328,-0.290284522906152,0.0769090495399289,0.254767531979386
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,34958,-0.0294137769769417,0.0258271975498373,-0.0800350841746229,0.0212075302207394,0.254800990233764
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDK5RAP3,CDK5 regulatory subunit-associated protein 3,34952,-0.0411150666561852,0.0361064505184421,-0.111883709672332,0.0296535763599614,0.254863718410926
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAB2,Disabled homolog 2,36032,-0.0783875782584763,0.068874256412739,-0.213381120827445,0.0566059643104923,0.255104582624314
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,34952,-0.0601861108477461,0.0528967685372953,-0.163863777180845,0.0434915554853526,0.255245596371964
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REG3G,Regenerating islet-derived protein 3-gamma,34949,-0.0290124323645667,0.0255130041032221,-0.0790179204068819,0.0209930556777485,0.255513261461135
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZP3,Zona pellucida sperm-binding protein 3,34815,0.190323440011,0.167375844629433,-0.137733215462689,0.51838009548469,0.255539405386136
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSTB,Cystatin-B,35863,-0.0313091507464822,0.0275849890475118,-0.0853757292796054,0.022757427786641,0.256409915183475
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIAP1,TP53-regulated inhibitor of apoptosis 1,36032,-0.0439460062172004,0.0387620841261203,-0.119919691104396,0.0320276786699954,0.256941483228016
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPOCK1,Testican-1,35902,0.0181880514879528,0.016063992826082,-0.0132973744511679,0.0496734774270735,0.25757710348474
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPPB,Natriuretic peptides B,35874,-0.0953441193174134,0.0842501188195523,-0.260474352203736,0.0697861135689092,0.257806574457031
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF3R,Granulocyte colony-stimulating factor receptor,34778,-0.0215566841748004,0.0190670397389954,-0.0589280820632315,0.0158147137136307,0.258278659911711
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAMPT,Nicotinamide phosphoribosyltransferase,35800,-0.0375953375862017,0.0332538039480405,-0.102772793324361,0.0275821181519576,0.258279040637028
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGAL,Integrin alpha-L,34778,-0.0310067584972713,0.0274431275168964,-0.0847952884303882,0.0227817714358456,0.258581136672221
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMOD4,Tropomodulin-4,34739,-0.0285058072106436,0.0252636833350058,-0.078022626547255,0.0210110121259678,0.259224079660927
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRXN3,Neurexin-3,34805,0.0252821087347287,0.022434087613438,-0.0186887029876098,0.0692529204570672,0.259806941965657
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL20RB,Interleukin-20 receptor subunit beta,34778,0.0295246309436329,0.026225315748665,-0.0218769879237504,0.0809262498110162,0.260291163377952
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCXR,L-xylulose reductase,35991,0.0377591093164477,0.0335530236963109,-0.0280048171283216,0.103523035761217,0.260474588917732
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNPY2,Protein canopy homolog 2,35874,-0.0415909858008072,0.0369620433193017,-0.114036590706638,0.030854619105024,0.260526580411317
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DGKA,Diacylglycerol kinase alpha,34778,-0.038906175771554,0.03461576002583,-0.106753065422181,0.0289407138790728,0.261080453380864
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,34736,-0.0462907731341217,0.0411998112574116,-0.127042403198648,0.0344608569304051,0.26124046274551
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH15,Cadherin-15,36037,0.0468920612423438,0.0418333907754317,-0.0351013846775025,0.12888550716219,0.262356310896826
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,34684,-0.021190643704084,0.0189095170613362,-0.0582532971443028,0.0158720097361349,0.262488009842502
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP1,Caspase-1,35782,-0.0485764049646026,0.0434283181996625,-0.133695908635941,0.0365430987067359,0.263372919950591
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,34964,-0.0618187666011064,0.0552859260424203,-0.17017918164425,0.0465416484420373,0.26353889733916
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DXO,Decapping and exoribonuclease protein,34958,-0.0320046474161342,0.0286481660702993,-0.0881550529139208,0.0241457580816524,0.263967205365432
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTB,Lymphotoxin-beta,34949,0.025428076389886,0.0227752810673542,-0.0192114745021282,0.0700676272819002,0.264260281538411
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EHD3,EH domain-containing protein 3,34815,-0.0820085510489702,0.0734544410203303,-0.225979255448818,0.0619621533508772,0.264270740082685
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMAD3,Mothers against decapentaplegic homolog 3,34949,-0.0361615676935987,0.0323906258819218,-0.0996471944221654,0.0273240590349681,0.2642843136005
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALB1,Calbindin,35937,0.030942890428555,0.027783166551329,-0.0235121160120498,0.0853978968691598,0.265432378655806
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJA4,DnaJ homolog subfamily A member 4,34958,-0.0503712245763664,0.0452431712830639,-0.139047840291172,0.0383053911384389,0.265602697775557
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLC,Galectin-10,35962,-0.0477244045724163,0.0428841749358159,-0.131777387446615,0.0363285783017828,0.265801675456153
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ID4,DNA-binding protein inhibitor ID-4,34869,-0.0308624981638017,0.0277470350260566,-0.0852466868148726,0.0235216904872693,0.266060027820649
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",35842,-0.0495018485747818,0.044518142441444,-0.136757407760012,0.0377537106104485,0.266197525143725
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REG1A,Lithostathine-1-alpha,35955,-0.0343687930615548,0.0309147203889805,-0.0949616450239566,0.0262240589008471,0.266290998799223
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TEX33,Testis-expressed protein 33,34869,-0.0266808481607211,0.0240024501616577,-0.0737256504775702,0.0203639541561281,0.266357736643913
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRIK2,"Glutamate receptor ionotropic, kainate 2",34952,-0.0293484608715337,0.026428529348677,-0.0811483783949407,0.0224514566518732,0.266832522781744
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINT3,Kunitz-type protease inhibitor 3,34964,0.118214156427074,0.106467687001809,-0.0904625100964723,0.326890822950619,0.26689924729181
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLRC1,NKG2-A/NKG2-B type II integral membrane protein,34750,0.0425561208322923,0.0383586076547907,-0.0326267501710975,0.117738991835682,0.267288884132066
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHM,Rab proteins geranylgeranyltransferase component A 1,34805,-0.043264319296497,0.0390277617014828,-0.119758732231403,0.0332300936384093,0.267666282776249
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAA80,N-alpha-acetyltransferase 80,34805,-0.0855245075793374,0.0771907191815367,-0.236818317175149,0.0657693020164745,0.26792047880755
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,35971,-0.0276438683201188,0.0249811399232837,-0.0766069025697549,0.0213191659295173,0.268507541206872
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17D,Interleukin-17D,35842,-0.0236614190502094,0.0213853413401549,-0.0655766880769131,0.0182538499764943,0.268576472999619
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LEP,Leptin,35972,0.0480646096750344,0.0434618750602208,-0.0371206654429983,0.133249884793067,0.268804677340419
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AP2B1,AP-2 complex subunit beta,34805,-0.0336860639014731,0.030530742653063,-0.0935263195014765,0.0261541916985303,0.269918429914842
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDCD6,Programmed cell death protein 6,35972,0.0480880236242131,0.0436188367405746,-0.0374048963873132,0.133580943635739,0.270297719736027
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INHBB,Inhibin beta B chain,34822,-0.0366814001331008,0.0332766951998282,-0.101903722724764,0.0285409224585625,0.270367388040003
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCARE,Photoreceptor cilium actin regulator,34750,-0.0590029194547049,0.0536362281861575,-0.164129926699574,0.0461240877901638,0.271350253606044
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ISM1,Isthmin-1,35971,0.027303194098504,0.0248257450559556,-0.021355266211169,0.075961654408177,0.271458003794581
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGBL1,Integrin beta-like protein 1,34965,-0.0270275939209882,0.0245821624057122,-0.0752086322361842,0.0211534443942078,0.271600371710713
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIPR,Gastric inhibitory polypeptide receptor,34778,0.0313846161885555,0.0285869141521159,-0.0246457355495917,0.0874149679267027,0.272305561942448
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LY6D,Lymphocyte antigen 6D,35917,-0.0263714316508555,0.0240213738120179,-0.0734533243224105,0.0207104610206995,0.272314002393252
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCRG1,Scrapie-responsive protein 1,34949,-0.0190268822479921,0.0173322789564977,-0.0529981490027277,0.0149443845067434,0.272345900351591
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,35874,-0.0149504630366778,0.0136227944442726,-0.0416511401474521,0.0117502140740966,0.272476972088723
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCN4,CCN family member 4,36032,-0.0265399659529478,0.0241850668952672,-0.0739426970676716,0.020862765161776,0.272515251343989
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PREB,Prolactin regulatory element-binding protein,35842,-0.018943334817141,0.017264208751773,-0.052781183970616,0.0148945143363341,0.272564002622281
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KCTD5,BTB/POZ domain-containing protein KCTD5,34828,-0.0314673621670872,0.0286902740796499,-0.087700299363201,0.0247655750290267,0.272773224029328
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NBN,Nibrin,35842,-0.0382720751824449,0.034917189917293,-0.106709767420339,0.0301656170554493,0.273079691603576
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRG3,Proteoglycan 3,34965,-0.0348375889031749,0.0317962701728105,-0.0971582784418834,0.0274831006355337,0.273273350647152
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THTPA,Thiamine-triphosphatase,34936,-0.0602948289722005,0.0550410448110688,-0.168175276801895,0.0475856188574945,0.273360250539307
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TDGF1,Teratocarcinoma-derived growth factor 1,35782,-0.099703214507913,0.0911314466345067,-0.278320849911546,0.0789144208957202,0.273965625124343
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB7,Integrin beta-7,36032,-0.0312295098006057,0.0285678463310785,-0.0872224886095195,0.0247634690083082,0.27435464037052
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CORO1A,Coronin-1A,35846,-0.0600903726697733,0.0550435814546134,-0.167975792320816,0.0477950469812691,0.275006915266302
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS3BP,Galectin-3-binding protein,34975,-0.0212730140418663,0.019508416408542,-0.0595095102026086,0.0169634821188761,0.275554795974833
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARTN,Artemin,35842,-0.0295742960379994,0.0271267937191137,-0.0827428117274623,0.0235942196514636,0.275650521955472
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCGB3A1,Secretoglobin family 3A member 1,34822,0.0179944725000761,0.0165152561765953,-0.0143754296060508,0.0503643746062029,0.275946273002743
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANG,Angiogenin,35978,-0.0224545365415238,0.0206114262442625,-0.0628529319802783,0.0179438588972307,0.276003514971562
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MPRIP,Myosin phosphatase Rho-interacting protein,34933,-0.0317277610741432,0.0291281045308715,-0.0888188459546513,0.0253633238063649,0.276085506877982
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAMBP,STAM-binding protein,35896,-0.0423424222706667,0.0389000067075572,-0.118586435417479,0.0339015908761454,0.276413055888763
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CUZD1,CUB and zona pellucida-like domain-containing protein 1,34805,-0.0260906736496069,0.0239884199547284,-0.0731079767608746,0.0209266294616609,0.276797993008974
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUSD4,Sushi domain-containing protein 4,34949,0.0265479521423313,0.0244306930970022,-0.0213362063277931,0.0744321106124557,0.277226628823546
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSNK1D,Casein kinase I isoform delta,34778,0.0440062502249461,0.0405371089550473,-0.0354464833269466,0.123458983776839,0.277707476861343
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GBP2,Guanylate-binding protein 2,35842,-0.0402607482226283,0.037110809019201,-0.112997933900262,0.0324764374550057,0.278011233677662
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCN1,Ficolin-1,34957,-0.0385264921912858,0.0355266297859587,-0.108158686571765,0.0311057021891933,0.278210959263738
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VEGFB,Vascular endothelial growth factor B,34778,-0.0208686963564142,0.0192517432910684,-0.0586021132069081,0.0168647204940798,0.278411553269603
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXNDC15,Thioredoxin domain-containing protein 15,35991,-0.0185401118044387,0.0171247667199302,-0.0521046545755019,0.0150244309666244,0.278999562033837
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRPAP1,Alpha-2-macroglobulin receptor-associated protein,36043,0.0376325366711643,0.0347675907416772,-0.0305119411825229,0.105777014524851,0.279108661289417
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT5,"Keratin, type II cytoskeletal 5",35782,-0.0341625132361142,0.031613418589348,-0.0961248136712363,0.0277997871990079,0.279896543764856
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),METAP2,Methionine aminopeptidase 2,36023,-0.0367672194109647,0.0340308296538292,-0.10346764553247,0.0299332067105405,0.279995128167814
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MESD,LRP chaperone MESD,35979,-0.0810248520190339,0.0750071166749887,-0.228038800702012,0.0659890966639439,0.280075585238857
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLRX5,"Glutaredoxin-related protein 5, mitochondrial",34822,-0.0598864411591727,0.0555405792553066,-0.168745976499574,0.0489730941812282,0.280965516931623
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,34949,0.0402324401162552,0.0373252335931442,-0.0329250177263074,0.113389897958818,0.281124468262605
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FST,Follistatin,35979,-0.0321624149789827,0.0298392519493328,-0.090647348799675,0.0263225188417096,0.281133284355439
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTLA,B- and T-lymphocyte attenuator,34739,-0.0625439536476299,0.0580415430080996,-0.176305377943505,0.0512174706482452,0.281267050882109
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP6V1D,V-type proton ATPase subunit D,35937,-0.0179138360043731,0.0166351377525464,-0.0505187059993642,0.0146910339906179,0.281574956249919
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSME2,Proteasome activator complex subunit 2,35871,-0.0242196354565576,0.0224919012660099,-0.0683037619379369,0.0198644910248218,0.28159827513068
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PMM2,Phosphomannomutase 2,34736,-0.0403593667388782,0.0375520835927082,-0.113961450580586,0.0332427171028299,0.282525772221788
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYPLA2,Acyl-protein thioesterase 2,34750,-0.0726671749620732,0.0676616523525052,-0.205284013572983,0.059949663648837,0.282874353628982
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOF,Apolipoprotein F,34966,0.0179266217970049,0.016699886733746,-0.0148051562011373,0.0506583997951471,0.283106501246215
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACP6,Lysophosphatidic acid phosphatase type 6,36023,-0.0431460162116602,0.0403314701971523,-0.122195697798079,0.0359036653747583,0.284750719591335
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DMD,Dystrophin,34815,-0.0359275461865309,0.0336048589684252,-0.101793069764644,0.0299379773915824,0.285058202866243
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTGES2,Prostaglandin E synthase 2,34737,-0.0374503763965457,0.0350421076100673,-0.106132907312278,0.0312321545191862,0.285235638345038
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLSTN3,Calsyntenin-3,34958,-0.0200181663481084,0.0187332110150011,-0.0567352599375105,0.0166989272412938,0.285293957180689
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSRC1,Proline/serine-rich coiled-coil protein 1,35800,-0.0394606494064732,0.0369455753527241,-0.111873977097813,0.0329526782848661,0.285522441620777
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL6A3,Collagen alpha-3(VI) chain,36072,-0.0232247931330463,0.021753568800467,-0.0658617879819617,0.0194122017158691,0.285721305349031
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INSL3,Insulin-like 3,34958,0.0604860776840276,0.0566870932929425,-0.0506206251701397,0.171592780538195,0.286004788732008
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WASF1,Wiskott-Aldrich syndrome protein family member 1,35874,-0.0618773656183094,0.0580258508415888,-0.175608033267823,0.0518533020312046,0.286289169384248
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",34958,-0.0654938718653752,0.0615648218831451,-0.18616092275634,0.0551731790255893,0.287450774868318
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC42BPB,Serine/threonine-protein kinase MRCK beta,34964,-0.0686673214121745,0.0645947925471578,-0.195273114804604,0.0579384719802548,0.28780082589546
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",35991,0.0229688281645248,0.0216528654906619,-0.0194707881971726,0.0654084445262222,0.288826622765256
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,35949,-0.0254457069961362,0.0240089046968737,-0.0725031602020087,0.0216117462097364,0.289250152880246
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFHR4,Complement factor H-related protein 4,34963,-0.0479942425390553,0.0453264103454709,-0.136834006816178,0.0408455217380677,0.289704543989938
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MUC2,Mucin-2,34965,0.0623344460322981,0.0589175351544449,-0.053143922870414,0.17781281493501,0.290097961565225
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBP1,Retinol-binding protein 1,34805,-0.0485954003355149,0.0459400401203977,-0.138637878971494,0.0414470783004646,0.290187554023506
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA1,Alpha-1-antitrypsin,34856,-0.00589519684068173,0.00557351733099503,-0.016819290809432,0.00502889712806853,0.290225910321773
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSE,Cathepsin E,34822,-0.0352031409732914,0.0332894184358783,-0.100450401107613,0.0300441191610301,0.2903302506257
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PHLDB2,Pleckstrin homology-like domain family B member 2,34739,-0.0614892915017149,0.0581485960177188,-0.175460539696444,0.052481956693014,0.290347410472153
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,35800,-0.0498195718851699,0.0471309642919985,-0.142196261897487,0.0425571181271471,0.290526304177316
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKR1C4,Aldo-keto reductase family 1 member C4,35874,0.0332441757388894,0.0314602925868256,-0.0284179977312888,0.0949063492090677,0.29068239053911
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACYP1,Acylphosphatase-1,34802,-0.0434508638571727,0.0411355159979105,-0.124076475213077,0.0371747474987318,0.290878777318925
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NENF,Neudesin,34949,-0.0757891761661553,0.0717513963230928,-0.216421912959417,0.0648435606271066,0.290882974968475
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRG1,Adhesion G-protein coupled receptor G1,35937,-0.052355470441086,0.0496951968948539,-0.149758056355,0.0450471154728277,0.292132019004458
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F3,Tissue factor,35975,0.0168490478512641,0.0159973781851864,-0.0145058133917011,0.0482039090942294,0.292266396117455
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZBTB17,Zinc finger and BTB domain-containing protein 17,35874,-0.027793751066934,0.0263977361148342,-0.0795333138520091,0.0239458117181412,0.292429184124873
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ABCA2,ATP-binding cassette sub-family A member 2,34736,-0.0240632636101511,0.0228837223547448,-0.0689153594254508,0.0207888322051486,0.293049766918237
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL12A_IL12B,Interleukin-12,35937,-0.0498613783368181,0.0474605997092796,-0.142884153767006,0.0431613970933699,0.293483987842116
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPP1,Osteopontin,36066,-0.0284461984515742,0.0270832012009614,-0.0815292728054586,0.0246368759023103,0.293602114147269
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,35874,0.0364520167153152,0.0347298579445664,-0.0316185048560349,0.104522538286665,0.293942783202197
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,35800,-0.0424786876621158,0.0404803577873785,-0.121820188925378,0.0368628136011461,0.294045188234628
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGA11,Integrin alpha-11,35971,-0.0220421530802205,0.0210156986020643,-0.0632329223402664,0.0191486161798255,0.294285105904787
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD6,T-cell differentiation antigen CD6,36056,-0.0331800117277576,0.0316401605092414,-0.0951947263258706,0.0288347028703555,0.294365113800891
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC4C,C-type lectin domain family 4 member C,35971,-0.0313664405734403,0.0299141777033721,-0.0899982288720498,0.0272653477251691,0.294420741733736
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLGN,Calmegin,34805,-0.0301545831238314,0.0287628225096013,-0.08652971524265,0.0262205489949871,0.29450095040872
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,35874,-0.0323191822051262,0.0308340218157787,-0.0927538649640524,0.0281155005538,0.294596824624169
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,36026,-0.0250742431309438,0.0239224381479991,-0.071962221901022,0.0218137356391344,0.294604777933812
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,34975,-0.0130230745486988,0.0124359330099826,-0.0373975032482647,0.011351354150867,0.295040910366177
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IDO1,"Indoleamine 2,3-dioxygenase 1",34815,-0.0417402879708928,0.0398735650632867,-0.119892475494935,0.0364118995531492,0.295225134434421
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM13A,Protein FAM13A,34964,-0.0448003597498126,0.0428013052996561,-0.128690918137138,0.0390901986375133,0.295275198904054
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINB1,Leukocyte elastase inhibitor,35956,-0.0577804524419171,0.0552624726669607,-0.16609489886916,0.0505339939853258,0.295796729393627
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,34822,-0.0240464543114569,0.0230015629197961,-0.0691295176342573,0.0210366090113434,0.295866287434234
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK11,Kallikrein-11,35911,-0.0199510126092297,0.0191032043181586,-0.0573932930728206,0.0174912678543611,0.296343947326785
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",34736,-0.0450676804997163,0.0431749666905774,-0.129690615213248,0.0395552542138154,0.296601365584613
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TDRKH,Tudor and KH domain-containing protein,35782,-0.0537219381911424,0.0516090772747445,-0.154875729649642,0.0474318532673567,0.297938567590383
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STOML2,"Stomatin-like protein 2, mitochondrial",34739,-0.0625310240750672,0.0600797961633414,-0.180287424555216,0.0552253764050821,0.298009581815093
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VIM,Vimentin,35874,-0.0744798475421981,0.0716123891820228,-0.214840130338963,0.0658804352545665,0.298355247434347
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL28A1,Collagen alpha-1(XXVIII) chain,34805,-0.0530820438783856,0.0510416092714767,-0.15312359805048,0.0469595102937087,0.298391614941324
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THOP1,Thimet oligopeptidase,35936,-0.0207960393079549,0.0200024681638751,-0.0600008769091502,0.0184087982932403,0.298525805555677
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BOLA2_BOLA2B,BolA-like protein 2,34815,-0.0352833483157982,0.0339426876155522,-0.10181101604228,0.031244319410684,0.298613728973706
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXNDC9,Thioredoxin domain-containing protein 9,34958,-0.0340180583509863,0.0327448621050647,-0.0981979880769131,0.0301618713749406,0.29889897494859
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LECT2,Leukocyte cell-derived chemotaxin-2,34949,-0.043506425463274,0.0419226241168355,-0.125674768732272,0.0386619178057236,0.299412404511232
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LMNB1,Lamin-B1,34948,-0.0413883320658817,0.0398863612057211,-0.119565600029095,0.0367889358973316,0.299469642240459
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCL1B,T-cell leukemia/lymphoma protein 1B,35874,-0.0507161523201601,0.0489291680246457,-0.146617321648466,0.0451850170081455,0.299993201452099
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HPCAL1,Hippocalcin-like protein 1,36067,-0.0470055191630862,0.0453902364494357,-0.13597038260398,0.0419593442778077,0.300428597154771
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSZ,Cathepsin Z,36000,-0.0205491310913644,0.0198676023194128,-0.0594896316374134,0.0183913694546847,0.301028089106342
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLIP2,CAP-Gly domain-containing linker protein 2,35971,-0.0724446327441613,0.0701573872860705,-0.20995311182486,0.0650638463365369,0.301824241472575
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ABRAXAS2,BRISC complex subunit Abraxas 2,34736,-0.0433380469902636,0.0420329295991338,-0.125722589004566,0.0390464950240386,0.30255806735702
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT14,"Keratin, type I cytoskeletal 14",35562,-0.0184769780443927,0.0179234723796628,-0.0536069839085317,0.0166530278197464,0.302632152649009
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100P,Protein S100-P,35874,-0.0357482540783181,0.0347296205723315,-0.103818310400088,0.0323218022434517,0.30335866954121
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,34949,-0.0256169606482507,0.0248878548754968,-0.0743971562042245,0.0231632349077231,0.303379978495125
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC14A,C-type lectin domain family 14 member A,35979,-0.0201184466317973,0.0195496853215572,-0.0584358298620496,0.0181989365984549,0.30346964982591
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1R1,Interleukin-1 receptor type 1,35967,-0.0145470490581212,0.0141576678290879,-0.0422960780031335,0.013201979886891,0.304217311963123
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNGR2,Interferon gamma receptor 2,35902,-0.0333326015002166,0.032464071380917,-0.0969621814068139,0.0302969784063806,0.304570523413775
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GOLGA3,Golgin subfamily A member 3,34952,-0.048870125265315,0.0477166399658743,-0.142394739598429,0.0446544890677986,0.305792264237675
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHI3L1,Chitinase-3-like protein 1,35839,-0.0531078325244696,0.0518553781928046,-0.154744373782366,0.0485287087334274,0.305797314762512
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EVI2B,Protein EVI2B,34739,-0.0256210040168297,0.0250200006191436,-0.0746602052303512,0.0234181971966918,0.305865743283475
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LPCAT2,Lysophosphatidylcholine acyltransferase 2,35937,-0.027509777793002,0.0268690205318369,-0.0801730580354022,0.0251535024493982,0.305941095861818
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HEPH,Hephaestin,34949,0.0178614339484638,0.0174527112825526,-0.0163458801653393,0.0520687480622669,0.306148835994907
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAEP,Glycodelin,35902,-0.0650038656066772,0.0635518671955552,-0.189565525309965,0.059557794096611,0.306413861390159
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH17,Cadherin-17,35972,0.0436254581375476,0.0427040980698762,-0.0400745740794097,0.127325490354505,0.307015404829053
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VAT1,Synaptic vesicle membrane protein VAT-1 homolog,35937,0.0122891397431304,0.0120555545523496,-0.0113397471794748,0.0359180266657357,0.308058233928193
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SDCCAG8,Serologically defined colon cancer antigen 8,34949,-0.0724331883748925,0.0710818656246184,-0.211753644999144,0.0668872682493595,0.308236669374804
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C8B,Complement component C8 beta chain,34975,-0.019456931512371,0.0190950621523303,-0.0568832533309385,0.0179693903061964,0.308264925630026
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PKD2,Polycystin-2,34736,-0.0371644737524742,0.0365272580804263,-0.10875789959011,0.0344289520851614,0.308981929308309
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNX18,Sorting nexin-18,34964,-0.0281204078425472,0.0276475632489829,-0.0823096318105536,0.0260688161254593,0.309143299116839
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZHX2,Zinc fingers and homeoboxes protein 2,34958,-0.0232136374987079,0.0228514906307649,-0.0680025591350071,0.0215752841375914,0.309740502894424
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARSA,Arylsulfatase A,35979,-0.0279488656101219,0.0275471076469905,-0.0819411965982232,0.0260434653779795,0.310337245325204
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACTN4,Alpha-actinin-4,35842,-0.020005772801656,0.0197283733641487,-0.0586733845953875,0.0186618389920754,0.310587552941273
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PFDN6,Prefoldin subunit 6,34805,-0.0388306897415975,0.0382954955712515,-0.113889861061251,0.0362284815780555,0.310634035030511
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPTL2,Angiopoietin-related protein 2,35963,-0.0245790260813267,0.0242424316230088,-0.0720941920624238,0.0229361398997705,0.310671175059782
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NXPE4,NXPE family member 4,34736,-0.0213106148599868,0.0210696726910998,-0.0626071733345424,0.0199859436145688,0.3118479203697
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTN,Pleiotrophin,35874,-0.0309832430730355,0.0306374157161589,-0.0910325778767069,0.0290660917306359,0.311912366800245
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RABGAP1L,Rab GTPase-activating protein 1-like,35842,-0.0380555712835939,0.0376315796439894,-0.111813467385813,0.0357023248186253,0.311922484044289
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MORF4L2,Mortality factor 4-like protein 2,34739,-0.0245211183129852,0.0242626792459354,-0.0720759696350185,0.0230337330090481,0.312222987516733
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DSG4,Desmoglein-4,35911,0.030213707643056,0.0299793878093726,-0.0285458924633143,0.0889733077494264,0.313576141591746
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RCC1,Regulator of chromosome condensation,34949,-0.0325848300930219,0.0323836389461614,-0.0960567624274982,0.0308871022414544,0.314351590907009
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA1,Annexin A1,34793,-0.0289944486065515,0.0288241371464067,-0.0854897574135086,0.0275008602004056,0.314498819754083
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,34952,-0.047886224823302,0.0476232310630707,-0.141227757706921,0.0454553080603166,0.314683678613482
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTBP2,Latent-transforming growth factor beta-binding protein 2,36072,-0.019423078312093,0.0193382249549718,-0.0573259992238376,0.0184798425996517,0.315224225272314
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,34750,0.021353564916483,0.0213076377657014,-0.0204094051042918,0.0631165349372577,0.31630795739287
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",35966,0.0198982351883393,0.0198881520372973,-0.0190825428047634,0.058879013181442,0.317098080413091
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPL,N-acetylneuraminate lyase,34949,-0.0293922537747081,0.0293828836827182,-0.0869827057928357,0.0281981982434196,0.317194327625318
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TTR,Transthyretin,34911,0.0158571511230751,0.0158746147979879,-0.0152570938809812,0.0469713961271313,0.317881482418161
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GYS1,"Glycogen [starch] synthase, muscle",35874,-0.055435768886517,0.0555838628528038,-0.164380140078012,0.0535086023049785,0.318634782375383
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSTN,Growth/differentiation factor 8,35874,0.0333442175690409,0.0334534078930641,-0.0322244619013647,0.0989128970394466,0.318925802682598
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNLZ,DNL-type zinc finger protein,34750,-0.0539232446525979,0.0541027768265913,-0.159964687232717,0.0521181979275212,0.318958273894995
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GUK1,Guanylate kinase,34736,-0.023728077597627,0.0238092719971932,-0.0703942507121256,0.0229380955168716,0.319002957686135
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLB1,Beta-galactosidase,35902,-0.0266464475108536,0.0267401028367302,-0.0790570490708448,0.0257641540491375,0.319041467141345
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATXN2L,Ataxin-2-like protein,34952,-0.0288278546657446,0.0289786673289738,-0.0856260426305333,0.027970333299044,0.31987351436917
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F11R,Junctional adhesion molecule A,35979,-0.0339005333948895,0.0340998744680781,-0.100736287352323,0.0329352205625436,0.320180400535185
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AIF1L,Allograft inflammatory factor 1-like,34815,-0.0348906509019914,0.0351068707387219,-0.103700117549886,0.0339188157459036,0.320338926324817
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEPTIN9,Septin-9,35937,-0.017913871429702,0.0180306368934693,-0.0532539197409018,0.0174261768814979,0.320487399257477
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FRZB,Secreted frizzled-related protein 3,35877,-0.0151214279583787,0.0152307503078029,-0.0449736985616725,0.014730842644915,0.320829590243052
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEZ6L,Seizure 6-like protein,35991,0.0167743797874592,0.0169126495682854,-0.0163744133663802,0.0499231729412986,0.321315624717573
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMAD5,Mothers against decapentaplegic homolog 5,35937,0.0119875840147858,0.0120893458925107,-0.0117075339345351,0.0356827019641068,0.321433921402293
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HTR1B,5-hydroxytryptamine receptor 1B,34750,0.0278179055497178,0.0280729364189376,-0.0272050498314,0.0828408609308356,0.321765866930511
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOH,Beta-2-glycoprotein 1,35979,-0.0224664227478987,0.0226749888814062,-0.0669094009554547,0.0219765554596574,0.32181479439534
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPRC5C,G-protein coupled receptor family C group 5 member C,34949,-0.0352734566305279,0.0356157505948813,-0.105080327796495,0.0345334145354393,0.322021638406329
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,34822,-0.0364291312679822,0.0367957513812837,-0.108548803975298,0.0356905414393339,0.322194852441829
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EGFL7,Epidermal growth factor-like protein 7,35800,-0.0241831676892205,0.0244286876700127,-0.0720633955224453,0.0236970601440043,0.322232058622593
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THBS2,Thrombospondin-2,35979,-0.0234218966983218,0.0237026178038843,-0.069879027593935,0.0230352341972914,0.323108391044308
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACRBP,Acrosin-binding protein,34949,-0.0240956842580265,0.0244008003838167,-0.0719212530103072,0.0237298844942542,0.323437344593363
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",35782,-0.0303277974027003,0.0307262895039056,-0.0905513248303552,0.0298957300249546,0.32366073753643
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OLR1,Oxidized low-density lipoprotein receptor 1,35901,-0.037821571272682,0.0383587517728153,-0.1130047247474,0.0373615822020361,0.324167807520938
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPTX2,Neuronal pentraxin-2,34965,-0.0212477359141168,0.0215647457774459,-0.0635146376379107,0.0210191658096772,0.324514368679289
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHL1,Neural cell adhesion molecule L1-like protein,36016,-0.0180072623228045,0.0182798329606083,-0.0538357349255968,0.0178212102799878,0.324612494434252
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,34822,-0.0432235620533936,0.0438975647850706,-0.129262789032132,0.0428156649253448,0.32483626715647
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLA,Alpha-galactosidase A,34811,-0.0239108332347182,0.0242888735239057,-0.0715170253415733,0.023695358872137,0.324939697806596
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDGFA,Platelet-derived growth factor subunit A,36072,-0.043682810994955,0.04437759007691,-0.130662887545699,0.0432972655557886,0.324978313120966
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC2L,C-type lectin domain family 2 member L,34805,0.0323836247152649,0.0329000596913031,-0.0321004922796892,0.0968677417102189,0.325004973556939
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WASHC3,WASH complex subunit 3,34958,-0.0470184587024411,0.0477854427611404,-0.140677926514276,0.0466410091093941,0.32517782333218
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PROS1,Vitamin K-dependent protein S,34975,0.0160739627879974,0.0163395002722958,-0.0159514577457024,0.0480993833216972,0.325276402177159
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PON3,Serum paraoxonase/lactonase 3,35992,0.0183886136854977,0.0187038409386414,-0.0182709145542395,0.0550481419252349,0.325567572571096
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGFR4,Fibroblast growth factor receptor 4,34822,0.0324574948394298,0.0330369019940075,-0.032294833068825,0.0972098227476845,0.325910583950811
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD164,Sialomucin core protein 24,35979,-0.0158965181924661,0.0161814311611627,-0.0476121232683451,0.0158190868834128,0.325938680067197
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF19,Tumor necrosis factor receptor superfamily member 19,36032,-0.0196587455624962,0.0200243278492653,-0.0589064281470561,0.0195889370220638,0.326258386864457
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,34964,-0.0247373891349795,0.0252044351517089,-0.074138082032329,0.0246633037623699,0.326398484048991
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINH1,Serpin H1,34869,-0.0799550164031202,0.081490836485097,-0.23967705591391,0.0797670231076698,0.326554931706276
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMBN,Ameloblastin,35842,-0.0166051408145217,0.016936984248432,-0.0498016299414485,0.016591348312405,0.326917921497703
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBXN1,UBX domain-containing protein 1,34822,-0.0423937816761396,0.0432453158457963,-0.1271546007339,0.0423670373816211,0.326971621777043
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,34949,-0.0217743988235177,0.0222136296014887,-0.0653131128424355,0.0217643151954001,0.327011444055413
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSPA2,Heat shock-related 70 kDa protein 2,34949,-0.022486240197973,0.022955812703389,-0.0674796330966154,0.0225071527006693,0.327348332505565
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRIP2,Cysteine-rich protein 2,35902,-0.0219007205826516,0.0223624541849457,-0.0657311307851453,0.021929689619842,0.327438390439978
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRC59,Leucine-rich repeat-containing protein 59,34949,-0.029532884971853,0.0301774518987193,-0.0886806906933429,0.0296149207496368,0.327794791513944
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEPTIN7,Septin-7,34869,-0.0325077721946829,0.0332237761275955,-0.0976263734047701,0.0326108290154044,0.327890034703614
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YARS1,"Tyrosine--tRNA ligase, cytoplasmic",34964,-0.0891375867084014,0.0912560811370662,-0.267999505737051,0.0897243323202483,0.328712647311187
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL4R,Interleukin-4 receptor subunit alpha,35971,-0.0225549087931289,0.0231039151946746,-0.0678385825746911,0.0227287649884333,0.328978813019601
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,35992,0.0266181021679905,0.0272858429220404,-0.0268621499592087,0.0800983542951898,0.329330371305598
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIA1,Nucleolysin TIA-1 isoform p40,35787,-0.0736495441792051,0.0756149996598971,-0.221854943512603,0.0745558551541933,0.330085810017644
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHIT1,Chitotriosidase-1,36015,-0.0937367804075146,0.0963830983236414,-0.282647653121852,0.0951740923068225,0.330811831825818
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALPP,"Alkaline phosphatase, placental type",35937,-0.0636613887894568,0.0655999937831597,-0.19223737660445,0.0649145990255363,0.331855176940417
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),L1CAM,Neural cell adhesion molecule L1,35991,-0.0177073393125539,0.0182551140800839,-0.0534873629095183,0.0180726842844106,0.332081546453234
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,35977,-0.0398233730500635,0.0410787143147901,-0.120337653107052,0.0406909070069251,0.332357191141884
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECE1,Endothelin-converting enzyme 1,35782,0.0203604867225395,0.0210030391104037,-0.0208054699338518,0.0615264433789309,0.332374957714693
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADM,Pro-adrenomedullin,36032,-0.0156109554864202,0.0161211361935702,-0.0472083824258178,0.0159864714529775,0.332899463285075
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PHACTR2,Phosphatase and actin regulator 2,34952,-0.0692063761820555,0.0714716112043286,-0.20929073414254,0.0708779817784285,0.33292853190625
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,36067,-0.0578762618628566,0.0597796312958525,-0.175044339202728,0.0592918154770143,0.332995707971541
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HAVCR2,Hepatitis A virus cellular receptor 2,35979,-0.0209985568730444,0.0217039462808849,-0.0635382915835789,0.0215411778374901,0.333326106470759
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGS10,Regulator of G-protein signaling 10,34952,-0.0363718795707428,0.0376002946618311,-0.110068457107932,0.0373246979664462,0.333416098307959
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EZR,Ezrin,36043,-0.0146315606924542,0.0151431236695985,-0.0443120830848672,0.0150489616999589,0.333966433603911
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLA2,Src-like-adapter 2,34952,-0.0642380320351709,0.0664837070219958,-0.194546097798283,0.066070033727941,0.333969803512034
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATG4A,Cysteine protease ATG4A,35800,-0.0361841095013865,0.0374548117868753,-0.109595540603662,0.0372273216008891,0.334039739029828
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C5,Complement C5,34975,-0.00901020155838617,0.00932849218976818,-0.0272940462503318,0.00927364313355946,0.334141002762741
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DLG4,Disks large homolog 4,34958,-0.0435917141070007,0.0451332440378517,-0.13205287242119,0.0448694442071886,0.334158526509663
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFBR3,Transforming growth factor beta receptor type 3,36072,0.0180130253374807,0.0186683248910419,-0.0185768914489615,0.0546029421239229,0.334627237861546
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TREML2,Trem-like transcript 2 protein,35979,-0.0204683071974275,0.0212458050223925,-0.0621100850413168,0.0211734706464618,0.335376067159694
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPRY2,Protein sprouty homolog 2,35842,-0.0556380951024085,0.0578676085154776,-0.169058607792745,0.0577824175879276,0.336346912528682
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPESP1,Sperm equatorial segment protein 1,34949,-0.0201735919013408,0.0209912799350447,-0.0613165005740285,0.0209693167713469,0.336565486989015
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPCDC,Phosphopantothenoylcysteine decarboxylase,36043,-0.0277080907516006,0.0288345426320913,-0.0842237943104995,0.0288076128072983,0.336616597894598
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLT8D2,Glycosyltransferase 8 domain-containing protein 2,35782,-0.0275320653158147,0.0286526768709334,-0.0836913119828441,0.0286271813512147,0.336639921569921
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,34805,-0.0254339953257279,0.0264814316667541,-0.077337601392566,0.0264696107411101,0.336868025625848
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,35937,0.0220068978517652,0.0229191895760006,-0.0229147137171961,0.0669285094207264,0.3369885785489
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRACR2A,EF-hand calcium-binding domain-containing protein 4B,35800,-0.0500127436963719,0.0520889349761628,-0.152107056249651,0.0520815688569072,0.337016288714565
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,34778,-0.0217763445596853,0.0226917672242543,-0.0662522083192237,0.022699519199853,0.337264731766535
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,35971,-0.0587795893845767,0.0613582559707836,-0.179041771087313,0.0614825923181592,0.33810749025682
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ROBO1,Roundabout homolog 1,35966,-0.0141190180686948,0.0147417882724038,-0.0430129230826063,0.0147748869452167,0.338217863652801
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IZUMO1,Izumo sperm-egg fusion protein 1,34739,-0.0271797962028452,0.0283906306453556,-0.0828254322677421,0.0284658398620517,0.338427864045218
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL6ST,Interleukin-6 receptor subunit beta,35972,0.0103546467591576,0.0108172785556152,-0.0108472192098482,0.0315565127281634,0.33848148526879
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,34949,-0.0408001688324761,0.0426432509281893,-0.124380940651727,0.0427806029867749,0.338715221440364
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,35874,-0.032800106036932,0.0342925181930718,-0.100013441695353,0.0344132296214888,0.33886159676643
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VWC2,Brorin,35884,0.0237318585305891,0.0248791921164186,-0.0250313580175914,0.0724950750787696,0.340174113544546
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZFYVE19,Abscission/NoCut checkpoint regulator,34964,-0.0534768800823796,0.0560799404464007,-0.163393563357325,0.0564398031925658,0.34033096129621
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCAM2,Neural cell adhesion molecule 2,35979,-0.0157911996565298,0.0165618731029525,-0.0482524709383168,0.0166700716252571,0.34038473421782
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRL1,Fc receptor-like protein 1,35972,-0.0266322803933915,0.0279772063486871,-0.0814676048368183,0.0282030440500353,0.341164809866717
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LDLRAP1,Low density lipoprotein receptor adapter protein 1,34952,-0.0594772710574961,0.0625206449182183,-0.182017735097204,0.0630631929822118,0.341477088597704
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SRPK2,SRSF protein kinase 2,35971,-0.0497227580652827,0.0522790286005589,-0.152189654122378,0.0527441379918127,0.341583110255691
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAG1,Dystroglycan,35992,-0.0278676184400974,0.0293029921488918,-0.0853014830519254,0.0295662461717306,0.341627276436864
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOS,Proto-oncogene c-Fos,34724,0.0219175198177377,0.0230462338466229,-0.0232530985216432,0.0670881381571186,0.341629760745379
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMPD3,Sphingomyelin phosphodiesterase 3,34778,0.034198704572765,0.0359623818152824,-0.0362875637851884,0.104684972930718,0.341663039986601
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),M6PR,Cation-dependent mannose-6-phosphate receptor,34815,-0.023358640029236,0.0245787725506915,-0.0715330342285914,0.0248157541701193,0.341967188967112
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARL13B,ADP-ribosylation factor-like protein 13B,34736,-0.0410282262638728,0.0431771745086353,-0.125655488300798,0.0435990357730525,0.342033061571779
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAG3,BAG family molecular chaperone regulator 3,35890,0.0231687483376675,0.0244104932661082,-0.0246758184639047,0.0710133151392396,0.342585609353073
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLT4,Vascular endothelial growth factor receptor 3,35991,0.0200167761690433,0.0210973234543133,-0.0213339778014109,0.0613675301394974,0.342762147310734
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC1A4,Neutral amino acid transporter A,34805,-0.0299433367301192,0.0316600979047889,-0.0919971286235055,0.032110455163267,0.344300063296043
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRV1,Adhesion G-protein coupled receptor V1,34750,-0.0413246772230419,0.0437027148073676,-0.126981998245482,0.0443326437993986,0.344396913512409
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNAR1,Interferon alpha/beta receptor 1,34964,-0.0147444349526752,0.0156036802139687,-0.0453276481720539,0.0158387782667036,0.344728871023571
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G7,Platelet-activating factor acetylhydrolase,35979,-0.018669573736931,0.0197590023299946,-0.0573972183037204,0.0200580708298583,0.344759152197145
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAEA,E3 ubiquitin-protein transferase MAEA,35800,-0.0220054217130195,0.0232946387607798,-0.067662913684148,0.023652070258109,0.344866194073643
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPL24,"39S ribosomal protein L24, mitochondrial",34736,0.0236544941283454,0.0250435324277144,-0.0254308294299747,0.0727398176866656,0.344933489858731
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PBK,Lymphokine-activated killer T-cell-originated protein kinase,34739,-0.0187413928520279,0.0198592697774362,-0.0576655616158028,0.0201827759117471,0.345354964654886
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA3,Alpha-1-antichymotrypsin,34957,-0.0095101573119553,0.0100815878156281,-0.0292700694305864,0.0102497548066758,0.345553407013058
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),POSTN,Periostin,34965,0.0224332275853225,0.0237846973337702,-0.0241847791888671,0.0690512343595121,0.345625138999637
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,35902,-0.0349776894606956,0.0371117674677338,-0.107716753697454,0.0377613747760627,0.345969978951641
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL2L1,Bcl-2-like protein 1,34958,-0.0579996415925564,0.0615387402404682,-0.178615572463874,0.0626162892787613,0.34597768544027
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MANSC4,MANSC domain-containing protein 4,34736,-0.0402439715797119,0.0427238408605592,-0.123982699666408,0.0434947565069841,0.346252330199513
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRG1,Leucine-rich alpha-2-glycoprotein,34975,-0.0160829588816617,0.0170793504980095,-0.0495584858577604,0.017392568094437,0.3464018908386
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),XG,Glycoprotein Xg,36039,-0.0199488678086949,0.0211872585891914,-0.0614758946435099,0.0215781590261202,0.346453544415209
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIPC3,PDZ domain-containing protein GIPC3,34964,-0.0585455391810989,0.0621948921351242,-0.180447527765942,0.0633564494037446,0.346574621507154
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JUN,Transcription factor AP-1,35842,0.028159811358306,0.0299171778191553,-0.0304778571672383,0.0867974798838503,0.346603569454871
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DSCAM,Down syndrome cell adhesion molecule,34952,-0.0212591624596607,0.0225925896320988,-0.0655406381385744,0.023022313219253,0.346751175634298
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,35971,-0.0868819254808304,0.092340112199219,-0.2678685453913,0.0941046944296389,0.346791858817495
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGAP1,Rho GTPase-activating protein 1,35800,-0.0267276065339626,0.0284370642663573,-0.082464252496023,0.0290090394280978,0.347307425795977
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRIM1,Cysteine-rich motor neuron 1 protein,35992,-0.0118273341933985,0.0125865545713701,-0.0364969811532839,0.0128423127664868,0.347412406673415
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP5,Fatty acid-binding protein 5,36015,-0.0387989166234357,0.0413216610972148,-0.119789372373977,0.0421915391271053,0.347787708747027
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKG1,cGMP-dependent protein kinase 1,34822,-0.0746468972654181,0.0795074373273377,-0.230481474427,0.0811876798961637,0.347835554908961
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,35965,-0.0344089658591742,0.0366583090800946,-0.10625925165616,0.0374413199378111,0.347946240091288
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HDGFL2,Hepatoma-derived growth factor-related protein 2,34958,-0.0377701395933291,0.0402503022903458,-0.116660732082407,0.0411204528957487,0.348084027668462
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPI,Glucose-6-phosphate isomerase,34966,-0.0281363406872487,0.0300087661434618,-0.0869535223284338,0.0306808409539363,0.348483498082859
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PEBP1,Phosphatidylethanolamine-binding protein 1,35979,-0.033005410568846,0.0352784568497315,-0.10215118599432,0.0361403648566277,0.349526049988909
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFRA3,GDNF family receptor alpha-3,35881,0.0161820066068223,0.0173120948815664,-0.0177496993610478,0.0501137125746923,0.34996226700023
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RWDD1,RWD domain-containing protein 1,36043,-0.0355713457148618,0.0380557567214234,-0.110160628888852,0.039017937459128,0.349964717651061
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VEGFD,Vascular endothelial growth factor D,36057,0.0224521952735004,0.0240239842623233,-0.0246348138806532,0.0695392044276541,0.35003805462098
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNAS,Neuroendocrine secretory protein 55,34952,-0.050606733168996,0.0542152245609821,-0.156868573308521,0.0556551069705289,0.350627611823392
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHRDL1,Chordin-like protein 1,35979,-0.0185949594751446,0.0199274247694364,-0.05765271202324,0.0204627930729508,0.35078126876668
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC16A1,Monocarboxylate transporter 1,35782,-0.0310121872446904,0.0332622101282542,-0.0962061190960686,0.0341817446066878,0.351184444177636
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS4,Galectin-4,35949,0.0321923811563909,0.0345339159529263,-0.0354940941113446,0.0998788564241264,0.351265823175745
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TJAP1,Tight junction-associated protein 1,35991,-0.0477501433603096,0.0512584832857662,-0.148216770600411,0.0527164838797922,0.351596501693313
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEK7,Serine/threonine-protein kinase Nek7,34869,0.0447141629858082,0.0480126503268454,-0.0493906316548089,0.138818957626425,0.351734460926127
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC123,Cell division cycle protein 123 homolog,34739,-0.0387241224518806,0.0416277601898553,-0.120314532423997,0.0428662875202357,0.35227949867267
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LSM1,U6 snRNA-associated Sm-like protein LSm1,35800,-0.0308474736890864,0.0331698595192605,-0.0958603983468369,0.0341654509686641,0.352409999942208
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP3,Insulin-like growth factor-binding protein 3,36026,0.0182266532092055,0.0196182503769079,-0.0202251175295339,0.0566784239479449,0.352884980675076
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC1B,C-type lectin domain family 1 member B,36043,-0.0544888365568712,0.0586948862693848,-0.169530813644865,0.060553140531123,0.353261106814094
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL3RA,Interleukin-3 receptor subunit alpha,35842,-0.0181428965011358,0.0195459957906249,-0.0564530482507605,0.020167255248489,0.35332672413182
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLUL1,Clusterin-like protein 1,35959,-0.026042642994038,0.0280719530875206,-0.0810636710455784,0.0289783850575024,0.353588234615168
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGAX,Integrin alpha-X,34869,-0.0299488178667712,0.0323109338776761,-0.0932782482670165,0.033380612533474,0.354017140185844
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTP4A3,Protein tyrosine phosphatase type IVA 3,34778,-0.030916726354323,0.033392477072363,-0.0963659814161545,0.0345325287075084,0.354555410806535
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,36026,-0.0243020845323403,0.0262489836210167,-0.0757500924295331,0.0271459233648525,0.354564656828957
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MDK,Midkine,35960,-0.0290477413265941,0.0313893963143687,-0.0905709581027568,0.0324754754495685,0.354788319166667
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAMR1,Inactive serine protease PAMR1,35979,-0.0149131554276275,0.0161347156863065,-0.0465371981727883,0.0167108873175332,0.355365601718693
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GKN1,Gastrokine-1,35645,0.0153167335344194,0.0165840226506416,-0.0171879508608381,0.0478214179296769,0.355734717624574
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RIDA,2-iminobutanoate/2-iminopropanoate deaminase,34822,-0.0302321062411393,0.0327532282047501,-0.0944284335224496,0.0339642210401709,0.356029049297736
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD248,Endosialin,34965,0.0235424607523859,0.0256834632539545,-0.0267971272253649,0.0738820487301367,0.359366636671023
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRKL,Crk-like protein,35964,-0.0590665013980777,0.0644535228160134,-0.185395406117464,0.0672624033213086,0.359476626121943
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCGB2A2,Mammaglobin-A,34736,0.0170580146619645,0.0186192343269897,-0.0194356846189352,0.0535517139428643,0.359624141435027
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GALNT7,N-acetylgalactosaminyltransferase 7,35937,0.011754674599633,0.012830736514186,-0.0133935689681716,0.0369029181674375,0.359626700757937
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIGYF2,GRB10-interacting GYF protein 2,34952,-0.0443285507539763,0.0483870058724026,-0.139167082263885,0.0505099807559328,0.359636060947182
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,34736,-0.0283711613470297,0.0310067370767009,-0.0891443660173634,0.032402043323304,0.360227637336822
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGMB,RGM domain family member B,36043,-0.0156611698519713,0.0171305605837034,-0.0492370685960299,0.0179147288920872,0.360628763054098
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MKI67,Proliferation marker protein Ki-67,34778,0.0238952677237784,0.0261556101033369,-0.027369728078762,0.0751602635263188,0.360972719233318
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WASF3,Wiskott-Aldrich syndrome protein family member 3,35782,-0.0472359456259237,0.0517124214311482,-0.148592291630974,0.0541204003791268,0.361044365864795
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBAC1,Ubiquitin-associated domain-containing protein 1,35937,-0.0190706272123657,0.0208826353396694,-0.0600005924781178,0.0218593380533864,0.361152146594207
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTN2,Contactin-2,36032,0.0249228520725787,0.027302842057204,-0.0285907183595413,0.0784364225046986,0.361361591261584
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NMI,N-myc-interactor,34920,-0.0407875411396972,0.0447188595176864,-0.128436505794362,0.046861423514968,0.36175711308855
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RET,Proto-oncogene tyrosine-protein kinase receptor Ret,35937,0.0204973195223199,0.0224824298242269,-0.0235682429331649,0.0645628819778046,0.361954550350521
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP3R1,Calcineurin subunit B type 1,35902,-0.0230251508736597,0.0252694443497848,-0.0725532617992378,0.0265029600519185,0.362227729699709
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSR,"Glutathione reductase, mitochondrial",34933,0.013145413739934,0.0144282118156001,-0.0151338814186422,0.0414247088985103,0.362282111732681
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMD9,26S proteasome non-ATPase regulatory subunit 9,35937,-0.0318944621446474,0.0350140357051294,-0.100521972126701,0.0367330478374062,0.362375326644851
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F12,Coagulation factor XII,34975,-0.0236277734790956,0.0259452171809654,-0.0744803991537877,0.0272248521955966,0.362498779799231
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MERTK,Tyrosine-protein kinase Mer,36067,0.013901750859804,0.0152768365003676,-0.0160408486809166,0.0438443504005245,0.362857762895423
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKT3,RAC-gamma serine/threonine-protein kinase,35769,-0.0325368241312315,0.0357875769252394,-0.102680474904701,0.0376068266422378,0.363293425977314
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLRT2,Leucine-rich repeat transmembrane protein FLRT2,35902,0.0159637392997296,0.0175790004489883,-0.0184911015802874,0.0504185801797465,0.363847876916872
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF2,Granulocyte-macrophage colony-stimulating factor,34736,-0.0216219814140175,0.0238236513773678,-0.0683163381136583,0.0250723752856233,0.364133323903718
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HARS1,"Histidine--tRNA ligase, cytoplasmic",35979,-0.0427053198301794,0.04706054991015,-0.134943997654073,0.0495333579937146,0.364195998094665
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRTG,Protogenin,36032,0.0140344027959369,0.0154694948353213,-0.0162858070812928,0.0443546126731667,0.364314152215405
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EXTL1,Exostosin-like 1,34736,-0.0267711026370539,0.0295390136081151,-0.0846675693089595,0.0311253640348517,0.364814560317095
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CR2,Complement receptor type 2,36026,-0.0261293825676688,0.0288690735929115,-0.0827127668097753,0.0304540016744378,0.365442067714985
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYDGF,Myeloid-derived growth factor,34949,-0.0565059647619819,0.0624385974878997,-0.178885615838265,0.0658736863143016,0.365507922306593
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL13,Interleukin-13,35842,-0.0282709811320421,0.0312445123785184,-0.0895102253939381,0.0329682631298539,0.365585402609962
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRAF2,TNF receptor-associated factor 2,35971,-0.0387282726031232,0.0428188298934418,-0.122653179194269,0.0451966339880227,0.365776716677195
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APPL2,DCC-interacting protein 13-beta,34822,-0.063808872008885,0.0706329715798514,-0.202249496305394,0.0746317522876236,0.366355782700759
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP8,Caspase-8,36013,-0.0345847032906302,0.0382996365676721,-0.109651990963268,0.0404825843820072,0.366553413956826
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGA6,Integrin alpha-6,35971,-0.0284733572448067,0.0315703069741729,-0.0903511589141856,0.0334044444245722,0.36713782167553
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",35782,-0.0168217360992825,0.0186600919306315,-0.0533955162833202,0.0197520440847552,0.367362354764432
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLP1R,Glucagon-like peptide 1 receptor,34750,0.0204025061753564,0.0226336053399147,-0.0239593602908765,0.0647643726415893,0.367397494169607
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RCOR1,REST corepressor 1,35874,0.0241214634911505,0.0267746618903399,-0.0283568738139156,0.0765998007962167,0.36766792954678
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,35800,0.0704641339824593,0.078322660853883,-0.0830482812911514,0.22397654925607,0.368328796691924
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERP29,Endoplasmic reticulum resident protein 29,34822,-0.0672206106641637,0.0747713559992168,-0.213772468422629,0.0793312470943014,0.368679175295461
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL15A1,Collagen alpha-1(XV) chain,34965,-0.0151138046113516,0.0168209292233592,-0.0480828258891357,0.0178552166664325,0.368946705962415
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB2B,Ras-related protein Rab-2B,34949,-0.0345901908327791,0.0385075321441215,-0.110064953835257,0.0408845721696992,0.369075271062688
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADRA2A,Alpha-2A adrenergic receptor,34736,0.038968072538559,0.0434381458441152,-0.0461706933159069,0.124106838393025,0.369704292787001
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,34815,-0.0422494625737599,0.0472682204592864,-0.134895174673961,0.0503962495264414,0.371450758922598
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TREM2,Triggering receptor expressed on myeloid cells 2,35949,-0.0291868474737664,0.0326603299621423,-0.0932010941995654,0.0348273992520326,0.371539372937035
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXN,Thioredoxin,34862,-0.0246167518496597,0.0275909496594477,-0.0786950131821772,0.0294615094828578,0.37231795494085
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC39A14,Zinc transporter ZIP14,35782,-0.0182372114472398,0.0204520044494818,-0.0583231401682241,0.0218487172737445,0.372579456376621
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPA2,Carboxypeptidase A2,36027,0.036690745409135,0.041151169131462,-0.0439655460885305,0.1173470369068,0.372631524347103
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GTPBP2,GTP-binding protein 2,34805,-0.0458625447731257,0.0515519452935567,-0.146904357548497,0.0551792680022454,0.373695041601402
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF14,Tumor necrosis factor ligand superfamily member 14,35902,-0.0320538909450847,0.0360887513773057,-0.102787843644604,0.0386800617544343,0.374464491568228
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A4,Protein S100-A4,35991,-0.0308215527093516,0.0347342084355129,-0.0989006012429568,0.0372574958242536,0.374916998984182
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NTF4,Neurotrophin-4,35800,-0.0214856618992263,0.0242486438302201,-0.0690130038064576,0.0260416800080051,0.375616820406731
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARAF,Serine/threonine-protein kinase A-Raf,34869,-0.0372411964844207,0.0421101181099204,-0.119777027979865,0.0452946350110233,0.376526950972548
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MILR1,Allergin-1,35842,-0.0281555822829747,0.0318623178601737,-0.090605725288915,0.0342945607229657,0.376906969163781
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IQGAP2,Ras GTPase-activating-like protein IQGAP2,35937,-0.0294979542470156,0.0333938991972059,-0.0949499966735392,0.035954088179508,0.377084979693529
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DBI,Acyl-CoA-binding protein,35947,-0.0423583887517582,0.0479967947781778,-0.136432106516987,0.0517153290134704,0.37752164351688
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK10,Kallikrein-10,35970,-0.0215321451443853,0.0244652975923451,-0.0694841284253816,0.026419838136611,0.378828594544738
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MCEMP1,Mast cell-expressed membrane protein 1,34778,-0.0492982951271519,0.0560325513753809,-0.159122095822898,0.0605255055685946,0.378993604157127
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,34805,-0.0299558783704451,0.0341311574506141,-0.0968529469736488,0.0369411902327585,0.380157042139694
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAMLG,Guided entry of tail-anchored proteins factor CAMLG,34805,-0.0298753153179637,0.0340404682260742,-0.0965946330410691,0.0368440024051418,0.380172475760769
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUGT1,Protein SGT1 homolog,35800,-0.0429548655674136,0.049085666113518,-0.139162771149909,0.0532530400150817,0.38154869700591
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIRREL1,Kin of IRRE-like protein 1,34750,-0.0312389318114268,0.0356973083025726,-0.101205656084469,0.0387277924616154,0.381550359326435
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYO6,Unconventional myosin-VI,34952,-0.0204029459490053,0.0233226459286152,-0.0661153319690912,0.0253094400710806,0.381708922399987
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,34952,-0.0362365342955033,0.0414633218437933,-0.117504645109338,0.0450315765183315,0.38218293377894
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",34949,-0.0172264703246335,0.0197366880098076,-0.0559103788238565,0.0214574381745894,0.382797123943228
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATOX1,Copper transport protein ATOX1,35991,-0.0380877164322789,0.0436620752691356,-0.123665383959785,0.0474899510952269,0.383056983865318
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLIC5,Chloride intracellular channel protein 5,34805,-0.0172138087957863,0.0197334547041164,-0.0558913800158545,0.021463762424282,0.383069749363754
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DHPS,Deoxyhypusine synthase,34949,0.0214578434595371,0.0246201644638574,-0.0267976788896233,0.0697133658086976,0.383483788988122
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,34942,-0.0429318531509011,0.0492764061276461,-0.139513609161087,0.0536499028592852,0.383653032648935
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBE2Z,Ubiquitin-conjugating enzyme E2 Z,34778,0.0322704879171888,0.0371649765112733,-0.0405728660449068,0.105113841879284,0.385261805742917
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACE2,Angiotensin-converting enzyme 2,35874,0.0288115632445653,0.0332189764053436,-0.0362976305099082,0.0939207569990388,0.3857939820296
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD82,CD82 antigen,34869,0.0226050728867863,0.0261053182138772,-0.0285613508124131,0.0737714965859857,0.38656810146219
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLSPN,Claspin,35776,0.0182625127636172,0.0210970233259619,-0.0230876529552682,0.0596126784825027,0.386714328671182
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,35800,-0.0348009591744556,0.0402217692843786,-0.113635626971838,0.0440337086229264,0.386943057553626
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DRAXIN,Draxin,35902,0.0227103714164692,0.0262661136403976,-0.02877121131871,0.0741919541516484,0.387272360822151
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB1BP2,Integrin beta-1-binding protein 2,35874,-0.059849635064336,0.069234052930457,-0.195548378808032,0.0758491086793597,0.38736719508725
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AARSD1,Alanyl-tRNA editing protein Aarsd1,35937,-0.0298392162244422,0.0345330118441046,-0.0975239194388873,0.0378454869900029,0.387573284005475
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUGP1,SURP and G-patch domain-containing protein 1,34964,-0.022160550308499,0.0256541170174002,-0.0724426196626033,0.0281215190456053,0.387719099742106
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMIGO2,Amphoterin-induced protein 2,35937,-0.0124505917347846,0.0144350260344247,-0.0407432427622571,0.0158420592926879,0.388426076259457
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KHDC3L,KH domain-containing protein 3,34739,0.036014422370273,0.0417769343918091,-0.0458683690376728,0.117897213778219,0.388685561378005
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COMMD1,COMM domain-containing protein 1,34815,-0.0331000734094843,0.0384123523347423,-0.108388283985579,0.0421881371666107,0.388883729514593
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL2,Apoptosis regulator Bcl-2,34964,-0.0291339267229645,0.0338174178619024,-0.0954160657322933,0.0371482122863643,0.388991577809484
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SATB1,DNA-binding protein SATB1,34952,-0.016337124895458,0.0189753510703687,-0.0535288129933806,0.0208545632024647,0.389289475506551
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALB2,Calretinin,35782,-0.0152841424812321,0.017760172910345,-0.0500940813855082,0.019525796423044,0.389495251108053
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",34949,-0.0419594169009366,0.0487880924441137,-0.137584078091399,0.0536652442895262,0.389802789651013
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1S,Complement C1s subcomponent,34975,-0.0115066569339738,0.0133796059180443,-0.0377306845333406,0.0147173706653931,0.38981331370856
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDT15,Nucleotide triphosphate diphosphatase NUDT15,34736,0.0267866717047163,0.0311976830885779,-0.0343607871488964,0.087934130558329,0.390588744200651
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLYR1,Putative oxidoreductase GLYR1,34949,-0.0313890446165953,0.0365738269633597,-0.10307374546478,0.0402956562315896,0.390793507429544
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF7,Fibroblast growth factor 7,34739,0.0431184094546982,0.050315862921296,-0.0555006818710421,0.141737500780438,0.391503434078337
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADD1,Alpha-adducin,34822,-0.0378332742459793,0.0441779522063509,-0.124422060570427,0.0487555120784685,0.391818606432595
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",34949,-0.039704067748453,0.046369539380412,-0.13058836493406,0.0511802294371545,0.391890041013674
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINC1,Antithrombin-III,34969,0.00806369650073668,0.00942164612612472,-0.0104027299064678,0.0265301229079411,0.392102343645491
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ELN,Elastin,34949,-0.018460085796508,0.021572572517466,-0.0607423279307414,0.0238221563377254,0.392184863272813
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMA1,Proteasome subunit alpha type-1,35800,0.0233050368680568,0.0272777796371809,-0.0301594112208178,0.0767694849569315,0.392934117908293
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF14,Tumor necrosis factor receptor superfamily member 14,35966,-0.016106068761731,0.0189246520154254,-0.0531983867119647,0.0209862491885028,0.394762091548917
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NECTIN1,Nectin-1,34778,-0.0179593284389221,0.0211244837748357,-0.0593633166376,0.0234446597597558,0.395265469590893
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NIT2,Omega-amidase NIT2,34933,-0.0390560000005352,0.0459478911520833,-0.129113866658619,0.0510018666575481,0.395353679528252
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IKBKG,NF-kappa-B essential modulator,35971,-0.0472745410556249,0.0556471334119563,-0.156342922543059,0.0617938404318093,0.395607720401813
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNM1,Dynamin-1,34964,-0.0613373179084042,0.0722661197014069,-0.202978912523162,0.0803042767063532,0.396041183954416
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DGKZ,Diacylglycerol kinase zeta,35842,0.0188099515175981,0.0221795160879469,-0.0246619000147778,0.0622818030499739,0.396422765350031
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",34750,-0.0290265642163471,0.0343091627867893,-0.0962725232784541,0.0382193948457599,0.39756919743656
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,34805,-0.0248250538627575,0.0293576656727527,-0.0823660785813529,0.0327159708558379,0.397804506103429
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,34949,-0.0181352493925138,0.0214756518890416,-0.0602275270950352,0.0239570283100077,0.398446294803139
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF4B,Eukaryotic translation initiation factor 4B,35902,-0.0289326665986193,0.034287830563001,-0.0961368145021012,0.0382714813048626,0.398799116242669
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C9orf40,Uncharacterized protein C9orf40,34964,-0.0430129866444336,0.0510438248439981,-0.14305888333867,0.0570329100498027,0.399445938595208
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPD52L2,Tumor protein D54,34822,-0.0572652507838579,0.0679623500809561,-0.190471456942532,0.0759409553748161,0.39948314131436
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUMF1,Formylglycine-generating enzyme,34778,-0.0355072797864423,0.0421711569472777,-0.118162747403107,0.047148187830222,0.399831619425771
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PADI2,Protein-arginine deiminase type-2,35842,0.0291678149874273,0.0346470865539685,-0.038740474658351,0.0970761046332056,0.399897050171028
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MFAP5,Microfibrillar-associated protein 5,36072,-0.0210156468106809,0.0249799650563045,-0.0699763783210377,0.0279450846996759,0.400206763977738
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNMBP,Dynamin-binding protein,35902,-0.0316881552249641,0.0377085958939833,-0.105597003177171,0.0422206927272431,0.400743603564338
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EVI5,Ecotropic viral integration site 5 protein homolog,34778,-0.0484591752675822,0.0576765813979046,-0.161505274807475,0.0645869242723108,0.40083546310886
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDF1,Endothelial differentiation-related factor 1,34952,-0.0369143630841773,0.0439767816913807,-0.123108855199284,0.0492801290309288,0.401273252376087
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RARRES1,Retinoic acid receptor responder protein 1,35800,-0.0163671223396242,0.0195352220588925,-0.0546561575750535,0.0219219128958051,0.402156089831539
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF3,Granulocyte colony-stimulating factor,35842,-0.0248751702130253,0.0297033978135723,-0.0830938299276269,0.0333434895015764,0.402366176523089
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SF3B4,Splicing factor 3B subunit 4,35937,-0.0379229324469798,0.0452841470747592,-0.126679860713508,0.0508339958195481,0.402370379092874
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTGR1,Prostaglandin reductase 1,34949,0.0439540808320948,0.0525032515026208,-0.0589522921130419,0.146860453777232,0.402529237016282
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACP5,Tartrate-resistant acid phosphatase type 5,36007,-0.0171682562834975,0.0205326706690164,-0.0574122907947696,0.0230757782277747,0.403101229038619
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPN1,Tyrosine-protein phosphatase non-receptor type 1,35902,-0.0403920623873446,0.048318851480004,-0.135097011288152,0.0543128865134633,0.403211334165648
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB33A,Ras-related protein Rab-33A,34736,-0.0350582059970305,0.041990248316345,-0.117359092697067,0.0472426807030058,0.403799175756515
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDNRB,Endothelin receptor type B,34778,0.0219970950293007,0.026365629111684,-0.0296795380295999,0.0736737280882013,0.404138853908081
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,34949,-0.0377009356079859,0.0452250420319765,-0.12634201799066,0.0509401467746881,0.404521077072553
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCTN3,Tectonic-3,34949,-0.0162280069910085,0.0194722019400137,-0.0543935227934354,0.0219375088114183,0.404654176467507
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPM3,Tropomyosin alpha-3 chain,34736,-0.0246998987594624,0.0296473556787704,-0.0828087158898525,0.0334089183709276,0.404807697817169
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPM1F,Protein phosphatase 1F,34949,-0.0280032221129507,0.0336225309463061,-0.0939033827677107,0.0378969385418093,0.404948963644056
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CST5,Cystatin-D,35805,0.0286803183875201,0.0344685818833465,-0.038878102103839,0.0962387388788792,0.405396266409062
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSPA1A,Heat shock 70 kDa protein 1A,35977,-0.0358469511130222,0.0431825070921138,-0.120484665013565,0.0487907627875209,0.406494028508402
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASE3,Eosinophil cationic protein,35939,-0.0595903835812751,0.0718482824478823,-0.200413017179124,0.0812322500165741,0.406909657701044
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DTNB,Dystrobrevin beta,34935,-0.0241735059234644,0.0291471210019605,-0.0813018630873069,0.0329548512403781,0.406931013751613
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",34815,-0.0132672013240221,0.0160097355476593,-0.0446462829974343,0.0181118803493901,0.407308360805768
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,35972,-0.0247393633832169,0.0298599146962408,-0.0832647961878488,0.033786069421415,0.40740617776608
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C4BPB,C4b-binding protein beta chain,35991,-0.0194639837263341,0.0235012878143275,-0.0655265078424159,0.0265985403897477,0.40757875383549
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAS2,Growth arrest-specific protein 2,34869,-0.0265373575540848,0.0320834700433154,-0.0894209588389829,0.0363462437308134,0.408192091093829
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOE,Apolipoprotein E,34975,-0.036510934519347,0.0441476754881132,-0.123040378476049,0.0500185094373549,0.408257655840564
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RPS10,40S ribosomal protein S10,34736,0.0218307811828657,0.026436831618336,-0.0299854087890728,0.0736469711548042,0.408965848267111
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP6,Gastrotropin,35859,0.0288014708011413,0.0348827563575009,-0.0395687316595606,0.0971716732618431,0.409021289477732
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGR,Tyrosine-protein kinase Fgr,35782,-0.0312567775992634,0.0378700379208552,-0.10548205192414,0.0429684967256129,0.409189209157824
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRR,Receptor-type tyrosine-protein phosphatase R,34958,-0.0196172777421268,0.0237744901848956,-0.0662152785045222,0.0269807230202687,0.409323191016446
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSLP,Thymic stromal lymphopoietin,35874,-0.030040366349672,0.0364154329506033,-0.101414614932854,0.0413338822335104,0.409435527170802
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NME1,Nucleoside diphosphate kinase A,34778,-0.0110963980066486,0.0134885124349449,-0.0375338823791406,0.0153410863658433,0.41073571767766
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOBR,Apolipoprotein B receptor,34815,0.0220741636021902,0.0268337004952431,-0.0305198893684862,0.0746682165728667,0.410750914201556
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RILPL2,RILP-like protein 2,34949,-0.0513160533253122,0.0624282395555177,-0.173675402854127,0.0710432962035024,0.411107395993611
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSLN,Mesothelin,35925,-0.0294448064333586,0.0358262205019493,-0.0996641986171792,0.0407745857504619,0.411172704445522
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HK2,Hexokinase-2,35874,-0.0136753015715819,0.0166706021264814,-0.0463496817394854,0.0189990785963216,0.41205808433038
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CC2D1A,Coiled-coil and C2 domain-containing protein 1A,35902,-0.0371878936367353,0.0453469752242936,-0.126067965076351,0.0516921778028802,0.412200461220659
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBCA,Tubulin-specific chaperone A,34822,-0.0429928663297015,0.0524356925905402,-0.14576682380716,0.0597810911477573,0.412295369453706
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCT5,T-complex protein 1 subunit epsilon,35800,-0.0226131828544563,0.0275935643511158,-0.0766965689826432,0.0314702032737306,0.412523018919948
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VIPR1,Vasoactive intestinal polypeptide receptor 1,34815,-0.0118692555088996,0.0145058773237667,-0.0403007750634823,0.0165622640456831,0.413252849180942
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LZTFL1,Leucine zipper transcription factor-like protein 1,34822,-0.0365551390439233,0.0447107856181465,-0.12418827885549,0.0510780007676438,0.413622034817739
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HNF1A,Hepatocyte nuclear factor 1-alpha,34805,-0.0377693933017542,0.0462010076041657,-0.128323368205919,0.0527845816024105,0.413673277151408
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL2,Interleukin-2,35842,-0.0157819570223028,0.0193132121092508,-0.0536358527564343,0.0220719387118288,0.413864689378493
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMEM106A,Transmembrane protein 106A,34949,-0.0368596529752585,0.0451219909380356,-0.125298755213808,0.0515794492632913,0.414022579216829
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGA,Fibrinogen alpha chain,34824,-0.0158050804871736,0.0193523004129375,-0.0537355892965312,0.022125428322184,0.414129473176867
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPART,Spartin,34822,-0.039823324370382,0.048767038760415,-0.135406720340795,0.0557600716000314,0.414186436965194
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOTCH2,Neurogenic locus notch homolog protein 2,34965,-0.0110197957070016,0.0135103114409475,-0.0375000061312587,0.0154604147172556,0.414726199075896
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VAMP8,Vesicle-associated membrane protein 8,34778,-0.045437675861975,0.0557303390305591,-0.154669140361871,0.0637937886379208,0.414924537959777
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RPL14,60S ribosomal protein L14,34815,-0.0201318532203918,0.0246989041574082,-0.0685417053689119,0.0282779989281282,0.415051485326607
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP350,Centrosome-associated protein 350,34739,-0.0191889819401391,0.0235499979440384,-0.0653469779104544,0.0269690140301762,0.415207624426439
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),USP25,Ubiquitin carboxyl-terminal hydrolase 25,34949,-0.0368782057575875,0.045274700994396,-0.125616619706604,0.0518602081914287,0.415364310117295
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGAP45,Rho GTPase-activating protein 45,34822,-0.0421615682782295,0.0517663558413573,-0.14362362572729,0.0593004891708308,0.415413289195177
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CBLN1,Cerebellin-1,34750,-0.0480130608702158,0.0589543268512323,-0.163563541498631,0.0675374197581995,0.415440988975487
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHA2,Ephrin type-A receptor 2,35699,-0.0161717693365001,0.0199034837967378,-0.0551825975781062,0.0228390589051059,0.416526592831079
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSDL2,Hydroxysteroid dehydrogenase-like protein 2,34815,-0.0245545297004834,0.0302426460661324,-0.0838301159901029,0.0347210565891361,0.416870140928565
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,34778,-0.016400559888773,0.0202142992871825,-0.0560205864916507,0.0232194667141046,0.417204816431636
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBC1D5,TBC1 domain family member 5,35971,-0.0394377186280165,0.0486254989314998,-0.134743696533756,0.0558682592777231,0.41736305331066
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRDX5,"Peroxiredoxin-5, mitochondrial",36067,-0.0326719260005882,0.0403144663383044,-0.111688280023665,0.0463444280224884,0.417720718331678
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",35926,0.0315465573611418,0.0389286921919561,-0.0447536793350921,0.107846794057376,0.417755160092255
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",35874,-0.0444034801845725,0.0549297254012715,-0.152065741971065,0.0632587816019196,0.418904701851188
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MDM1,Nuclear protein MDM1,34805,-0.0160453647335746,0.0198687245628242,-0.0549880648767101,0.0228973354095609,0.419369731635587
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NTRK3,NT-3 growth factor receptor,36043,0.0103283822966864,0.0127991985915831,-0.0147580469428164,0.0354148115361892,0.419717969349861
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB37,Ras-related protein Rab-37,35842,-0.0407255982463698,0.0504790808396427,-0.139664596692069,0.0582134001993299,0.419818762637393
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),USP8,Ubiquitin carboxyl-terminal hydrolase 8,35874,-0.0464080418470483,0.0575559138690519,-0.15921763303039,0.0664015493362933,0.420089154322094
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OFD1,Oral-facial-digital syndrome 1 protein,34869,0.0328462935324506,0.0407402464760203,-0.0470045895605492,0.11269717662545,0.420136798560965
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FZD10,Frizzled-10,34805,-0.0304715396817704,0.037817452439829,-0.104593746463835,0.0436506671002943,0.420415947244756
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACY1,Aminoacylase-1,35972,0.0312709394970261,0.0388223616657302,-0.0448208893678051,0.107362768361857,0.420564210855859
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYL3,Myosin light chain 3,34815,-0.0400537252008957,0.0497287204646817,-0.137522017311672,0.0574145669098804,0.420594025199887
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAMD9L,Sterile alpha motif domain-containing protein 9-like,35971,-0.0363292413773324,0.0451125172165446,-0.12474977512176,0.0520912923670951,0.420670879001373
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IMPACT,Protein IMPACT,34958,-0.0277974655105451,0.0345332261853745,-0.0954825888338792,0.039887657812789,0.420879550367299
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSDE1,Cold shock domain-containing protein E1,34736,-0.0608921343107689,0.0757306114528366,-0.209324132758329,0.0875398641367908,0.42139210937885
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SFRP4,Secreted frizzled-related protein 4,34822,-0.0204314599818819,0.0254111823937679,-0.070237377473667,0.0293744575099032,0.421407935002898
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CIAPIN1,Anamorsin,35991,-0.0304648272614793,0.0378953971597637,-0.104739805694616,0.0438101511716576,0.421469649674392
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,34736,0.0282516060330141,0.0351563216037604,-0.0406547843103563,0.0971579963763844,0.421659382050039
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OGFR,Opioid growth factor receptor,35937,-0.0161594923455359,0.0201209487171248,-0.0555965518311005,0.0232775671400288,0.421932658004232
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENPEP,Glutamyl aminopeptidase,34736,-0.0221231996364463,0.0275479588714764,-0.0761171990245399,0.0318707997516474,0.421959920859584
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGFBP1,Fibroblast growth factor-binding protein 1,35991,0.0159654863214517,0.0199033267237469,-0.0230450340570922,0.0549760066999956,0.422491032398464
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL14,C-X-C motif chemokine 14,35842,-0.0295081342428269,0.0369150470056164,-0.101861626373835,0.0428453578881813,0.424112274584341
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ORM1,Alpha-1-acid glycoprotein 1,34952,-0.0102723652341804,0.0128532364207212,-0.035464708618794,0.0149199781504333,0.424201687705341
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRL6,Fc receptor-like protein 6,35971,-0.0336052706355786,0.0420509301961407,-0.116025093820014,0.0488145525488571,0.424225470851803
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIRREL2,Kin of IRRE-like protein 2,35782,-0.0189814772941759,0.0237679744306468,-0.0655667071782437,0.0276037525898918,0.424539694423108
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCN1,CCN family member 1,35927,0.0357715655143905,0.0448291103519944,-0.0520934907755186,0.1236366218043,0.424923076230176
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC28A1,Sodium/nucleoside cotransporter 1,34739,-0.0286726177624102,0.0359376985093059,-0.0991105068406498,0.0417652713158294,0.424992842325948
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMC3,26S proteasome regulatory subunit 6A,34739,0.0156324737748695,0.0195936730176532,-0.0227711253397307,0.0540360728894698,0.424998419915886
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP2,Caspase-2,35971,-0.0335598876858801,0.0420734484797054,-0.116023846706103,0.0489040713343424,0.425099300770102
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD300LG,CMRF35-like molecule 9,35979,0.0181087237140694,0.022703751037236,-0.0263906283189132,0.0626080757470519,0.425122898813012
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSBP1,Heat shock factor-binding protein 1,34815,-0.0472849281090053,0.0593603237787152,-0.163631162715287,0.0690613064972766,0.42572854178946
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NDRG1,Protein NDRG1,35782,-0.0315091389412373,0.0395594042129567,-0.109045571198632,0.0460272933161578,0.425766723745406
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BMP10,Bone morphogenetic protein 10,34822,-0.0141337250046918,0.0177451091738635,-0.0489141389854642,0.0206466889760807,0.425780195513458
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,35971,-0.0419687573350384,0.0527404164429771,-0.145339973563273,0.0614024588931967,0.426196690438339
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DYNLT3,Dynein light chain Tctex-type 3,34949,-0.0221980956291462,0.0279232590404963,-0.076927683348519,0.0325314920902265,0.426661869571758
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRAME,Melanoma antigen preferentially expressed in tumors,34739,-0.0127762621404962,0.0160858712217582,-0.0443045697351423,0.0187520454541499,0.427078474710867
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPIND1,Heparin cofactor 2,34969,-0.0146591993342127,0.0184599131518316,-0.0508406291118027,0.0215222304433773,0.427161055255475
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",36013,-0.0348132775504405,0.0438417172191376,-0.12074304329995,0.0511164881990692,0.427181624201966
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARMCX2,Armadillo repeat-containing X-linked protein 2,34750,0.0303451283262739,0.0382440698894723,-0.0446132486570917,0.10530350530964,0.427540649562807
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA4,Carbonic anhydrase 4,36072,0.011856238658364,0.0149433785902642,-0.0174327833785537,0.0411452606952818,0.427563686865041
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASRGL1,Isoaspartyl peptidase/L-asparaginase,34815,-0.0506211119725714,0.0638027505074903,-0.175674502967252,0.0744322790221096,0.42757501039928
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL15RA,Interleukin-15 receptor subunit alpha,35842,-0.0169056341236545,0.0213083746123022,-0.0586700483637668,0.0248587801164578,0.427582564880344
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBPMS,RNA-binding protein with multiple splicing,34778,-0.0341153976207671,0.0430909919838779,-0.118573741909168,0.0503429466676336,0.428562508624309
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,36043,-0.033907748507077,0.0428491853733881,-0.117892151838918,0.0500766548247637,0.428777987692663
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUCA1,Tissue alpha-L-fucosidase,36016,-0.0401448977995153,0.0507829104447467,-0.139679402271219,0.0593896066721883,0.429249523275024
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPARC,SPARC,35991,0.0341654892656259,0.0432273576033254,-0.0505601316368919,0.118891110168144,0.429338660181361
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EHBP1,EH domain-binding protein 1,34949,-0.0374536421855837,0.0474244960511393,-0.130405654445817,0.0554983700746494,0.429701474383606
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YY1,Transcriptional repressor protein YY1,34778,0.0141366884998203,0.0179371227028101,-0.0210200719976876,0.0492934489973282,0.430654037742645
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP13,Collagenase 3,35782,-0.0154031392620081,0.0195906756845969,-0.0538008636038179,0.0229945850798018,0.431747860761507
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEO1,Neogenin,34952,-0.0116232183609674,0.0147890169057307,-0.0406096914961997,0.0173632547742648,0.431934395069566
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL34,Interleukin-34,35772,0.0171914695401374,0.0218839194719051,-0.0257010126247966,0.0600839517050714,0.432142211940765
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,34736,-0.0195182495470082,0.024850038293512,-0.0682243246022917,0.0291878255082752,0.432225125780999
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPVL,Probable serine carboxypeptidase CPVL,36015,-0.0192641498621336,0.0245937441789584,-0.067467888452892,0.0289395887286248,0.433479082358857
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MLLT1,Protein ENL,34739,0.0342574546968527,0.0437359647665789,-0.0514650362456419,0.119979945639347,0.433493616200198
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXNRD1,"Thioredoxin reductase 1, cytoplasmic",35979,-0.022216262748808,0.0283649525464734,-0.0778115697398958,0.0333790442422799,0.433517591467389
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDIA2,Protein disulfide-isomerase A2,34739,-0.0199272521303935,0.0254452762464607,-0.0697999935734565,0.0299454893126694,0.4335742256829
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTF,Ciliary neurotrophic factor,34750,0.0175200463247008,0.0224076786041747,-0.0263990037394817,0.0614390963888832,0.434317020667794
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICOSLG,ICOS ligand,35937,0.00900112642015528,0.0115296222367425,-0.01359693316386,0.0315991860041706,0.435006681123823
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD40,Tumor necrosis factor receptor superfamily member 5,35958,-0.0239398464667153,0.0306817702511079,-0.0840761161588869,0.0361964232254562,0.435261255089061
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEZ6L2,Seizure 6-like protein 2,35937,-0.0114882104071059,0.0147280776445326,-0.0403552425903898,0.017378821776178,0.435403653939512
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRSS53,Serine protease 53,34958,-0.018827083700232,0.0241624706756447,-0.0661855262244956,0.0285313588240316,0.435898550974422
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIRT2,NAD-dependent protein deacetylase sirtuin-2,35937,-0.0416790894761885,0.053526609985005,-0.146591245046798,0.0632330660944212,0.436204482754993
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,35980,-0.0104869175674706,0.013477150709625,-0.0369021329583356,0.0159282978233944,0.436519848054582
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHRM1,Muscarinic acetylcholine receptor M1,34805,-0.0177192438702763,0.0227749300183549,-0.0623581067062518,0.0269196189656993,0.436589661106936
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPQ,Carboxypeptidase Q,34960,0.017790578068416,0.0229065067978077,-0.027106175255287,0.062687331392119,0.437388004866287
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSPAN8,Tetraspanin-8,34964,0.0466066472198899,0.0600194002066217,-0.0710313771850887,0.164244671624868,0.437467113826624
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMBS,Porphobilinogen deaminase,36032,-0.0195902613554699,0.0252911319211443,-0.0691608799209128,0.029980357209973,0.438606528251141
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",35937,-0.0171622559839398,0.0221636393547947,-0.0606029891193375,0.0262784771514579,0.438753012954991
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MANF,Mesencephalic astrocyte-derived neurotrophic factor,35992,-0.0577463097149817,0.0746304193413315,-0.204021931623991,0.088529312194028,0.439095284399447
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",34815,-0.0211477325638121,0.0273540680598931,-0.0747617059612025,0.0324662408335783,0.439486057634788
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,36006,0.0277643235603998,0.0359352143159274,-0.0426686964988179,0.0981973436196176,0.439771000178174
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLKB1,Plasma kallikrein,34843,0.0119330269957546,0.0154626437768826,-0.0183737548069352,0.0422398087984444,0.44030200090399
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TLR2,Toll-like receptor 2,34869,0.0118025454977216,0.0152937473546232,-0.0181731993173398,0.041778290312783,0.44030724859787
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRG2,Adhesion G-protein coupled receptor G2,35972,0.0129813428581336,0.016834353694013,-0.0200139903821318,0.045976676098399,0.440659252239626
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PYDC1,Pyrin domain-containing protein 1,34815,-0.0198895190487575,0.0257941613204443,-0.0704460752368283,0.0306670371393133,0.440685216878025
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NMRK2,Nicotinamide riboside kinase 2,34739,-0.0198656943282231,0.0257935801416803,-0.0704211114059166,0.0306897227494703,0.44122288197619
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATXN3,Ataxin-3,34958,-0.0303095231140002,0.0393781477405727,-0.107490692685523,0.0468716464575222,0.441504011883443
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAT2,Thialysine N-epsilon-acetyltransferase,34869,-0.0334918256688675,0.0435171174331666,-0.118785375837874,0.0518017245001391,0.441551856693497
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALMS1,Alstrom syndrome protein 1,34869,-0.0215896340554394,0.0280572453854255,-0.0765818350108733,0.0334025668999946,0.441634339941063
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSPG5,Chondroitin sulfate proteoglycan 5,34750,-0.0249634479837811,0.0324508154652328,-0.0885670462956374,0.0386401503280753,0.441762417598743
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OTUD7B,OTU domain-containing protein 7B,34952,-0.0302463728969948,0.0393660840073503,-0.107403897551401,0.0469111517574118,0.442316255298643
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERI1,3'-5' exoribonuclease 1,34869,-0.0167258596323292,0.0218283195070412,-0.0595093658661299,0.0260576466014715,0.443558871387982
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMOX2,Heme oxygenase 2,35782,-0.021902569153326,0.0285918351584093,-0.0779425660638083,0.0341374277571563,0.443676017824696
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSAP,Gamma-secretase-activating protein,35800,-0.0389812953972574,0.0509121563648054,-0.138769121872276,0.0608065310777611,0.443904973450807
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,36072,-0.0115513143793266,0.0151143364716108,-0.0411754138636838,0.0180727851050306,0.444735205643666
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLNS1A,Methylosome subunit pICln,34805,-0.0165913327149383,0.0217135010141133,-0.0591497947026005,0.0259671292727238,0.444835427902894
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SRPX,Sushi repeat-containing protein SRPX,34949,-0.0183844585968712,0.0240836089429552,-0.0655883321250633,0.028819414931321,0.44527721853621
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP2B4,Plasma membrane calcium-transporting ATPase 4,34736,-0.0296893423959608,0.0389116203755096,-0.10595611833196,0.0465774335400381,0.445496159982712
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AXIN1,Axin-1,35971,-0.0451496366549886,0.0591978401250789,-0.161177403300143,0.070878129990166,0.445672339481429
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALDH2,"Aldehyde dehydrogenase, mitochondrial",34949,-0.0230378905984769,0.0302313043279313,-0.0822912470812222,0.0362154658842685,0.446055999999635
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BIN2,Bridging integrator 2,35979,-0.0418087766688553,0.0548837771799566,-0.14938097994157,0.0657634266038597,0.446222050411299
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAAA,N-acylethanolamine-hydrolyzing acid amidase,35865,0.0281414046359143,0.0369444942721353,-0.0442698041374709,0.100552613409299,0.446251143544823
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TADA3,Transcriptional adapter 3,34949,-0.0194844269364019,0.025594066443066,-0.0696487971648113,0.0306799432920076,0.446514011040388
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OPLAH,5-oxoprolinase,34815,-0.0330868136750933,0.043529847497676,-0.118405314770538,0.0522316874203518,0.44722671216554
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MCTS1,Malignant T-cell-amplified sequence 1,34964,-0.0127129618317542,0.0167259318269425,-0.0454957882125614,0.0200698645490531,0.447237939993474
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PXDNL,Peroxidasin-like protein,34949,-0.0277476676246023,0.036518795073839,-0.0993245059693268,0.0438291707201222,0.447391105886661
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFAIP8,Tumor necrosis factor alpha-induced protein 8,35842,-0.0174596114166422,0.0229857126992358,-0.0625116083071444,0.02759238547386,0.447527182423321
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FHIT,Bis(5'-adenosyl)-triphosphatase,35782,-0.0333664262332965,0.0439282778172714,-0.119465850755148,0.0527329982885554,0.447538979381973
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NLGN1,Neuroligin-1,34805,-0.0325086886755503,0.0428326653687677,-0.116460712798335,0.0514433354472344,0.447899602364249
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD2AP,CD2-associated protein,35972,-0.029444583834722,0.0388273027417548,-0.105546097208561,0.0466569295391175,0.448267284431266
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPR1,Atrial natriuretic peptide receptor 1,34736,0.0207552303620481,0.0273975110660674,-0.032943891327444,0.0744543520515403,0.44874413921193
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,35874,0.0382397243853704,0.0505464555437301,-0.0608313284803406,0.137310777251081,0.449358194501496
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGLC2,Immunoglobulin lambda constant 2,34966,-0.0125661542855397,0.0166325629503236,-0.0451659776681738,0.0200336690970945,0.449967862013773
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,34869,-0.0503999958085061,0.0667558213381958,-0.18124140563137,0.0804414140143576,0.450283180197138
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TAP1,Antigen peptide transporter 1,34869,-0.0283579942297371,0.0375783736142348,-0.102011606513637,0.0452956180541631,0.450495752670869
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMPD3,AMP deaminase 3,34958,-0.0340488770147697,0.0451870772391051,-0.122615548403416,0.0545177943738763,0.451171905136454
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TWF2,Twinfilin-2,34965,-0.0403005069843613,0.0536091270915463,-0.145374396083792,0.0647733821150694,0.452230942374049
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",35800,-0.0382740855771809,0.0509378441858352,-0.138112260181418,0.0615640890270562,0.452443732528957
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",35800,-0.0358765614339838,0.0477678619638923,-0.129501570883213,0.0577484480152452,0.452640702384962
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMCN2,Hemicentin-2,34805,-0.027286933906252,0.0363449292734506,-0.0985229952822152,0.0439491274697113,0.452815393772768
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CETN2,Centrin-2,35782,-0.0313847291024842,0.04181528523548,-0.113342688164025,0.0505732299590566,0.452944269625832
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL20RA,Interleukin-20 receptor subunit alpha,35842,0.0193474321367966,0.0257933982465493,-0.0312076284264401,0.0699024927000333,0.453223420474684
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ROBO4,Roundabout homolog 4,34815,-0.0085230257115096,0.0113826474994162,-0.0308330148103654,0.0137869633873462,0.454022022637179
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZNRF4,E3 ubiquitin-protein ligase ZNRF4,34949,-0.0251102925319761,0.0335363784287364,-0.0908415942522995,0.0406210091883473,0.454036910960979
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G4A,Cytosolic phospholipase A2,35992,-0.0405133319771609,0.0541446980101633,-0.146636940077081,0.0656102761227592,0.454338063796032
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAG4,BAG family molecular chaperone regulator 4,34778,-0.0237489892043934,0.0318655835347603,-0.0862055329325235,0.0387075545237368,0.456126892822155
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HDAC9,Histone deacetylase 9,34750,-0.0316446985856007,0.0425296440375427,-0.115002800899184,0.051713403727983,0.456867300370956
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RRAS,Ras-related protein R-Ras,34805,-0.0609100854575707,0.0818886494358153,-0.221411838351769,0.0995916674366273,0.457015979503407
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOM,Apolipoprotein M,36014,0.0129321014225081,0.01741395610097,-0.0211992525353931,0.0470634553804093,0.457730110632323
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMP4,Metalloproteinase inhibitor 4,35979,-0.0183349644663638,0.024690808416384,-0.0667289489624764,0.0300590200297489,0.457758069947765
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RYR1,Ryanodine receptor 1,34736,-0.015727683496992,0.0211871119136072,-0.0572544228476621,0.025799055853678,0.457919987974585
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOC1,Apolipoprotein C-I,34969,-0.0181871254236822,0.0245235834789902,-0.0662533490425029,0.0298790981951385,0.458346295562421
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDAP1,28 kDa heat- and acid-stable phosphoprotein,34949,-0.0455223351615372,0.0614361785238084,-0.165937245068202,0.0748925747451273,0.458739330078896
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCG2,Secretogranin-2,36001,0.014977008323103,0.0202321124391357,-0.0246779320576029,0.054631948703809,0.459166185788364
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL1,Growth-regulated alpha protein,35949,-0.0423005140362304,0.0571738564698238,-0.154361272717085,0.0697602446446243,0.459410018253729
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OSCAR,Osteoclast-associated immunoglobulin-like receptor,35966,-0.0154470546584395,0.0208879083730008,-0.0563873550695211,0.025493245752642,0.459614033257483
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMFR,E3 ubiquitin-protein ligase AMFR,35782,-0.0288596901880477,0.0390329774585716,-0.105364326006848,0.0476449456307526,0.459708421042041
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSBP1,"Single-stranded DNA-binding protein, mitochondrial",34778,-0.0163923262842644,0.022174885917489,-0.0598551026825429,0.0270704501140142,0.459795832503809
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGT1,Glutathione hydrolase 1 proenzyme,35967,-0.023684395220436,0.0320749830139208,-0.0865513619277207,0.0391825714868487,0.460290622703617
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEGF10,Multiple epidermal growth factor-like domains protein 10,35949,0.0180972493607738,0.0245275879135467,-0.0299768229497777,0.0661713216713253,0.460639852616361
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,34952,-0.0147529938383501,0.0199971684901795,-0.0539474440791019,0.0244414564024017,0.460691118438703
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOA2,Apolipoprotein A-II,34966,-0.0230661657893412,0.0312665331242555,-0.0843485707128819,0.0382162391341995,0.460707550640324
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD226,CD226 antigen,34778,-0.0198106572241345,0.0268558484641787,-0.0724481202139248,0.0328268057656558,0.460745207067795
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PI16,Peptidase inhibitor 16,34966,0.0112662277892273,0.0152784065456594,-0.0186794490402652,0.0412119046187198,0.460909066065755
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IRAK1,Interleukin-1 receptor-associated kinase 1,35842,-0.0319093853213817,0.0432781669959421,-0.116734592633428,0.0529158219906649,0.460958300692316
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MOCS2,Molybdopterin synthase catalytic subunit,34822,0.0312861453465965,0.0424602860847885,-0.051936015379589,0.114508306072782,0.461251616954185
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLITRK6,SLIT and NTRK-like protein 6,35874,0.0157177223588975,0.0213503775166025,-0.0261290175736435,0.0575644622914385,0.461644860262218
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP6V1G1,V-type proton ATPase subunit G 1,34815,-0.033594042327098,0.045717823753341,-0.123200976883646,0.0560128922294504,0.46248123153444
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UPK3A,Uroplakin-3a,34750,-0.0229023502891029,0.0311877388757529,-0.0840303184855785,0.0382256179073727,0.462770593778854
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DOCK9,Dedicator of cytokinesis protein 9,34750,-0.0537400024197142,0.0732978376505225,-0.197403764214738,0.0899237593753098,0.463480808098027
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIGAR,"Fructose-2,6-bisphosphatase TIGAR",35776,0.0211635068810027,0.0288915216909883,-0.0354638756333343,0.0777908893953397,0.463877499848757
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCDC134,Coiled-coil domain-containing protein 134,34949,-0.0222881377353722,0.0304300801808778,-0.0819310948898927,0.0373548194191482,0.463928496547144
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPBGL,Trophoblast glycoprotein-like,34805,0.0195605882534704,0.0267099139191172,-0.0327908430279994,0.0719120195349403,0.463992160053952
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HNMT,Histamine N-methyltransferase,35869,0.0217376098920268,0.0296843843356418,-0.0364437834058311,0.0799190031898846,0.464014531912865
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G10,Group 10 secretory phospholipase A2,35902,0.0264059838209533,0.0360871564483436,-0.0443248428178002,0.0971368104597068,0.464358067879227
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAPK9,Mitogen-activated protein kinase 9,35971,-0.0193571311302515,0.0264839832444263,-0.0712657382893269,0.032551476028824,0.464863749731066
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KCNC4,Potassium voltage-gated channel subfamily C member 4,34750,-0.0261859485422598,0.0358413537018351,-0.0964350017978566,0.044063104713337,0.46504698712998
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNAP25,Synaptosomal-associated protein 25,34750,0.0221385965379456,0.0303049782134444,-0.0372591607604053,0.0815363538362966,0.465096109751481
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MUC16,Mucin-16,35937,0.0848447588136953,0.116168508386573,-0.142845517623988,0.312535035251378,0.465193865041686
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOD,Apolipoprotein D,34719,0.0194882537186859,0.0267216053274223,-0.0328860927230617,0.0718626001604336,0.465841807761668
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAS6,Growth arrest-specific protein 6,36034,-0.0114523139631287,0.015714604273915,-0.0422529383400021,0.0193483104137446,0.466166030674795
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICAM4,Intercellular adhesion molecule 4,35971,-0.023488226929776,0.0322388893349745,-0.0866764500263259,0.039699996166774,0.466289032331212
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSPAN1,Tetraspanin-1,35874,-0.0319794990827567,0.0439162977782503,-0.118055442728127,0.0540964445626139,0.466519469537956
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,35937,-0.0208303849860969,0.0286544757628305,-0.0769931574812446,0.0353323875090509,0.467279483129371
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,34739,0.0199270913659332,0.027426774392598,-0.0338293864435588,0.0736835691754253,0.467525605359366
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,34952,-0.0544972324521078,0.075238084078832,-0.201963877246619,0.092969412342403,0.468889587412916
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,34736,-0.0222978348244324,0.0308867341903281,-0.0828358338374755,0.0382401641886108,0.470369507692722
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSME1,Proteasome activator complex subunit 1,35886,-0.0164902801174578,0.02288879407235,-0.0613523164992638,0.0283717562643482,0.471269784504951
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGRN,Agrin,35992,-0.0154411380717152,0.021476742770555,-0.057535553902003,0.0266532777585726,0.472182006750787
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",34952,-0.0367143040812137,0.0510718263397511,-0.136815083707126,0.0633864755446984,0.472243842664213
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDAN1,Codanin-1,34958,0.00982287561623792,0.0136935766349673,-0.017016534588298,0.0366622858207738,0.473194046820108
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,34736,-0.0248886306432911,0.0347584329365688,-0.0930151591989659,0.0432378979123837,0.473990304867203
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAVS,Mitochondrial antiviral-signaling protein,35800,-0.039920380069437,0.0558243664946148,-0.149336138398882,0.069495378260008,0.474566283418542
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRP11,Low-density lipoprotein receptor-related protein 11,35972,0.0161768577408171,0.0226232570703632,-0.0281647261170947,0.060518441598729,0.474598121296998
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPP6,Dipeptidyl aminopeptidase-like protein 6,35937,0.0151279109757621,0.021165458038813,-0.0263563867803113,0.0566122087318355,0.474789200671586
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALDH1A1,Retinal dehydrogenase 1,35979,0.0240973992909819,0.0337233618345413,-0.0420003899047191,0.0901951884866829,0.4749029521537
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL26,C-C motif chemokine 26,35971,-0.0399759111291507,0.0559558412908321,-0.149649360059182,0.0696975378008802,0.474990805674292
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFYA,Nuclear transcription factor Y subunit alpha,34736,-0.0180397447185105,0.0252743200674337,-0.0675774120506805,0.0314979226136595,0.475404065764579
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LEG1,Protein LEG1 homolog,34602,-0.0312497713900391,0.0437849945391558,-0.117068360686785,0.0545688179067063,0.475434513641979
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNPEP,Aspartyl aminopeptidase,34958,0.0251550344620043,0.0352484298021236,-0.0439318879501579,0.0942419568741665,0.475469957169212
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DBNL,Drebrin-like protein,35992,-0.0404620565000913,0.0567774573322032,-0.15174587287121,0.0708217598710269,0.476089201059703
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERVV_1,,34736,-0.0190234327697309,0.0267185479032708,-0.0713917866601416,0.0333449211206798,0.47649586236001
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJA2,DnaJ homolog subfamily A member 2,36045,-0.0357158302111701,0.0501990403300568,-0.134105949258081,0.0626742888357412,0.476806453482431
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNAPIN,SNARE-associated protein Snapin,34952,-0.0258713603748189,0.0363658891866642,-0.0971485031806807,0.045405782431043,0.476851163725922
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHH,Sonic hedgehog protein,34778,-0.0192454160766218,0.0270531089431076,-0.0722695096051127,0.033778677451869,0.476867050340198
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MST1,Hepatocyte growth factor-like protein,34865,0.0303486067127503,0.0426627079327971,-0.053270300835532,0.113967514261033,0.476886751810506
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCBP2,Poly(rC)-binding protein 2,34952,-0.0323007232922529,0.0454517380816149,-0.121386129932218,0.0567846833477123,0.47732116522457
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINB5,Serpin B5,35874,-0.0212716613980454,0.0299414729439349,-0.0799569483681578,0.0374136255720669,0.477453245612966
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LBR,Delta(14)-sterol reductase LBR,36043,-0.0305095692663249,0.042984807498848,-0.114759791964067,0.0537406534314172,0.477865512050239
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPT1,Angiopoietin-1,35932,0.0364809929081265,0.0514025548830628,-0.0642680146626765,0.13723000047893,0.477905524743878
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,34778,0.0199352741092073,0.0280994861315887,-0.0351397187087065,0.0750102669271211,0.478069974188882
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FYB1,FYN-binding protein 1,35962,-0.0400833746276498,0.056521027082886,-0.150864587710106,0.0706978384548067,0.478237516638516
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGA2,Integrin alpha-2,34822,0.0153367379787733,0.0216303348331404,-0.0270587182941819,0.0577321942517284,0.47832721399503
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALPI,Intestinal-type alkaline phosphatase,34778,0.0556657342154664,0.0785494664981065,-0.0982912201208224,0.209622688551755,0.478555362429837
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,35800,0.0192211997224537,0.0271426464878678,-0.0339783873937673,0.0724207868386746,0.478871956804767
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TG,Thyroglobulin,34949,-0.0468219777700576,0.0661386898713535,-0.17645380991791,0.0828098543777954,0.479010818486007
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDC,Nuclear migration protein nudC,36067,-0.0275292161592365,0.0389378288585041,-0.103847360721905,0.0487889284034314,0.479585808536532
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THAP12,52 kDa repressor of the inhibitor of the protein kinase,34724,0.0378021559914701,0.0535143363795224,-0.0670859433123939,0.142690255295334,0.479970607008844
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASE4,Ribonuclease 4,34743,-0.0124360860500477,0.0176335157221623,-0.0469977768654859,0.0221256047653904,0.480679678092253
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17RA,Interleukin-17 receptor A,35979,0.0191689891046517,0.0271837490640083,-0.0341111590608046,0.072449137270108,0.48073071698685
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NGF,Beta-nerve growth factor,35902,0.00523529135671556,0.00742462547056268,-0.0093169745655873,0.0197875572790184,0.480754746170864
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAT2,Signal transducer and activator of transcription 2,34778,-0.0349153800121346,0.0495253518125926,-0.131985069564816,0.0621543095405469,0.480836725614244
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",35971,0.0177212234838097,0.0251696176993224,-0.0316112272068622,0.0670536741744816,0.481410167661628
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMOT,Angiomotin,34822,0.0164587016345316,0.0234058045463951,-0.0294166752764028,0.062334078545466,0.481964354391915
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDH17,Protocadherin-17,35972,0.0162319819233647,0.0231139824542649,-0.0290714236869944,0.0615353875337238,0.482540375993796
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPL28,"39S ribosomal protein L28, mitochondrial",34952,-0.0173016790141242,0.0246392339603793,-0.0655945775764676,0.0309912195482192,0.482579949129602
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM172A,Cotranscriptional regulator FAM172A,34815,-0.0269631108425829,0.0384433855859034,-0.102312146590954,0.0483859249057878,0.483097206657391
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMAD2,Mothers against decapentaplegic homolog 2,34949,-0.0312306401106171,0.0445344382529375,-0.118518139086375,0.0560568588651403,0.483160589768332
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UROD,Uroporphyrinogen decarboxylase,34822,-0.0298798995772928,0.0426197485408001,-0.113414606717261,0.0536548075626754,0.483278631599248
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCTN6,Dynactin subunit 6,35782,-0.0302991280574046,0.0432192399637797,-0.115008838386413,0.0544105822716035,0.483290483771423
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFD,Complement factor D,34975,-0.00872691245658978,0.0124718964250546,-0.0331718294496967,0.0157180045365171,0.484123854059678
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCTN2,Dynactin subunit 2,35937,-0.0408134370184918,0.0583830938718933,-0.155244301007403,0.0736174269704191,0.48453507334754
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUMB,Protein numb homolog,34778,-0.0371761125098237,0.0532309374639482,-0.141508749939162,0.0671565249195148,0.484957758261979
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,34869,-0.0503550271100096,0.0722808428035247,-0.192025479004918,0.0913154247848989,0.486042681365531
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGOLN2,Trans-Golgi network integral membrane protein 2,34966,0.0117436608368606,0.0168615353006003,-0.021304948352316,0.0447922700260371,0.486155981554376
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPEP1,Dipeptidase 1,35896,0.0197479463305926,0.0284669768890789,-0.0360473283720021,0.0755432210331873,0.48788353855182
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINI2,Serpin I2,34964,-0.0249219250444088,0.0359300575997532,-0.0953448379399251,0.0455009878511075,0.487943794062699
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UNC5D,Netrin receptor UNC5D,34778,0.0117553821518753,0.0169483131210955,-0.0214633115654719,0.0449740758692224,0.487957979124893
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGT,Angiotensinogen,34966,0.00963553615720075,0.0139011660151466,-0.0176107492324866,0.0368818215468881,0.488243284956862
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCLRE1C,Protein artemis,34739,-0.0135234066627788,0.0195269720834101,-0.0517962719462625,0.024749458620705,0.488618123836801
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM5,Tripartite motif-containing protein 5,35971,0.0370644125758297,0.0536455889557351,-0.0680809417774111,0.142209766929071,0.489642233200668
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFPI2,Tissue factor pathway inhibitor 2,35972,-0.016709603511171,0.0242225250669872,-0.064185752642466,0.030766545620124,0.490318165780343
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYOM3,Myomesin-3,34822,0.0423916133182833,0.0615104602049356,-0.0781688886833904,0.162952115319957,0.490737394358199
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,35991,-0.0403936645002246,0.0586181386731831,-0.155285216299664,0.0744978872992143,0.490782989647557
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM3D,Protein FAM3D,34964,-0.0381939294963818,0.0554564537636035,-0.146888578873045,0.0705007198802812,0.49102504008692
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCLY,Selenocysteine lyase,36013,-0.020349542200474,0.0295515205434795,-0.0782705224656939,0.0375714380647459,0.491088792383113
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BLMH,Bleomycin hydrolase,36072,0.0131567369788339,0.0191127066613214,-0.024304168077356,0.0506176420350238,0.491237126673438
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPR,Nucleoprotein TPR,34736,-0.0222624085011086,0.0323673530909116,-0.0857024205592954,0.0411776035570782,0.491601950967272
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRCAM,Neuronal cell adhesion molecule,35972,-0.0120800603263963,0.0175679803878091,-0.0465133018865022,0.0223531812337096,0.491714974378119
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYPD3,Ly6/PLAUR domain-containing protein 3,35927,-0.0142113435854321,0.0207776134906145,-0.0549354660270366,0.0265127788561723,0.494013330784835
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ELAC1,Zinc phosphodiesterase ELAC protein 1,34952,-0.0361516546517215,0.0528622983997235,-0.13976175951518,0.0674584502117366,0.494073668799672
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACTN2,Alpha-actinin-2,34736,0.0278630137908285,0.0407453243636505,-0.0519978219619265,0.107723849543583,0.494106194482146
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD55,Complement decay-accelerating factor,35739,-0.0112225641630817,0.0164141506511061,-0.0433942994392498,0.0209491711130863,0.494178757902502
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRDX1,Peroxiredoxin-1,35746,-0.0380236577974097,0.0557019037339281,-0.147199389115909,0.0711520735210894,0.494864306091844
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CES3,Carboxylesterase 3,35937,0.0290981248093049,0.0426357302764138,-0.054467906532466,0.112664156151076,0.494955672877684
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FMNL1,Formin-like protein 1,35782,-0.0276212641834995,0.0404952809889153,-0.106992014921774,0.0517494865547744,0.495206569405048
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL4A4,Collagen alpha-4(IV) chain,34860,0.0222220295938496,0.0326258601824882,-0.0417246563638273,0.0861687155515264,0.495822624082379
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARID3A,AT-rich interactive domain-containing protein 3A,34750,0.0173680908103134,0.0255171345880882,-0.0326454929823396,0.0673816746029663,0.49612224692481
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARNT,Aryl hydrocarbon receptor nuclear translocator,35842,-0.0156250526489243,0.0230833167985675,-0.0608683535741166,0.0296182482762681,0.498492246996593
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMEM25,Transmembrane protein 25,34952,-0.0192432656875582,0.0284394637068015,-0.0749846145528891,0.0364980831777727,0.498659322434853
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DSC2,Desmocollin-2,35898,-0.0144520284235055,0.0213836102305214,-0.0563639044753275,0.0274598476283164,0.499159811330622
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HEXIM1,Protein HEXIM1,35971,-0.0332816611625637,0.0492740722423207,-0.129858842757512,0.0632955204323848,0.499417681811858
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,35800,-0.0201355954498884,0.0298306178884891,-0.078603606511327,0.0383324156115503,0.499698964970644
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL22RA1,Interleukin-22 receptor subunit alpha-1,35842,-0.0185542103352065,0.0275042731427081,-0.0724625856949144,0.0353541650245014,0.499955448507255
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KHK,Ketohexokinase,34815,-0.0267976053990378,0.0397378471229848,-0.104683785760088,0.0510885749620124,0.500107695529552
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UGDH,UDP-glucose 6-dehydrogenase,34736,-0.0428402982841834,0.0635350132076209,-0.16736892417112,0.0816883276027535,0.500159622625251
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASPN,Asporin,34949,-0.0114272516440917,0.0169495412487954,-0.0446483524917307,0.0217938492035472,0.500213555498875
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTSL5,ADAMTS-like protein 5,34949,0.0173982470294055,0.0258321110081993,-0.0332326905466651,0.0680291846054761,0.500645880346769
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GMFG,Glia maturation factor gamma,34949,-0.0303736307430605,0.0451898870799403,-0.118945809419743,0.0581985479336224,0.501523256753658
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LPA,Apolipoprotein(a),34846,0.0771582730072202,0.1148192555183,-0.147887467808647,0.302204013823088,0.501610030111646
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,35937,-0.01176107112497,0.0175051231481289,-0.0460711124953027,0.0225489702453626,0.501691105099167
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLIN1,Perilipin-1,35782,0.0140906655968056,0.0209729769506257,-0.0270163692264207,0.055197700420032,0.501701683684074
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SELL,L-selectin,34975,-0.00986917616676438,0.0146933313362953,-0.0386681055859032,0.0189297532523745,0.50181353549845
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHEK2,Serine/threonine-protein kinase Chk2,35874,0.0134770035925493,0.0200680933887833,-0.0258564594494659,0.0528104666345646,0.501882803149973
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSH3,Protein phosphatase Slingshot homolog 3,34739,0.0123239598498448,0.0183541919421533,-0.0236502563567756,0.0482981760564653,0.501957858802511
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL7,Interleukin-7,35971,-0.0268784717358595,0.0401063613172565,-0.105486939917682,0.0517299964459633,0.502764197549687
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERBB2,Receptor tyrosine-protein kinase erbB-2,35991,0.0101655110874819,0.0151704847407309,-0.0195686390043507,0.0398996611793146,0.502824674714449
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF10,Tumor necrosis factor ligand superfamily member 10,36067,-0.0104451133841534,0.015591650762713,-0.0410047488790709,0.0201145221107641,0.502931357040985
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGMN,Legumain,35992,-0.0148923151554196,0.0222333889537671,-0.058469757504803,0.0286851271939639,0.502994996782357
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLEKHO1,Pleckstrin homology domain-containing family O member 1,34958,-0.0292363896390146,0.0436828040572051,-0.114854685591137,0.0563819063131074,0.503335891208881
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSTM1,V-set and transmembrane domain-containing protein 1,35782,-0.0207778650920182,0.0311110297241216,-0.0817554833512966,0.0401997531672601,0.504243339736185
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSH1,Chorionic somatomammotropin hormone 1,34966,0.0121741329276468,0.0182537646126165,-0.0236032457130816,0.0479515115683752,0.504835780484526
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",34815,-0.0316678796154061,0.0476172693210609,-0.124997727484685,0.0616619682538732,0.50604299345903
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TET2,Methylcytosine dioxygenase TET2,34861,-0.0414039941883175,0.0622773691746984,-0.163467637770726,0.0806596493940914,0.506182374461708
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC12A,C-type lectin domain family 12 member A,34778,-0.00830731903657749,0.0125186808305221,-0.0328439334644008,0.0162292953912458,0.506975084906988
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,34964,-0.0130299157754297,0.0196442462718358,-0.0515326384682279,0.0254728069173686,0.507166137376967
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCC,Netrin receptor DCC,34805,-0.00966494840357284,0.0145792483232638,-0.0382402751171699,0.0189103783100243,0.507403204486702
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH22,Cadherin-22,34869,0.0112161250851788,0.0169486448852668,-0.0220032188899442,0.0444354690603017,0.508142188481931
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GP6,Platelet glycoprotein VI,35962,-0.0358345148662137,0.0541888928419235,-0.142044744836384,0.0703757151039563,0.508447734955616
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCT,Secretin,34805,0.019834504863796,0.0300866758115173,-0.0391353797267778,0.0788043894543699,0.509762614129562
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),METAP1D,"Methionine aminopeptidase 1D, mitochondrial",35971,-0.0336929764134757,0.0511395047756605,-0.13392640577377,0.066540452946819,0.510016271278835
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKR1B10,Aldo-keto reductase family 1 member B10,34805,0.027584900933188,0.041869529693043,-0.0544793772651763,0.109649179131552,0.51002940678424
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MED21,Mediator of RNA polymerase II transcription subunit 21,34736,-0.0208942936894744,0.0317243995468914,-0.0830741168013815,0.0412855294224327,0.510165142666937
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,35800,-0.0276264439826958,0.0420377515096009,-0.110020436941513,0.0547675489761219,0.511085051577899
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NELL2,Protein kinase C-binding protein NELL2,35992,-0.0118893124759603,0.0181503648925085,-0.0474640276652769,0.0236854027133563,0.512458926543059
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJB2,DnaJ homolog subfamily B member 2,34822,-0.0221976446537822,0.0338930858423342,-0.0886280929047572,0.0442328035971927,0.512536161655752
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,35937,-0.0182616959034993,0.0278973048823623,-0.0729404134729295,0.0364170216659308,0.5127430702757
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFRA1,GDNF family receptor alpha-1,36023,-0.0113642964839045,0.017388612631747,-0.0454459772421287,0.0227173842743196,0.513423169663058
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRADD,Death domain-containing protein CRADD,35896,-0.0299562757079273,0.0458882015597408,-0.119897150765019,0.0599845993491646,0.513899360545064
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAPT,Microtubule-associated protein tau,35782,0.0205922621349496,0.0315688954244218,-0.0412827728969171,0.0824672971668163,0.514231157943088
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEP1B,Meprin A subunit beta,35972,0.0461928142569993,0.0708389667328786,-0.0926515605394427,0.185037189053441,0.514368612739597
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPSD1,Tryptase delta,34952,-0.0151199316554578,0.0232203255883951,-0.0606317698087121,0.0303919064977965,0.514972754858609
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF4E,Eukaryotic translation initiation factor 4E,34778,-0.0367200572266043,0.0564610507219502,-0.147383716641627,0.0739436021884181,0.515483340218266
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CGN,Cingulin,34805,-0.0155801597674794,0.0239564081526308,-0.0625347197466359,0.031374400211677,0.515487286997611
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCR,Breakpoint cluster region protein,35971,-0.0366152910546635,0.0563555330582624,-0.147072135848858,0.0738415537395309,0.515893645566934
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS3,Galectin-3,36004,0.0119005007347024,0.0183238876709646,-0.0240143191003881,0.047815320569793,0.516065871274118
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,35971,-0.0489244992171802,0.0753839171150294,-0.196676976762638,0.0988279783282774,0.516355706723608
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMED8,Protein TMED8,34964,-0.0419934667134178,0.0648223212573242,-0.169045216377773,0.0850582829509377,0.517122047937853
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCRLB,Fc receptor-like B,35800,-0.0240384670972221,0.0371131700456169,-0.0967802803866312,0.0487033461921869,0.517195004609303
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFKBIE,NF-kappa-B inhibitor epsilon,35800,-0.0194951755028362,0.0301186548483842,-0.0785277390056693,0.0395373879999969,0.517471967890965
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CYB5A,Cytochrome b5,34739,-0.0288466813534109,0.0446156504393537,-0.116293356214544,0.0585999935077224,0.517941121199519
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP9,Fatty acid-binding protein 9,35971,0.0225199881197692,0.0348876302789886,-0.0458597672270485,0.0908997434665869,0.518622887693749
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAX,Protein max,35782,-0.0420809509177638,0.0652765592583486,-0.170023007064127,0.0858611052285994,0.519170473876664
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PENK,Proenkephalin-A,34822,-0.0125409460962087,0.0194658688289484,-0.0506940490009475,0.0256121568085302,0.519435079602685
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CABP2,Calcium-binding protein 2,34805,-0.0261702164255562,0.0407449383177361,-0.106030295528319,0.0536898626772066,0.520706245132825
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MNAT1,CDK-activating kinase assembly factor MAT1,34869,-0.0182298337947398,0.0283842235926062,-0.0738629120362479,0.0374032444467683,0.520732844144685
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDAR,Tumor necrosis factor receptor superfamily member EDAR,35971,0.0360019358612825,0.0561378059699976,-0.0740281638399128,0.146032035562478,0.521338924507818
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,34736,-0.0125384417875893,0.0195641941060864,-0.0508842622355187,0.0258073786603401,0.521619900060236
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HS1BP3,HCLS1-binding protein 3,34815,-0.0366448260590476,0.057185391877541,-0.148728194139028,0.0754385420209327,0.521671408188798
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FH,"Fumarate hydratase, mitochondrial",34750,-0.0337314443417443,0.0526584816966113,-0.136942068467102,0.0694791797836138,0.52182595299991
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALCAM,CD166 antigen,36072,0.00765365711215657,0.0119504557288237,-0.015769236116338,0.0310765503406511,0.521900391340251
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSPAN7,Tetraspanin-7,34750,-0.0399765537498653,0.0625091890985838,-0.16249456438309,0.082541456883359,0.522501482943395
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,35971,-0.0403142609884614,0.0631090160254353,-0.164007932398315,0.0833794104213918,0.522970612506729
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL3,C-C motif chemokine 3,35971,-0.0232905401877189,0.0365067775823176,-0.0948438242490613,0.0482627438736236,0.523507476436652
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHAD,Chondroadherin,34822,-0.0187695020788012,0.0294626253389099,-0.0765162477430646,0.0389772435854623,0.524108272430188
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DOC2B,Double C2-like domain-containing protein beta,34805,-0.0138345090598618,0.0217415697125407,-0.0564479856964415,0.0287789675767179,0.524593937269003
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,35902,-0.0271819092369886,0.0427361831129074,-0.110944828138287,0.05658100966431,0.52477047850538
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DIABLO,"Diablo homolog, mitochondrial",35949,0.0433001502014075,0.0681216068514543,-0.090218199227443,0.176818499630258,0.525037276357964
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,34750,-0.0230940500898989,0.0363497157439626,-0.0943394929480655,0.0481513927682677,0.525237114577056
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTNAP2,Contactin-associated protein-like 2,35971,-0.0166788539920027,0.0262562177343056,-0.0681410407512418,0.0347833327672363,0.525295237503051
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBCB,Tubulin-folding cofactor B,35902,-0.0389828509229802,0.061405328823642,-0.159337295417319,0.0813715935713581,0.525549561373239
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TP53INP1,Tumor protein p53-inducible nuclear protein 1,35874,-0.0122815230666651,0.0193480290988088,-0.0502036601003304,0.0256406139670002,0.525599251341831
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSTA1,Glutathione S-transferase A1,35962,0.033467285562141,0.0529121754387935,-0.0702405782978943,0.137175149422176,0.527075720926017
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",34958,-0.0218343947259159,0.0345890949668522,-0.0896290208609462,0.0459602314091145,0.527899226947868
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,35800,-0.0232674934372684,0.0369108233129721,-0.0956127071306937,0.0490777202561568,0.528472225380997
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDZD2,PDZ domain-containing protein 2,34736,-0.0237097195131034,0.0376519246962353,-0.0975074919177245,0.0500880528915178,0.52890907046271
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDHD2,Phospholipase DDHD2,34952,-0.0259877770804115,0.0412892922371533,-0.106914789865232,0.0549392357044089,0.529105153127064
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNX5,Sorting nexin-5,34815,-0.0118078103083428,0.0187741765117627,-0.0486051962713976,0.024989575654712,0.529412159144859
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCN1,Transcobalamin-1,34844,-0.0134668769376604,0.0214256490490674,-0.0554611490738324,0.0285273951985116,0.52967325769731
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD36,Platelet glycoprotein 4,34778,0.0185059309682809,0.0294440035748976,-0.0392043160385184,0.0762161779750802,0.529691346982039
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA8,Carbonic anhydrase-related protein,34778,0.010150316233274,0.0161556489490326,-0.0215147557068299,0.0418153881733779,0.529841926927917
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),B4GALT1,"Beta-1,4-galactosyltransferase 1",35992,-0.0105713705104217,0.0168303664070183,-0.0435588886681776,0.0224161476473341,0.529949377416375
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP7,Caspase-7,34958,-0.032941697781399,0.0525581908694865,-0.135955751885592,0.0700723563227945,0.530835003316233
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MIA,Melanoma-derived growth regulatory protein,35991,0.0143577709977853,0.022929861379819,-0.03058475730666,0.0593002993022306,0.531229079885973
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SORD,Sorbitol dehydrogenase,35997,0.0265432594276695,0.0423992056806087,-0.0565591837063235,0.109645702561663,0.531313270097246
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMSB10,Thymosin beta-10,35979,-0.0292025268383964,0.0466561135387591,-0.120648509374364,0.0622434556975714,0.531393350545242
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPHA2,Glycoprotein hormone alpha-2,34964,0.0169006223578028,0.0270707839934107,-0.0361581142692823,0.0699593589848878,0.532444912595385
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM26,Tripartite motif-containing protein 26,34739,-0.0219576260311461,0.0351827521475546,-0.0909158202403531,0.0470005681780609,0.532583789864696
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KDR,Vascular endothelial growth factor receptor 2,35991,0.00979224283844327,0.0157101669718072,-0.0209996844262989,0.0405841701031854,0.533102626074491
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,34869,0.0255660459140967,0.0411096279690217,-0.0550088249051859,0.106140916733379,0.534030748065525
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSD,Cathepsin D,35543,-0.0156801169565866,0.0252239799257322,-0.0651191176110218,0.0337588836978486,0.534202097600543
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GDNF,Glial cell line-derived neurotrophic factor,35782,-0.0145729385612427,0.0234833873610535,-0.0606003777889076,0.0314545006664222,0.53490639806899
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCYT2,Ethanolamine-phosphate cytidylyltransferase,34964,-0.0293222581552367,0.0472527140243756,-0.121937577643013,0.0632930613325395,0.534923727096354
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGEF12,Rho guanine nucleotide exchange factor 12,35971,-0.0394364549467433,0.0636161221691127,-0.164124054398204,0.0852511445047176,0.535334293186424
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NECTIN4,Nectin-4,35991,-0.0127275550303757,0.0205458187745848,-0.0529973598285619,0.0275422497678105,0.535624698489875
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BIRC2,Baculoviral IAP repeat-containing protein 2,35800,-0.0245055385209182,0.0395601112456953,-0.102043356562481,0.0530322795206447,0.535639091925953
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD40LG,CD40 ligand,36067,-0.0305009962940601,0.0492495952885292,-0.127030203059577,0.0660282104714572,0.535727984388803
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MUC13,Mucin-13,35782,-0.0199029715601489,0.0321627944980478,-0.0829420487763226,0.0431361056560248,0.5360547543457
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,35902,-0.0357108913870086,0.0578539883048577,-0.14910470846453,0.0776829256905125,0.537083192921582
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DAND5,DAN domain family member 5,34778,-0.0235925804286809,0.0382895781049296,-0.0986401535143429,0.0514549926569812,0.537810351250261
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDGFC,Platelet-derived growth factor C,35800,-0.0108480567268482,0.0176141472413096,-0.0453717853198151,0.0236756718661187,0.537998596845027
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMTOR5,Ragulator complex protein LAMTOR5,34949,-0.0160088971761793,0.025998663506281,-0.0669662776484901,0.0349484832961315,0.538076015662702
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEZ6,Seizure protein 6 homolog,34805,-0.0124261885312103,0.0201881518939726,-0.0519949662433966,0.027142589180976,0.538234683035225
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PKD1,Polycystin-1,34949,-0.0104004156509129,0.0169029759615697,-0.0435302485355895,0.0227294172337637,0.538378102962733
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNPO1,Transportin-1,34869,-0.0143808950712332,0.0234043131928963,-0.0602533489293099,0.0314915587868435,0.538937061568609
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA4D,Semaphorin-4D,36043,-0.0112670386561622,0.0183639730258958,-0.0472604257869179,0.0247263484745935,0.539537852406901
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GORASP2,Golgi reassembly-stacking protein 2,34964,-0.018421671906089,0.0300390448980547,-0.0772981999062763,0.0404548560940983,0.539727954922674
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF2,Fibroblast growth factor 2,35971,-0.0260057108384259,0.0424099288125406,-0.109129171311005,0.0571177496341536,0.539763921120242
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH6,Cadherin-6,35972,0.0146165786258483,0.0238528208686843,-0.032134950276773,0.0613681075284695,0.540039414551505
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REG3A,Regenerating islet-derived protein 3-alpha,36072,-0.0237121248527283,0.0387006651826321,-0.0995654286106872,0.0521411789052306,0.540089484929834
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSNL1,Visinin-like protein 1,34958,0.0150714486607447,0.024604287284337,-0.0331529544165557,0.0632958517380452,0.540193348673947
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSC,Dipeptidyl peptidase 1,35941,0.0167826962072188,0.0274835835879116,-0.0370851276250879,0.0706505200395255,0.541453931437232
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PROK1,Prokineticin-1,35971,-0.0188070408565018,0.0308026017499464,-0.0791801402863967,0.041566058573393,0.541505342523367
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBFOX3,RNA binding protein fox-1 homolog 3,34952,-0.0155740981310558,0.0255406818673141,-0.0656338345909913,0.0344856383288798,0.542031927696536
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,35962,0.04688217671737,0.0770703774517085,-0.104175763087979,0.197940116522719,0.543004997479875
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRD1,Adhesion G-protein coupled receptor D1,34822,-0.0160508346040748,0.0263927400150277,-0.0677806050335292,0.0356789358253796,0.543107935336483
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTC,Probetacellulin,35800,0.027873793377477,0.0459041478011239,-0.0620983363127258,0.11784592306768,0.543725850985677
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DENR,Density-regulated protein,34778,-0.0219319983248109,0.0362109873645735,-0.0929055335593749,0.0490415369097531,0.544754514877766
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,35972,0.0119084976713644,0.0197090931956161,-0.0267213249920431,0.0505383203347718,0.545720384593169
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLOD4,Glyoxalase domain-containing protein 4,35943,-0.0128333068790274,0.0212719749887001,-0.0545263778568796,0.0288597640988248,0.546330131387975
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPPED1,Serine/threonine-protein phosphatase CPPED1,36043,-0.0246646374007538,0.0410155410528984,-0.105055097864435,0.055725823062927,0.547626152566079
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL13,C-C motif chemokine 13,36057,-0.0252942469464912,0.0420965242427836,-0.107803434462347,0.0572149405693647,0.547949451931791
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,34964,-0.0139708287138526,0.0232585787081937,-0.0595576429819122,0.031615985554207,0.548078381184694
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCAR2,Cell cycle and apoptosis regulator protein 2,34958,0.0201816385719209,0.0337489046893865,-0.0459662146192767,0.0863294917631185,0.549865313702494
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IKZF2,Zinc finger protein Helios,35800,0.0326369452351907,0.0545854595265106,-0.0743505554367701,0.139624445907151,0.549921810142137
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPRING1,SREBP regulating gene protein,34739,-0.0236731766115731,0.039623499660347,-0.101335235945853,0.0539888827227071,0.550227049086708
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM3C,Protein FAM3C,35962,-0.0110269741327021,0.0184853185103669,-0.0472581984130212,0.0252042501476171,0.550842194877708
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KCNIP4,Kv channel-interacting protein 4,35782,-0.0182380852406364,0.0305862298048325,-0.078187095658108,0.0417109251768352,0.551004184140119
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL6,C-X-C motif chemokine 6,36067,-0.0277296116643632,0.0465336704497427,-0.118935605745859,0.0634763824171326,0.5512572604245
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOA4,Apolipoprotein A-IV,34975,0.0131755051263211,0.022114733972273,-0.0301693734593339,0.0565203837119762,0.551343691571247
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,34815,-0.0082171178307624,0.0138157033200014,-0.0352958963379651,0.0188616606764402,0.552021199624103
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VWF,von Willebrand factor,36072,0.0275049061971498,0.0463317855780416,-0.0633053935358116,0.118315205930111,0.552763599659594
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LXN,Latexin,35862,0.0255307005032905,0.0430269812152964,-0.0588021826786905,0.109863583685272,0.552955451577405
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HAVCR1,Hepatitis A virus cellular receptor 1,36022,-0.0234464215131754,0.03957176483559,-0.101007080590932,0.054114237564581,0.553531319104229
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX4,Syntaxin-4,35937,-0.0218777242324142,0.0369365879236956,-0.0942734365628575,0.0505179880980291,0.553664647325822
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A13,Protein S100-A13,34778,0.0134736511232687,0.0227491858894482,-0.0311147532200498,0.0580620554665872,0.553691747150188
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,34952,0.0144745484323969,0.0244523754779457,-0.0334521075043766,0.0624012043691705,0.553906103132682
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,34736,-0.0185772932667296,0.0314529812797356,-0.0802251365750115,0.0430705500415523,0.554785447339577
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SORBS1,Sorbin and SH3 domain-containing protein 1,34952,-0.0141162256370702,0.0239078607170641,-0.0609756326425159,0.0327431813683755,0.554914788920924
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOS2,"Nitric oxide synthase, inducible",34736,0.0150107267152285,0.0254433451741756,-0.0348582298261557,0.0648796832566127,0.555234690314482
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HBZ,Hemoglobin subunit zeta,34949,-0.0398568719825309,0.0675633108691752,-0.172280961286114,0.0925672173210524,0.555266035886811
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRB3,Adhesion G protein-coupled receptor B3,35890,0.0121336513262435,0.0206396267065459,-0.0283200170185865,0.0525873196710735,0.556630154430057
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LACTB2,Endoribonuclease LACTB2,35972,-0.0237136990724793,0.0403627728099895,-0.102824733780059,0.0553973356351001,0.556876462078503
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,36008,-0.0367760572271759,0.0626111064585441,-0.159493825885922,0.0859417114315706,0.556971298549577
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMAD1,Mothers against decapentaplegic homolog 1,35800,-0.0307723971437446,0.0524197636610768,-0.133515133919455,0.0719703396319659,0.55719654192871
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MCFD2,Multiple coagulation factor deficiency protein 2,35936,-0.0163707132797231,0.0279025347480673,-0.071059681385935,0.0383182548264888,0.557416131841229
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCND2,G1/S-specific cyclin-D2,34869,-0.0143776439197525,0.0245077365858666,-0.0624128076280511,0.0336575197885461,0.557454977954583
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LPO,Lactoperoxidase,35697,-0.0218934475526165,0.0373414016061127,-0.0950825947005974,0.0512956995953645,0.557689270388667
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,35902,-0.0139352332261096,0.0238729629288561,-0.0607262405666675,0.0328557741144483,0.559423714295425
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYL6B,Myosin light chain 6B,34805,0.0339978008122769,0.0583971664625695,-0.0804606454543594,0.148456247078913,0.560464998503061
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRP,Gastrin-releasing peptide,34815,0.0198831960770947,0.0341687671279924,-0.0470875874937703,0.0868539796479597,0.560647448612607
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA2,Carbonic anhydrase 2,35954,-0.0246156711858547,0.0423120109240387,-0.10754721259697,0.0583158702252612,0.560742429854945
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BEX3,Protein BEX3,34739,0.0168758047082467,0.0290549455810444,-0.0400718886306004,0.0738234980470938,0.561380515090568
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",34952,-0.0282884259704665,0.0487713989768366,-0.123880367965066,0.0673035160241333,0.561921162308702
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRYZL1,Quinone oxidoreductase-like protein 1,34815,-0.032808750640435,0.0565910464983428,-0.143727201777187,0.0781097004963168,0.562103145133347
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASE6,Ribonuclease K6,34922,-0.011574457220367,0.0199683638518985,-0.050712450370088,0.0275635359293541,0.562178242969372
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIGIT,T-cell immunoreceptor with Ig and ITIM domains,34869,-0.0135232070883689,0.023394851081638,-0.0593771152083793,0.0323307010316415,0.563256509090005
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FSTL1,Follistatin-related protein 1,34815,-0.00862747112924523,0.0149364818173132,-0.0379029754911791,0.0206480332326886,0.563547932231405
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUP50,Nuclear pore complex protein Nup50,34736,-0.0114220220788708,0.0197777747875876,-0.0501864606625424,0.0273424165048008,0.563610733491353
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD63,CD63 antigen,35890,0.0178179681673027,0.0308563975809427,-0.0426605710913449,0.0782965074259503,0.563654621847417
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IRAK4,Interleukin-1 receptor-associated kinase 4,35971,-0.036835922351597,0.0638307163653054,-0.161944126427596,0.0882722817244016,0.563897825951676
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL31,Interleukin-31,34778,-0.0200838102183188,0.0348054792569451,-0.0883025495619313,0.0481349291252937,0.563940126939056
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FN1,Fibronectin,34975,-0.00993064031859769,0.0172213604216617,-0.0436845067450546,0.0238232261078592,0.564198517769067
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RFC4,Replication factor C subunit 4,34949,0.00824110646954096,0.0143094206699298,-0.0198053580435214,0.0362875709826034,0.564688492318459
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,34805,0.019071705128263,0.0331154733352564,-0.0458346226088395,0.0839780328653656,0.564693373510917
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAPN3,Calpain-3,34949,-0.0139874179485957,0.0242873419852326,-0.0615906082396516,0.0336157723424601,0.564693789429157
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMA1,Laminin subunit alpha-1,34736,-0.0179705500696243,0.0312060711444737,-0.0791344495127926,0.0431933493735441,0.564726125838301
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALCA,Calcitonin,35896,-0.0248755386434606,0.0432298277799922,-0.109606001092245,0.0598549238053242,0.565021411439293
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MXRA8,Matrix remodeling-associated protein 8,34822,-0.0110841618561352,0.0192875316412346,-0.048887723872955,0.0267194001606846,0.565528401955113
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLU,Clusterin,34975,0.0109420231086918,0.0190616208870148,-0.0264187538298572,0.0483028000472407,0.565964881507731
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OGA,Protein O-GlcNAcase,34964,-0.0256015333879439,0.0446331146138631,-0.113082438031116,0.0618793712552278,0.566259101592705
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RTN4R,Reticulon-4 receptor,36032,0.0119006574202939,0.0207619528825019,-0.0287927702294097,0.0525940850699976,0.566529690751917
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CBLIF,Cobalamin binding intrinsic factor,35962,0.0268474105874389,0.046855459453767,-0.0649892899419444,0.118684111116822,0.566673286870922
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,34958,-0.0226422381872049,0.0395214844221168,-0.100104347654554,0.0548198712801439,0.566726157808825
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD109,CD109 antigen,35979,0.0120013769186534,0.0209551466067073,-0.0290707104304928,0.0530734642677996,0.566853509123993
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PROCR,Endothelial protein C receptor,34736,-0.0134673495957713,0.0235415550799747,-0.0596087975525217,0.032674098360979,0.567297460666913
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DKKL1,Dickkopf-like protein 1,35937,0.0297821304279729,0.052176965732192,-0.0724847224071234,0.132048983263069,0.568158961341953
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOL1,Apolipoprotein L1,34966,0.0195361513831745,0.0342287355630505,-0.0475521703204044,0.0866244730867535,0.568187274075406
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM3B,Protein FAM3B,35937,0.0125245620627162,0.0219587032381962,-0.0305144962841484,0.0555636204095809,0.568444964074919
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP2,Insulin-like growth factor-binding protein 2,36066,-0.0212586703646293,0.0373021410300552,-0.0943708667835375,0.0518535260542788,0.568759396016119
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL4,C-C motif chemokine 4,35971,-0.0224548760506289,0.0394258726771518,-0.0997295864978465,0.0548198343965887,0.569002537429471
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX58,Antiviral innate immune response receptor RIG-I,35800,-0.0200389514732094,0.0352064510710186,-0.0890435955724059,0.048965692625987,0.569248978103507
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDLIM7,PDZ and LIM domain protein 7,35992,-0.0441333011387641,0.0776401217581454,-0.196307939784729,0.108041337507201,0.569757435071421
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,34815,0.0119417111445249,0.0210166990238946,-0.0292510189423084,0.0531344412313582,0.569918963654938
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDH1,Protocadherin-1,36042,-0.00724178799960727,0.0127495109543984,-0.0322308294702282,0.0177472534710137,0.570048600873132
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLXNB2,Plexin-B2,36032,-0.00854420095172978,0.015046025283046,-0.0380344105064999,0.0209460086030404,0.57013974061771
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOXJ3,Forkhead box protein J3,34778,-0.0163501021692954,0.0288266426910945,-0.0728503218438407,0.0401501175052498,0.570607624684023
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MOG,Myelin-oligodendrocyte glycoprotein,36032,0.01169832001107,0.0206331607065785,-0.0287426749738238,0.0521393149959638,0.570753764918235
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD58,Lymphocyte function-associated antigen 3,35934,0.00598669693431741,0.0105651916575184,-0.0147210787144187,0.0266944725830535,0.57097377012712
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LMOD2,Leiomodin-2,34750,-0.0225120868021514,0.0399017305638101,-0.100719478707219,0.0556953051029163,0.572646609897712
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TAX1BP1,Tax1-binding protein 1,34958,-0.0218049861329237,0.038674628657563,-0.0976072583017472,0.0539972860358998,0.572906080363198
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHMT1,"Serine hydroxymethyltransferase, cytosolic",35979,-0.0292511387246824,0.0519023016668503,-0.130979649991709,0.0724773725423442,0.573056608178628
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FSHB,Follitropin subunit beta,34815,-0.0139555087243732,0.0249011511698,-0.0627617650171812,0.0348507475684348,0.575202086897946
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK8,Serine protease inhibitor Kazal-type 8,34736,-0.0126919469794369,0.0226592391060975,-0.0571040556273879,0.0317201616685141,0.575416412753532
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL9A1,Collagen alpha-1(IX) chain,35971,-0.0153468774001312,0.0274098089365891,-0.0690701029158459,0.0383763481155834,0.575561542811715
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA9,Serpin A9,35905,0.0250956714972941,0.0449036260708688,-0.0629154356016089,0.113106778596197,0.576261770045553
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NTF3,Neurotrophin-3,35971,0.0118925439009678,0.0212822041681367,-0.0298205762685802,0.0536056640705158,0.57631365148687
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SORT1,Sortilin,35962,-0.0132142942278136,0.0236584734847576,-0.0595849022579384,0.0331563138023113,0.576490075297446
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK12,Kallikrein-12,35800,-0.0455389367277961,0.0816002780675198,-0.205475481740135,0.114397608284543,0.576811681736182
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,34964,-0.0378396544999878,0.0678690074240313,-0.170862909051089,0.0951836000511136,0.57717846814739
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUSD1,Sushi domain-containing protein 1,35874,-0.0165794170931786,0.0297752430336822,-0.0749388934391956,0.0417800592528385,0.577668322427301
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF5,E3 ubiquitin-protein ligase RNF5,34815,-0.0253533460493999,0.0455442058086853,-0.114619989434423,0.0639132973356232,0.577769164913124
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARSB,Arylsulfatase B,35937,-0.0192981869107455,0.0347198493903395,-0.0873490917158109,0.0487527178943199,0.578346917349152
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DTD1,D-aminoacyl-tRNA deacylase 1,34822,-0.0303667902018076,0.054646667167848,-0.13747425785079,0.0767406774471744,0.578440474995956
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPMT,Thiopurine S-methyltransferase,35800,-0.0248620687895246,0.044745303651977,-0.112562863947399,0.0628387263683502,0.578477480381755
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,35800,-0.0231744391180912,0.0417327015998057,-0.10497053425371,0.0586216560175279,0.578702307618923
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM171B,Protein FAM171B,34949,-0.00892811383359089,0.0161133971017306,-0.0405103721529829,0.0226541444858011,0.579543493500213
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YWHAQ,14-3-3 protein theta,34822,-0.0255844462880975,0.046180656661241,-0.11609853334413,0.0649296407679349,0.57959338306642
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DYNLT1,Dynein light chain Tctex-type 1,34805,-0.027012124332896,0.0487772307163482,-0.122615496536938,0.0685912478711466,0.579745590183806
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLPBP,Pyridoxal phosphate homeostasis protein,35972,-0.0229078326929822,0.0413804794035811,-0.104013572324001,0.0581979069380368,0.579876043549904
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPLX2,Complexin-2,34739,-0.0106200535789277,0.0192351684792201,-0.0483209837981991,0.0270808766403436,0.580888647743627
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCTD,Deoxycytidylate deaminase,34822,-0.0331665582879404,0.0601480522761007,-0.151056740749098,0.084723624173217,0.581368793077383
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KYAT1,Kynurenine--oxoglutarate transaminase 1,35961,-0.0192781526750585,0.0349738545012545,-0.0878269074975173,0.0492706021474002,0.581502255350864
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFER,FAD-linked sulfhydryl oxidase ALR,35800,-0.0217575156286711,0.0395239051749337,-0.0992243697715412,0.055709338514199,0.582000393492144
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOMO1,Nodal modulator 1,35979,0.00786536743388346,0.0142939936612012,-0.020150860142071,0.0358815950098379,0.582159895035713
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ROBO2,Roundabout homolog 2,36043,-0.00751942576451607,0.0136825972605279,-0.0343373163951507,0.0192984648661185,0.582636805703369
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYH4,Myosin-4,34736,0.0156008205792363,0.0284050649176175,-0.040073106659294,0.0712747478177666,0.582869856984412
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DLL4,Delta-like protein 4,34815,-0.0309477413174305,0.0563698898870106,-0.141432725495971,0.0795372428611102,0.583016994551526
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAL,Galanin peptides,35992,-0.0226052071875335,0.0411914216508864,-0.103340393623271,0.0581299792482038,0.583170032405149
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACHE,Acetylcholinesterase,34822,-0.0117321235841144,0.0213888933472605,-0.053654354544745,0.0301901073765163,0.583358181130238
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINB9,Serpin B9,35902,-0.0108773061519246,0.019866166938441,-0.049814993351269,0.0280603810474198,0.584031961342375
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLPS,Colipase,35962,-0.0237241213846736,0.0433441120214155,-0.108678580946648,0.0612303381773008,0.584159301370991
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTN2A1,Butyrophilin subfamily 2 member A1,35992,-0.00897798812940071,0.0164145286058226,-0.041150464196813,0.0231944879380116,0.58442701111691
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGXT,Serine--pyruvate aminotransferase,35972,0.0257151256472883,0.0470524228915982,-0.0665076232202442,0.117937874514821,0.584724565445555
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDSN,Corneodesmosin,36055,-0.0147279312987625,0.0269508762663786,-0.0675516487808645,0.0380957861833395,0.584757066796735
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MB,Myoglobin,36072,0.0187095444669689,0.0342463114072603,-0.0484132258912613,0.0858323148251991,0.5848603033646
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PXN,Paxillin,35782,-0.017903784390029,0.0327745047828632,-0.0821418137644409,0.046334244984383,0.584896156206476
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,34778,0.013006458123554,0.0238157678035183,-0.0336724467713418,0.0596853630184497,0.584997660162929
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC4M,C-type lectin domain family 4 member M,34952,-0.0169851351136529,0.0311257349034541,-0.0779915755244228,0.0440213052971171,0.58529527524053
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMOX1,Heme oxygenase 1,35896,-0.0165481158691013,0.0303991659404644,-0.0761304811124114,0.0430342493742089,0.586209815368668
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AOC3,Membrane primary amine oxidase,36026,0.00976324479067489,0.0179438950257722,-0.0254067894598385,0.0449332790411883,0.586390088422985
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCTN1,Dynactin subunit 1,36032,-0.0212630584221964,0.0391623936862351,-0.0980213500472172,0.0554952332028243,0.587183380573131
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INSR,Insulin receptor,34778,-0.00610498137843857,0.0112464721075171,-0.028148066709172,0.0159381039522949,0.587262830129933
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",35800,0.0167126128439214,0.0308662869357821,-0.0437853095502114,0.0772105352380542,0.588212825652483
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECM1,Extracellular matrix protein 1,34805,0.0125308980880254,0.0231472478692323,-0.0328377077356699,0.0578995039117207,0.588281766029099
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GHRHR,Growth hormone-releasing hormone receptor,35782,-0.017236190607991,0.0318912494635569,-0.0797430395565626,0.0452706583405805,0.58889128218788
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACRV1,Acrosomal protein SP-10,34778,-0.0365556580227396,0.0676618404401058,-0.169172865285347,0.0960615492398678,0.589030365123547
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYH7B,Myosin-7B,34739,-0.0145134917289816,0.0268740523508192,-0.0671866343365873,0.038159650878624,0.589178041137908
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BANK1,B-cell scaffold protein with ankyrin repeats,35971,-0.0350506859783141,0.0649119544807957,-0.162278116760674,0.0921767448040455,0.589232143921279
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),USO1,General vesicular transport factor p115,35937,-0.0294313203109429,0.0545152533169687,-0.136281216812202,0.0774185761903158,0.589300915773938
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCAM,Basal cell adhesion molecule,35979,0.00818406850936995,0.0151710141974995,-0.0215511193177291,0.037919256336469,0.589589714124676
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TAGLN3,Transgelin-3,34739,0.0212653861208771,0.0394890693811611,-0.0561331898661988,0.0986639621079529,0.590242301733693
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDIA5,Protein disulfide-isomerase A5,34739,0.020354973049773,0.0378037223885719,-0.0537403228318279,0.0944502689313739,0.590293993468252
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JPT2,Jupiter microtubule associated homolog 2,34964,-0.0295465434163606,0.0550583598826645,-0.137460928786383,0.0783678419536619,0.591534751111413
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TEF,Thyrotroph embryonic factor,34736,-0.0142127224247618,0.0265293132661186,-0.0662101764263543,0.0377847315768306,0.592160065640506
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC1A,C-type lectin domain family 1 member A,35874,-0.0110834656778045,0.0207243447538867,-0.0517031813954224,0.0295362500398134,0.592801636540148
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERCC1,DNA excision repair protein ERCC-1,34739,0.0115680756086528,0.0216327044571544,-0.0308320251273698,0.0539681763446753,0.592842527197546
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT17,"Keratin, type I cytoskeletal 17",34736,0.0137590600945291,0.0257377201427378,-0.0366868713852371,0.0642049915742952,0.592954589034451
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIT1,ARF GTPase-activating protein GIT1,34778,-0.0325724345137015,0.0609557518419816,-0.152045708123986,0.0869008390965825,0.593110366062687
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMUT,"Methylmalonyl-CoA mutase, mitochondrial",34736,-0.0173750337800703,0.0325302588278995,-0.0811343410827533,0.0463842735226127,0.593278459792191
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,34964,-0.0169421563550573,0.0317447694974869,-0.0791619045701316,0.0452775918600169,0.593568339847869
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DKK4,Dickkopf-related protein 4,35888,0.015097976122446,0.0282967181836293,-0.0403635915174675,0.0705595437623595,0.593662769712116
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,34822,-0.0212216500714366,0.0398471137872617,-0.0993219930944695,0.0568786929515963,0.594345553843167
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM171A2,Protein FAM171A2,34952,-0.0534569339655654,0.100432618707081,-0.250304866631444,0.143390998700313,0.594559940356365
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDK1,Cyclin-dependent kinase 1,34739,0.0122918300107016,0.0231116366924542,-0.0330069779065086,0.0575906379279118,0.594851950508302
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCOF1,Treacle protein,34949,-0.011001734381273,0.0206933980612752,-0.0515607945813723,0.0295573258188264,0.594984038979462
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNPY4,Protein canopy homolog 4,35937,-0.0248025157936663,0.0466784480953343,-0.116292274060522,0.066687242473189,0.595193499945922
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CYTH3,Cytohesin-3,34739,-0.0256743141374071,0.0483800865920889,-0.120499283857901,0.0691506555830872,0.595660176487975
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTNL10,Butyrophilin-like protein 10,34739,-0.0125141965178607,0.0236180103439076,-0.0588054967919195,0.0337771037561982,0.596229408980407
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRELD1,Protein disulfide isomerase CRELD1,34822,-0.0124075431736631,0.0234288227871362,-0.05832803583645,0.0335129494891238,0.596418885582777
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDHB15,Protocadherin beta-15,34949,-0.013486670897892,0.025473233685379,-0.0634142089212349,0.0364408671254508,0.596515444193034
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C7,Complement component C7,34822,-0.0111742896142559,0.0211103423225276,-0.0525505605664099,0.0302019813378982,0.596597005388048
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FHIP2A,FHF complex subunit HOOK interacting protein 2A,34736,-0.0158283526440047,0.0299283897283554,-0.0744879965115813,0.0428312912235719,0.596911862619356
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,36016,-0.0156684538478174,0.0296385736006733,-0.0737600581051371,0.0424231504095024,0.597063575567061
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ABL1,Tyrosine-protein kinase ABL1,35937,-0.0220249294547549,0.0416880748287541,-0.103733556119113,0.0596836972096031,0.597288474928748
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPIE,Peptidyl-prolyl cis-trans isomerase E,34869,-0.0206663163897521,0.0391303491213833,-0.0973618006676634,0.0560291678881592,0.597420618812491
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCARF2,Scavenger receptor class F member 2,36043,-0.0092154491159478,0.0174530426801883,-0.043423412769117,0.0249925145372214,0.597505429986142
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,34750,-0.0214795442971853,0.0407149235631013,-0.101280794480864,0.0583217058864933,0.59782414751132
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REEP4,Receptor expression-enhancing protein 4,34952,-0.0207031689579112,0.0392516628087062,-0.0976364280629753,0.056230090147153,0.597901684029189
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIAE,Sialate O-acetylesterase,35980,-0.0150660036152161,0.0286794042599602,-0.0712776359647382,0.0411456287343059,0.599373170185285
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANK2,Ankyrin-2,34736,-0.0226728515276987,0.0431614736919057,-0.107269339963834,0.0619236369084365,0.59939155399662
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGLON5,IgLON family member 5,34739,-0.0293448401959257,0.0559912724713138,-0.139087734239701,0.0803980538478493,0.600230216024531
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ABHD14B,Protein ABHD14B,35878,-0.0182319755650438,0.0348288708576099,-0.0864965624459591,0.0500326113158715,0.600661032211379
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DUSP3,Dual specificity protein phosphatase 3,35782,0.0268328593891563,0.0512839508486344,-0.0736836842741672,0.12734940305248,0.600836348613269
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THPO,Thrombopoietin,35874,0.0125353401048753,0.0239630930341096,-0.0344323222419796,0.0595030024517301,0.600913451709704
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HTRA2,"Serine protease HTRA2, mitochondrial",35991,-0.0195493520477023,0.0374437080762942,-0.0929390198772389,0.0538403157818342,0.601616500603391
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SBSN,Suprabasin,34948,-0.0115758601686182,0.0222843903090591,-0.055253265174374,0.0321015448371377,0.603457773467513
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EGFLAM,Pikachurin,34964,-0.0103830443429781,0.0199888044465523,-0.0495611010582206,0.0287950123722644,0.603469923729054
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRL,Prolactin,36043,-0.0232918498371626,0.0448491797787161,-0.111196242203446,0.0646125425291209,0.603541021458178
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNAP29,Synaptosomal-associated protein 29,35991,-0.0292868831971828,0.05643255246149,-0.139894686021703,0.0813209196273376,0.603796193597832
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,34778,-0.0268490958752355,0.0518693769214976,-0.128513074641371,0.0748148828908997,0.60473564845075
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FTCD,Formimidoyltransferase-cyclodeaminase,34944,-0.028252083332871,0.0546076608583139,-0.135283098615166,0.0787789319494243,0.604919541820015
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF9,Fibroblast growth factor 9,34724,-0.0132546314185836,0.025643056695318,-0.0635150225414069,0.0370057597042397,0.605251836794928
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERBB3,Receptor tyrosine-protein kinase erbB-3,35930,-0.00628029575448952,0.0121805800202097,-0.0301542325941005,0.0175936410851214,0.606150008656607
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,34869,-0.0139814838391872,0.027233630033731,-0.0673593987052999,0.0393964310269255,0.607696361121342
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DMP1,Dentin matrix acidic phosphoprotein 1,34815,-0.0183741665828301,0.0357901202836893,-0.0885228023388612,0.0517744691732009,0.607699197009515
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GP1BA,Platelet glycoprotein Ib alpha chain,35968,-0.0105013906170861,0.0204914243946014,-0.0506645824305048,0.0296618011963326,0.608332338869041
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFHD1,EF-hand domain-containing protein D1,34952,-0.0113478264834519,0.0221786512807451,-0.0548179829937122,0.0321223300268085,0.608909997928644
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFB118,Beta-defensin 118,34750,-0.0190266223561758,0.0372115284260844,-0.0919612180713012,0.0539079733589496,0.609152439488779
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL6R,Interleukin-6 receptor subunit alpha,35957,-0.0106836933846564,0.0209076738638125,-0.0516627341577288,0.0302953473884161,0.609370675780228
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CYB5R2,NADH-cytochrome b5 reductase 2,34886,-0.0179560121401031,0.0351707717779627,-0.0868907248249101,0.0509787005447038,0.609692593428842
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSC22D1,TSC22 domain family protein 1,34952,0.0211206735245106,0.0414293289566896,-0.0600808112306009,0.102322158279622,0.610209269853145
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VNN1,Pantetheinase,34966,-0.023505822884303,0.0461318458290748,-0.11392424070929,0.0669125949406837,0.610394435412304
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF12,Fibroblast growth factor 12,34778,-0.015030427773804,0.029510479934105,-0.0728709684446497,0.0428101128970417,0.610542566769469
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PKLR,Pyruvate kinase PKLR,35964,-0.0205787724456799,0.0404658066576382,-0.0998917534946508,0.0587342086032909,0.611084884952317
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEMA4C,Semaphorin-4C,35937,-0.00898402462754305,0.0176729744739788,-0.0436230545965415,0.0256550053414554,0.611224461975844
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYO9B,Unconventional myosin-IXb,35842,-0.0207176256042892,0.0407959692811726,-0.100677725395388,0.0592424741868092,0.61158445000434
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLI1,Friend leukemia integration 1 transcription factor,35800,-0.0351032672956352,0.0691242491906961,-0.170586795709399,0.100380261118129,0.611589141268057
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDT,D-dopachrome decarboxylase,34965,-0.0137879032681159,0.0272066939353626,-0.0671130233814266,0.0395372168451949,0.612324297758019
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TEK,Angiopoietin-1 receptor,35991,0.0069199151561884,0.013665921792116,-0.019865291556359,0.0337051218687358,0.612617050244948
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINE1,Plasminogen activator inhibitor 1,36072,-0.0207269364705227,0.0409899890907649,-0.101067315088422,0.0596134421473766,0.613111321120022
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX25,ATP-dependent RNA helicase DDX25,34805,-0.0109572329876143,0.021696896504016,-0.0534831501354858,0.0315686841602571,0.613567051559528
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GHR,Growth hormone receptor,34822,-0.00892588407730665,0.0177284991214478,-0.0436737423553443,0.025821974200731,0.614647066944494
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MGMT,Methylated-DNA--protein-cysteine methyltransferase,35971,0.0371632157614149,0.0740793531403406,-0.108032316393653,0.182358747916482,0.615916299813341
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRDX6,Peroxiredoxin-6,36032,0.0185972346392981,0.0370756795514664,-0.0540710972815761,0.0912655665601723,0.615962377262193
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAT,Linker for activation of T-cells family member 1,36067,-0.0236016021142509,0.0470939599594614,-0.115905763634795,0.0687025594062934,0.616273398625928
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,35902,-0.0105182864219604,0.0210124465562293,-0.0517026816721699,0.030666108828249,0.616685984226868
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENO2,Gamma-enolase,36043,-0.0198269450381232,0.0396682436809786,-0.0975767026528412,0.0579228125765947,0.617217250224331
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDRG1,p53 and DNA damage-regulated protein 1,34805,0.0166990232426193,0.0334417288294319,-0.0488467652630672,0.0822448117483058,0.617552732082731
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBP2,Retinol-binding protein 2,35937,0.0240310923464842,0.0481711409067306,-0.0703843438307077,0.118446528523676,0.61788657973715
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK6,Serine protease inhibitor Kazal-type 6,36032,-0.0161096331695362,0.0322971176755748,-0.0794119838136627,0.0471927174745904,0.617938739314052
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KAZN,Kazrin,34964,-0.0327065501573677,0.0655719181350666,-0.161227509702098,0.0958144093873628,0.617945291205509
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCN3,CCN family member 3,36062,-0.0104965649253853,0.0210518056874578,-0.0517581040728027,0.030764974222032,0.618071396196907
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SV2A,Synaptic vesicle glycoprotein 2A,34805,-0.0197895105185999,0.0396895756274666,-0.0975810787484344,0.0580020577112346,0.618073763939778
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COCH,Cochlin,34949,-0.0144392339921758,0.0290235687424094,-0.0713254287272982,0.0424469607429466,0.618853524198657
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMED1,Transmembrane emp24 domain-containing protein 1,34869,-0.0178014199990507,0.0358018852810105,-0.0879731151498313,0.05237027515173,0.619051226612085
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC5,Sialic acid-binding Ig-like lectin 5,35979,-0.0350154854923054,0.0706123471553813,-0.173415685916853,0.103384714932242,0.619991500210376
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRM,Receptor-type tyrosine-protein phosphatase mu,35955,0.00748741409773235,0.0151011063170808,-0.0221107542837459,0.0370855824792106,0.620036995437867
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MLN,Promotilin,35971,-0.0272890221895377,0.0552271568664021,-0.135534249647686,0.0809562052686105,0.621233863873991
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSD17B3,Testosterone 17-beta-dehydrogenase 3,34736,-0.0149974271737497,0.0303566435888013,-0.0744964486078002,0.0445015942603009,0.621294894340741
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL7A,B-cell CLL/lymphoma 7 protein family member A,34739,-0.0197663531436799,0.0400254153720104,-0.0982161672728203,0.0586834609854605,0.621433284362661
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BPIFB1,BPI fold-containing family B member 1,35969,0.0193915459993468,0.0393152749820561,-0.057666392965483,0.0964494849641767,0.621863470163443
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OPHN1,Oligophrenin-1,34958,-0.0333874730129281,0.0677443638240993,-0.166166426108163,0.0993914800823066,0.62213911026815
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SDC1,Syndecan-1,35972,-0.0123249339967365,0.0250153149309951,-0.0613549512614869,0.0367050832680138,0.622242405899653
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNX2,Sorting nexin-2,34949,0.0261810468500174,0.0533042459234609,-0.0782952751599659,0.130657368860001,0.623328494350181
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAG,Myelin-associated glycoprotein,34805,-0.0148025932275181,0.0301843355124115,-0.0739638908318447,0.0443587043768085,0.623863644244846
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHD,SH2 domain-containing adapter protein D,34726,-0.0258165549880116,0.0526702398476147,-0.129050225089336,0.0774171151133132,0.624042129703273
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL10RA,Interleukin-10 receptor subunit alpha,35842,-0.0174111088129841,0.0355248590112903,-0.0870398324751131,0.0522176148491449,0.624070507665004
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF13,Tumor necrosis factor ligand superfamily member 13,35992,-0.00822055881886416,0.016797171014018,-0.0411430140063395,0.0247018963686112,0.624572074822045
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APCS,Serum amyloid P-component,34921,-0.0101491267049563,0.0207796890710738,-0.050877317284261,0.0305790638743483,0.625272355401937
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJB8,DnaJ homolog subfamily B member 8,35874,0.0166260786206467,0.0340478812368387,-0.0501077686035571,0.0833599258448504,0.625341718086571
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACP1,Low molecular weight phosphotyrosine protein phosphatase,34778,0.0140783889517794,0.0288337836169748,-0.0424358269374912,0.0705926048410501,0.625382877429681
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL32,Interleukin-32,35971,0.0134581153982263,0.0275636823111055,-0.0405667019315404,0.0674829327279931,0.625383506345628
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENDOU,Poly(U)-specific endoribonuclease,34465,-0.0180823086617063,0.0370379363991708,-0.0906766640040809,0.0545120466806684,0.625419014329334
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYPD1,Ly6/PLAUR domain-containing protein 1,35782,-0.0186923916288296,0.0383037642399033,-0.09376776953904,0.0563829862813809,0.62556187804221
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGA4,Pepsin A-4,34966,0.0231485129841912,0.0474936376305536,-0.0699390167716938,0.116236042740076,0.625989975897977
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FES,Tyrosine-protein kinase Fes/Fps,35800,-0.0143455511135447,0.0294412048960451,-0.0720503127097932,0.0433592104827037,0.626088211723954
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DENND2B,DENN domain-containing protein 2B,34736,-0.0144644888840514,0.0297292723697748,-0.07273386272881,0.0438048849607072,0.626601521514091
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGSF3,Immunoglobulin superfamily member 3,35937,-0.0108676178501636,0.0223598059932958,-0.0546928375970233,0.0329576018966961,0.626957831742251
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHNAK2,Protein AHNAK2,34815,0.00928530402066493,0.0191458650825359,-0.0282405915411054,0.0468111995824353,0.627709760545043
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F9,Coagulation factor IX,36014,0.00537685141523904,0.0110941988884976,-0.0163677784062162,0.0271214812366942,0.627935892643725
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CREBZF,CREB/ATF bZIP transcription factor,34739,0.00819819672300478,0.0169530491964565,-0.02502977970205,0.0414261731480596,0.62869949417794
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGBL2,Cytosolic carboxypeptidase 2,34750,0.0291234030646732,0.060314462885008,-0.0890929441899424,0.147339750319289,0.629212785197745
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CBX2,Chromobox protein homolog 2,34736,-0.0118730019014984,0.0246132017849387,-0.0601148773999783,0.0363688735969815,0.62955076216995
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIAA2013,Uncharacterized protein KIAA2013,34949,-0.0173342004907116,0.0359460467233903,-0.0877884520685567,0.0531200510871334,0.629660408786502
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBM25,RNA-binding protein 25,34739,-0.0142971090429098,0.0296502670257636,-0.0724116324134064,0.0438174143275869,0.629687049838326
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOXO3,Forkhead box protein O3,35800,0.027944565312261,0.0580024040808901,-0.0857401466862836,0.141629277310806,0.629974835264787
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C2orf69,UPF0565 protein C2orf69,34805,-0.0180010376938782,0.0373924801003463,-0.091290298690557,0.0552882233028006,0.630243554153753
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LEPR,Leptin receptor,35972,-0.00925903964315104,0.0192362926070086,-0.046962173152888,0.0284440938665859,0.630294974807728
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTRB1,Chymotrypsinogen B,35979,0.0168484789894199,0.0350063668135633,-0.0517639999651641,0.085460957944004,0.630319301393693
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SFRP1,Secreted frizzled-related protein 1,35876,0.0125551398540197,0.0261037823930356,-0.0386082736363301,0.0637185533443694,0.630552183908203
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAP18,Histone deacetylase complex subunit SAP18,34869,-0.0223801162217335,0.0465576674787321,-0.113633144480048,0.0688729120365815,0.630748865008014
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DOK1,Docking protein 1,34958,-0.0410077499521076,0.0854650982710217,-0.20851934256331,0.126503842659095,0.631372839773756
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCK2,Cytoplasmic protein NCK2,35992,-0.0315901820813742,0.0658792317210682,-0.160713476254668,0.0975331120919196,0.631585381653002
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VIT,Vitrin,34949,-0.0115358927662244,0.0240578670845662,-0.0586893122519741,0.0356175267195254,0.631595182930468
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,34805,-0.0136936745141469,0.0286524248594223,-0.0698524272386146,0.0424650782103207,0.632721307964541
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDR1,Epithelial discoidin domain-containing receptor 1,36043,-0.0070010325987708,0.0146549063668647,-0.0357246490778255,0.0217225838802839,0.63285912920592
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BOLA1,BolA-like protein 1,34750,-0.0165338253101971,0.0346637889323017,-0.0844748516175084,0.0514072009971142,0.633395544948249
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C2CD2L,Phospholipid transfer protein C2CD2L,35776,0.0118917969966854,0.0249505553277117,-0.0370112914456294,0.0607948854390003,0.633651152775311
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COPB2,Coatomer subunit beta',34736,-0.0134555460476403,0.0282544414148593,-0.0688342512207646,0.0419231591254839,0.633929163667701
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RHOC,Rho-related GTP-binding protein RhoC,35862,-0.0347064329167992,0.0731217149448878,-0.178024994208779,0.108612128375181,0.635058427007246
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCGB1A1,Uteroglobin,35968,0.0152722897505554,0.0321886067642884,-0.0478173795074499,0.0783619590085606,0.635184129728162
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNXB,Tenascin-X,35979,-0.00760742937655801,0.0160458463498708,-0.0390572882223049,0.0238424294691888,0.63543846611324
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TOP1,DNA topoisomerase 1,34964,-0.0360618124785173,0.0760803745936442,-0.18517934668206,0.113055721725025,0.635518840285093
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,34965,-0.00775914472216652,0.0163925241840392,-0.0398884921228833,0.0243702026785503,0.635990894140835
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCN2,CCN family member 2,35955,0.0166659168290932,0.0352169794305329,-0.0523593628547513,0.0856911965129378,0.636059380374894
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITPA,Inosine triphosphate pyrophosphatase,34736,0.0200645743061993,0.0424150956666802,-0.0630690132004939,0.103198161812892,0.636192428709976
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPTN,Neuroplastin,35800,-0.0220997199631951,0.0469966374724157,-0.11421312940913,0.0700136894827395,0.638197480486613
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,35941,0.056304898922852,0.119751808528667,-0.178408645793335,0.291018443639039,0.638240427540236
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),QSOX1,Sulfhydryl oxidase 1,34843,-0.0122471305711841,0.0260693230959498,-0.0633430038392458,0.0388487426968775,0.638520830088026
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD200R1,Cell surface glycoprotein CD200 receptor 1,35948,-0.0103404803515179,0.0220128658890166,-0.0534856974939904,0.0328047367909547,0.638549638116242
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICA1,Islet cell autoantigen 1,35842,-0.0231250570510729,0.0492317685280104,-0.119619323365973,0.0733692092638274,0.638570514922711
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LMNB2,Lamin-B2,34958,-0.00857132051027636,0.0182514630818281,-0.0443441881506593,0.0272015471301066,0.638639959440285
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDGFB,Platelet-derived growth factor subunit B,35992,-0.0248106492242769,0.052957385353631,-0.128607124517394,0.07898582606884,0.639439344010893
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH5,Cadherin-5,36072,0.00866323540041704,0.018548153678458,-0.0276911458093607,0.0450176166101948,0.640465373028339
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLA2G1B,Phospholipase A2,36063,0.012355412334738,0.0265208543225014,-0.0396254621373647,0.0643362868068407,0.641318320814218
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDDM3B,Epididymal secretory protein E3-beta,34949,0.0181081349116685,0.038950026413761,-0.0582339168593031,0.0944501866826402,0.642014093057799
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRX,Cone-rod homeobox protein,35874,0.0301255047283135,0.0648527255121175,-0.0969858372754368,0.157236846732064,0.642287848001588
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SFTPA1,Pulmonary surfactant-associated protein A1,35800,-0.0156947624394327,0.0338239456364444,-0.0819896958868638,0.0506001710079984,0.642652206755841
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GM2A,Ganglioside GM2 activator,34813,-0.0113028219064537,0.0243677719936859,-0.0590636550140781,0.0364580112011708,0.64277644070437
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNG,Interferon gamma,35842,-0.0324262377313306,0.0699876999937077,-0.169602129718998,0.104749654256336,0.643153680557894
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMA4,Laminin subunit alpha-4,35992,-0.00962181626668321,0.0208904444483427,-0.0505670873854349,0.0313234548520685,0.645110236552639
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTPN,Myotrophin,35874,0.00950976123832766,0.0206520868077547,-0.0309683289048716,0.0499878513815269,0.645189370063056
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FBLN2,Fibulin-2,34965,-0.00943361324768689,0.0204931271082432,-0.0496001423798435,0.0307329158844697,0.645294674203915
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINK5,Serine protease inhibitor Kazal-type 5,35979,0.0100201900668396,0.0217691895273286,-0.0326474214067245,0.0526878015404037,0.645319998599462
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HCG22,Protein PBMUCL2,34736,-0.016173930113076,0.0352790944686543,-0.0853209552716385,0.0529730950454864,0.646640745522181
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMOTL2,Angiomotin-like protein 2,34926,0.0140015978946025,0.0305783125489839,-0.0459318947014058,0.0739350904906108,0.647044981348099
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NGFR,Tumor necrosis factor receptor superfamily member 16,34949,-0.00880768652238937,0.0192407985938659,-0.0465196517663665,0.0289042787215878,0.647139848015201
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TINAGL1,Tubulointerstitial nephritis antigen-like,35947,-0.00626093583612528,0.0136892676995492,-0.0330919005272416,0.0205700288549911,0.647425184657478
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OTOA,Otoancorin,34750,0.015215400271666,0.0333000954042774,-0.0500527867207178,0.0804835872640497,0.647746397941632
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAT1,Diamine acetyltransferase 1,34736,0.0137247620069868,0.0301310959720857,-0.0453321860983012,0.0727817101122747,0.648764544342331
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXLNA,Alpha-taxilin,35902,-0.024573531913151,0.0540010057809858,-0.130415503243883,0.0812684394175812,0.649081811405556
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPN6,Tyrosine-protein phosphatase non-receptor type 6,35979,-0.0253646632984663,0.0559004761949735,-0.134929596640614,0.0842002700436818,0.65002440808488
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,36043,0.0127573733884615,0.0281789684669961,-0.0424734048068507,0.0679881515837738,0.650758695766939
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRHBP,Corticotropin-releasing factor-binding protein,35949,-0.00768349671967543,0.0169847606415494,-0.0409736275771123,0.0256066341377614,0.651011543835413
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAM20A,Pseudokinase FAM20A,34949,-0.00808836319983436,0.0178966999342165,-0.0431658950708988,0.0269891686712301,0.651322468201888
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1RAP,Interleukin-1 receptor accessory protein,35979,0.012470008206507,0.0276030419355041,-0.0416319539870809,0.066571970400095,0.651453653085188
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL33,Interleukin-33,35842,-0.0110713431004835,0.0245176656314992,-0.0591259677382219,0.0369832815372549,0.651595222902404
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRELP,Prolargin,35949,-0.00639588167597784,0.0141645203922628,-0.0341583416448129,0.0213665782928572,0.651611990635178
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COMP,Cartilage oligomeric matrix protein,35925,-0.00934440377535593,0.02070013480329,-0.0499166679898043,0.0312278604390924,0.651702013539575
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFB116,Beta-defensin 116,34750,-0.0209927566018076,0.0466144009875799,-0.112356982537464,0.070371469333849,0.652474567512451
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENOX2,Ecto-NOX disulfide-thiol exchanger 2,34736,-0.00792317949768708,0.0176036843891197,-0.0424264009003617,0.0265800419049875,0.652664019873142
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AFP,Alpha-fetoprotein,35878,0.0179250523230965,0.0399644031117198,-0.0604051777758743,0.0962552824220673,0.653787367926093
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPT1,Translationally-controlled tumor protein,35842,0.0178458631333694,0.0398364187628252,-0.060233517641768,0.0959252439085069,0.654182041103113
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],35937,0.0155410808191921,0.034698031952498,-0.0524670618077039,0.0835492234460881,0.65424208066701
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL7,C-C motif chemokine 7,35971,-0.0156246372217818,0.0349091308109908,-0.0840465336113238,0.0527972591677601,0.654469317750561
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFH,Complement factor H,34613,-0.00656816661532702,0.0146892062122514,-0.0353590107913397,0.0222226775606857,0.654788367026104
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD99,CD99 antigen,35979,0.00536169429972292,0.0119927657983671,-0.0181441266650767,0.0288675152645225,0.654832313047701
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,35979,-0.00980107997832099,0.021945146479777,-0.052813567078684,0.033211407122042,0.655164577606498
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REST,RE1-silencing transcription factor,34739,-0.0101742892681725,0.0228312353126333,-0.0549235104809338,0.0345749319445888,0.655880064754209
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",35937,-0.0190124630579091,0.0426841344417303,-0.102673366563701,0.0646484404478824,0.65602777971424
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSG1,Pregnancy-specific beta-1-glycoprotein 1,35902,0.0306989131024841,0.0689676880468965,-0.104477755469433,0.165875581674401,0.656246064949967
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTN5,Contactin-5,35988,-0.0102276001022741,0.0230301853488273,-0.0553667633859756,0.0349115631814273,0.656986596005176
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATF4,Cyclic AMP-dependent transcription factor ATF-4,34739,-0.00934197316248218,0.0210704002098858,-0.0506399575738584,0.031956011248894,0.657514104892994
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,34949,-0.0170227270477731,0.0384268079033736,-0.0923392705383855,0.0582938164428392,0.65778739384903
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF4,E3 ubiquitin-protein ligase RNF4,34869,-0.0181723621156595,0.0410660909640643,-0.0986619004052255,0.0623171761739065,0.658131829536936
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SRC,Proto-oncogene tyrosine-protein kinase Src,35975,-0.0330379488863788,0.0747538583228449,-0.179555511199155,0.113479613426397,0.658533688357408
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMED10,Transmembrane emp24 domain-containing protein 10,34736,-0.0118481540946024,0.0268340897312269,-0.0644429699678071,0.0407466617786024,0.658842250752907
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF3,Fibroblast growth factor 3,34778,-0.00848325867059063,0.0192247911820095,-0.0461638493873293,0.029197332046148,0.659035428940609
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1R,Complement C1r subcomponent,34975,-0.00543381123507972,0.012322540023332,-0.0295859896808105,0.0187183672106511,0.659253149339326
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMPRSS11B,Transmembrane protease serine 11B,34750,-0.0206096039065693,0.0467631461882442,-0.112265370435528,0.0710461626223894,0.659428882194128
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADGRF5,Adhesion G protein-coupled receptor F5,34949,-0.0074658294934453,0.0169419273421612,-0.0406720070840812,0.0257403480971906,0.659465623395046
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD3E,T-cell surface glycoprotein CD3 epsilon chain,34869,-0.00975622591072916,0.022162208460942,-0.0531941544941754,0.0336817026727171,0.659793655245245
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP5IF1,"ATPase inhibitor, mitochondrial",35992,-0.0296127378677906,0.0672762206079985,-0.161474130259468,0.102248654523887,0.659829397915121
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYAR,Cell growth-regulating nucleolar protein,35800,-0.0146164723451561,0.033236046803235,-0.0797591240794966,0.0505261793891844,0.660111317287399
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YOD1,Ubiquitin thioesterase OTU1,34736,-0.0173392285572377,0.0395072450224087,-0.0947734288011587,0.0600949716866834,0.660758644016845
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",34778,-0.0121946151467861,0.0277895033135723,-0.0666620416413878,0.0422728113478157,0.66080665287309
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDH12,Protocadherin-12,34952,-0.00691101067688052,0.0158036184169229,-0.0378861027740495,0.0240640814202884,0.661904608598801
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VPS28,Vacuolar protein sorting-associated protein 28 homolog,34869,-0.0185661543031806,0.0424838956614667,-0.101834589799655,0.0647022811932942,0.662114589306558
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCARB2,Lysosome membrane protein 2,35754,-0.00841517622966283,0.019310424638314,-0.0462636085207582,0.0294332560614326,0.663006521448846
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBCC,Tubulin-specific chaperone C,35902,-0.021623911434275,0.0496278908813017,-0.118894577561626,0.0756467546930763,0.66305208823022
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,36072,-0.00623938648047232,0.014329979793091,-0.0343261468749307,0.0218473739139861,0.663278949928088
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STK24,Serine/threonine-protein kinase 24,35782,-0.0165046481432236,0.0379577458485964,-0.0909018300064725,0.0578925337200253,0.663708807275071
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL4A1,Collagen alpha-1(IV) chain,35972,0.0104277084248723,0.0240645226288674,-0.0367387559277078,0.0575941727774524,0.664792891297573
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAP,Prolyl endopeptidase FAP,36072,-0.00725802597438401,0.0167666148393826,-0.0401205910595739,0.0256045391108059,0.665110382658555
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LDLR,Low-density lipoprotein receptor,35988,-0.0136067835503849,0.0314492533581114,-0.0752473201322832,0.0480337530315134,0.665275586712573
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TREML1,Trem-like transcript 1 protein,34966,-0.0145402469653271,0.0336367664374861,-0.0804683091827998,0.0513878152521456,0.665558059714315
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPINT2,Kunitz-type protease inhibitor 2,35992,-0.010405624475476,0.024092102308206,-0.0576261449995598,0.0368148960486078,0.665819286043911
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAG6,Large proline-rich protein BAG6,35874,-0.00975405660067975,0.0225866788494552,-0.0540239471456119,0.0345158339442524,0.66586325771999
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAGEA3,Melanoma-associated antigen 3,34869,-0.0241645723062342,0.0559693931127487,-0.133864582807222,0.0855354381947533,0.665940739129083
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GASK1A,Golgi-associated kinase 1A,34736,0.0116694775716787,0.027028945316904,-0.0413072552494531,0.0646462103928105,0.665945541670472
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MITD1,MIT domain-containing protein 1,35902,-0.0258308480179072,0.0598717790993706,-0.143179535052674,0.0915178390168591,0.666164028792604
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBL1X,F-box-like/WD repeat-containing protein TBL1X,35800,-0.0226788556874813,0.0525724193942344,-0.125720797700181,0.0803630863252181,0.666202717894157
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCN3B,Sodium channel subunit beta-3,34750,-0.0132017076853654,0.0306975555993063,-0.0733689166600058,0.0469655012892749,0.667169032817244
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OGN,Mimecan,35979,-0.0111703497650529,0.0260374811199352,-0.0622038127601258,0.03986311323002,0.667928192178975
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF1R,Macrophage colony-stimulating factor 1 receptor,34966,-0.0110639463512131,0.025837903753582,-0.0617062377082338,0.0395783450058075,0.668515608273212
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,36032,0.0091747003768293,0.0214278616876347,-0.0328239085309347,0.0511733092845933,0.668542045135044
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPTL1,Angiopoietin-related protein 1,35851,-0.00769551815727057,0.017992988526278,-0.0429617756687754,0.0275707393542342,0.66888561134929
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,34750,0.0154471676851287,0.0362107664745914,-0.0555259346050705,0.0864202699753278,0.669692575702247
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,34750,-0.0162788065278828,0.0381748885845183,-0.0911015881535387,0.0585439750977731,0.669811592367716
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP164,Centrosomal protein of 164 kDa,35842,-0.0169873085948095,0.0398616435070547,-0.0951161298686368,0.0611415126790178,0.670006292961888
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DOK2,Docking protein 2,35972,-0.0323651738162759,0.0760505964438302,-0.181424342846183,0.116693995213631,0.670430546436379
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HRG,Histidine-rich glycoprotein,34950,0.0084873535329053,0.0199527587445541,-0.0306200536064207,0.0475947606722313,0.670579613227536
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLASP1,CLIP-associating protein 1,34739,-0.0207036304639558,0.048730982597229,-0.116216356354525,0.0748090954266131,0.670956838655757
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",34815,0.0184020150424392,0.0433922284491044,-0.0666467527178054,0.103450782802684,0.671518135011377
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RASA1,Ras GTPase-activating protein 1,35782,-0.0082612543013851,0.0194955010938322,-0.0464724364452963,0.0299499278425261,0.671759500336155
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,34949,-0.00831668552193718,0.0196339894568497,-0.0467993048573626,0.0301659338134882,0.671882024445178
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP2,Microtubule-associated protein 2,34958,-0.0122157599132872,0.0288562124643373,-0.0687739363433884,0.044342416516814,0.672067324002317
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRR5,Proline-rich protein 5,34778,0.0120904439842126,0.0285731500411483,-0.0439129300964381,0.0680938180648634,0.672207815676043
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FRMD4B,FERM domain-containing protein 4B,34736,-0.0185655566737528,0.0439075518534708,-0.104624358306555,0.0674932449590499,0.672432012503388
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,34822,-0.00770919561106902,0.0182473901923057,-0.0434740803879882,0.0280556891658502,0.672687766828964
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMB1,Laminin subunit beta-1,34815,-0.0083226463773886,0.0197295879121176,-0.0469926386851391,0.0303473459303619,0.673159467522371
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL10,Interleukin-10,35842,0.0199987411156444,0.0474109232773951,-0.07292666850805,0.112924150739339,0.673170998242771
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSNK2A1,Casein kinase II subunit alpha,34952,0.0118708767001175,0.0281680101705657,-0.0433384232341913,0.0670801766344263,0.673454542534935
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAMP1,Lysosome-associated membrane glycoprotein 1,34787,-0.00707523430368979,0.0167897603567273,-0.0399831646028754,0.0258326959954958,0.673476384673992
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),H2AP,Huntingtin-interacting protein M,34739,-0.013166168949321,0.0312951773573236,-0.0745047165696752,0.0481723786710331,0.673982170543914
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHMP6,Charged multivesicular body protein 6,34949,-0.0151867608416744,0.0361222589020193,-0.0859863882896323,0.0556128666062835,0.674188020574108
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VTCN1,V-set domain-containing T-cell activation inhibitor 1,35800,0.0082527909071695,0.0196862475185347,-0.0303322542291585,0.0468378360434975,0.675070750145851
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPA4,Carboxypeptidase A4,34680,-0.0115806329074614,0.0277021145205374,-0.0658767773677147,0.0427155115527919,0.675931554484483
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHB6,Ephrin type-B receptor 6,35896,0.00836224636356026,0.0200366650168878,-0.0309096170695399,0.0476341097966604,0.676436737259943
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),METAP1,Methionine aminopeptidase 1,35782,-0.00766689724661822,0.0184137571278406,-0.0437578612171858,0.0284240667239493,0.677153261357781
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH2B3,SH2B adapter protein 3,35800,-0.0252881543449424,0.0607671687449667,-0.144391805085077,0.0938154963951924,0.677313887387668
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DHODH,Dihydroorotate dehydrogenase,34736,0.012108205115729,0.0291623157860397,-0.0450499338249088,0.0692663440563669,0.678009724741398
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,34869,0.0179141663836855,0.0433326296596454,-0.0670177877492195,0.10284612051659,0.679319984773902
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH4,Cadherin-4,34750,0.0124492114257551,0.0301545585175839,-0.0466537232687094,0.0715521461202196,0.679733290582146
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHNAK,Neuroblast differentiation-associated protein AHNAK,34815,0.00846085841558389,0.0205252888443546,-0.0317687077193511,0.0486904245505189,0.680195115518898
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJB6,DnaJ homolog subfamily B member 6,34768,-0.0217672757745722,0.0528543759973765,-0.12536185272943,0.0818273011802858,0.680474761968475
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCR1,Natural cytotoxicity triggering receptor 1,35963,0.00957140667712119,0.0232744280881155,-0.0360464723755853,0.0551892857298276,0.680907556715262
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TJP3,Tight junction protein ZO-3,34750,-0.010491701693506,0.0255167833476716,-0.0605045970549424,0.0395211936679305,0.680963191283705
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLT1,Vascular endothelial growth factor receptor 1,35923,-0.00558107120403655,0.0135753839210916,-0.0321888236893762,0.0210266812813031,0.680998770126456
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPHS2,Podocin,34778,0.0267474332241426,0.0651662501830452,-0.100978417134626,0.154473283582911,0.68149071774531
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA10,Annexin A10,35782,-0.0203078034748287,0.049506512440871,-0.117340567858936,0.0767249609092785,0.681668038194765
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP7,Matrilysin,35863,-0.0126794148417963,0.030950114977152,-0.0733416401970143,0.0479828105134217,0.68205819577995
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SEC31A,Protein transport protein Sec31A,34815,0.0198056261767942,0.0484166117015877,-0.0750909327583178,0.114702185111906,0.682504769211815
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MFAP3L,Microfibrillar-associated protein 3-like,34805,0.0173731455965679,0.0424798016586256,-0.0658872656543383,0.100633556847474,0.682572663043521
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOX2,Transcription factor SOX-2,34938,-0.00634174210551854,0.0155094075414808,-0.0367401808868209,0.0240566966757838,0.682629450046283
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHRDL2,Chordin-like protein 2,35972,0.0117161716858478,0.0286533742826982,-0.0444444419082406,0.0678767852799362,0.682629871535249
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DRG2,Developmentally-regulated GTP-binding protein 2,35937,-0.0143947373844342,0.0353095107886573,-0.0836013785302026,0.0548119037613342,0.683525590572559
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,34965,0.0360136743666669,0.0884679397426127,-0.137383487528854,0.209410836262188,0.683961713253021
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCLN,Nicalin,35842,0.0124046783232958,0.0305119308588738,-0.0473987061600968,0.0722080628066884,0.684349268256158
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCN3A,Sodium channel protein type 3 subunit alpha,34805,-0.00923874885744266,0.0228123652409157,-0.0539509847296374,0.0354734870147521,0.685499819486997
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDHR1,Cadherin-related family member 1,35782,0.0105679320758853,0.0261215919808122,-0.0406303882065066,0.0617662523582771,0.685807924414648
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FURIN,Furin,35991,-0.00830266907851493,0.0205592805256984,-0.0485988589088838,0.0319935207518539,0.686341733483863
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CELA3A,Chymotrypsin-like elastase family member 3A,36062,-0.0146590650220664,0.0363077299769278,-0.0858222157768449,0.056504085732712,0.686411802414117
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL8,Interleukin-8,35911,0.0170723722293836,0.0423527167431633,-0.0659389525872164,0.100083697045984,0.686886584890523
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FAS,Tumor necrosis factor receptor superfamily member 6,36049,-0.0085476714254694,0.0212406032336047,-0.0501792537633347,0.0330839109123958,0.687385535026296
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBQLN3,Ubiquilin-3,34736,-0.0137922609864687,0.0342850026037716,-0.080990866089861,0.0534063441169235,0.687490049821807
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,34766,0.00894289134675917,0.0222325565498548,-0.0346329194909563,0.0525187021844746,0.687519105577154
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LARP1,La-related protein 1,34949,-0.0156195175189102,0.0388338364539738,-0.0917338369686988,0.0604948019308784,0.687539988290398
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THBD,Thrombomodulin,35972,-0.00722935951234178,0.0179914610013443,-0.0424926230749767,0.0280339040502931,0.687826896400809
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSLNL,Mesothelin-like protein,34805,0.00916747392167302,0.0228156818973937,-0.0355512625972187,0.0538862104405647,0.687840772224142
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSMG4,Proteasome assembly chaperone 4,34778,0.0150170603077527,0.0373883336801738,-0.058264073705388,0.0882981943208934,0.687954809338135
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YES1,Tyrosine-protein kinase Yes,35937,-0.028314940838449,0.070631274829794,-0.166752239504845,0.110122357827947,0.688517278191465
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),XIAP,E3 ubiquitin-protein ligase XIAP,34778,-0.0147906160927814,0.0369688171436236,-0.0872494976942837,0.0576682655087208,0.689108802500341
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AGR3,Anterior gradient protein 3,35784,-0.0142918488680385,0.0357266834429838,-0.0843161484162868,0.0557324506802097,0.689144176819957
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTSL,Cathepsin L1,35972,0.00604954667259996,0.0151283871979413,-0.023602092235365,0.0357011855805649,0.689256138714803
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FBP1,"Fructose-1,6-bisphosphatase 1",35972,0.0183568758767156,0.045967572834719,-0.0717395668793337,0.108453318632765,0.689651295188453
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,35962,0.0150323089952604,0.0377314224606496,-0.0589212790276127,0.0889858970181336,0.690344757131418
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SELENOP,Selenoprotein P,34975,0.00574664708330581,0.0144682445444383,-0.0226111122237933,0.0341044063904049,0.691240396245033
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AXL,Tyrosine-protein kinase receptor UFO,36026,0.0066745583840225,0.0168231768567634,-0.0262988682552337,0.0396479850232787,0.691564849431953
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPBP,Platelet basic protein,34933,-0.0214504366235679,0.054202895322155,-0.127688111454992,0.0847872382078559,0.692307685829183
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHP1,Calcineurin B homologous protein 1,34750,0.0188655907293966,0.0476952275436786,-0.0746170552562135,0.112348236715007,0.692454717176064
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STXBP3,Syntaxin-binding protein 3,35800,-0.0105641146560858,0.0267105148977197,-0.0629167238556165,0.0417884945434449,0.692482710687098
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASGR2,Asialoglycoprotein receptor 2,34966,-0.00656321134889684,0.0166968667589158,-0.0392890701963719,0.0261626474985782,0.694273249611962
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,34869,-0.00962149284887032,0.0244830054982043,-0.0576081836253508,0.0383651979276102,0.694342748117254
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,34750,0.0195437900678834,0.0497970579634063,-0.0780584435403929,0.11714602367616,0.694725483392797
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENOPH1,Enolase-phosphatase E1,34949,-0.0124282684098827,0.0316768083267086,-0.0745148127302315,0.049658275910466,0.694815764374902
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HPGDS,Hematopoietic prostaglandin D synthase,35800,0.00913120620983453,0.0233071340297597,-0.0365507764884946,0.0548131889081636,0.695234358381243
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPY,Pro-neuropeptide Y,36032,0.0152282885494574,0.0389869193917773,-0.0611860734584261,0.0916426505573409,0.696104161977509
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NMT1,Glycylpeptide N-tetradecanoyltransferase 1,34952,-0.0159398027645116,0.0408190549676519,-0.0959451505011094,0.0640655449720862,0.696180642147933
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R9B,Neurabin-2,36067,-0.0227281492190808,0.0582247260923539,-0.136848612360094,0.0913923139219328,0.696287272547235
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C3,Complement C3,34636,-0.01100476840891,0.0282154948904507,-0.0663071383941933,0.0442976015763733,0.696531298041702
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTX3,Pentraxin-related protein PTX3,35971,-0.0118927166278111,0.0304961852577154,-0.0716652397329333,0.0478798064773111,0.696567106679415
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F13B,Coagulation factor XIII B chain,34950,-0.00619510838176219,0.0159967632776016,-0.0375487644058614,0.025158547642337,0.698567374081903
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCDH7,Protocadherin-7,34964,-0.008975305222036,0.0231887041367441,-0.0544251653300544,0.0364745548859824,0.698728390268702
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL16,C-C motif chemokine 16,36072,-0.0123516167789011,0.0319815776805997,-0.0750355090328765,0.0503322754750743,0.699351874608025
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRIM21,E3 ubiquitin-protein ligase TRIM21,35971,-0.0172168658598282,0.0446073602335545,-0.104647291917595,0.0702135601979385,0.699533960614512
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CALY,Neuron-specific vesicular protein calcyon,34736,-0.00936980200901392,0.0242841559640088,-0.0569667476984712,0.0382271436804434,0.699628445619992
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,34607,-0.0260799295391344,0.0676213110774395,-0.158617699250916,0.106457840172647,0.699750156738162
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB1,Integrin beta-1,35990,-0.00504197150208967,0.0130883735850884,-0.0306951837288628,0.0206112407246835,0.70008165173752
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",35937,-0.0231228880197773,0.0600687308122829,-0.140857600411852,0.0946118243722972,0.700292647581293
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCP11,T-complex protein 11 homolog,34869,0.0137972305218607,0.0358484547995172,-0.0564657408851931,0.0840602019289145,0.700341917831788
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNER,Delta and Notch-like epidermal growth factor-related receptor,35940,0.00614507592551073,0.0159859340609359,-0.0251873548339237,0.0374775066849451,0.700689294862122
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA12,Serpin A12,35760,0.0261090872916442,0.068005678348072,-0.107182042270577,0.159400216853865,0.701045357747565
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EVPL,Envoplakin,34869,0.00794895152965451,0.0207158108886233,-0.0326540378120471,0.0485519408713562,0.701203273242694
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),INPP1,Inositol polyphosphate 1-phosphatase,35937,0.0127610861718743,0.0332620483558765,-0.0524325286056437,0.0779547009493922,0.701246734379749
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCRIB,Protein scribble homolog,34815,-0.0213743030865659,0.0557211358874863,-0.130587729426039,0.0878391232529072,0.701292379883193
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TTN,Titin,34736,0.0166725504637451,0.0434721312675858,-0.0685328268207231,0.101877927748213,0.701345507368423
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPD1,Glycerol-3-phosphate dehydrogenase,34949,0.0131648156716999,0.0343280365357919,-0.0541181359384523,0.0804477672818521,0.701361615860224
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPKOW,G-patch domain and KOW motifs-containing protein,35782,-0.00710530331085178,0.018534809216751,-0.0434335293756838,0.0292229227539802,0.701472249363257
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1R2,Interleukin-1 receptor type 2,35937,0.004647785756887,0.012131194105111,-0.0191293546891306,0.0284249262029046,0.701636837962112
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MSRA,Mitochondrial peptide methionine sulfoxide reductase,35991,-0.0170622787468928,0.0446055259924838,-0.104489109692161,0.0703645521983754,0.702090470796833
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FETUB,Fetuin-B,36014,-0.00725644713547754,0.0190360661367314,-0.0445671367634711,0.030054242492516,0.703069719387245
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGCT,Gamma-glutamylcyclotransferase,34944,-0.0116710274118637,0.030712688123328,-0.0718678961335866,0.0485258413098593,0.703953159067893
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTK7,Inactive tyrosine-protein kinase 7,35782,-0.00872166400009407,0.0229649021451301,-0.053732872204549,0.0362895442043609,0.704118230793332
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),B4GAT1,"Beta-1,4-glucuronyltransferase 1",35979,0.00574083649325964,0.0151255216119709,-0.0239051858662033,0.0353868588527226,0.704293115447879
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HBEGF,Proheparin-binding EGF-like growth factor,36013,0.0172166734296256,0.0453964999140188,-0.0717604664018513,0.106193813261102,0.704512256359678
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1RN,Interleukin-1 receptor antagonist protein,35944,0.0123031184863997,0.0325529652101036,-0.0515006933254034,0.0761069302982028,0.705484929825381
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",34750,0.010770706523703,0.028505497950703,-0.0451000694596749,0.0666414825070808,0.705557566168394
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD93,Complement component C1q receptor,35705,0.00731854738245915,0.0194329488107033,-0.0307700322865193,0.0454071270514376,0.706478352585708
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,34778,0.00805634612650196,0.021394917336733,-0.0338776918534947,0.0499903841064986,0.706517855940201
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLAU,Urokinase-type plasminogen activator,35979,-0.00665060472194707,0.0176788840656275,-0.0413012174905769,0.0280000080466828,0.706787081400364
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CACYBP,Calcyclin-binding protein,34811,-0.0243614242318243,0.0648046582892844,-0.151378554478822,0.102655706015173,0.706988555279656
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANGPTL7,Angiopoietin-related protein 7,36032,0.0085477678097024,0.0227405354831426,-0.0360236817372572,0.053119217356662,0.707015029104729
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HMMR,Hyaluronan mediated motility receptor,34725,-0.0116257833077692,0.0309936637857808,-0.0723733643278995,0.0491217977123611,0.707597644535311
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGAP5,Rho GTPase-activating protein 5,34739,-0.0184477061234669,0.0492043423044017,-0.114888217040094,0.0779928047931604,0.707732702284021
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMEM132A,Transmembrane protein 132A,34815,-0.0151421537589928,0.040424429772637,-0.0943740361133612,0.0640897285953757,0.70798616572056
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,34750,0.00766408747863544,0.0204770099964237,-0.0324708521143551,0.047799027071626,0.708210651080922
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,36043,0.0118587905153587,0.0317576539794555,-0.050386211284374,0.0741037923150914,0.708850087751424
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DTX2,Probable E3 ubiquitin-protein ligase DTX2,34805,-0.0140445934201018,0.0377221156461909,-0.087979940086636,0.0598907532464324,0.709669390385376
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPS16,"28S ribosomal protein S16, mitochondrial",34778,-0.0067395407570555,0.0181107044736444,-0.0422365215253985,0.0287574400112875,0.709808647727025
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ART5,Ecto-ADP-ribosyltransferase 5,34750,-0.0146677259861848,0.0394206386863299,-0.0919321778113915,0.0625967258390219,0.709844317193427
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZP4,Zona pellucida sperm-binding protein 4,34739,-0.00687245498306272,0.0184826391713339,-0.0430984277588771,0.0293535177927517,0.710030032950777
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CMIP,C-Maf-inducing protein,34949,-0.0196175032282688,0.0529667413670499,-0.123432316307687,0.0841973098511489,0.711116207623293
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,36067,-0.00815570395683874,0.0220655264531559,-0.0514041358050243,0.0350927278913468,0.711681394582975
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,35971,-0.0092848298241646,0.025129543533401,-0.0585387351496306,0.0399690755013014,0.711781597535099
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX1B,Syntaxin-1B,34805,0.00939876542003992,0.0254492457249659,-0.0404817562008933,0.0592792870409731,0.711906214801641
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C7orf50,Uncharacterized protein C7orf50,34958,-0.00582183550341008,0.0157836245746192,-0.0367577396696636,0.0251140686628435,0.712249662797567
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANKRA2,Ankyrin repeat family A protein 2,34739,-0.0129501296557529,0.0351396192497918,-0.0818237833853448,0.055923524073839,0.712488119309093
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TK1,"Thymidine kinase, cytosolic",34869,0.0106960514833355,0.0290678313201084,-0.046276897904077,0.0676690008707481,0.712909012063556
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,36011,-0.0257393498963533,0.0699791369265667,-0.162898458272424,0.111419758479717,0.713021968288492
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUB1,NEDD8 ultimate buster 1,35971,-0.0190444890052051,0.0519359949580362,-0.120839039122956,0.0827500611125458,0.713859657042959
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,34750,-0.0137706064189304,0.0375995337563655,-0.0874656925814069,0.0599244797435461,0.714195555239006
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AFM,Afamin,34975,0.0046190951386339,0.0126425438577111,-0.0201602908224799,0.0293984810997477,0.714853912791166
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYL4,Myosin light chain 4,34815,-0.012689710763301,0.034731962360896,-0.0807643569906571,0.0553849354640552,0.714854247998958
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB1BP1,Integrin beta-1-binding protein 1,35800,-0.00918045952943487,0.0251722300575764,-0.0585180304422846,0.0401571113834149,0.715341703267702
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHX2,Bifunctional epoxide hydrolase 2,35874,0.0137436676483349,0.0377026537232458,-0.0601535336492269,0.0876408689458967,0.715474470534417
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",34739,-0.0119649908906285,0.0328907759249703,-0.0764309117035703,0.0525009299223133,0.716035179291038
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,35979,-0.00629862125503346,0.0173161632852289,-0.040238301294082,0.0276410587840151,0.716060865530731
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAC3,Ras-related C3 botulinum toxin substrate 3,34805,0.0149149158636455,0.0411620792413877,-0.0657627594494743,0.0955925911767653,0.717105807367221
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HLA_A,,34952,0.00739616816831973,0.0204145530612558,-0.0326163558317417,0.0474086921683812,0.717140804224679
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRSS27,Serine protease 27,35949,-0.00886250978227904,0.0244694807014461,-0.0568226919571134,0.0390976723925553,0.71722325805529
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AFAP1,Actin filament-associated protein 1,34822,-0.0189302241311555,0.0522778994747915,-0.121394907101747,0.0835344588394359,0.717283930258879
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),P4HB,Protein disulfide-isomerase,35924,-0.00864400752327095,0.0239097597866721,-0.0555071367051483,0.0382191216586064,0.717716460026541
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MATN2,Matrilin-2,35966,-0.00658011687736564,0.0182044059407603,-0.0422607525212558,0.0291005187665245,0.717767927115704
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGAV,Integrin alpha-V,36032,0.0036251389800574,0.0101147735865331,-0.0161998172495475,0.0234500952096623,0.720053865838169
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAD51,DNA repair protein RAD51 homolog 1,34869,0.0116799524306405,0.0326439477562484,-0.0523021851716063,0.0756620900328873,0.72050623010003
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD209,CD209 antigen,35999,-0.00856537280024142,0.0239415440667268,-0.055490799171026,0.0383600535705432,0.720531694284194
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNTN4,Contactin-4,35979,0.00513196202623232,0.0143705371286545,-0.0230342907459306,0.0332982147983952,0.721014486901062
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NID2,Nidogen-2,35979,-0.01620198726346,0.0453716703126417,-0.105130461076238,0.0727264865493176,0.721031053228925
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAU1,Double-stranded RNA-binding protein Staufen homolog 1,34739,-0.0150717789811108,0.0422317275029685,-0.0978459648869291,0.0677024069247074,0.721191780331812
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DEFB103A_DEFB103B,Beta-defensin 103,34728,-0.00931730885097586,0.0261698520254662,-0.0606102188208896,0.0419756011189379,0.721828739505572
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TERF1,Telomeric repeat-binding factor 1,34778,0.00638335342442865,0.0179391432704701,-0.0287773673856927,0.04154407423455,0.721977188097576
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BAX,Apoptosis regulator BAX,35772,0.0197374186023318,0.0554899988736247,-0.0890229791899725,0.128497816394636,0.722080754013548
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPTP,Ceramide-1-phosphate transfer protein,34736,0.00880082143872513,0.0247603041464091,-0.0397293746882368,0.057331017565687,0.722271631842501
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGSF21,Immunoglobulin superfamily member 21,34815,0.0089323073240088,0.0252297940234972,-0.0405180889620457,0.0583827036100632,0.723322370597554
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DIPK2B,Divergent protein kinase domain 2B,34822,0.00641913139730109,0.0181903185958949,-0.0292338930506529,0.0420721558452551,0.724184928011359
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD177,CD177 antigen,35968,0.027228237874035,0.0773850210748019,-0.124446403432577,0.178902879180647,0.724957736726702
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CADPS,Calcium-dependent secretion activator 1,34805,0.00881415577721558,0.0250568456895057,-0.0402972617742157,0.0579255733286468,0.725025422489392
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,34805,-0.0225521843457351,0.064220131142166,-0.14842364138438,0.10331927269291,0.725472727371083
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPPP2,Tubulin polymerization-promoting protein family member 2,34869,0.0170257272017279,0.0485013372599465,-0.0780368938277673,0.112088348231223,0.725572954552507
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD46,Membrane cofactor protein,35948,-0.00622357948577111,0.0177500623711806,-0.0410137017332851,0.0285665427617428,0.725881276790145
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITGB5,Integrin beta-5,35991,0.0082830061840065,0.0236332067158515,-0.0380380789790625,0.0546040913470755,0.725987218513904
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,34736,0.00812719549560546,0.0232841840208882,-0.0375098051853354,0.0537641961765463,0.727068551471893
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL2RG,Cytokine receptor common subunit gamma,34949,-0.00789516316323517,0.022680014476684,-0.0523479915375357,0.0365576652110654,0.727768343301299
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRTAP,Cartilage-associated protein,34805,0.0109084799442969,0.0314391174146057,-0.0507121901883302,0.072529150076924,0.728624443544164
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSPG4,Chondroitin sulfate proteoglycan 4,34965,0.00731589708836461,0.0210958885692372,-0.0340320445073403,0.0486638386840695,0.728758635305779
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THRAP3,Thyroid hormone receptor-associated protein 3,34736,-0.0229370198418423,0.0662264446409063,-0.152740851338019,0.106866811654334,0.729097350085815
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SGSH,N-sulphoglucosamine sulphohydrolase,34872,0.0124607095178381,0.0359781459157472,-0.0580564564770264,0.0829778755127027,0.729098025312519
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TP73,Tumor protein p73,34805,-0.00757079963660086,0.0218875110806686,-0.0504703213547113,0.0353287220815095,0.729432700943359
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UROS,Uroporphyrinogen-III synthase,34805,0.0141476100081057,0.0409255480463399,-0.0660664641627206,0.0943616841789319,0.729586366974193
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,35902,-0.0228310175011637,0.0660865695015888,-0.152360693724278,0.10669865872195,0.729749984170986
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD160,CD160 antigen,36067,-0.0101826087017726,0.0294992519980936,-0.068001142618036,0.0476359252144909,0.729967326319646
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,34822,0.00934279747042543,0.0270817891303626,-0.0437375092250852,0.0624231041659361,0.730117684670409
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",35937,-0.00943163629669436,0.027407660578556,-0.0631506510306641,0.0442873784372754,0.730762827580653
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLMP,CXADR-like membrane protein,36032,0.00466773863138041,0.0135957456055607,-0.0219799227555185,0.0313154000182793,0.731364833164074
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GMPR2,GMP reductase 2,34822,-0.0142350665738774,0.0414983857276163,-0.0955719026000054,0.0671017694522506,0.731589740035424
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,35977,-0.0107916535491325,0.0314644058878869,-0.0724618890893909,0.0508785819911259,0.731623479434815
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GART,Trifunctional purine biosynthetic protein adenosine-3,34952,-0.00560125983784693,0.0164494616176445,-0.0378422046084302,0.0266396849327363,0.733481297616315
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINB6,Serpin B6,36015,-0.0121605073418428,0.0358555718003876,-0.0824374280706025,0.0581164133869168,0.734504443476649
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNPDA2,Glucosamine-6-phosphate isomerase 2,34822,0.00786806621267439,0.0232116072050964,-0.0376266839093146,0.0533628163346634,0.734642869605372
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFL4,Insulin growth factor-like family member 4,34778,-0.0156594442295324,0.0462473793094164,-0.106304307675989,0.0749854192169238,0.734921260102297
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PEAR1,Platelet endothelial aggregation receptor 1,36072,-0.00471626737139127,0.0139685913712581,-0.0320947064590571,0.0226621717162745,0.7356487176273
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",34778,0.00598747057980068,0.0177483691606028,-0.0287993329749808,0.0407742741345821,0.735862058860395
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PMVK,Phosphomevalonate kinase,35772,-0.0226844080016995,0.0672535045721736,-0.15450127696316,0.109132460959761,0.735902861462379
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PODXL,Podocalyxin,35937,0.00310015255041986,0.009210183764026,-0.0149518076270711,0.0211521127279108,0.736427698540505
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKT2,RAC-beta serine/threonine-protein kinase,34952,-0.0268609202853193,0.0798098553919707,-0.183288236853582,0.129566396282943,0.736458642381968
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAT5B,Signal transducer and activator of transcription 5B,35937,-0.0282785160122294,0.0842505123244505,-0.193409520168152,0.136852488143694,0.73714591951275
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGL1,Fibrinogen-like protein 1,34966,-0.013741180006832,0.0409474801955915,-0.0939982411901913,0.0665158811765273,0.737198213176869
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WAS,Wiskott-Aldrich syndrome protein,35842,-0.013653471506668,0.0407250825909608,-0.0934746333849511,0.0661676903716152,0.7374390399382
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYBPC1,"Myosin-binding protein C, slow-type",34949,0.0164187452186007,0.0489884781447729,-0.0795986719451542,0.112436162382356,0.737519056178823
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAT2,Linker for activation of T-cells family member 2,35937,-0.026235675178808,0.0783578879965304,-0.179817135652008,0.127345785294392,0.737771530558714
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL2L15,Bcl-2-like protein 15,34778,-0.0123500216554073,0.0369046989078255,-0.0846832315147453,0.0599831882039308,0.737903260020295
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP9,Caspase-9,34778,-0.0127986266248598,0.0382514807716299,-0.0877715289372544,0.0621742756875348,0.737944491844204
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PHLDB1,Pleckstrin homology-like domain family B member 1,34964,0.011166164230964,0.0334660421484983,-0.0544272783800927,0.0767596068420207,0.738649731717367
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMIGO1,Amphoterin-induced protein 1,34805,-0.0111083705734459,0.0333096153185494,-0.0763952165978027,0.0541784754509109,0.738776906739873
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RABEPK,Rab9 effector protein with kelch motifs,35800,-0.0117758511304761,0.0353718869259689,-0.0811047495053751,0.057553047244423,0.739207725368408
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRP1,Neuropilin-1,36035,-0.00553892379067842,0.0167306932448267,-0.0383310825505388,0.027253234969182,0.740605763954653
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF21,Tumor necrosis factor receptor superfamily member 21,36043,-0.00562180972520639,0.0170124058698664,-0.0389661252301446,0.0277225057797318,0.741066594200687
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STC2,Stanniocalcin-2,35970,-0.004855032879068,0.0147055923806126,-0.0336779939450686,0.0239679281869326,0.741296956183068
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOTCH3,Neurogenic locus notch homolog protein 3,36072,0.00681236272619361,0.0206637159032596,-0.0336885204441953,0.0473132458965825,0.741652878553031
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDLIM5,PDZ and LIM domain protein 5,34952,-0.0245436745403459,0.0746192742028283,-0.170797451977889,0.121710102897198,0.742227984259997
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA11,Carbonic anhydrase-related protein 11,35800,0.00626744172003312,0.0191219980574167,-0.0312116744725037,0.0437465579125699,0.743102044921733
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FADD,FAS-associated death domain protein,35972,-0.0153143731464337,0.0468034981705306,-0.107049229560674,0.0764204832678063,0.743521571818439
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NOS1,"Nitric oxide synthase, brain",35782,-0.0117465865729949,0.0359733295866815,-0.0822543125628906,0.0587611394169008,0.74402838358369
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,36016,-0.00641124223777012,0.0196398883598186,-0.0449054234230146,0.0320829389474743,0.74410080209311
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH1,Cadherin-1,35749,-0.00835544535642693,0.0255975153374577,-0.0585265754178439,0.0418156847049901,0.744118988002771
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZBTB16,Zinc finger and BTB domain-containing protein 16,35800,-0.0146447966062896,0.0452736276004116,-0.103381106703096,0.0740915134905171,0.746346438972493
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LY75,Lymphocyte antigen 75,35971,0.00769357863730732,0.0238041431699373,-0.0389625419757698,0.0543496992503845,0.746550418003375
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPPK1,Epiplakin,34815,-0.014967182806864,0.0463579371658596,-0.105828739651949,0.0758943740382208,0.74681116439564
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17RB,Interleukin-17 receptor B,35878,-0.0106941487492407,0.033155315690909,-0.0756785675034223,0.0542902700049408,0.747047576730096
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PF4,Platelet factor 4,34929,-0.0197562441338734,0.0612716156679738,-0.139848610843102,0.100336122575355,0.747132206728564
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMP3,Metalloproteinase inhibitor 3,35992,0.0255540795509068,0.079386904073637,-0.130044252433422,0.181152411535235,0.747542945875
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFKB2,Nuclear factor NF-kappa-B p100 subunit,34869,-0.0115902254816785,0.0360190606907215,-0.0821875844354926,0.0590071334721357,0.747629840066474
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXK,Tyrosine-protein kinase TXK,34869,-0.0156009802286805,0.0485647330655642,-0.110787857037186,0.0795858965798254,0.748038522469738
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRYBB1,Beta-crystallin B1,34949,-0.0133495584038475,0.0415990330969169,-0.0948836632738047,0.0681845464661097,0.748288926517267
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),USP47,Ubiquitin carboxyl-terminal hydrolase 47,34736,0.0176104452660398,0.0549133772214489,-0.090019774088,0.12524066462008,0.748452461008666
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP4,Caspase-4,34869,-0.033359961765689,0.104092997138224,-0.237382236156607,0.170662312625229,0.748613437469762
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VPS37A,Vacuolar protein sorting-associated protein 37A,35937,-0.0157466851325723,0.0492597990768427,-0.112295891323184,0.0808025210580393,0.749230604153164
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VAV3,Guanine nucleotide exchange factor VAV3,34750,0.0200489917190744,0.0627942054421105,-0.103027650947462,0.143125634385611,0.749524343369541
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGHMBP2,DNA-binding protein SMUBP-2,34736,0.0115224118027287,0.0361024020400682,-0.0592382961958049,0.0822831198012623,0.749616699203057
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNX9,Sorting nexin-9,35972,-0.0132114562626729,0.0414034011372212,-0.0943621224916264,0.0679392099662806,0.749666483126884
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MASP1,Mannan-binding lectin serine protease 1,35896,-0.00451158285851961,0.0141979226213194,-0.0323395111963055,0.0233163454792663,0.750673365190629
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,35874,0.00702397888375247,0.0221074846936048,-0.0363066911157129,0.0503546488832178,0.750706841500405
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STAM,Signal transducing adapter molecule 1,34949,-0.00731343424760237,0.0230200032813201,-0.0524326406789898,0.0378057721837851,0.750723644308027
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF31,E3 ubiquitin-protein ligase RNF31,34778,0.00730147635228365,0.0230264258725053,-0.0378303183578267,0.052433271062394,0.751185138468293
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKCQ,Protein kinase C theta type,35842,0.00820727991738823,0.0259143389879439,-0.0425848244989818,0.0589993843337583,0.751474264224409
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DTX3,Probable E3 ubiquitin-protein ligase DTX3,35937,-0.00466590997671938,0.0147349829726771,-0.0335464766031665,0.0242146566497277,0.75151420333059
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRME1,Break repair meiotic recombinase recruitment factor 1,34750,-0.00792828796783628,0.0250630482477876,-0.0570518625335,0.0411952865978274,0.751759934450814
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUSD5,Sushi domain-containing protein 5,34786,0.00691946022315466,0.0219231747806487,-0.0360499623469168,0.0498888827932261,0.752299254974963
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",35953,0.0134289820082625,0.0426559648310587,-0.0701767090606125,0.0970346730771375,0.752906703710246
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RALY,RNA-binding protein Raly,34949,0.00960952432229985,0.0306561423742458,-0.0504765147312219,0.0696955633758216,0.753940265673019
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOA1,Apolipoprotein A-I,34975,0.00540029928394912,0.0172298629735835,-0.0283702321442744,0.0391708307121727,0.753966747258053
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPACA5_SPACA5B,Sperm acrosome-associated protein 5,34952,0.00614469704484979,0.0196453889004446,-0.0323602652000216,0.0446496592897212,0.754457603493361
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGEF10,Rho guanine nucleotide exchange factor 10,34952,0.018346553616785,0.0587681565269284,-0.0968390331759946,0.133532140409565,0.754909962575088
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZPR1,Zinc finger protein ZPR1,34750,0.0190237090094665,0.0610073760818446,-0.100550748110949,0.138598166129882,0.755183047899151
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCSK7,Proprotein convertase subtilisin/kexin type 7,34949,-0.00879748756920399,0.0282780389906916,-0.0642224439909596,0.0466274688525516,0.755729716755301
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSTA3,Glutathione S-transferase A3,35800,0.0148844346823724,0.0479034353954222,-0.079006298692655,0.1087751680574,0.75602440250762
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PARD3,Partitioning defective 3 homolog,34869,0.0147069656620958,0.0474881768108059,-0.0783698608870837,0.107783792211275,0.756801361154036
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRP2BP,LRP2-binding protein,34805,-0.0153012847982132,0.0494503192248344,-0.112223910478889,0.0816213408824622,0.757006803199376
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTD,Biotinidase,34975,0.00404611593054691,0.0130966333731221,-0.0216232854807724,0.0297155173418662,0.757374823722651
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGF1R,Insulin-like growth factor 1 receptor,35937,-0.00409938673084358,0.0133041038308192,-0.0301754302392492,0.0219766567775621,0.757992549318666
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GP2,Pancreatic secretory granule membrane major glycoprotein GP2,35777,-0.0158577985368952,0.0516664459126277,-0.117124032525646,0.0854084354518552,0.758908264643233
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CERT,Ceramide transfer protein,35782,-0.0114170282745447,0.0373942789528173,-0.0847098150220667,0.0618757584729773,0.760135222813451
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TXNL1,Thioredoxin-like protein 1,34736,0.0197211859255724,0.064918047068615,-0.107518186328913,0.146960558180058,0.761301326633813
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL36G,Interleukin-36 gamma,34756,0.0126667422789951,0.0417227189690066,-0.0691097869002579,0.0944432714582481,0.761447937157355
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TYMP,Thymidine phosphorylase,35933,-0.0124407687544908,0.040987480260914,-0.0927762300658824,0.0678946925569007,0.761497594897474
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CYTL1,Cytokine-like protein 1,34965,-0.00491292722578604,0.0161862943054186,-0.0366380640644065,0.0268122096128344,0.761500554505909
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LATS1,Serine/threonine-protein kinase LATS1,34778,-0.0165105028659414,0.0544741459659733,-0.123279828959249,0.0902588232273664,0.761832403584048
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL16,C-X-C motif chemokine 16,36061,-0.00435918303312013,0.0143968080845966,-0.0325769268789294,0.0238585608126891,0.762059748051588
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRR4,Proline-rich protein 4,34780,-0.0134763202564115,0.0446497690753263,-0.100989867644051,0.0740372271312281,0.76279727187575
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,36061,-0.00520839821027494,0.0172906397411848,-0.0390980521029971,0.0286812556824472,0.763250208017229
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD33,Myeloid cell surface antigen CD33,35991,-0.014740728116438,0.0490073465775187,-0.110795127408375,0.0813136711754987,0.763586077227417
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APP,Amyloid-beta precursor protein,35961,0.0121526263868775,0.040645449229841,-0.0675124541036108,0.0918177068773658,0.764955299088117
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DIPK1C,Divergent protein kinase domain 1C,34805,-0.00811777623576125,0.027163474681928,-0.0613581866123401,0.0451226341408176,0.765065297937662
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZNF174,Zinc finger protein 174,34778,-0.00698253351900896,0.0234040205591593,-0.0528544138149611,0.0388893467769432,0.765447906332458
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HGFAC,Hepatocyte growth factor activator,34910,-0.00520073881066773,0.0174338028688007,-0.0393709924335171,0.0289695148121816,0.765473721367583
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),JAM2,Junctional adhesion molecule B,36043,0.00481600129035357,0.0161698237174828,-0.0268768531959126,0.0365088557766198,0.765834493701172
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,34952,0.00466195128394523,0.0156754978957282,-0.0260620245916821,0.0353859271595726,0.766168034396376
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMP2,Metalloproteinase inhibitor 2,34949,-0.00505323102645427,0.0169959589913078,-0.0383653106494176,0.0282588485965091,0.766232277834544
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REXO2,"Oligoribonuclease, mitochondrial",34736,-0.00923893865355105,0.0310998147763012,-0.0701945756151014,0.0517166983079993,0.766420259107721
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",34822,-0.0194131703391129,0.0654613758694705,-0.147717467043275,0.108891126365049,0.766812996280003
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OPTC,Opticin,35937,0.00830375346109665,0.0280763265706768,-0.0467258466174299,0.0633333535396232,0.767424486447193
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FCER2,Low affinity immunoglobulin epsilon Fc receptor,35979,-0.0093991000759536,0.0318369810338956,-0.071799582902389,0.0530013827504818,0.767829655276168
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLXNA4,Plexin-A4,35971,0.014538627212371,0.0493967246026574,-0.0822789530088376,0.11135620743358,0.768518845006324
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ESAM,Endothelial cell-selective adhesion molecule,36072,-0.00585401746095453,0.019893170967276,-0.0448446325568155,0.0331365976349064,0.768557693460093
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IMPA1,Inositol monophosphatase 1,35902,-0.010972991313367,0.0373369732902745,-0.0841534589623051,0.062207476335571,0.768849734806358
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAN2B2,Epididymis-specific alpha-mannosidase,34949,-0.0111415087833303,0.0379240409334367,-0.0854726290128663,0.0631896114462057,0.768931913307243
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEP1A,Meprin A subunit alpha,34964,-0.0139925659866633,0.0477207388966168,-0.107525214224032,0.0795400822507056,0.769365305293287
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBPL1,Insulin-like growth factor-binding protein-like 1,35972,-0.00609503157473692,0.0208096468718339,-0.0468819394435313,0.0346918762940575,0.769611019653135
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNST,Consortin,35972,0.0195738772944184,0.0668952972581189,-0.111540905331495,0.150688659920331,0.769832568131445
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PADI4,Protein-arginine deiminase type-4,35772,-0.0138055198664696,0.0472559493265745,-0.106427180546556,0.0788161408136164,0.77018533539465
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA9,Carbonic anhydrase 9,36032,0.00840595242422649,0.0288790438341731,-0.0481969734907528,0.0650088783392058,0.771002486281825
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,34822,0.00405516472046026,0.0139371988945001,-0.0232617451127599,0.0313720745536804,0.771091756498453
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL5,Interleukin-5,35842,-0.0245321629498516,0.0843808532145993,-0.189918635250466,0.140854309350763,0.771265085584515
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFX1,Transcriptional repressor NF-X1,34736,-0.0120394577210618,0.0415652940400594,-0.0935074340395782,0.0694285185974545,0.772092503899916
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOX9,Transcription factor SOX-9,34805,0.00500496029762199,0.0172906044285421,-0.0288846243823206,0.0388945449775646,0.772238085739353
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRSS8,Prostasin,35935,-0.00744603811758238,0.0258529802653886,-0.058117879437744,0.0432258032025793,0.773343630651114
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEGF9,Multiple epidermal growth factor-like domains protein 9,36049,0.00341365326094015,0.0118949337758123,-0.019900416939652,0.0267277234615323,0.774132708842004
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UHRF2,E3 ubiquitin-protein ligase UHRF2,34736,0.00609329748028464,0.0212330640380087,-0.0355235080342123,0.0477101029947816,0.774143354663486
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NECAP2,Adaptin ear-binding coat-associated protein 2,34736,0.0116811155791609,0.0407641083663882,-0.06821653681896,0.0915787679772818,0.774463566410237
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UBE2B,Ubiquitin-conjugating enzyme E2 B,34949,-0.00502962859328385,0.0176376572803057,-0.039599436862683,0.0295401796761153,0.775527640778087
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MFAP3,Microfibril-associated glycoprotein 3,35874,0.00827853838246088,0.0290568360639219,-0.048672860302826,0.0652299370677478,0.775722386189552
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,34869,0.0116625264938716,0.0410255433560262,-0.0687475384839396,0.0920725914716829,0.776209215994535
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIAA1549,UPF0606 protein KIAA1549,34869,0.0124677721044476,0.0439502363343649,-0.0736746911109077,0.0986102353198028,0.776665530401701
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINF1,Pigment epithelium-derived factor,34883,-0.00470983150412467,0.016640190259994,-0.037324604413713,0.0279049414054636,0.777155865128148
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINE2,Glia-derived nexin,34949,-0.0116251055693123,0.0410855355574168,-0.0921527552618491,0.0689025441232246,0.777225261532709
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASE10,Inactive ribonuclease-like protein 10,34815,-0.00841358867903115,0.029741143742059,-0.0667062304134669,0.0498790530554046,0.777267578260079
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",34736,-0.0152867376902461,0.0541813239531458,-0.121482132638412,0.0909086572579197,0.777845410276303
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLB,Beta-klotho,35782,-0.0131174931529275,0.0465406772829671,-0.104337220627543,0.078102234321688,0.778066596930412
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1GALT1C1,C1GALT1-specific chaperone 1,34736,-0.00574532516989491,0.0204639501564711,-0.0458546674765783,0.0343640171367885,0.778908954013266
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAD23B,UV excision repair protein RAD23 homolog B,35800,-0.00799619182545048,0.028544282400452,-0.0639429853303364,0.0479506016794354,0.779383612968415
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLB1,"Phospholipase B1, membrane-associated",34958,0.010276816431665,0.0367599215764202,-0.0617726298581186,0.0823262627214485,0.779819752053542
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,35896,-0.0191136807136402,0.0691058366653061,-0.15456112057764,0.11633375915036,0.782106141944428
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CENPJ,Centromere protein J,34869,-0.0124580872351506,0.0450637373495058,-0.100783012440182,0.0758668379698808,0.782207872574297
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,36043,-0.00592219949288141,0.0214538949446185,-0.0479718335843336,0.0361274345985708,0.782522632890879
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,34736,-0.00448885666232291,0.0162705819850284,-0.0363791973529786,0.0274014840283327,0.782643460056355
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THY1,Thy-1 membrane glycoprotein,36043,0.00483788023233506,0.0175511397695222,-0.0295623537159285,0.0392381141805986,0.782828556637293
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSHB,Thyrotropin subunit beta,35972,-0.0116895095800335,0.0424210922607181,-0.094834850411041,0.0714558312509739,0.782894602973662
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VEGFC,Vascular endothelial growth factor C,35991,-0.00943308084966001,0.0344312780423943,-0.0769183858127528,0.0580522241134328,0.784116591164211
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL9A2,Collagen alpha-2(IX) chain,34869,-0.00737158505926034,0.0270551080839612,-0.0603995969038244,0.0456564267853037,0.785273045832716
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSTT2B,Glutathione S-transferase theta-2B,34958,0.0405708568003951,0.150102260109971,-0.253629573015149,0.334771286615939,0.786947381543071
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,34815,-0.00438343661537241,0.0162349602184216,-0.0362039586434788,0.027437085412734,0.787169343300447
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BSG,Basigin,36056,-0.00330586937888143,0.012272173525632,-0.0273593294891201,0.0207475907313573,0.787645276408416
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFRAL,GDNF family receptor alpha-like,34784,-0.0105834767217955,0.0394003952782608,-0.0878082514671866,0.0666412980235957,0.788236109183856
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IPCEF1,Interactor protein for cytohesin exchange factors 1,35890,0.0147112614072012,0.0547950093402585,-0.0926869568997054,0.122109479714108,0.788338906912539
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFNA1,Ephrin-A1,35967,-0.00464857289075338,0.0173957389138635,-0.0387442211619259,0.0294470753804191,0.789303560980899
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,34949,-0.0126178263625628,0.0472891430874836,-0.105304546814031,0.080068894088905,0.789614186130661
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD164L2,CD164 sialomucin-like 2 protein,34805,-0.00600834158312135,0.0225427427549179,-0.0501921173827604,0.0381754342165177,0.789839082434338
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSAP,Prosaposin,34903,-0.00470233848188421,0.0176526453570775,-0.0393015233817561,0.0298968464179877,0.789954110503854
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP6V1G2,V-type proton ATPase subunit G 2,34736,0.0156946949714291,0.0589367053834818,-0.0998212475801951,0.131210637523053,0.790019076409115
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTUS1,Microtubule-associated tumor suppressor 1,34869,-0.0096253237743091,0.0361729484843393,-0.080524302803614,0.0612736552549958,0.790177286233512
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS8,Galectin-8,36043,-0.00983738747624935,0.0370939636172205,-0.0825415561660015,0.0628667812135028,0.790861320270217
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP290,Centrosomal protein of 290 kDa,34869,0.00869488964031416,0.0328091472830972,-0.0556110390345564,0.0730008183151847,0.791007242388349
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LGALS1,Galectin-1,35972,0.0057053835990127,0.0215294823283766,-0.0364924017646054,0.0479031689626308,0.791014338220939
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC12A2,Solute carrier family 12 member 2,34736,-0.00418422367568883,0.0157976504677459,-0.0351476185924708,0.0267791712410931,0.791123382948145
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC4A,C-type lectin domain family 4 member A,35971,-0.00589012406082443,0.0222442245134901,-0.0494888041072651,0.0377085559856162,0.791176017700223
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJC21,DnaJ homolog subfamily C member 21,34958,0.00663505940693422,0.0250676704198958,-0.0424975746160616,0.0557676934299301,0.791260004761615
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NRGN,Neurogranin,34966,-0.0153643883992795,0.0580730827648058,-0.129187630618299,0.0984588538197399,0.791349392627477
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNDP1,Beta-Ala-His dipeptidase,36026,0.00738579659033615,0.0279778924412763,-0.0474508725945654,0.0622224657752377,0.791797352248423
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHB4,Ephrin type-B receptor 4,36072,-0.00413021440108063,0.0156852157348039,-0.0348732372412962,0.026612808439135,0.792312022315891
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,34736,-0.00769863655620548,0.0293001149705137,-0.0651268618984123,0.0497295887860014,0.792751272508924
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),B2M,Beta-2-microglobulin,34975,-0.00536334655416377,0.0204188517274561,-0.0453842959399778,0.0346576028316502,0.792816193691494
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NID1,Nidogen-1,36000,-0.0058273835184059,0.0223606221444814,-0.0496542029215894,0.0379994358847776,0.794401156977044
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATRN,"Attractin, Isoform 2",34975,-0.00278011207468065,0.0106961216002982,-0.0237445104112651,0.0181842862619038,0.794935597310781
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OMP,Olfactory marker protein,34750,0.00780384890929077,0.0301674047092823,-0.0513242643209025,0.066931962139484,0.795887108990399
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,34739,0.0137102926178467,0.0530407511145313,-0.0902495795666345,0.117670164802328,0.796040502802352
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SUOX,"Sulfite oxidase, mitochondrial",34952,-0.0103139224027155,0.0399844910882477,-0.0886835249356809,0.0680556801302499,0.796455339883818
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,34949,-0.0164314117964776,0.0637341698468183,-0.141350384696241,0.108487561103286,0.796560624937441
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSRP3,Cysteine and glycine-rich protein 3,34736,-0.0157836787719072,0.0618616695408284,-0.137032551071931,0.105465193528116,0.798619871236917
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNAP23,Synaptosomal-associated protein 23,35972,0.0136143304537832,0.0536383711224034,-0.0915168769461275,0.118745537853694,0.799644017542672
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANKRD54,Ankyrin repeat domain-containing protein 54,35800,-0.00937126828209189,0.0369672123354851,-0.0818270044596427,0.0630844678954589,0.799887427971624
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAPRT,Nicotinate phosphoribosyltransferase,34958,-0.00532392456017609,0.0210223848215954,-0.0465277988105031,0.035879949690151,0.800083012943852
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD34,Hematopoietic progenitor cell antigen CD34,36024,0.00370878607385178,0.014645759258028,-0.0249969020718832,0.0324144742195867,0.800095362375978
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,34805,-0.00505940102688161,0.019980484442265,-0.0442211505337209,0.0341023484799577,0.800108814664305
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL21R,Interleukin-21 receptor,34778,-0.00887638674735285,0.0350698605287641,-0.0776133133837304,0.0598605398890247,0.800194842181436
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP1,Insulin-like growth factor-binding protein 1,36061,0.0194915844046848,0.077011213095431,-0.13145039326236,0.17043356207173,0.800197446670286
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC13A1,Solute carrier family 13 member 1,34949,-0.00945262438121879,0.0374178843984005,-0.0827916778020838,0.0638864290396462,0.800567605527998
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CST6,Cystatin-M,35786,0.00768376918713964,0.0304619585964531,-0.0520216696619084,0.0673892080361877,0.800861640384689
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCUN1D1,DCN1-like protein 1,34750,0.0119922104311685,0.0475587701218599,-0.0812229790076769,0.105207399870014,0.800929218066463
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FLT3,Receptor-type tyrosine-protein kinase FLT3,35800,-0.00466704856727457,0.0187038181879115,-0.0413265322155811,0.031992435081032,0.802962719152003
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA5,Plasma serine protease inhibitor,34892,0.00467525858961702,0.0187646291687503,-0.0321034145811337,0.0414539317603677,0.803250774849341
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RTKN2,Rhotekin-2,34736,0.00822215299132911,0.0330593813138354,-0.0565742343837882,0.0730185403664464,0.803594506755987
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF41,E3 ubiquitin-protein ligase NRDP1,35800,-0.0102782067911284,0.0413439959060674,-0.0913124387670205,0.0707560251847636,0.803675625885748
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RIPK4,Receptor-interacting serine/threonine-protein kinase 4,34736,-0.0106640274006772,0.043021949941625,-0.0949870492862622,0.0736589944849078,0.804240108972208
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TAFA5,Chemokine-like protein TAFA-5,35937,-0.00555248731905608,0.0224215873934662,-0.0494987986102499,0.0383938239721378,0.80441970159077
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOXO1,Forkhead box protein O1,35971,-0.0131132852056906,0.0529932986102234,-0.116980150481728,0.0907535800703472,0.804565509883785
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPNMB,Transmembrane glycoprotein NMB,35790,-0.00447817931730367,0.0181231143644769,-0.0399994834716783,0.031043124837071,0.804839692483144
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCN5,CCN family member 5,35979,-0.00569436281356671,0.0230502220872394,-0.050872798104556,0.0394840724774225,0.804882933307558
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD59,CD59 glycoprotein,35719,-0.00349780620205431,0.0141829367994369,-0.0312963623289507,0.0243007499248421,0.805208871940075
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFIC,Nuclear factor 1 C-type,34952,-0.00676269639224596,0.0274346832330088,-0.0605346755289432,0.0470092827444513,0.805301844477458
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NT5C3A,Cytosolic 5'-nucleotidase 3A,35961,-0.012949817709029,0.0525504129696957,-0.115948627129632,0.0900489917115745,0.805358916291423
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTH,Parathyroid hormone,34805,0.012717148945288,0.0517115055245176,-0.0886374018827665,0.114071699773342,0.805748470429867
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERP44,Endoplasmic reticulum resident protein 44,35927,0.00398850992846208,0.0162337782014373,-0.0278296953463551,0.0358067152032792,0.805927523423886
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRSS22,Brain-specific serine protease 4,34778,0.00577215512540211,0.023493334852406,-0.0402747811853136,0.0518190914361178,0.805927815269124
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GH2,Growth hormone variant,35800,0.0241259620156143,0.098385567634139,-0.168709750547298,0.216961674578527,0.806294235872168
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HEBP1,Heme-binding protein 1,35874,0.00802073250815772,0.0327950963992444,-0.0562576564343613,0.0722991214506768,0.806795448689532
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TST,Thiosulfate sulfurtransferase,35772,-0.0112693177619202,0.046129874020723,-0.101683870842537,0.0791452353186968,0.807009004850755
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REG4,Regenerating islet-derived protein 4,35966,0.00764240446416281,0.0313437494149967,-0.0537913443892308,0.0690761533175564,0.807372782895948
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRS,Receptor-type tyrosine-protein phosphatase S,36072,0.00376433864712819,0.0154439723902157,-0.0265058472376947,0.034034524531951,0.807437638919716
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENO1,Alpha-enolase,35965,-0.0117390877194062,0.0481717864565987,-0.10615578917434,0.0826776137355273,0.807476016603189
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASQ2,Calsequestrin-2,34736,0.00730055356677397,0.0300230975109361,-0.0515447175546608,0.0661458246882088,0.807886041239121
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRD1,Bromodomain-containing protein 1,34869,0.00459032566333559,0.0189375511155181,-0.0325272745230798,0.041707925849751,0.808483757439482
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",35927,-0.0116764024480598,0.0481954431251874,-0.106139470973427,0.0827866660773074,0.808576252527072
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CES2,Cocaine esterase,35937,0.00842777457198871,0.0348911171522285,-0.0599588150463792,0.0768143641903566,0.809139500980738
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAB39B,Ras-related protein Rab-39B,34736,-0.0139501206491277,0.0580958719924501,-0.12781802975433,0.0999177884560746,0.810243384903537
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIAA1549L,UPF0606 protein KIAA1549L,34869,-0.00431368724940274,0.0180505884581609,-0.0396928406273981,0.0310654661285926,0.811130723506103
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,34815,0.00642803940044334,0.0269031799856003,-0.0463021933713333,0.05915827217222,0.811165936073596
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CREB3,Cyclic AMP-responsive element-binding protein 3,34739,-0.00810696483236265,0.0339322404380436,-0.0746141560909281,0.0584002264262028,0.811178472495392
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),YAP1,Transcriptional coactivator YAP1,34958,-0.00426381600448848,0.0179761905864221,-0.0394971495538758,0.0309695175448988,0.812515164664299
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPM,Carboxypeptidase M,36001,0.00497032097517257,0.0210035583276863,-0.0361966533470925,0.0461372952974376,0.81294119678262
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSIG10,V-set and immunoglobulin domain-containing protein 10,34949,0.00516959956660511,0.0218632051754774,-0.0376822825773306,0.0480214817105408,0.813089542800187
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RLN1,Prorelaxin H1,34952,-0.00623307009011724,0.0264453973428543,-0.0580660488821118,0.0455999087018773,0.813676298180124
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1A,Interleukin-1 alpha,35842,0.00847218136434792,0.0361668735472939,-0.0624148907883481,0.0793592535170439,0.814795563847856
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,35749,-0.0119778850943189,0.0511989676331535,-0.1123278616553,0.088372091466662,0.815032213869679
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAGE2A,G antigen 2A,34739,0.00937785015779373,0.0401405162179711,-0.0692975616294296,0.088053261945017,0.815283480672008
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RBKS,Ribokinase,35794,-0.00739839245846122,0.0317391909660419,-0.0696072067519033,0.0548104218349808,0.815690703541824
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NARS1,"Asparagine--tRNA ligase, cytoplasmic",34952,-0.0068058140438721,0.0293725694633178,-0.0643760501919749,0.0507644221042307,0.816773478499107
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PVR,Poliovirus receptor,36043,-0.0053192693381466,0.0229629455442185,-0.0503266426048148,0.0396881039285216,0.816819518234344
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LPP,Lipoma-preferred partner,34736,-0.00961580835772447,0.0415431989382402,-0.0910404782766752,0.0718088615612263,0.81696107018068
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRLF1,Cytokine receptor-like factor 1,35992,0.00353614358661894,0.0152808521993198,-0.0264143267240479,0.0334866138972858,0.817002621841583
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZNF830,Zinc finger protein 830,34949,0.0113035696856271,0.0488506689959097,-0.0844437415463558,0.10705088091761,0.817019076883324
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARG1,Arginase-1,35909,0.00737433571408429,0.0319271700421805,-0.0552029175685895,0.0699515889967581,0.817341720365059
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC7A,C-type lectin domain family 7 member A,36067,-0.00867927822274595,0.0376446264343225,-0.0824627460340181,0.0651041895885262,0.817664341657389
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MENT,Protein MENT,34822,0.00342831908779857,0.0148707236850831,-0.0257182993349643,0.0325749375105615,0.817678591460821
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLXNB3,Plexin-B3,35950,-0.00682518884535062,0.02961688352831,-0.0648742805608383,0.051223902870137,0.817749101882751
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD69,Early activation antigen CD69,35939,0.0124633561273606,0.0544164069720015,-0.0941928015377622,0.119119513792483,0.818846747260299
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPSAB1,Tryptase alpha/beta-1,36058,0.00740827678490097,0.0329263782693369,-0.0571274246229993,0.0719439781928012,0.821989179190445
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYBPC2,"Myosin-binding protein C, fast-type",34815,0.0122014035594603,0.0543241681774711,-0.094273966068383,0.118676773187304,0.822295050196056
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FDX2,"Ferredoxin-2, mitochondrial",34736,-0.00785855860884972,0.0349952541444802,-0.0764492567320308,0.0607321395143314,0.822328521534425
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX4,Probable ATP-dependent RNA helicase DDX4,34778,-0.00764632942229794,0.0340655514124187,-0.0744148101906387,0.0591221513460428,0.822407364814771
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANPEP,Aminopeptidase N,36012,0.00374466442216666,0.0166851744400432,-0.0289582774803181,0.0364476063246514,0.822428415566699
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,34822,-0.0121576446471142,0.0543884969863394,-0.118759098740339,0.0944438094461111,0.823127744142766
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SULT2A1,Bile salt sulfotransferase,35971,-0.00810907867006547,0.0363206658385333,-0.0792975837135908,0.0630794263734599,0.823336626448812
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDKN1A,Cyclin-dependent kinase inhibitor 1,35937,-0.0148466903232393,0.0665077180218308,-0.145201817646028,0.115508436999549,0.823360701212009
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPK1,Thiamin pyrophosphokinase 1,34949,0.00387277856986503,0.0173741180786618,-0.030180492864312,0.0379260500040421,0.823616580542154
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TF,Serotransferrin,34975,-0.00306606012407677,0.0137919717507253,-0.0300983247554983,0.0239662045073448,0.824081558400674
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLXDC1,Plexin domain-containing protein 1,35800,0.00454010174227733,0.0204740393922243,-0.0355890154664822,0.0446692189510369,0.824515420547151
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLHL41,Kelch-like protein 41,34952,0.00718269667382623,0.0324347861175494,-0.0563894841165705,0.070754877464223,0.82474886370092
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DPT,Dermatopontin,36072,-0.00343063611790429,0.0154920099264662,-0.033794975573778,0.0269337033379694,0.824751607319274
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNMA2,Paraneoplastic antigen Ma2,34750,0.00653743359133635,0.0295441826957083,-0.051369164492252,0.0644440316749247,0.824884486332918
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFT20,Intraflagellar transport protein 20 homolog,34805,-0.00610835227993958,0.027728154590856,-0.0604555352780173,0.0482388307181382,0.825649266060703
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINF2,Alpha-2-antiplasmin,34853,0.00188717290966318,0.00856965519363577,-0.0149093512698629,0.0186836970891893,0.825710332305731
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GIPC2,PDZ domain-containing protein GIPC2,34958,-0.00430759289612222,0.0195627272526287,-0.0426505383112745,0.03403535251903,0.825727229097766
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPB1,Carboxypeptidase B,36072,0.00825613438680332,0.0376027340892522,-0.0654452244281309,0.0819574932017375,0.826218226595034
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OBP2B,Odorant-binding protein 2b,35875,0.00780025687922476,0.0355716066572332,-0.0619200921689524,0.0775206059274019,0.826435574655881
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCAM1,Neural cell adhesion molecule 1,36026,0.00441622499752749,0.0201989545361132,-0.0351737258932544,0.0440061758883094,0.826939369537722
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KYNU,Kynureninase,36067,-0.00609505801035736,0.0279893421750376,-0.060954168673431,0.0487640526527162,0.827619310164697
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL2RB,Interleukin-2 receptor subunit beta,35842,-0.00509174605387867,0.0234176073093583,-0.0509902563802209,0.0408067642724636,0.827877525784162
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PODXL2,Podocalyxin-like protein 2,35991,0.00378380829081312,0.0174272307662731,-0.0303735640110822,0.0379411805927084,0.828120465536008
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,36032,0.0035187495748562,0.0162461430247482,-0.0283236907536502,0.0353611899033626,0.828533946269721
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSPB6,Heat shock protein beta-6,36032,0.0054236758129276,0.0250885532427214,-0.0437498885428063,0.0545972401686615,0.828852369860157
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAPGEF2,Rap guanine nucleotide exchange factor 2,34869,-0.00709041192531218,0.0328201388482161,-0.0714178840678158,0.0572370602171914,0.828964805202052
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GNPDA1,Glucosamine-6-phosphate isomerase 1,34815,0.00473595648973922,0.0219246328026154,-0.0382363238033869,0.0477082367828654,0.828986452918177
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL2A1,Collagen alpha-1(II) chain,34815,0.0106496693745893,0.0493887284283669,-0.0861522383450099,0.107451577094188,0.829283594510251
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHA1,Ephrin type-A receptor 1,35977,0.00424698827273228,0.0197108767236137,-0.0343863301055506,0.0428803066510152,0.829411377830586
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TACSTD2,Tumor-associated calcium signal transducer 2,35121,0.00401781911703781,0.0186837783348496,-0.0326023864192673,0.040638024653343,0.829740377537586
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COMMD9,COMM domain-containing protein 9,34949,-0.00516552361605101,0.0241137420481,-0.0524284580303271,0.0420974107982251,0.830386331373837
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",34799,-0.0106846181975515,0.0498852271874425,-0.108459663484939,0.0870904270898359,0.830410606389346
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL27,C-C motif chemokine 27,35972,0.00832929604706356,0.0389897389307336,-0.0680905922571744,0.0847491843513015,0.830843148275051
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TP53,Cellular tumor antigen p53,35800,-0.00566258429490535,0.0266466554322678,-0.0578900289421503,0.0465648603523396,0.831718016363297
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGAP25,Rho GTPase-activating protein 25,35800,-0.00801315733459203,0.0378004452496278,-0.0821020300238626,0.0660757153546785,0.832124118941037
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SESTD1,SEC14 domain and spectrin repeat-containing protein 1,35782,0.00824039493312431,0.0390215305176186,-0.0682418048814082,0.0847225947476569,0.832756245020338
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEPE,Matrix extracellular phosphoglycoprotein,35949,-0.00309664505810769,0.0146828894228009,-0.0318751083267975,0.0256818182105821,0.832969893127468
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),APOB,Apolipoprotein B-100,34966,-0.00303961659441934,0.0144878867001925,-0.0314358745267966,0.0253566413379579,0.833827364081664
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF19,Fibroblast growth factor 19,35992,0.0100982709326225,0.0483340628574538,-0.0846364922679869,0.104833034133232,0.834511303184296
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL5,C-X-C motif chemokine 5,35945,-0.0147079097515544,0.070429805737606,-0.152750328997262,0.123334509494153,0.834586149755271
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYOM2,Myomesin-2,34736,0.00743424112690154,0.0356957902547762,-0.0625295077724598,0.0773979900262629,0.83502771592828
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGACT,Gamma-glutamylaminecyclotransferase,34949,-0.00927350993181775,0.0445309939305803,-0.0965542580357551,0.0780072381721196,0.835041669287665
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GP5,Platelet glycoprotein V,34822,0.00482471800598835,0.0231799709785674,-0.0406080251120038,0.0502574611239805,0.835125159618874
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRI1,Methylthioribose-1-phosphate isomerase,34805,0.00874258289875252,0.0421343784573892,-0.0738407988777304,0.0913259646752354,0.835631773483074
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL31RA,Interleukin-31 receptor subunit alpha,34756,0.00505789992402992,0.0243797692078959,-0.042726447723446,0.0528422475715058,0.835655152360196
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BGN,Biglycan,35790,-0.0148695781815956,0.0720098112564687,-0.156008808244274,0.126269651881083,0.836411069160141
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGFBP3,Fibroblast growth factor-binding protein 3,34958,-0.00483299642482661,0.0234143335892104,-0.0507250902596789,0.0410590974100257,0.83647580736544
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DBH,Dopamine beta-hydroxylase,34957,0.0145346604968516,0.0707114513951054,-0.124059784237555,0.153129105231258,0.837149884669957
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMY2A,Pancreatic alpha-amylase,35685,0.00618555621446599,0.0301407567364281,-0.0528903269889331,0.0652614394178651,0.837404322377101
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",34805,-0.0098480563842181,0.0483039789351208,-0.104523855097055,0.0848277423286186,0.838456530138374
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VWA1,von Willebrand factor A domain-containing protein 1,36023,0.00535256441668008,0.0263545068860636,-0.0463022690800045,0.0570073979133647,0.839063504059934
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLF4,Krueppel-like factor 4,34750,0.00563581933849969,0.0278861779495382,-0.0490210894425951,0.0602927281195945,0.839844594077625
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHCY,Adenosylhomocysteinase,35972,-0.00827899996425097,0.041032543522311,-0.0887027852679806,0.0721447853394787,0.840104700539677
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINA4,Kallistatin,34862,0.00298646674234822,0.0148203687259739,-0.0260614559605606,0.0320343894452571,0.84030560493152
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF16,Fibroblast growth factor 16,34778,-0.00578141904952678,0.0287028505105684,-0.0620390060502409,0.0504761679511873,0.840374333067228
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPB2,Carboxypeptidase B2,34969,0.00288473122538309,0.0143688324372852,-0.0252781803516959,0.0310476428024621,0.840890234298876
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,36067,0.0048140372458268,0.0240101883069358,-0.0422459318357674,0.051874006327421,0.841095197888863
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GBP6,Guanylate-binding protein 6,34736,0.00532091835933605,0.0267169215003922,-0.0470442477814326,0.0576860845001047,0.842144881440818
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,34964,-0.0149661321802618,0.0752491258028398,-0.162454418753828,0.132522154393304,0.842356875866408
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RGMA,Repulsive guidance molecule A,36043,-0.00390037500078548,0.0196355855562168,-0.0423861226909704,0.0345853726893994,0.842551289472582
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA11,Annexin A11,35961,-0.00806353991276283,0.040663469205903,-0.0877639395563328,0.0716368597308071,0.842816328576071
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MBL2,Mannose-binding protein C,34893,0.013865623334657,0.0700129886304472,-0.123359834381019,0.151091081050333,0.843017359177367
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHCHD6,MICOS complex subunit MIC25,34949,-0.00363121434583787,0.0183769634317645,-0.0396500626720963,0.0323876339804206,0.843367495338168
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCDC2C,Doublecortin domain-containing protein 2C,34739,-0.00759852431239669,0.0384900424198784,-0.0830390074553583,0.067841958830565,0.843509072135602
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX6,Syntaxin-6,35800,0.00785300938414237,0.0400823324476006,-0.0707083622131548,0.0864143809814395,0.844676772886319
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYL1,"Myosin light chain 1/3, skeletal muscle isoform",34736,0.00502880850304033,0.0257062184794585,-0.0453553797166983,0.055412996722779,0.844909270064749
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CELA2A,Chymotrypsin-like elastase family member 2A,34965,-0.00789964484844661,0.0404539873444136,-0.0871894600434973,0.0713901703466041,0.845184046059717
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP5F1D,"ATP synthase subunit delta, mitochondrial",34736,-0.00622557856726103,0.0319683438651642,-0.0688835325429829,0.0564323754084609,0.84560139336238
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,34869,-0.00631596670907386,0.0325951031676767,-0.0702023689177201,0.0575704354995724,0.846361930253727
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MME,Neprilysin,35937,-0.00926561473159719,0.048205634057512,-0.103748657484321,0.0852174280211263,0.847582873104546
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRYBB2,Beta-crystallin B2,34958,-0.00849417163380021,0.0443546367929904,-0.0954292597480614,0.078440916480461,0.848135426827925
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,35782,-0.0130354129789898,0.0685125593471993,-0.1473200292995,0.121249203341521,0.84910833269177
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GUSB,Beta-glucuronidase,36007,0.00719724808171992,0.0379327772100271,-0.0671509952499333,0.0815454914133731,0.849520492183163
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ELAVL4,ELAV-like protein 4,34750,-0.0101040985388072,0.0532726702072003,-0.11451853214492,0.0943103350673055,0.849575884861607
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FXYD5,FXYD domain-containing ion transport regulator 5,35842,0.00762282708305184,0.0402432242885598,-0.0712538925225254,0.0864995466886291,0.849769824621484
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRELD2,Protein disulfide isomerase CRELD2,35979,-0.00602350502505357,0.0318821912017351,-0.0685125997804543,0.0564655897303472,0.850152811305153
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MPHOSPH8,M-phase phosphoprotein 8,35874,-0.00883559107813894,0.0468367382032792,-0.100635597956566,0.0829644158002882,0.850375075333501
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MGLL,Monoglyceride lipase,35979,-0.0102156858441157,0.0542840466555718,-0.116612417289036,0.0961810456008051,0.850733303362522
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRK1,Protein BRICK1,35782,0.00516669627996823,0.027532231421709,-0.0487964773065815,0.0591298698665179,0.851148554380556
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,35800,-0.00386272823135284,0.0206681020584318,-0.0443722082658791,0.0366467518031734,0.851749617656802
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",35937,-0.00485065267058787,0.025968794407534,-0.0557494897093546,0.0460481843681789,0.851832216578503
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PSCA,Prostate stem cell antigen,34964,-0.0304866614314516,0.163775614279628,-0.351486865419522,0.290513542556619,0.852333875706297
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,35941,-0.00311416513250131,0.0167653542862112,-0.0359742595334753,0.0297459292684727,0.852645921391099
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATXN10,Ataxin-10,35782,0.0082688126072644,0.0446377760564105,-0.0792212284633002,0.095758853677829,0.853044077483786
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLAT,Tissue-type plasminogen activator,36049,0.00590552510800177,0.0319213380739724,-0.0566602975169841,0.0684713477329877,0.853232166298282
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,34949,-0.00514703767463167,0.0278369988750063,-0.059707555469644,0.0494134801203807,0.853314036590304
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GCG,Pro-glucagon,35800,0.0141557416268082,0.0765630222775904,-0.135907782037269,0.164219265290885,0.85332047663621
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLG,Plasminogen,34814,-0.00245864024001682,0.0133758538501733,-0.0286753137863565,0.0237580333063229,0.854167068862461
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMN,Protein amnionless,35842,0.00537936903301434,0.029278732080715,-0.052006945845187,0.0627656839112157,0.854230749277819
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZBP1,Z-DNA-binding protein 1,34778,0.00478347652409886,0.0260555743538513,-0.0462854492094497,0.0558524022576474,0.854343131927761
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA13,Carbonic anhydrase 13,35872,-0.0121081899993922,0.0659728813771907,-0.141415037498686,0.117198657499902,0.854385074027753
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENO3,Beta-enolase,34815,-0.00721407020725589,0.0393244615191648,-0.0842900147848189,0.0698618743703071,0.854450976519355
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTRL,Chymotrypsin-like protease CTRL-1,34958,-0.00795259421248362,0.0434369030453507,-0.0930889241813711,0.0771837357564038,0.854738087315504
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC37,Hsp90 co-chaperone Cdc37,35991,-0.00943676076180834,0.0515745671542135,-0.110522912384067,0.0916493908604502,0.85482410861175
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGSF8,Immunoglobulin superfamily member 8,35972,-0.00347673367328171,0.0190645774868886,-0.0408433055475834,0.03388983820102,0.85530039999327
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PLIN3,Perilipin-3,35972,0.004771624011311,0.0263412838701087,-0.046857292374102,0.056400540396724,0.856257785911339
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",35878,-0.00458051195071886,0.0253107081246909,-0.054189499875113,0.0450284759736753,0.856395136299662
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAA4,Serum amyloid A-4 protein,34975,0.00381341746893064,0.021090060601097,-0.0375231013092195,0.0451499362470808,0.856517860714733
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GLRX,Glutaredoxin-1,35927,-0.00643822525624137,0.0356294695855405,-0.0762719856439007,0.0633955351314179,0.85660849482437
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),XRCC4,DNA repair protein XRCC4,35782,-0.00407757409243332,0.0225828251790418,-0.0483399114433553,0.0401847632584887,0.856717383011697
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFHR5,Complement factor H-related protein 5,34875,-0.00478991076367865,0.0265705927691518,-0.0568682725912162,0.0472884510638589,0.856945541097556
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLK14,Kallikrein-14,36032,-0.00510183071618337,0.028364380279042,-0.0606960160631056,0.0504923546307389,0.857261478842165
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAFB2,Scaffold attachment factor B2,34952,0.00315154240331861,0.0175874211700508,-0.031319803089981,0.0376228878966182,0.857791891210713
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRC1,Protein regulator of cytokinesis 1,34949,0.0049066365769499,0.0273958179777483,-0.0487891666594369,0.0586024398133367,0.857863590672423
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCDC80,Coiled-coil domain-containing protein 80,35972,-0.00391954939103137,0.0219020761649181,-0.0468476186742709,0.0390085198922081,0.857975682659771
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPR101,Probable G-protein coupled receptor 101,34750,-0.00611756806839258,0.0343123785954399,-0.0733698301154548,0.0611346939786697,0.858500781742547
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF5,Fibroblast growth factor 5,35842,0.00370410909848549,0.0209585517182086,-0.0373746522692034,0.0447828704661744,0.859721509897036
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL9,Interleukin-9,34869,0.00585504659118344,0.03326470414039,-0.059343773523981,0.0710538667063479,0.860288795257444
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TOP1MT,"DNA topoisomerase I, mitochondrial",34739,-0.00530162432369999,0.0302478752062624,-0.0645874597279743,0.0539842110805744,0.860871205536956
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC4A1,Band 3 anion transport protein,34965,-0.00538985826622453,0.0307799769503825,-0.0657186130889742,0.0549388965565252,0.860999370465074
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SELPLG,P-selectin glycoprotein ligand 1,35971,0.00296796707349856,0.0170011155651788,-0.0303542194342519,0.0362901535812491,0.8614185122554
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NINJ1,Ninjurin-1,35800,-0.00577519765834355,0.0331392264195405,-0.070728081440643,0.0591776861239559,0.86165758958647
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GFAP,Glial fibrillary acidic protein,35791,0.00503424303111579,0.0289461868558871,-0.051700283206423,0.0617687692686546,0.861935341929483
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPO,Erythropoietin,35971,0.00784248100956442,0.0451764731201385,-0.0807034063059071,0.0963883683250359,0.862187290733397
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SARG,Specifically androgen-regulated gene protein,34927,-0.0119343562303292,0.0692510615095581,-0.147666436789063,0.123797724328405,0.8631799708727
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ASS1,Argininosuccinate synthase,34736,0.00839292507588014,0.0489077966845216,-0.0874663564257823,0.104252206577543,0.863752085453801
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GID8,Glucose-induced degradation protein 8 homolog,34952,0.00362515012424016,0.0211628614386898,-0.0378540582955918,0.0451043585440721,0.863995121633247
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CASP10,Caspase-10,35782,-0.00737261026384449,0.0433675880778415,-0.0923730828964139,0.0776278623687249,0.865012743565771
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NAA10,N-alpha-acetyltransferase 10,34736,0.00537464761182713,0.0316349192814757,-0.0566297941798652,0.0673790894035194,0.86509749389854
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRISP3,Cysteine-rich secretory protein 3,34902,0.0029451952472008,0.0173616267441429,-0.0310835931713193,0.0369739836657209,0.865300117343918
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARHGAP30,Rho GTPase-activating protein 30,34869,-0.00427060074268337,0.0252804902579026,-0.0538203616481726,0.0452791601628058,0.865858162238718
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCARA5,Scavenger receptor class A member 5,36043,-0.00313298427467816,0.0185677328915532,-0.0395257407421224,0.0332597721927661,0.866011457413745
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDKN2D,Cyclin-dependent kinase 4 inhibitor D,35937,-0.00973749921877728,0.057990467861983,-0.123398816228264,0.103923817790709,0.866654373056017
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,34975,-0.00256927099963744,0.0153716831952993,-0.0326977700624241,0.0275592280631492,0.867262744186247
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPON2,Spondin-2,35941,0.00355837211590768,0.0213055451466633,-0.0382004963715524,0.0453172406033677,0.867361868085082
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CXCL3,C-X-C motif chemokine 3,35958,0.00989352460405812,0.0594402518001775,-0.10660936892429,0.126396418132406,0.867811443622441
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TEX101,Testis-expressed protein 101,34805,-0.00634412365951418,0.0384207194820748,-0.0816487338443808,0.0689604865253525,0.868852975242905
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TBC1D23,TBC1 domain family member 23,35937,-0.00922422035478951,0.0558810238905265,-0.118751027180222,0.100302586470642,0.868894281890297
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIF22,Kinesin-like protein KIF22,34736,-0.0128358592830141,0.0783595414950316,-0.166420560613276,0.140748842047248,0.869888296394208
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EFCAB2,Dynein regulatory complex protein 8,34869,0.00362592847389478,0.022240247566365,-0.0399649567561806,0.0472168137039702,0.870496496550115
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADH1B,All-trans-retinol dehydrogenase,34822,-0.00792807713488993,0.0486864388541515,-0.103353497289027,0.0874973430192469,0.870650066332617
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HEPACAM2,HEPACAM family member 2,34958,-0.00444509085200044,0.0273368208756477,-0.05802525976827,0.0491350780642691,0.870834989162043
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PGLYRP2,N-acetylmuramoyl-L-alanine amidase,34893,0.00297634328574841,0.0183902096642268,-0.0330684676561362,0.039021154227633,0.871433975959107
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOD2,"Superoxide dismutase [Mn], mitochondrial",35979,-0.00388332782451842,0.0240746791914115,-0.0510696990396849,0.0433030433906481,0.871858854363924
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",35782,-0.0053041603176081,0.0329259707832662,-0.0698390630528099,0.0592307424175937,0.872024280054982
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STK4,Serine/threonine-protein kinase 4,35972,0.00872514764761761,0.0542745343074703,-0.0976529395950242,0.115103234890259,0.872287220027683
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VASH1,Tubulinyl-Tyr carboxypeptidase 1,35971,-0.00820261155582903,0.0510796323256345,-0.108318690914073,0.0919134678024146,0.872424843114991
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP10,Stromelysin-2,35942,0.00550167368736468,0.0344518910842324,-0.0620240328377309,0.0730273802124602,0.873128500685025
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,36043,-0.00447095903706707,0.0281853907666655,-0.0597143249397314,0.0507724068655973,0.873967196996082
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNN,Tenascin-N,34965,0.00429589719407391,0.0272124800493941,-0.0490405637027384,0.0576323580908863,0.874568213880537
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAP3K5,Mitogen-activated protein kinase kinase kinase 5,35800,-0.00946701429697801,0.0600832831737479,-0.127230249317524,0.108296220723568,0.874804111042461
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLITRK2,SLIT and NTRK-like protein 2,36032,-0.00395673961400169,0.0252866834373937,-0.0535186391512933,0.0456051599232899,0.875662692225217
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTBS,Di-N-acetylchitobiase,34876,0.00266864033859191,0.0171438710737331,-0.0309333469659251,0.0362706276431089,0.876304867913843
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,35874,-0.00298247537309407,0.0192958992634041,-0.040802437929366,0.0348374871831779,0.877168360325272
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD14,Monocyte differentiation antigen CD14,35840,0.00396290277198661,0.0256419483450851,-0.0462953159843801,0.0542211215283534,0.877182253727239
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLINT1,Clathrin interactor 1,34739,0.00470734098400107,0.0305070966500206,-0.0550865684500393,0.0645012504180414,0.877375789200531
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL24,Interleukin-24,35842,0.00452036906262474,0.0293079032659388,-0.0529231213386154,0.0619638594638648,0.877427006208281
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FIS1,Mitochondrial fission 1 protein,35956,-0.00729596961225563,0.0473460601188585,-0.100094247445218,0.085502308220707,0.877536085695939
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TMPRSS15,Enteropeptidase,35937,0.00826256343615467,0.0538788950919244,-0.0973400709440171,0.113865197816326,0.878123052417624
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC4G,C-type lectin domain family 4 member G,35971,0.00314231014951168,0.020578300343267,-0.0371911585232915,0.0434757788223149,0.87863889904296
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GC,Vitamin D-binding protein,34975,-0.00251169740435278,0.0164863737151777,-0.034824989886101,0.0298015950773955,0.878915790115115
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYZL2,Lysozyme-like protein 2,34739,0.00355332040929792,0.0233470358936335,-0.0422068699422238,0.0493135107608196,0.879037521268683
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LIPF,Gastric triacylglycerol lipase,34815,-0.00593057857926075,0.0391241853237186,-0.0826139818137493,0.0707528246552278,0.879520415740262
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTRC,Chymotrypsin-C,35952,-0.00592153626050355,0.0391560266355194,-0.0826673484661216,0.0708242759451145,0.879799032258722
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMOC2,SPARC-related modular calcium-binding protein 2,35992,-0.00361234175251681,0.0238985716561641,-0.0504535421985984,0.0432288586935648,0.879859117949254
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYOC,Myocilin,35979,0.00414412626527748,0.0274664085528845,-0.0496900344983761,0.0579782870289311,0.880074658471107
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GDF2,Growth/differentiation factor 2,35972,0.00327432327302846,0.0218456554275566,-0.0395431613649825,0.0460918079110395,0.88085990851987
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MORC3,MORC family CW-type zinc finger protein 3,34958,-0.00255467184888165,0.0170632599807132,-0.0359986614110796,0.0308893177133163,0.880992100585289
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),QDPR,Dihydropteridine reductase,35938,-0.003895563043204,0.0260713317063395,-0.0549953731876293,0.0472042471012213,0.881226801656962
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,34869,-0.00620228084756241,0.0417931282301655,-0.0881168121786869,0.0757122504835621,0.882028462674343
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDHR2,Cadherin-related family member 2,35937,-0.00610060662965029,0.0412150145295319,-0.0868820351075327,0.0746808218482322,0.882331814378256
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COPE,Coatomer subunit epsilon,35782,0.0042554718465452,0.0288095931289147,-0.0522113306861276,0.060722274379218,0.88257559824724
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DCUN1D2,DCN1-like protein 2,34739,-0.00749387943096597,0.0507700254201562,-0.107003129254472,0.0920153703925402,0.882659825247955
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FASLG,Tumor necrosis factor ligand superfamily member 6,36067,0.00331104972424734,0.0225626603889918,-0.0409117646381767,0.0475338640866713,0.88333403692571
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ING1,Inhibitor of growth protein 1,35776,-0.00427476418498955,0.0291618813243399,-0.0614320515806957,0.0528825232107166,0.88346182207941
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GET3,ATPase GET3,34949,0.00484580776641022,0.0331323823555385,-0.0600936616504453,0.0697852771832657,0.883723988880514
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT6C,"Keratin, type II cytoskeletal 6C",34736,0.00331056064458927,0.0226494165848881,-0.0410822958617914,0.04770341715097,0.883795634012645
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA4,Annexin A4,35942,-0.00649354932579083,0.0444539622723697,-0.0936233153796355,0.0806362167280538,0.883867314553532
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKAP12,A-kinase anchor protein 12,34822,-0.00184401634793338,0.012631865785071,-0.0266024732866725,0.0229144405908057,0.883940869755597
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UXS1,UDP-glucuronic acid decarboxylase 1,35800,-0.00463488783094936,0.0319263629796962,-0.067210559271154,0.0579407836092553,0.884577309453036
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAGED1,Melanoma-associated antigen D1,35800,-0.00423862642191155,0.0293553629733376,-0.0617751378496532,0.0532978850058301,0.885196404507012
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C19orf12,Protein C19orf12,35782,-0.00594657417715788,0.0411882182305775,-0.0866754819090898,0.0747823335547741,0.88520792546893
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDH23,Cadherin-23,34958,-0.0024272214970805,0.0168737879124648,-0.0354998458055115,0.0306454028113506,0.885626889278703
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MARS1,"Methionine--tRNA ligase, cytoplasmic",34811,-0.00772610154665943,0.0537220494153838,-0.113021318400812,0.0975691153074928,0.88565026782846
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MEGF11,Multiple epidermal growth factor-like domains protein 11,34736,0.00298344113369307,0.0207540387479245,-0.037694474812239,0.0436613570796251,0.885700778682577
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CST1,Cystatin-SN,34110,-0.00928960458115768,0.0648104607949131,-0.136318107739187,0.117738898576872,0.886030890857107
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SAG,S-arrestin,34750,-0.0048769315624841,0.034032709849295,-0.0715810428671024,0.0618271797421342,0.886056923988565
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAD1,Glutamate decarboxylase 1,34739,-0.00240815076923792,0.0168165787885369,-0.0353686451947703,0.0305523436562944,0.886136146007116
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RAP1A,Ras-related protein Rap-1A,34778,-0.00630718539346671,0.0441221499911196,-0.0927865993760611,0.0801722285891276,0.886335690945709
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VWC2L,von Willebrand factor C domain-containing protein 2-like,34952,-0.00406095488868827,0.0284517837985864,-0.0598264511339177,0.0517045413565411,0.886507067364844
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTS,6-pyruvoyl tetrahydrobiopterin synthase,35745,-0.00493388931298988,0.0346566121401188,-0.0728608491076228,0.062993070481643,0.886795704253571
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HSPB1,Heat shock protein beta-1,35863,0.00620459651075852,0.0436060278931912,-0.0792632181598961,0.0916724111814132,0.886856797166198
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF21,Fibroblast growth factor 21,36023,-0.0106036132170192,0.0748011090470295,-0.157213786949197,0.136006560515159,0.887275454786412
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",34815,0.00331279393297231,0.0234366749174377,-0.0426230889052056,0.0492486767711503,0.887597361155219
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTA,Lymphotoxin-alpha,35971,-0.00347608910343761,0.0246459642982466,-0.051782179128001,0.0448300009211258,0.8878414821066
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,35673,-0.00326060897397571,0.0232299746319443,-0.0487913592525865,0.0422701413046351,0.888377865618298
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BPIFA2,BPI fold-containing family A member 2,34583,0.00976978688053225,0.0696240992336323,-0.126693447617387,0.146233021378452,0.888410374140906
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPTX1,Neuronal pentraxin-1,35979,-0.00355009281029843,0.0253726637440805,-0.0532805137486962,0.0461803281280993,0.888728584120868
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD7,T-cell antigen CD7,34768,-0.00385690164330471,0.0276792835503709,-0.0581082974020317,0.0503944941154223,0.889184025920118
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ESPL1,Separin,34739,-0.00476322860783077,0.0342104252071614,-0.0718156620138671,0.0622892047982056,0.889270403635273
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,35972,0.00707058977590413,0.0510858038664153,-0.0930575858022698,0.107198765354078,0.889923211770195
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNLIPRP2,Pancreatic lipase-related protein 2,35949,-0.0253267868605841,0.183014510935996,-0.384035228295135,0.333381654573967,0.889938544729667
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGFR2,Fibroblast growth factor receptor 2,35991,-0.00191109849540431,0.0138099753863949,-0.0289786502527383,0.0251564532619297,0.889939632126952
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFB,Complement factor B,34865,-0.00287657818214825,0.0208749727647094,-0.0437915248009787,0.0380383684366822,0.890402650185214
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD207,C-type lectin domain family 4 member K,35786,-0.00331804563918625,0.0241342568068407,-0.050621188980594,0.0439850977022215,0.890653024708585
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COLEC12,Collectin-12,35949,-0.0022377393472862,0.0163995612731238,-0.0343808794426089,0.0299054007480365,0.891468360522346
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEMIP2,Cell surface hyaluronidase,34778,0.0028076617776703,0.0205950846372964,-0.0375587041114306,0.0431740276667712,0.891567388128138
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SOST,Sclerostin,35962,-0.00326820647055912,0.023990070171934,-0.0502887440075497,0.0437523310664315,0.89164189246581
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGM2,Protein-glutamine gamma-glutamyltransferase 2,35962,-0.00636367488017434,0.0467388460417331,-0.0979718131219711,0.0852444633616224,0.891703362693649
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,35937,0.00350239156989556,0.0259037997529051,-0.0472690559457984,0.0542738390855895,0.892451417572016
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUOM,Fucose mutarotase,34822,0.00537234005948164,0.040714908969452,-0.0744288815206442,0.0851735616396075,0.895027954572923
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NPHS1,Nephrin,34778,-0.00289017279032224,0.0219216610196545,-0.0458566283888451,0.0400762828082006,0.895114382700095
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPXM1,Probable carboxypeptidase X1,35991,0.00555344993862425,0.0428784161815474,-0.0784882457772087,0.0895951456544572,0.896952723872235
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DUSP13,Dual specificity protein phosphatase 13 isoform A,34949,-0.00355686029156011,0.0274846451014854,-0.0574267646904714,0.0503130441073512,0.897035251385446
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FUT8,"Alpha-(1,6)-fucosyltransferase",35902,-0.00460521551806078,0.0356714249713358,-0.074521208461879,0.0653107774257574,0.897281311183127
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSPAN15,Tetraspanin-15,34736,0.00386182790558417,0.0300039453321159,-0.054945904945363,0.0626695607565314,0.897590810535841
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",34739,0.00435063941744823,0.0338752374343989,-0.0620448259539736,0.0707461047888701,0.897811901256694
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIF1C,Kinesin-like protein KIF1C,34736,-0.00293486022984006,0.0229011091880233,-0.0478210342383657,0.0419513137786856,0.89803159657056
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SKAP2,Src kinase-associated phosphoprotein 2,35992,-0.00812783013767205,0.0637225868060521,-0.133024100277534,0.11676844000219,0.898508395295157
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SULT1A1,Sulfotransferase 1A1,36043,0.0101149388086972,0.0793127429649202,-0.145338037402546,0.165567915019941,0.898522532691691
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CANT1,Soluble calcium-activated nucleotidase 1,35949,-0.00156456327933442,0.0122914237702671,-0.025655753869058,0.0225266273103892,0.898715133373332
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FZD8,Frizzled-8,34750,-0.00346227726040789,0.027285288021493,-0.0569414417825341,0.0500168872617183,0.899030244599344
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGFBP6,Insulin-like growth factor-binding protein 6,35966,0.00243883427016678,0.0192913294514802,-0.0353721714547344,0.040249839995068,0.899401920726029
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,34778,-0.00383277797045289,0.0304509593432475,-0.063516658283218,0.0558511023423122,0.899841116903396
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAPKAPK2,MAP kinase-activated protein kinase 2,34869,0.00581674979854107,0.0462540988141515,-0.0848412838771958,0.0964747834742779,0.899928773552014
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRHR1,Corticotropin-releasing factor receptor 1,35874,0.0046632328127884,0.0371424427711232,-0.0681359550186131,0.0774624206441899,0.90009163221484
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UPB1,Beta-ureidopropionase,34949,0.00729299607338258,0.0581581089671474,-0.106696897502226,0.121282889648991,0.900211277536983
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VGF,Neurosecretory protein VGF,34952,-0.00239751916426953,0.0191813056144873,-0.0399928781686646,0.0351978398401256,0.900533450594211
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NBL1,Neuroblastoma suppressor of tumorigenicity 1,35991,0.00206133141794118,0.0165402362716458,-0.0303575316744845,0.0344801945103669,0.90082361066522
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DKK1,Dickkopf-related protein 1,36043,-0.00453725767231935,0.0366788115834193,-0.0764277283758211,0.0673532130311824,0.901554237517354
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPHA4,Ephrin type-A receptor 4,34822,-0.00225580387530815,0.0182813978052547,-0.0380873435736074,0.0335757358229911,0.901799566856128
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LHB,Lutropin subunit beta,35800,0.0067089963484072,0.0546910804913653,-0.100485521414669,0.113903514111483,0.902371243703612
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AOC1,Amiloride-sensitive amine oxidase [copper-containing],35842,-0.00442165139097326,0.0361211312049639,-0.0752190685527026,0.0663757657707561,0.902576318785232
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,34559,0.00406266762494768,0.0334712789933711,-0.0615410392020597,0.0696663744519551,0.903395953505238
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",34736,-0.00491437433965414,0.0405363204306175,-0.0843655623836645,0.0745368137043563,0.903509780184888
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TREH,Trehalase,34965,-0.00572313107185841,0.0474278040553733,-0.09868162702039,0.0872353648766732,0.90395593077368
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FOSB,Protein fosB,35782,-0.00293888808298735,0.0244480411959135,-0.0508570488269778,0.0449792726610031,0.904320513605216
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRD3,Bromodomain-containing protein 3,34736,0.00355750991229364,0.0296011207229941,-0.0544606867047749,0.0615757065293622,0.90434323161982
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPM1A,Protein phosphatase 1A,35800,0.00238313459402898,0.0198363162761704,-0.0364960453072649,0.0412623144953229,0.904375616237507
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACTA2,"Actin, aortic smooth muscle",35874,0.00318751484313537,0.0267109200732603,-0.0491658885004548,0.0555409181867256,0.905014223978315
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKT1S1,Proline-rich AKT1 substrate 1,35782,0.00475927585097799,0.0404297063689626,-0.0744829486321888,0.0840015003341447,0.906294950928086
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRPL52,"39S ribosomal protein L52, mitochondrial",34725,-0.00188232911472736,0.0160036839596868,-0.0332495496757134,0.0294848914462587,0.90637381166909
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPL,Periplakin,34778,-0.00244595135070317,0.0208337901322213,-0.0432801800098568,0.0383882773084505,0.90654445146602
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EP300,Histone acetyltransferase p300,34778,-0.00225957599030833,0.0193071889378939,-0.0401016663085803,0.0355825143279636,0.906837799615878
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HDDC2,5'-deoxynucleotidase HDDC2,34964,0.00324895234404965,0.0277914033117881,-0.0512221981470549,0.0577201028351542,0.906939072175875
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ENAH,Protein enabled homolog,35842,-0.00340472610128925,0.029251889613962,-0.0607384297446548,0.0539289775420763,0.907344014548936
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PCBD1,Pterin-4-alpha-carbinolamine dehydratase,34807,-0.00358265766255263,0.0310014582013147,-0.0643455157371294,0.0571802004120241,0.908001702242231
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LYN,Tyrosine-protein kinase Lyn,35937,-0.00611141906873148,0.0528987238516577,-0.109792917817981,0.0975700796805177,0.908027762710967
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TTF2,Transcription termination factor 2,34805,0.00371712592872739,0.0322794829156864,-0.0595506605860179,0.0669849124434726,0.908326432371076
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TCL1A,T-cell leukemia/lymphoma protein 1A,35893,-0.0072652476946951,0.063480506780005,-0.131687040983505,0.117156545594115,0.908885433184163
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GPR158,Probable G-protein coupled receptor 158,34952,-0.00243512657308436,0.0215374792888037,-0.0446485859791396,0.0397783328329709,0.909982909653578
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDA,Cytidine deaminase,34940,0.00342471388247395,0.0303272723036446,-0.0560167398326695,0.0628661675976173,0.910093417182643
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LIFR,Leukemia inhibitory factor receptor,35971,-0.00167504304474752,0.0148436311644926,-0.0307685601271531,0.0274184740376581,0.910155794019123
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FMR1,Synaptic functional regulator FMR1,35800,-0.00246343365962639,0.0218525425843163,-0.0452944171248863,0.0403675498056335,0.910247884735822
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFBR2,TGF-beta receptor type-2,35991,0.00232794106872523,0.0206761009845076,-0.0381972168609097,0.0428530989983602,0.910357947991464
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAD2,Glutamate decarboxylase 2,34778,-0.00313377247965446,0.0278954126317481,-0.0578087812378807,0.0515412362785718,0.910557425005231
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KLRB1,Killer cell lectin-like receptor subfamily B member 1,36067,-0.00264619309988282,0.023579977229326,-0.0488629484693619,0.0435705622695962,0.910650372284434
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKR7L,Aflatoxin B1 aldehyde reductase member 4,34778,-0.00492436958205203,0.0438832488653489,-0.0909355373581359,0.0810867981940319,0.910656386337567
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VPS53,Vacuolar protein sorting-associated protein 53 homolog,35937,-0.00537566696963336,0.0480770494581992,-0.0996066839077038,0.0888553499684371,0.910974279176357
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRRN1,Leucine-rich repeat neuronal protein 1,35842,0.002764261819266,0.0249708145998806,-0.0461785347964999,0.0517070584350319,0.911857547151189
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,36026,0.00288378299337485,0.0262075414532154,-0.0484829982549274,0.0542505642416771,0.912383496309202
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTGDS,Prostaglandin-H2 D-isomerase,35938,-0.00207961965096477,0.0190359435933355,-0.0393900690939023,0.0352308297919728,0.913009573246279
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDGFRB,Platelet-derived growth factor receptor beta,36072,0.00234233363184362,0.021464710383619,-0.0397284987200495,0.0444131659837368,0.913106383226796
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SKAP1,Src kinase-associated phosphoprotein 1,35896,0.00476364524531988,0.0440441523883605,-0.0815628934358666,0.0910901839265064,0.91387481486577
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",34952,-0.00436146565394122,0.0403422310705323,-0.0834322385521846,0.0747093072443022,0.913910531976414
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BDNF,Brain-derived neurotrophic factor,34965,-0.00572004163236381,0.0529236360098294,-0.109450368211629,0.0980102849469017,0.9139348144204
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DSG3,Desmoglein-3,36004,0.00233554403435401,0.021632446002841,-0.0400640501312143,0.0447351381999223,0.914026491215607
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,35874,-0.0023963577069247,0.0222576854938767,-0.046021421274923,0.0412287058610736,0.914264973678383
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCP2,Non-specific lipid-transfer protein,35800,-0.00497083206102091,0.0462049865381478,-0.0955326056757905,0.0855909415537487,0.914330149963701
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BATF,Basic leucine zipper transcriptional factor ATF-like,34805,-0.00567884576983087,0.0529822420119379,-0.109524040113229,0.0981663485735675,0.914646516421821
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BCL7B,B-cell CLL/lymphoma 7 protein family member B,34949,-0.00306610871866956,0.0286751588715099,-0.0592694201068289,0.0531372026694898,0.914851377899325
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PALM2,Paralemmin-2,34958,0.00267903636207564,0.0251161955364856,-0.0465487068894361,0.0519067796135873,0.915057566839197
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CTF1,Cardiotrophin-1,35874,-0.00550416623183138,0.0517779125024478,-0.106988874736629,0.0959805422729664,0.915344594749881
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL17A,Interleukin-17A,35826,-0.00286473309928002,0.0270497718567679,-0.0558822859385451,0.0501528197399851,0.915659874379215
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),REPS1,RalBP1-associated Eps domain-containing protein 1,34778,0.00268024090850756,0.0253271580357599,-0.0469609888415819,0.052321470658597,0.915724811872129
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HYOU1,Hypoxia up-regulated protein 1,36072,0.00148140643833379,0.0140056884363864,-0.0259697428969836,0.0289325557736512,0.915766275671993
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCN4B,Sodium channel subunit beta-4,34815,-0.00291054062763762,0.0275688260502307,-0.0569454396860898,0.0511243584308145,0.915924066960016
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VCAN,Versican core protein,36043,0.00193640427290487,0.0185158398261044,-0.0343546417862598,0.0382274503320695,0.916711142811329
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC26,Anaphase-promoting complex subunit CDC26,34950,-0.00455062094309033,0.0435295722308826,-0.0898685825156201,0.0807673406294395,0.916743409017408
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CDC27,Cell division cycle protein 27 homolog,35800,-0.00392781093370595,0.0375727754920987,-0.0775704508982194,0.0697148290308075,0.916744731554209
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TFPI,Tissue factor pathway inhibitor,35978,-0.00197521247331957,0.0189281443168872,-0.0390743753344184,0.0351239503877793,0.91689189546681
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEDD9,Enhancer of filamentation 1,34778,0.00229126183640596,0.0219896594385459,-0.0408084706631441,0.045390994335956,0.917016205990502
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL1A1,Collagen alpha-1(I) chain,36072,-0.00148307328813343,0.0144340637911049,-0.029773838318699,0.0268076917424322,0.91816561841812
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP1,"Fatty acid-binding protein, liver",35949,-0.00600584893793551,0.0586459346803496,-0.120951880911421,0.10894018303555,0.918435140005983
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NEFL,Neurofilament light polypeptide,35756,-0.00293180275884838,0.0288531127660856,-0.0594839037803762,0.0536202982626794,0.919068043915441
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SETMAR,Histone-lysine N-methyltransferase SETMAR,35878,-0.00192052469085333,0.0189283221426755,-0.0390200360904974,0.0351789867087907,0.919185708346235
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ITM2A,Integral membrane protein 2A,35971,-0.00382462143877617,0.0378298842612973,-0.0779711945909189,0.0703219517133666,0.91947340520484
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL20,Interleukin-20,35842,-0.00310915669924895,0.0308191495165346,-0.0635146897516567,0.0572963763531588,0.919645398467017
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NCS1,Neuronal calcium sensor 1,36032,-0.00175000824619845,0.0173531585593648,-0.0357621990225534,0.0322621825301565,0.919674899029482
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DBN1,Drebrin,34778,0.00324250512838475,0.0322208429807565,-0.0599103471138979,0.0663953573706674,0.919844448064791
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MMP1,Interstitial collagenase,35734,0.00573385986193738,0.0571343795499004,-0.106249524055867,0.117717243779742,0.920063379976062
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FABP3,"Fatty acid-binding protein, heart",34949,-0.00341100684008359,0.0340649548737557,-0.0701783183926448,0.0633563047124776,0.920242347767625
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GABARAP,Gamma-aminobutyric acid receptor-associated protein,34949,0.00298766543189289,0.0298878623221841,-0.0555925447195879,0.0615678755833737,0.920377253194353
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,34952,0.00163749318241853,0.0163894262070519,-0.0304857821834032,0.0337607685482403,0.920417689652923
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SERPINI1,Neuroserpin,34811,-0.00180322200193935,0.0181164325393607,-0.0373114297790862,0.0337049857752075,0.920716585572778
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CKB,Creatine kinase B-type,34965,0.0036668356616892,0.0368879523088091,-0.0686335508635766,0.075967222186955,0.920820085307415
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BMP4,Bone morphogenetic protein 4,35890,-0.00285252890323872,0.0287368758827554,-0.0591768056334393,0.0534717478269619,0.920931620909628
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLSTN2,Calsyntenin-2,36067,-0.00243825204478661,0.0245691083695016,-0.0505937044490098,0.0457172003594365,0.9209499364847
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CBS,Cystathionine beta-synthase,34815,-0.00329318200686774,0.0331912442090501,-0.0683480206566059,0.0617616566428705,0.920968069065857
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCAMP3,Secretory carrier-associated membrane protein 3,35937,-0.00505389691513744,0.0517780613695226,-0.106538897199402,0.0964311033691269,0.922247098269683
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EIF5A,Eukaryotic translation initiation factor 5A-1,35842,-0.00178290292817817,0.0183698928620628,-0.0377878929378213,0.034222087081465,0.92268484163065
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RELB,Transcription factor RelB,34778,-0.00287729973998277,0.0297104540630956,-0.0611097897036502,0.0553551902236846,0.92285287386548
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACAN,Aggrecan core protein,35901,-0.00161173134505095,0.0167993360077327,-0.034538429920207,0.0313149672301051,0.923570714684132
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HBQ1,Hemoglobin subunit theta-1,36032,0.00370333946339343,0.039011147112371,-0.0727585088768537,0.0801651878036406,0.924372757377044
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TP53I3,Quinone oxidoreductase PIG3,34668,-0.00313703484019221,0.0333555445531088,-0.0685139021642855,0.062239832483901,0.92507383259213
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP112,Centrosomal protein of 112 kDa,34736,-0.00273803712289169,0.0291301590757154,-0.0598331489112938,0.0543570746655104,0.925117620394879
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MN1,Transcriptional activator MN1,34805,-0.003386239989603,0.0361096600359625,-0.0741611736600896,0.0673886936808836,0.925289673402195
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MDH1,"Malate dehydrogenase, cytoplasmic",34930,0.00232998467417979,0.025137664136715,-0.0469398370337816,0.0515998063821411,0.926153578097508
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCRN1,Secernin-1,35971,-0.0031668696759094,0.0342455499727138,-0.0702881476224285,0.0639544082706097,0.926322877673971
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DLGAP5,Disks large-associated protein 5,34952,0.00275978775272291,0.030083743616953,-0.056204349736505,0.0617239252419508,0.926910014792442
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFHR2,Complement factor H-related protein 2,34929,0.00331703346331442,0.0362275165968659,-0.0676888990665427,0.0743229659931716,0.927049608866533
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ANXA5,Annexin A5,35755,-0.001662514625241,0.0183742416025807,-0.0376760281662992,0.0343509989158172,0.927907746331158
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GJA8,Gap junction alpha-8 protein,34739,0.00355378258198295,0.0393636142548086,-0.0735989013574419,0.0807064665214078,0.92806694181652
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DNAJA1,DnaJ homolog subfamily A member 1,34739,-0.00267556743464079,0.029672510374414,-0.0608336877684922,0.0554825528992106,0.928155141017127
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ADIPOQ,Adiponectin,34975,-0.00395716496342293,0.044159963922205,-0.0905106942509446,0.0825963643240988,0.928600121742064
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AAMDC,Mth938 domain-containing protein,34815,-0.00292512559482078,0.0327518288964901,-0.0671187102319413,0.0612684590422998,0.928836974803508
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ABO,Histo-blood group ABO system transferase,34966,-0.00803986907336009,0.0913262962422357,-0.187039409708142,0.170959671561422,0.929851987618659
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KITLG,Kit ligand,35972,0.00205699465516676,0.0233663165726379,-0.0437409858272036,0.0478549751375371,0.929853256955421
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1RL,Complement C1r subcomponent-like protein,34959,-0.00107397996822685,0.0122550100555736,-0.0250937996771511,0.0229458397406974,0.930168753847101
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ZCCHC8,Zinc finger CCHC domain-containing protein 8,34736,-0.00334523664897554,0.0386283838110819,-0.079056868918696,0.0723663956207449,0.930991908601256
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SPTBN2,"Spectrin beta chain, non-erythrocytic 2",34750,0.00167424914220161,0.019697522033832,-0.0369328940441092,0.0402813923285124,0.932265781152599
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LCAT,Phosphatidylcholine-sterol acyltransferase,34966,-0.00118766333885925,0.0140049901227112,-0.0286374439793731,0.0262621173016546,0.932420779495366
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",34805,0.00285632703794113,0.0337189373563794,-0.0632327901805625,0.0689454442564447,0.932494776256538
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C9,Complement component C9,34966,-0.00305558885946406,0.0363824507495898,-0.0743651923286601,0.0682540146097319,0.933070807804583
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRPEL1,"GrpE protein homolog 1, mitochondrial",35937,-0.00317097338310133,0.0378511498452873,-0.0773592270798645,0.0710172803136618,0.933237751375945
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BTN1A1,Butyrophilin subfamily 1 member A1,34936,0.00204579764049328,0.0244208345034215,-0.0458190379862128,0.0499106332671994,0.933239852606695
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BRAP,BRCA1-associated protein,34899,0.00569714161146864,0.0691574741485168,-0.129851507719624,0.141245790942562,0.93434774479771
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PON1,Serum paraoxonase/arylesterase 1,34966,-0.00141244639880451,0.017302110220324,-0.0353245824306395,0.0324996896330305,0.934940057078765
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KRT8,"Keratin, type II cytoskeletal 8",34750,0.00431192102989424,0.0534167405542152,-0.100384890456367,0.109008732516156,0.935665445226421
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ERBIN,Erbin,35937,-0.0050934159983989,0.0633646091035932,-0.129288049841441,0.119101217844644,0.935935107824186
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARID4B,AT-rich interactive domain-containing protein 4B,35782,0.00212283869274403,0.0264320356540016,-0.0496839511890991,0.0539296285745872,0.935990478195159
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),FGF20,Fibroblast growth factor 20,34778,0.00230280228592844,0.028708924296635,-0.0539666893354762,0.0585722939073331,0.936071187570428
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NXPH1,Neurexophilin-1,35782,0.00179210145327367,0.0226926492757443,-0.0426854911271851,0.0462696940337324,0.937056479082509
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ODAM,Odontogenic ameloblast-associated protein,35772,-0.00261675667978708,0.0332157088543749,-0.0677195460343619,0.0624860326747877,0.937209256060979
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),F2,Prothrombin,34975,-0.000729327425359553,0.00936606985088444,-0.0190868243330931,0.0176281694823739,0.937934623557952
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGH,Gamma-glutamyl hydrolase,35862,-0.00160645493697358,0.0210009253300845,-0.0427682685839392,0.0395553587099921,0.939027809834872
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HIF1A,Hypoxia-inducible factor 1-alpha,34778,-0.00299186171431942,0.0391967479932564,-0.0798174877811019,0.0738337643524631,0.939159559410103
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GRAP2,GRB2-related adapter protein 2,35972,-0.00610948285289312,0.0801440504060834,-0.163191821648817,0.15097285594303,0.939237172726388
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,34869,0.00404830651798492,0.0534958999309157,-0.10080365734661,0.10890027038258,0.939680016939836
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PACS2,Phosphofurin acidic cluster sorting protein 2,34736,-0.00293542842625827,0.0388962207444666,-0.0791720210854128,0.0733011642328963,0.939844644839984
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RALB,Ras-related protein Ral-B,34778,0.00141785925244599,0.0188786862802194,-0.0355843658567841,0.038420084361676,0.940134633027449
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEP20,Centrosomal protein 20,35800,-0.00347584864263984,0.0467861448474547,-0.0951766925436511,0.0882249952583714,0.940779895985904
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,34736,-0.000969228725535538,0.013079258707962,-0.026604575793141,0.0246661183420699,0.940929844931687
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ELOB,Elongin-B,34736,-0.00174583627363942,0.0241289453831163,-0.0490385692245473,0.0455468966772685,0.942322201426307
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IFNGR1,Interferon gamma receptor 1,35992,0.000956567475753222,0.0132687630288119,-0.0250502080607182,0.0269633430122246,0.94253089432611
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EGF,Pro-epidermal growth factor,35937,0.00462348054890779,0.0644679930338879,-0.121733785797512,0.130980746895328,0.942828717626224
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRUNE2,Protein prune homolog 2,34869,-0.00124239430283707,0.0175994806894257,-0.0357373764541115,0.0332525878484373,0.94372419738735
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MED18,Mediator of RNA polymerase II transcription subunit 18,35800,0.00330060436893221,0.0473822251884334,-0.0895685570003973,0.0961697657382617,0.944466910362772
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SIGLEC9,Sialic acid-binding Ig-like lectin 9,36022,-0.00130707917662219,0.0188116479414258,-0.0381779091418168,0.0355637507885724,0.944607482528798
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SFTPA2,Pulmonary surfactant-associated protein A2,35800,-0.00218812101317278,0.0315761799348542,-0.0640774336854869,0.0597011916591414,0.944755479034121
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLC27A4,Long-chain fatty acid transport protein 4,35782,0.00285394678529967,0.0412602512442284,-0.078016145653388,0.0837240392239873,0.944856706370385
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100G,Protein S100-G,34952,-0.00210269354576225,0.0305480694104665,-0.0619769095902767,0.0577715224987522,0.945125282620405
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KCNH2,Potassium voltage-gated channel subfamily H member 2,34805,-0.00323914712550639,0.0475345078242061,-0.0964067824609504,0.0899284882099376,0.945673943545047
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ISM2,Isthmin-2,34965,0.00189920154614128,0.0278867118880648,-0.0527587537544658,0.0565571568467484,0.945704844967565
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IDS,Iduronate 2-sulfatase,36067,0.000365138095875928,0.00537441790943061,-0.0101687210066081,0.0108989971983599,0.945835194777985
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL28,C-C motif chemokine 28,35939,-0.00246726844427223,0.0364064319174397,-0.0738238750024541,0.0688893381139096,0.945970471961491
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CFP,Properdin,34975,-0.000916533551459189,0.0135871384602684,-0.0275473249335853,0.025714257830667,0.946220831508211
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),DDX1,ATP-dependent RNA helicase DDX1,34964,0.002059659765332,0.0305569472693467,-0.0578319568825876,0.0619512764132516,0.94626222077878
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MAMDC4,Apical endosomal glycoprotein,34949,0.00237376121316334,0.0357569517161814,-0.0677098641505523,0.0724573865768789,0.947072601411521
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RICTOR,Rapamycin-insensitive companion of mTOR,34778,-0.00202511665878286,0.0305363225055948,-0.0618763087697487,0.0578260754521829,0.947126568707534
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,36026,0.00170888340295781,0.0265641404028976,-0.0503568317867215,0.0537745985926372,0.948708830694381
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,35902,0.00204878654576308,0.0322386572634306,-0.0611389816905609,0.0652365547820871,0.949329793988207
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIFBP,KIF-binding protein,35937,-0.00325145801464323,0.0512108987509311,-0.103624819566468,0.0971219035371818,0.949376837962928
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,34736,0.00186815288694154,0.0298955994448081,-0.0567272220248823,0.0604635277987653,0.950175276464635
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PPP1R2,Protein phosphatase inhibitor 2,35972,-0.00310711572311182,0.0498360731489874,-0.100785819095127,0.0945715876489034,0.950288413458963
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,35979,-0.00282764807779635,0.0468816877459946,-0.0947157560599457,0.089060459904353,0.951906744162023
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLSTN1,Calsyntenin-1,35782,0.0018433333696616,0.0310293012211419,-0.0589740970237764,0.0626607637630996,0.952630214988337
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AHSP,Alpha-hemoglobin-stabilizing protein,35962,-0.00303698811861215,0.051168154527543,-0.103326570992596,0.0972525947553721,0.952672486268109
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TSNAX,Translin-associated protein X,34736,0.00148590519459024,0.0254557832240976,-0.0484074299246411,0.0513792403138216,0.953454211491526
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AIFM1,"Apoptosis-inducing factor 1, mitochondrial",35925,-0.00360649582775543,0.064715485030083,-0.130448846486718,0.123235854831207,0.955559628249687
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MTR,Methionine synthase,34736,0.00226686095471544,0.040894358127449,-0.0778860809750846,0.0824198028845154,0.955796012079349
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TGFB2,Transforming growth factor beta-2 proprotein,34949,0.00180292807535944,0.0325644616213203,-0.0620234167024284,0.0656292728531472,0.955849502835388
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),THBS4,Thrombospondin-4,36000,-0.00154506988828628,0.0280764056942568,-0.0565748250490297,0.0534846852724571,0.956115331646934
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CEND1,Cell cycle exit and neuronal differentiation protein 1,34750,-0.00213473811616584,0.0389736402946068,-0.0785230730935951,0.0742535968612634,0.95632037640816
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),UNC79,Protein unc-79 homolog,34739,0.00189518329759046,0.0352748486168254,-0.0672435199913874,0.0710338865865683,0.957155062728477
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRYGD,Gamma-crystallin D,34958,0.00327403482894102,0.0612383238402203,-0.116753079897891,0.123301149555773,0.957364035172096
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNLIPRP1,Inactive pancreatic lipase-related protein 1,34958,-0.00270251376033519,0.0518863638784814,-0.104399786962159,0.0989947594414884,0.958462409347946
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRDX2,Peroxiredoxin-2,34858,-0.00207407190972018,0.03985681878908,-0.080193436736317,0.0760452929168767,0.958500020247853
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BPIFB2,BPI fold-containing family B member 2,34936,-0.00202032184521246,0.0388972401724031,-0.0782589125831225,0.0742182688926976,0.958578155815339
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CLEC11A,C-type lectin domain family 11 member A,35973,0.00152366375495358,0.029632959360506,-0.0565569365916382,0.0596042641015453,0.958993935525878
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),STX7,Syntaxin-7,34778,0.00158977269430296,0.0309402420234651,-0.0590531016716887,0.0622326470602946,0.959022758530224
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TPRKB,EKC/KEOPS complex subunit TPRKB,34739,-0.00197987294101156,0.0389403337492422,-0.0783029270895263,0.0743431812075031,0.959451675516578
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNF149,E3 ubiquitin-protein ligase RNF149,34815,-0.000989154067258899,0.0197608001910564,-0.0397203224417293,0.0377420143072116,0.960079070659286
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NFASC,Neurofascin,36067,0.000877008730720608,0.0178578360791016,-0.0341243499843186,0.0358783674457598,0.960832483510491
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA7,Carbonic anhydrase 7,34869,-0.00108795685727909,0.0221766746131235,-0.0445542390990012,0.0423783253844431,0.960874149977024
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CRH,Corticoliberin,35788,0.00259408697171947,0.0532509403510543,-0.101777756116347,0.106965930059786,0.961148262922281
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,34778,0.00174317454771716,0.0358184499100312,-0.0684609872759439,0.0719473363713782,0.961186291512031
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GSTM4,Glutathione S-transferase Mu 4,34736,-0.00217334387767679,0.0449566874296815,-0.0902884512398525,0.085941763484499,0.961444410380803
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGSF9,Protein turtle homolog A,34949,0.00262931191356981,0.0545796630262689,-0.104346827617917,0.109605451445057,0.961579214454814
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NECTIN2,Nectin-2,35962,-0.000889453384799137,0.018826372544674,-0.0377891435723602,0.0360102368027619,0.962319184367584
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LTO1,Protein LTO1 homolog,35842,0.00116539501541265,0.0250648002199784,-0.047961613415745,0.0502924034465703,0.962916774513038
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,34958,-0.00251866936943101,0.0544345561670134,-0.109210399456777,0.104173060717915,0.96309676026023
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CHMP1A,Charged multivesicular body protein 1a,35902,0.00219914421296852,0.0487164950595347,-0.0932851861037195,0.0976834745296565,0.963995617376703
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MVK,Mevalonate kinase,35842,0.00229239559103501,0.0508998919163833,-0.0974713925650763,0.102056183747146,0.964078790153491
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",35842,0.00316863009934591,0.0723851018314569,-0.13870616949031,0.145043429689001,0.965085267337161
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MRC1,Macrophage mannose receptor 1,34966,-0.000794041596924523,0.0184847675161559,-0.0370241859285901,0.035436102734741,0.965737527626556
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SDC4,Syndecan-4,35972,0.00121717341692983,0.0290653356152795,-0.055750884389018,0.0581852312228777,0.966597766222685
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RTBDN,Retbindin,35937,-0.000768535113629498,0.0185561039773872,-0.0371384989093084,0.0356014286820494,0.966964718140146
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,34736,0.000918832300212326,0.0222871377078134,-0.0427639576071019,0.0446016222075265,0.967116253458607
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NME3,Nucleoside diphosphate kinase 3,35966,-0.000614147340494666,0.01500125173778,-0.0300166007465434,0.0287883060655541,0.967345045891165
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TACC3,Transforming acidic coiled-coil-containing protein 3,35937,0.00296961986713869,0.0725931510747328,-0.139312956239338,0.145252195973615,0.967370580732591
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TYRO3,Tyrosine-protein kinase receptor TYRO3,35972,0.000704243940873088,0.0175109262506527,-0.0336171715104061,0.0350256593921523,0.967920894014143
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),COL3A1,Collagen alpha-1(III) chain,34965,-0.000582442827141238,0.0147438395376007,-0.0294803683208385,0.028315482666556,0.968489684994937
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL11,Eotaxin,36067,0.000880740124606649,0.0231247118686462,-0.0444436951379399,0.0462051753871532,0.969619705991897
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AKR1B1,Aldo-keto reductase family 1 member B1,35800,-0.00167009598532363,0.0452195923260016,-0.0903004969442868,0.0869603049736396,0.970539437589702
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PRKAB1,5'-AMP-activated protein kinase subunit beta-1,35842,0.00120816680043562,0.0335483057089879,-0.0645465123891806,0.0669628459900519,0.971273183784081
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CSF2RB,Cytokine receptor common subunit beta,34778,-0.000968400471670262,0.0269121098267509,-0.0537161357321021,0.0517793347887616,0.971296424226318
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),C2,Complement C2,36014,-0.000486333509096557,0.0135558538305899,-0.0270558070170527,0.0260831399988596,0.971381981147761
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAPS,Calcyphosin,34958,-0.00205219328443687,0.057936421409225,-0.115607579246518,0.111503192677644,0.971744775844716
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA1,Carbonic anhydrase 1,35839,-0.00128513118120756,0.0362845124938698,-0.0724027756691924,0.0698325133067773,0.971747269499637
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BABAM1,BRISC and BRCA1-A complex member 1,34778,0.000640219047434123,0.0182526011512544,-0.0351348792090245,0.0364153173038927,0.972020673529612
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GCLM,Glutamate--cysteine ligase regulatory subunit,34736,-0.000912178857099517,0.0275856319786653,-0.0549800175352834,0.0531556598210844,0.973622096328618
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PALM3,Paralemmin-3,34736,-0.00158259133677586,0.0481935808782558,-0.0960420098581572,0.0928768271846055,0.973804668789764
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,35949,0.000587865141201615,0.0182310209844899,-0.0351449359883986,0.0363206662708018,0.974277288923577
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD22,B-cell receptor CD22,36067,-0.00081818699273625,0.0261252277797232,-0.0520236334409938,0.0503872594555213,0.975016860783061
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PDCD1LG2,Programmed cell death 1 ligand 2,35937,0.000602961625636535,0.0195370132480081,-0.0376895843404594,0.0388955075917325,0.975380013151497
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CPA1,Carboxypeptidase A1,36072,-0.00119584063061713,0.0390266207547626,-0.0776880173099518,0.0752963360487176,0.975556132423121
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EXOSC10,Exosome component 10,34736,-0.00113675534457783,0.0373048343342361,-0.0742542306396805,0.0719807199505249,0.975691562798234
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACSL1,Long-chain-fatty-acid--CoA ligase 1,34736,-0.000684990232356386,0.0228818460866176,-0.0455334085621268,0.044163428097414,0.976119093262506
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),POLR2A,DNA-directed RNA polymerase II subunit RPB1,34778,-0.000545628674876929,0.0186896026823647,-0.0371772499323118,0.036085992582558,0.976710621121944
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SCG3,Secretogranin-3,35966,0.00058631984752882,0.0202159999439294,-0.0390370400425729,0.0402096797376305,0.976863172980197
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL7R,Interleukin-7 receptor subunit alpha,35979,0.000909326331465051,0.0315518655437718,-0.0609323301343278,0.0627509827972579,0.977008889595534
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMBP,Protein AMBP,36022,0.000354105860895625,0.0123263962490452,-0.0238056307872329,0.0245138425090242,0.977082740434784
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CA3,Carbonic anhydrase 3,36061,-0.00105297302817434,0.0375664333552714,-0.0746831824045063,0.0725772363481576,0.977639272991377
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAM,Peptidyl-glycine alpha-amidating monooxygenase,36053,-0.000479998870978544,0.0174193576677501,-0.0346219398997688,0.0336619421578117,0.978017422743189
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SLK,STE20-like serine/threonine-protein kinase,34869,0.00136297855144469,0.04951319217968,-0.0956828781207282,0.0984088352236176,0.978039815621285
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTPRN2,Receptor-type tyrosine-protein phosphatase N2,35882,-0.000562454854354773,0.0206264582993269,-0.0409903131210355,0.039865403412326,0.978246240078921
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PAK4,Serine/threonine-protein kinase PAK 4,35782,-0.00103423561044741,0.0379819886909423,-0.0754789334446942,0.0734104622237994,0.978277337331089
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GAMT,Guanidinoacetate N-methyltransferase,34736,-0.000553376599920945,0.0216847162275278,-0.0430554204058754,0.0419486672060335,0.979641664311902
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNU13,NHP2-like protein 1,34736,0.00106698962120934,0.0421055145082289,-0.0814598188149194,0.0835937980573381,0.979783913052471
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CBLN4,Cerebellin-4,36032,-0.00047439590453299,0.0191028274770828,-0.0379159377596153,0.0369671459505493,0.980188193095709
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SKIV2L,Helicase SKI2W,34736,0.000596910459520559,0.0243163580972174,-0.0470631514110255,0.0482569723300666,0.980416540990476
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MPI,Mannose-6-phosphate isomerase,35937,-0.00125821351330433,0.0523198039829723,-0.10380502931993,0.101288602293321,0.980814565675594
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MANSC1,MANSC domain-containing protein 1,35991,-0.000401033341613168,0.0171045544738095,-0.0339259601102799,0.0331238934270535,0.981295147302439
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),RNASEH2A,Ribonuclease H2 subunit A,34952,0.000703475119898001,0.0316469033495878,-0.061324455445294,0.06273140568509,0.982266081025642
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ECSCR,Endothelial cell-specific chemotaxis regulator,34750,0.000710033934054855,0.0323593431425653,-0.0627142786253731,0.0641343464934828,0.982494804664337
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAT,Catalase,34881,-0.00075419165154644,0.0345985190781068,-0.0685672890446357,0.0670589057415428,0.982609479214509
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),BSND,Barttin,34739,-0.000449284274978168,0.0206861746722656,-0.0409941866326188,0.0400956180826625,0.982672765299397
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),A1BG,Alpha-1B-glycoprotein,34975,0.000224032146645082,0.0105498496511811,-0.0204536731696698,0.02090173746296,0.983058398768289
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IGDCC3,Immunoglobulin superfamily DCC subclass member 3,34750,0.000654053314118696,0.0308396748195154,-0.0597917093321314,0.0610998159603688,0.983080278635741
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ICAM2,Intercellular adhesion molecule 2,36072,-0.000419706023012893,0.0200365324660312,-0.039691309656434,0.0388518976104082,0.983288462617558
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OXT,Oxytocin-neurophysin 1,36043,0.00182859032206843,0.0889792507221295,-0.172570741093305,0.176227921737442,0.983604578959934
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HDGF,Hepatoma-derived growth factor,36016,-0.00104982086350011,0.056060154898887,-0.110927724465319,0.108828082738318,0.985059644189175
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),GGA1,ADP-ribosylation factor-binding protein GGA1,35782,-0.00076281351211594,0.041689748208958,-0.0824747200016737,0.0809490929774418,0.985402119197671
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PTTG1,Securin,34869,-0.000491815149148745,0.0271143030795384,-0.0536358491850441,0.0526522188867466,0.985528872151343
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,34736,-0.000451317414368576,0.0252994019414591,-0.0500381452196285,0.0491355103908913,0.985767828587209
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIAA0319,Dyslexia-associated protein KIAA0319,34958,-0.000326046405655818,0.0196532242059652,-0.0388463658493476,0.038194273038036,0.986764246551468
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MFGE8,Lactadherin,35979,-0.000447475236628419,0.0275697676410721,-0.0544842198131298,0.0535892693398729,0.987050822681659
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL3,Interleukin-3,34739,0.000622218032377452,0.0386248160627023,-0.075082421450519,0.0763268575152739,0.987147732448409
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),PNLIP,Pancreatic triacylglycerol lipase,34966,0.000586936063791585,0.0409856050031372,-0.0797448497423573,0.0809187218699404,0.988574700193418
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),HAO1,Hydroxyacid oxidase 1,36032,-0.000967771201781208,0.0755736015525405,-0.149092030244761,0.147156487841198,0.98978317025162
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),OMD,Osteomodulin,35992,-0.000316553072828986,0.0253027450825073,-0.0499099334345433,0.0492768272888854,0.990018566064969
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),IL1B,Interleukin-1 beta,35808,0.000439180318096439,0.035258700414812,-0.0686678724949351,0.069546233131128,0.990062198104215
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LMOD1,Leiomodin-1,34952,0.000266012030682166,0.0220767013978506,-0.0430043227091051,0.0435363467704694,0.990386543778565
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SHPK,Sedoheptulokinase,34869,0.000294410125708852,0.0251443709403756,-0.0489885569174274,0.0495773771688451,0.990658324326087
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),NT5C1A,Cytosolic 5'-nucleotidase 1A,34958,-0.000220191557574994,0.0197432696905039,-0.0389170001509627,0.0384766170358127,0.991101935165529
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),LAYN,Layilin,35896,-0.000239125654049347,0.0215237785358954,-0.0424257315844043,0.0419474802763056,0.9911361193222
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KEL,Kell blood group glycoprotein,35782,-0.000249047045347677,0.0224298914358949,-0.0442116342597017,0.0437135401690063,0.991141294964886
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,35800,0.000304329172934158,0.0274158614637349,-0.0534307592959863,0.0540394176418546,0.991143589248033
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,34949,-0.000517478512614383,0.0561166939240048,-0.110506198603664,0.109471241578435,0.992642723993454
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),AMY2B,Alpha-amylase 2B,35453,0.000257900549036014,0.0309650375430206,-0.0604335730352843,0.0609493741333564,0.993354925530887
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CCL8,C-C motif chemokine 8,36022,-0.000286862150261168,0.0368971996307339,-0.0726053734264996,0.0720316491259772,0.993797012576278
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),CD276,CD276 antigen,35949,-0.000135525646151277,0.021962792033613,-0.0431825980320328,0.0429115467397303,0.995076698093624
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),S100A3,Protein S100-A3,34949,0.000157526556095166,0.0267875693368009,-0.0523461093440347,0.052661162456225,0.995308184481928
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MFAP4,Microfibril-associated glycoprotein 4,34822,-0.000111411428916437,0.0203940293034125,-0.0400837088636049,0.039860886005772,0.995641398576256
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,35991,-0.000119239227647144,0.0227502859015692,-0.0447097995947227,0.0444713211394284,0.99581827298581
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),MUCL3,Mucin-like protein 3,34739,-7.76069872986148e-05,0.0262287529603207,-0.0514859627895273,0.05133074881493,0.997639277585273
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",34869,-9.59434839699515e-05,0.0424991759665747,-0.0833943283784563,0.0832024414105164,0.998198819034373
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SNCG,Gamma-synuclein,35902,8.65372122105152e-05,0.0408512144481484,-0.0799818431061604,0.0801549175305815,0.99830985954959
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),EPB41L5,Band 4.1-like protein 5,34805,-7.24478382622426e-05,0.0391017401683995,-0.0767118585683253,0.0765669628918008,0.998521737156326
Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,34949,3.90521293497604e-05,0.0458123426266798,-0.0897531394189427,0.0898312436776422,0.999319880656408
